data_2mxe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mxe _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.534 0.206 . . . . 1.0 111.013 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -104.11 119.12 38.26 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.33 1.452 . . . . 1.0 108.022 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.42 142.92 28.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -133.67 152.16 51.82 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.397 1.079 . . . . 1.0 109.267 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -133.87 143.33 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.546 1.538 . . . . 1.0 109.614 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -117.59 94.15 45.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.58 0.752 . . . . 1.0 111.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.97 -25.77 6.72 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.553 3.502 . . . . 1.0 116.525 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -71.37 -22.59 61.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.828 1.047 . . . . 1.0 113.828 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.2 p -129.38 -21.2 3.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.04 1.336 . . . . 1.0 113.774 -174.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.99 -6.7 82.62 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.584 1.564 . . . . 1.0 114.047 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -66.21 152.93 43.79 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.57 141.83 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 127.317 2.247 . . . . 1.0 108.876 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.5 pt -140.79 163.95 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.994 1.718 . . . . 1.0 110.737 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.64 136.89 34.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.412 1.885 . . . . 1.0 111.15 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.92 158.46 43.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.636 1.574 . . . . 1.0 110.812 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.26 -4.56 58.55 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.935 -1.103 . . . . 1.0 113.507 170.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.57 3.75 16.15 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.021 1.296 . . . . 1.0 114.667 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.61 179.52 43.65 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.441 1.121 . . . . 1.0 114.107 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.69 83.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.066 1.346 . . . . 1.0 112.391 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -108.03 94.32 5.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.961 1.704 . . . . 1.0 109.862 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -39.21 -46.15 1.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 127.453 2.301 . . . . 1.0 115.445 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 m -60.59 -39.07 86.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.435 1.094 . . . . 1.0 113.155 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.0 tp -69.14 -46.42 67.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.674 -0.641 . . . . 1.0 109.459 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.15 -43.3 78.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.245 0.618 . . . . 1.0 111.846 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -60.38 -43.53 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -64.36 -43.01 95.88 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.062 -0.398 . . . . 1.0 111.917 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -62.09 -39.83 93.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.073 0.949 . . . . 1.0 110.596 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.17 -36.18 77.1 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.709 0.804 . . . . 1.0 113.008 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -97.19 -17.34 19.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -130.95 -3.78 4.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.767 1.395 . . . . 1.0 114.767 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.99 131.25 7.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.371 1.462 . . . . 1.0 112.014 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.92 -34.39 81.63 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.617 2.211 . . . . 1.0 113.442 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.3 -40.22 86.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.988 0.813 . . . . 1.0 111.957 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.66 78.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.362 0.665 . . . . 1.0 110.94 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.66 -39.24 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.362 0.665 . . . . 1.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.41 -26.2 67.12 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.232 -1.543 . . . . 1.0 111.977 171.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 t -69.38 -27.53 65.39 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.212 -0.93 . . . . 1.0 112.167 169.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -71.09 -17.45 62.58 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.011 -1.056 . . . . 1.0 112.73 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.53 52.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.44 0.904 . . . . 1.0 113.44 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.42 120.66 14.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 1.0 110.732 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 mt -76.0 118.02 18.32 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.54 1.136 . . . . 1.0 110.48 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 124.635 1.174 . . . . 1.0 112.405 -177.687 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.322 0.106 . . . . 1.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.27 119.91 38.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.501 1.521 . . . . 1.0 108.796 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -83.56 148.23 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.112 1.365 . . . . 1.0 107.642 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -135.04 150.38 50.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.571 1.148 . . . . 1.0 109.214 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -132.68 143.6 49.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.467 1.507 . . . . 1.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -118.72 91.39 42.23 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.001 0.92 . . . . 1.0 111.104 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.33 -27.47 13.44 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.987 3.125 . . . . 1.0 116.277 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -75.98 -16.54 59.96 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.368 1.067 . . . . 1.0 113.868 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.6 p -128.73 -20.9 3.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.809 1.244 . . . . 1.0 113.828 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.49 -6.82 82.14 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.624 1.583 . . . . 1.0 114.209 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.59 154.66 41.67 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.205 1.557 . . . . 1.0 115.205 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.47 141.61 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.065 2.146 . . . . 1.0 109.107 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.1 pt -141.33 165.61 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.157 1.783 . . . . 1.0 110.759 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -138.0 140.2 40.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.873 2.069 . . . . 1.0 110.866 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.21 161.39 42.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.519 1.528 . . . . 1.0 110.853 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -90.24 -1.91 57.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.903 1.281 . . . . 1.0 113.233 171.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.05 3.88 22.83 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.035 1.303 . . . . 1.0 114.717 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.51 179.27 43.73 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.398 1.099 . . . . 1.0 114.144 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -66.72 83.7 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.879 1.272 . . . . 1.0 112.337 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -104.81 94.01 5.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.74 1.616 . . . . 1.0 109.803 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -42.17 -43.85 3.49 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.831 2.052 . . . . 1.0 115.452 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -59.93 -37.43 79.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.089 0.956 . . . . 1.0 113.205 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.8 -44.85 65.75 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.652 -0.655 . . . . 1.0 109.948 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -57.16 -42.31 80.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.48 0.712 . . . . 1.0 112.096 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -56.93 -44.72 82.78 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.982 0.513 . . . . 1.0 112.329 172.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -65.93 -40.94 91.87 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.917 -0.49 . . . . 1.0 112.118 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.26 -40.32 93.65 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.937 0.79 . . . . 1.0 110.689 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.93 77.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.981 0.912 . . . . 1.0 113.083 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -98.1 -17.68 18.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -132.37 -5.71 3.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.76 132.65 7.63 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.396 1.474 . . . . 1.0 112.613 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.9 -35.51 66.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.406 2.071 . . . . 1.0 113.409 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.24 -40.54 81.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.753 0.706 . . . . 1.0 111.875 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.34 73.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.356 0.662 . . . . 1.0 110.903 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.18 -39.84 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.351 0.66 . . . . 1.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.35 -26.2 67.17 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.411 -1.431 . . . . 1.0 112.204 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.9 t -72.68 -25.36 61.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.672 -0.643 . . . . 1.0 112.645 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -70.55 -16.59 62.89 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.98 -1.075 . . . . 1.0 112.989 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.97 54.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.676 0.991 . . . . 1.0 113.676 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.19 118.69 12.94 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.211 1.805 . . . . 1.0 110.976 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.5 mt -63.72 133.1 52.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.818 0.847 . . . . 1.0 110.711 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.289 1.036 . . . . 1.0 111.953 177.329 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.3 t . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.29 0.091 . . . . 1.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -113.86 122.96 48.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.926 1.69 . . . . 1.0 109.094 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.59 147.54 25.88 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.564 1.546 . . . . 1.0 107.819 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -135.15 149.14 49.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.811 1.244 . . . . 1.0 109.165 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.76 139.02 48.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.967 1.307 . . . . 1.0 109.868 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -115.49 90.02 24.17 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.414 1.085 . . . . 1.0 110.783 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -12.24 24.42 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.333 2.689 . . . . 1.0 115.336 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -65.41 -27.75 68.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.01 0.924 . . . . 1.0 113.245 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.1 p -127.38 -20.43 4.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.045 1.338 . . . . 1.0 113.713 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.85 -1.34 74.55 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.258 1.409 . . . . 1.0 113.628 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.25 152.91 32.17 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.256 1.576 . . . . 1.0 115.256 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.35 142.55 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.82 2.048 . . . . 1.0 109.635 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -141.02 165.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.965 1.706 . . . . 1.0 110.528 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.11 141.06 42.31 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.554 1.942 . . . . 1.0 110.91 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.19 160.99 43.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 1.0 110.805 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.33 -0.13 57.24 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.446 1.099 . . . . 1.0 113.491 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.51 4.09 26.93 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.167 1.365 . . . . 1.0 114.774 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.94 179.64 47.1 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.387 1.094 . . . . 1.0 113.598 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.62 83.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.813 1.245 . . . . 1.0 112.129 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -102.05 94.05 5.56 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.429 1.492 . . . . 1.0 109.986 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.5 -41.89 3.12 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.571 2.348 . . . . 1.0 115.307 -169.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 m -59.96 -39.05 84.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.99 0.916 . . . . 1.0 113.338 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 tp -70.43 -42.74 71.17 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.531 0.732 . . . . 1.0 109.609 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.18 -43.05 78.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.538 0.735 . . . . 1.0 112.341 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.66 -46.37 84.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -62.49 -41.6 98.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.784 -0.572 . . . . 1.0 112.186 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.6 -41.1 96.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 1.0 110.692 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.93 78.95 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 1.0 112.884 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -83.17 -32.31 26.67 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.593 1.331 . . . . 1.0 114.593 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -129.25 -4.1 4.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.253 1.575 . . . . 1.0 115.253 -173.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 130.22 6.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.286 1.422 . . . . 1.0 111.921 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.83 -35.52 78.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.649 2.232 . . . . 1.0 113.525 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.1 -40.25 82.65 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.567 0.622 . . . . 1.0 111.948 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.3 -48.98 73.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 1.0 111.207 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.2 -40.18 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.917 -0.49 . . . . 1.0 112.166 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.06 -25.14 66.9 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.294 -1.504 . . . . 1.0 112.165 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -73.18 -25.71 60.89 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.607 -0.683 . . . . 1.0 112.709 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -69.87 -16.46 63.25 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.97 -1.081 . . . . 1.0 112.877 171.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.19 144.96 56.46 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.77 1.026 . . . . 1.0 113.77 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.06 117.85 12.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.212 1.805 . . . . 1.0 110.707 170.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -63.74 131.31 47.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.032 0.933 . . . . 1.0 110.54 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 122.102 0.953 . . . . 1.0 111.746 178.119 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 110.545 -0.169 . . . . 1.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.86 120.44 41.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.404 1.482 . . . . 1.0 108.659 168.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -86.5 146.6 26.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.64 151.62 50.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.815 1.246 . . . . 1.0 108.983 175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -132.02 144.71 50.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.273 1.429 . . . . 1.0 109.87 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -119.52 92.86 46.67 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.071 0.948 . . . . 1.0 112.246 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.63 -25.1 3.28 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.811 3.674 . . . . 1.0 117.091 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -67.09 -27.06 67.04 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.5 p -130.1 -17.5 3.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.929 1.291 . . . . 1.0 114.126 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.62 85.7 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.985 1.279 . . . . 1.0 113.896 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.14 154.6 30.6 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.228 1.566 . . . . 1.0 115.228 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 142.04 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.857 2.063 . . . . 1.0 109.565 171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 pt -140.63 164.04 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.237 1.815 . . . . 1.0 110.656 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -140.23 137.41 34.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.055 1.742 . . . . 1.0 111.579 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.44 158.65 43.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.38 1.472 . . . . 1.0 111.166 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -83.32 -2.7 56.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.19 0.996 . . . . 1.0 113.515 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.26 25.91 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.082 1.325 . . . . 1.0 114.53 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.88 179.52 41.32 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.564 1.078 . . . . 1.0 113.805 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.6 83.79 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.132 1.373 . . . . 1.0 112.025 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -107.56 94.0 4.85 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.793 1.637 . . . . 1.0 109.865 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -41.36 -44.02 2.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.007 2.123 . . . . 1.0 115.24 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -60.82 -39.65 89.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.895 0.878 . . . . 1.0 113.23 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.93 -44.82 72.3 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.618 -0.676 . . . . 1.0 109.743 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -56.5 -43.12 79.43 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.384 0.674 . . . . 1.0 111.923 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.69 -48.38 79.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 122.662 0.385 . . . . 1.0 111.875 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.03 -43.71 98.49 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.818 -0.551 . . . . 1.0 112.211 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -62.53 -41.09 98.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 1.0 110.709 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.34 80.72 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -81.41 -32.9 32.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -129.66 -0.6 4.89 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -172.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.29 128.17 6.15 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.51 1.529 . . . . 1.0 112.113 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.88 -34.45 91.18 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.744 2.296 . . . . 1.0 113.213 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.27 -42.46 88.42 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.859 0.754 . . . . 1.0 111.646 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.49 80.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.406 0.683 . . . . 1.0 111.163 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.33 -36.4 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 1.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -66.89 -28.75 68.58 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.259 -1.525 . . . . 1.0 111.995 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.6 m -68.75 -23.77 64.36 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.138 -0.977 . . . . 1.0 112.216 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -72.9 -15.41 61.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.329 0.968 . . . . 1.0 112.442 169.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.47 148.13 47.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 119.17 12.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.587 1.955 . . . . 1.0 110.931 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.26 129.42 38.39 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.204 1.002 . . . . 1.0 110.625 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 124.328 1.051 . . . . 1.0 112.829 -178.768 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -113.3 121.26 43.86 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.685 1.594 . . . . 1.0 108.54 169.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -86.98 147.0 25.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.95 147.87 49.88 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.117 1.367 . . . . 1.0 109.018 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -129.99 137.49 50.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.075 1.35 . . . . 1.0 109.995 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -111.12 91.64 13.68 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.103 0.961 . . . . 1.0 110.543 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.22 -14.35 37.67 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.824 2.349 . . . . 1.0 114.896 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -69.78 -23.62 63.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.665 1.186 . . . . 1.0 113.562 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -127.93 -21.77 3.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.075 1.35 . . . . 1.0 113.619 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.27 -4.95 74.56 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.607 1.575 . . . . 1.0 113.873 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -66.03 153.18 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.71 141.59 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 126.914 2.086 . . . . 1.0 109.219 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -140.93 163.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.913 1.685 . . . . 1.0 110.65 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -139.18 138.54 37.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.155 1.782 . . . . 1.0 111.305 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.41 159.6 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.399 1.48 . . . . 1.0 110.876 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -87.24 -1.88 58.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.551 1.14 . . . . 1.0 113.517 171.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.75 5.49 18.15 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.151 1.358 . . . . 1.0 115.004 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.54 179.23 43.88 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.443 1.122 . . . . 1.0 114.205 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.79 83.87 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.344 1.458 . . . . 1.0 112.13 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -106.2 94.01 4.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.421 1.489 . . . . 1.0 110.215 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -37.56 -47.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.11 2.564 . . . . 1.0 115.463 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -61.49 -38.29 86.74 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.133 0.973 . . . . 1.0 113.039 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 tp -70.01 -44.41 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.675 -0.641 . . . . 1.0 109.616 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.3 -43.12 78.6 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.407 0.683 . . . . 1.0 112.203 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -58.71 -42.95 89.85 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -65.22 -41.51 94.37 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.879 0.326 . . . . 1.0 111.879 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.52 -40.01 93.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.662 0.785 . . . . 1.0 110.558 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.87 -36.0 77.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.074 0.949 . . . . 1.0 113.163 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.78 -17.62 19.25 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -131.37 -6.41 3.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.63 132.08 7.45 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.506 1.527 . . . . 1.0 112.2 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.07 -36.42 70.59 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.926 2.417 . . . . 1.0 113.447 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.78 -39.96 84.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.639 0.654 . . . . 1.0 111.9 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.91 74.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.268 0.627 . . . . 1.0 110.993 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.62 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.187 0.595 . . . . 1.0 112.17 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -66.6 -24.22 66.29 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.475 -1.39 . . . . 1.0 112.044 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -74.82 -23.63 58.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.528 -0.733 . . . . 1.0 112.718 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -71.33 -17.27 62.45 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.143 -0.973 . . . . 1.0 112.897 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.98 145.34 55.58 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.966 1.098 . . . . 1.0 113.966 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.42 117.96 12.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.116 1.766 . . . . 1.0 110.885 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.16 133.17 53.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.023 0.929 . . . . 1.0 110.777 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.011 0.924 . . . . 1.0 111.382 176.643 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.82 -0.067 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.58 116.0 31.72 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.086 1.355 . . . . 1.0 108.219 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -84.07 146.33 27.98 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.955 1.302 . . . . 1.0 107.533 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.6 150.47 50.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.828 1.251 . . . . 1.0 109.354 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 139.71 48.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.356 1.462 . . . . 1.0 110.022 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -116.13 89.65 26.12 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.71 1.204 . . . . 1.0 111.015 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 -12.12 23.07 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.179 2.586 . . . . 1.0 115.422 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -65.0 -28.09 69.28 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.0 p -127.71 -19.45 4.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.179 1.392 . . . . 1.0 113.963 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.45 -1.97 77.03 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.235 1.398 . . . . 1.0 113.631 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.02 152.76 31.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.236 1.569 . . . . 1.0 115.236 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 t -136.58 141.62 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.953 . . . . 1.0 109.466 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.9 pt -140.84 165.87 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.017 1.727 . . . . 1.0 110.727 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -139.31 139.18 37.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.617 1.967 . . . . 1.0 110.851 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.21 158.0 43.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.344 1.458 . . . . 1.0 110.659 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.96 -3.02 59.05 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.215 1.006 . . . . 1.0 113.514 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.54 2.62 14.92 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.813 1.197 . . . . 1.0 115.288 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.11 179.05 42.86 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.468 1.134 . . . . 1.0 113.829 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -66.57 83.79 0.1 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.086 1.355 . . . . 1.0 111.991 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -99.46 94.3 6.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.328 1.451 . . . . 1.0 110.249 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -39.84 -45.64 1.83 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 128.095 2.558 . . . . 1.0 115.118 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.8 m -60.55 -39.98 89.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.222 1.009 . . . . 1.0 113.576 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.1 tp -68.67 -42.39 77.94 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.546 -0.721 . . . . 1.0 109.918 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.07 -43.6 78.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 1.0 112.282 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.7 -45.38 85.77 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.16 -41.68 98.54 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.598 -0.689 . . . . 1.0 112.115 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -61.88 -40.91 97.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.414 1.086 . . . . 1.0 110.854 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 -38.17 79.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.481 0.713 . . . . 1.0 112.846 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.01 -33.08 30.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -129.78 -3.22 4.69 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -171.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.09 129.66 6.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.448 1.499 . . . . 1.0 112.335 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.93 -35.21 78.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.544 2.163 . . . . 1.0 113.569 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.61 -39.8 80.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.73 0.696 . . . . 1.0 112.2 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.14 -49.47 72.01 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.24 0.616 . . . . 1.0 110.805 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.4 -41.55 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.297 0.639 . . . . 1.0 112.072 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.525 -1.36 . . . . 1.0 112.269 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -75.94 -21.48 56.98 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.572 -0.705 . . . . 1.0 112.897 169.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -72.85 -16.37 61.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.548 1.067 . . . . 1.0 112.871 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.6 144.13 56.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.684 0.994 . . . . 1.0 113.684 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.09 118.45 12.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.296 1.838 . . . . 1.0 110.809 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 mt -71.23 116.47 11.58 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.514 1.126 . . . . 1.0 110.375 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 123.587 0.755 . . . . 1.0 111.487 176.358 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.9 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.3 0.095 . . . . 1.0 110.833 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -111.22 120.55 42.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.47 1.508 . . . . 1.0 108.647 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.8 148.73 25.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.654 -1.239 . . . . 1.0 107.654 169.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -136.67 149.82 48.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.098 1.359 . . . . 1.0 108.851 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -131.59 144.23 50.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.357 1.463 . . . . 1.0 109.95 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.89 91.75 47.85 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.147 0.979 . . . . 1.0 111.763 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.5 -25.99 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.835 3.69 . . . . 1.0 116.976 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.42 -27.07 67.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -129.51 -17.62 3.68 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.776 1.23 . . . . 1.0 113.935 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.24 0.14 85.24 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.033 1.301 . . . . 1.0 113.826 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.19 154.72 30.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.29 1.589 . . . . 1.0 115.29 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.55 141.23 41.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 126.852 2.061 . . . . 1.0 109.405 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -139.91 163.58 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.955 1.702 . . . . 1.0 110.674 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -139.93 137.89 35.15 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.105 1.762 . . . . 1.0 111.348 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 157.78 43.03 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.187 1.395 . . . . 1.0 111.014 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.61 -4.54 58.66 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.263 1.025 . . . . 1.0 113.442 171.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.41 1.91 19.9 Favored Glycine 0 N--CA 1.478 1.438 0 C-N-CA 125.053 1.311 . . . . 1.0 114.806 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.78 179.13 38.47 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 118.576 1.188 . . . . 1.0 113.807 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -67.42 83.87 0.16 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.737 1.215 . . . . 1.0 112.186 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.06 94.03 5.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.489 1.516 . . . . 1.0 109.903 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.33 -42.47 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.664 1.986 . . . . 1.0 115.664 -169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -59.07 -39.23 81.47 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.095 0.958 . . . . 1.0 113.013 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.96 -44.82 68.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.428 0.691 . . . . 1.0 109.777 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -56.4 -43.44 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.485 0.714 . . . . 1.0 112.156 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.63 -46.62 83.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.587 0.355 . . . . 1.0 111.877 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -62.18 -41.92 98.79 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.549 -0.719 . . . . 1.0 111.937 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.39 -41.07 96.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.966 0.906 . . . . 1.0 110.778 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.22 -38.7 78.67 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.555 0.742 . . . . 1.0 112.736 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -81.38 -32.65 32.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.94 -2.31 4.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.73 128.82 6.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.125 1.345 . . . . 1.0 112.358 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.66 -35.32 81.16 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.659 2.24 . . . . 1.0 113.513 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.7 -39.53 80.47 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.867 0.758 . . . . 1.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.05 72.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.147 0.579 . . . . 1.0 110.869 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.77 -40.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.702 -0.623 . . . . 1.0 112.176 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.43 -24.79 66.5 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.364 -1.46 . . . . 1.0 112.207 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -74.7 -21.44 59.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.561 -0.712 . . . . 1.0 112.9 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -72.95 -16.5 61.53 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.428 1.013 . . . . 1.0 112.96 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.7 145.66 55.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.39 118.06 12.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.432 1.893 . . . . 1.0 111.197 170.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 mt -63.88 131.09 46.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.174 0.99 . . . . 1.0 110.543 172.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 123.659 0.783 . . . . 1.0 111.479 175.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.481 0.181 . . . . 1.0 111.124 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -104.02 118.45 36.69 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.293 1.437 . . . . 1.0 107.854 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -85.86 145.46 27.18 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.102 1.361 . . . . 1.0 107.37 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -136.62 152.66 50.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.586 1.154 . . . . 1.0 109.565 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -133.31 144.74 49.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.406 1.483 . . . . 1.0 109.727 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -121.37 91.49 48.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.191 0.996 . . . . 1.0 111.749 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.4 -25.52 5.04 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.752 3.635 . . . . 1.0 116.898 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -65.34 -26.82 68.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 p -129.96 -17.2 3.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.952 1.301 . . . . 1.0 113.952 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.54 86.79 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.982 1.277 . . . . 1.0 114.064 -173.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.33 154.82 34.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.03 140.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.915 2.086 . . . . 1.0 109.452 172.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -141.99 164.42 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.98 1.712 . . . . 1.0 110.89 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.13 138.02 34.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.389 1.876 . . . . 1.0 110.878 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.4 156.9 41.64 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.46 1.504 . . . . 1.0 111.025 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -84.73 -2.87 58.19 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.504 1.121 . . . . 1.0 113.663 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.65 2.28 19.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.863 1.22 . . . . 1.0 114.985 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 179.35 42.16 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.292 1.046 . . . . 1.0 113.877 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.6 83.79 0.18 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.784 1.234 . . . . 1.0 112.011 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -102.51 94.12 5.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.568 1.547 . . . . 1.0 109.858 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -39.83 -45.5 1.8 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.434 2.293 . . . . 1.0 115.429 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.1 m -60.38 -39.45 87.31 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.203 1.001 . . . . 1.0 113.015 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -69.92 -43.67 71.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.348 -0.845 . . . . 1.0 109.869 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -56.36 -43.52 79.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.377 0.671 . . . . 1.0 111.952 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -58.45 -47.46 83.92 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.015 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -60.6 -42.35 96.62 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.769 -0.582 . . . . 1.0 112.109 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.69 -40.24 96.49 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 1.0 110.782 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.39 -39.25 78.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.803 0.841 . . . . 1.0 112.971 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.58 -32.73 42.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.818 1.247 . . . . 1.0 114.133 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.2 -4.31 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.87 130.72 7.12 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.405 1.478 . . . . 1.0 111.764 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.55 -34.75 84.54 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.73 2.287 . . . . 1.0 113.424 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.456 0.703 . . . . 1.0 111.951 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.61 77.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.268 0.627 . . . . 1.0 111.005 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.74 -39.86 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.8 -0.563 . . . . 1.0 112.208 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -66.72 -27.12 67.37 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.23 -1.544 . . . . 1.0 112.178 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 t -67.96 -27.07 66.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.12 -0.988 . . . . 1.0 112.277 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.7 m0 -72.33 -15.72 61.88 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.0 -1.062 . . . . 1.0 113.115 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.68 145.92 55.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.5 0.926 . . . . 1.0 113.5 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.48 117.48 11.76 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.267 1.827 . . . . 1.0 110.443 170.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.89 118.25 13.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.471 1.109 . . . . 1.0 110.345 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 CA--C 1.543 0.689 0 C-N-CA 123.388 0.675 . . . . 1.0 112.086 178.132 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 110.704 -0.11 . . . . 1.0 110.704 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -102.86 117.94 35.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.575 1.15 . . . . 1.0 108.554 168.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -86.63 145.64 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.223 1.409 . . . . 1.0 107.611 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -136.4 151.85 49.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.59 1.156 . . . . 1.0 109.91 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -132.83 137.82 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.279 1.432 . . . . 1.0 109.596 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -111.65 92.47 17.08 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.83 0.852 . . . . 1.0 110.586 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.75 -14.19 38.87 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.996 2.464 . . . . 1.0 114.782 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -70.32 -22.63 62.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.592 1.157 . . . . 1.0 113.55 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.2 p -127.58 -23.16 3.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.242 1.417 . . . . 1.0 113.449 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.28 -6.4 71.84 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.829 1.68 . . . . 1.0 113.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -66.93 152.79 45.03 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.164 1.542 . . . . 1.0 115.164 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.8 t -134.09 140.39 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.96 2.104 . . . . 1.0 109.191 171.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 pt -140.94 164.56 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.756 1.622 . . . . 1.0 110.766 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -139.72 137.47 35.17 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.551 1.94 . . . . 1.0 110.884 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.59 158.49 43.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.933 1.293 . . . . 1.0 111.323 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -86.43 -2.83 58.78 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.389 1.076 . . . . 1.0 113.188 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.44 3.19 19.11 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.098 1.333 . . . . 1.0 115.015 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.2 179.21 42.86 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.569 1.184 . . . . 1.0 113.907 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -67.4 83.76 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.03 1.332 . . . . 1.0 112.055 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -104.67 94.38 5.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.704 1.602 . . . . 1.0 109.865 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -41.5 -43.2 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.832 2.053 . . . . 1.0 115.547 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -60.19 -37.82 81.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.044 0.938 . . . . 1.0 113.096 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -71.64 -44.25 64.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.273 0.629 . . . . 1.0 109.604 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -56.8 -43.14 80.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.436 0.694 . . . . 1.0 112.06 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -57.28 -44.78 84.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 172.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.18 -41.36 90.37 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.069 -0.394 . . . . 1.0 112.052 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -62.12 -38.73 90.04 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.986 0.812 . . . . 1.0 110.703 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.16 75.8 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.755 0.822 . . . . 1.0 112.916 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -98.4 -16.1 19.41 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.972 1.842 . . . . 1.0 115.972 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -130.84 -8.24 3.98 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.761 1.393 . . . . 1.0 114.761 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.36 134.25 8.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.379 1.466 . . . . 1.0 112.161 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.42 -35.88 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.605 2.203 . . . . 1.0 113.228 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -39.56 86.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.553 0.741 . . . . 1.0 111.693 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.54 78.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.398 0.679 . . . . 1.0 111.453 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.7 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.945 -0.472 . . . . 1.0 112.205 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -65.86 -27.15 68.01 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.514 -1.366 . . . . 1.0 112.239 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -68.64 -27.57 66.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.958 0.799 . . . . 1.0 112.394 170.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -72.15 -15.92 61.98 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.054 -1.029 . . . . 1.0 112.85 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.08 147.28 53.59 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.19 120.36 14.71 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.293 1.837 . . . . 1.0 110.761 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.15 116.0 15.4 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.647 1.179 . . . . 1.0 110.295 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 123.33 0.652 . . . . 1.0 111.815 178.723 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 111.05 0.018 . . . . 1.0 111.05 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -106.42 119.82 40.26 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.45 1.5 . . . . 1.0 107.829 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -86.35 145.29 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.164 1.386 . . . . 1.0 107.279 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -136.2 152.09 50.4 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.737 1.215 . . . . 1.0 109.698 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -133.92 144.5 48.87 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.599 1.56 . . . . 1.0 109.435 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.67 93.94 44.74 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.763 0.825 . . . . 1.0 111.453 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.21 -26.09 7.7 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.476 3.451 . . . . 1.0 116.441 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -72.07 -21.96 61.43 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.987 1.106 . . . . 1.0 113.987 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -128.91 -21.75 3.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.095 1.358 . . . . 1.0 113.545 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.21 -6.74 82.42 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.544 1.545 . . . . 1.0 113.797 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.25 152.65 45.35 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.874 1.435 . . . . 1.0 114.874 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.05 139.97 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 127.07 2.148 . . . . 1.0 109.177 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -141.7 164.42 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.017 1.727 . . . . 1.0 110.832 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -140.51 136.06 32.53 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.326 1.851 . . . . 1.0 110.872 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.71 157.3 41.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.872 1.269 . . . . 1.0 111.173 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.96 -4.78 58.64 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.929 -1.107 . . . . 1.0 113.711 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.65 2.43 17.1 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.841 1.21 . . . . 1.0 114.925 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.87 179.12 38.8 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 118.415 1.107 . . . . 1.0 113.803 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -68.13 83.74 0.23 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.585 1.154 . . . . 1.0 112.127 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -102.87 94.92 5.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.616 1.566 . . . . 1.0 109.771 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -41.57 -43.18 2.64 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 126.784 2.034 . . . . 1.0 115.699 -170.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -37.97 79.39 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.229 1.011 . . . . 1.0 113.269 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -44.14 63.89 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.353 0.661 . . . . 1.0 109.764 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.09 -43.4 78.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.484 0.714 . . . . 1.0 111.871 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.97 -44.56 87.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.47 -40.92 89.63 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.985 -0.447 . . . . 1.0 112.015 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -62.73 -38.75 91.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.048 0.84 . . . . 1.0 110.388 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -36.3 75.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 1.0 113.169 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.1 -16.77 19.42 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.843 1.794 . . . . 1.0 115.843 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -130.72 -9.16 4.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 134.18 8.07 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.436 1.493 . . . . 1.0 111.98 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 -34.68 71.87 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.522 2.148 . . . . 1.0 113.098 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.74 -39.84 84.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.62 0.768 . . . . 1.0 111.913 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.87 80.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 1.0 111.108 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.96 -41.03 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.731 -0.605 . . . . 1.0 112.126 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.6 -30.04 71.21 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.45 -1.406 . . . . 1.0 112.123 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 t -67.99 -27.54 66.66 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.343 -0.848 . . . . 1.0 112.523 171.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -72.74 -15.44 61.66 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.15 -0.969 . . . . 1.0 113.065 170.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.04 147.53 53.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.692 0.997 . . . . 1.0 113.692 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.08 116.64 11.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.297 1.839 . . . . 1.0 110.323 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.23 132.04 46.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.962 0.905 . . . . 1.0 110.347 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 CA--C 1.547 0.852 0 CA-C-O 121.959 0.885 . . . . 1.0 112.293 178.01 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -104.74 119.21 38.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.918 1.287 . . . . 1.0 108.657 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -86.45 145.89 26.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.221 -1.4 . . . . 1.0 107.221 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -135.9 152.5 51.07 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.615 1.166 . . . . 1.0 109.61 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -133.05 144.97 50.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.412 1.485 . . . . 1.0 109.184 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -118.03 92.12 41.48 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.179 0.992 . . . . 1.0 110.946 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.34 -27.16 12.87 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.307 3.338 . . . . 1.0 116.077 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.04 -15.71 59.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 p -128.91 -22.51 3.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.931 1.292 . . . . 1.0 113.802 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.49 80.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.928 1.727 . . . . 1.0 114.171 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.09 154.5 41.85 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.143 1.535 . . . . 1.0 115.143 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.26 140.16 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.326 2.25 . . . . 1.0 109.205 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -142.67 165.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.036 1.734 . . . . 1.0 110.994 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -138.87 138.92 37.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.74 2.016 . . . . 1.0 111.002 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.29 158.44 43.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.463 1.505 . . . . 1.0 110.977 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.52 -3.21 58.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.275 1.03 . . . . 1.0 113.545 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.94 4.32 22.76 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.091 1.329 . . . . 1.0 114.866 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 179.32 38.66 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.277 1.039 . . . . 1.0 113.789 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -65.45 83.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.222 1.409 . . . . 1.0 112.212 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -103.08 94.04 5.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.574 1.549 . . . . 1.0 110.341 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -39.77 -45.53 1.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 128.093 2.557 . . . . 1.0 115.441 -171.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.4 m -61.21 -39.87 91.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.172 0.989 . . . . 1.0 113.425 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.96 -42.66 72.88 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.643 -0.661 . . . . 1.0 109.772 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.43 -44.11 75.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.456 0.703 . . . . 1.0 112.181 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -57.66 -44.16 85.48 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -65.2 -41.46 94.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.003 -0.435 . . . . 1.0 112.028 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -62.46 -39.03 92.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.887 0.875 . . . . 1.0 110.463 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.98 76.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.037 0.935 . . . . 1.0 113.124 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -98.07 -18.11 18.73 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.853 1.797 . . . . 1.0 115.853 -171.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -129.4 -8.11 4.7 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.61 134.16 8.28 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.467 1.508 . . . . 1.0 111.937 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.85 -34.3 72.64 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.5 2.133 . . . . 1.0 113.065 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.08 -39.49 82.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.51 0.724 . . . . 1.0 112.072 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.97 76.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.458 0.703 . . . . 1.0 110.973 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.54 -41.2 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.126 0.57 . . . . 1.0 112.305 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.98 -28.26 68.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.437 -1.414 . . . . 1.0 112.241 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 m -68.91 -22.83 64.14 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 30.0 m0 -76.73 -14.19 59.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.009 0.923 . . . . 1.0 112.975 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.08 147.86 51.76 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.21 0.914 . . . . 1.0 113.362 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -139.11 117.65 12.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.57 1.948 . . . . 1.0 110.687 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -71.19 123.99 23.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.479 1.112 . . . . 1.0 110.782 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 124.165 0.986 . . . . 1.0 112.556 -178.142 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 110.39 -0.226 . . . . 1.0 110.39 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -100.65 115.52 30.42 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.375 1.07 . . . . 1.0 108.841 168.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.15 145.87 28.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 1.0 107.539 169.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -133.76 149.82 51.46 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.754 1.222 . . . . 1.0 109.074 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -130.97 144.39 51.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.517 1.527 . . . . 1.0 109.306 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -118.34 92.61 43.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.873 . . . . 1.0 111.62 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.57 -26.34 8.96 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.299 3.333 . . . . 1.0 116.78 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -18.19 57.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.02 1.118 . . . . 1.0 114.02 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -130.83 -21.22 2.75 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.08 81.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.814 1.673 . . . . 1.0 114.154 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.3 156.44 37.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.326 1.602 . . . . 1.0 115.326 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.39 140.77 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 127.141 2.176 . . . . 1.0 109.109 169.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.7 pt -140.19 166.24 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.861 1.664 . . . . 1.0 110.612 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -140.06 138.45 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.58 1.952 . . . . 1.0 111.072 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.24 159.27 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.374 1.469 . . . . 1.0 110.966 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -86.67 -2.65 58.7 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.035 -1.041 . . . . 1.0 113.314 171.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.74 4.57 22.92 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.183 1.373 . . . . 1.0 114.945 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.07 179.18 45.59 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.327 1.063 . . . . 1.0 113.871 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.18 83.99 0.09 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.987 1.315 . . . . 1.0 112.143 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -105.3 94.08 5.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.687 1.595 . . . . 1.0 109.812 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -42.01 -43.77 3.29 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.763 2.025 . . . . 1.0 115.47 -169.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -59.23 -39.16 81.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.055 0.942 . . . . 1.0 112.945 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.21 -44.69 71.57 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.682 -0.636 . . . . 1.0 109.851 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -57.07 -42.81 81.3 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.636 0.774 . . . . 1.0 112.168 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -57.73 -45.87 85.21 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.082 0.401 . . . . 1.0 112.082 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -62.4 -41.7 98.87 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.725 -0.609 . . . . 1.0 112.133 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.33 -41.42 96.98 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.009 0.924 . . . . 1.0 110.806 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.81 78.15 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.031 0.752 . . . . 1.0 113.031 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.05 -33.19 30.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.449 1.278 . . . . 1.0 114.449 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.19 -2.95 4.47 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.363 1.616 . . . . 1.0 115.363 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.38 129.23 6.56 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.433 1.492 . . . . 1.0 112.477 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.92 -35.59 76.86 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.78 2.32 . . . . 1.0 113.564 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -39.75 80.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.843 0.747 . . . . 1.0 112.18 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.21 -49.57 71.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.228 0.611 . . . . 1.0 110.816 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -40.63 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.317 0.647 . . . . 1.0 112.146 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.1 -25.38 66.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.494 -1.379 . . . . 1.0 112.178 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -74.72 -21.25 59.47 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 169.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -73.41 -16.5 61.33 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.38 0.991 . . . . 1.0 113.118 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.22 144.39 56.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.6 p -139.02 121.14 15.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.482 1.913 . . . . 1.0 110.923 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.67 115.13 12.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.542 1.137 . . . . 1.0 110.642 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 123.32 0.648 . . . . 1.0 111.895 176.383 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 111.5 0.185 . . . . 1.0 111.5 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -99.64 115.6 29.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.702 1.201 . . . . 1.0 108.04 168.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -84.91 145.78 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.127 1.371 . . . . 1.0 107.471 168.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -136.69 153.59 50.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.617 1.167 . . . . 1.0 109.583 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -133.61 144.68 49.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.397 1.479 . . . . 1.0 109.837 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.73 91.8 47.54 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.245 1.018 . . . . 1.0 111.817 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.06 -25.65 4.35 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.797 3.665 . . . . 1.0 117.079 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -65.49 -27.3 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -129.85 -17.85 3.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.956 1.303 . . . . 1.0 113.895 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.87 0.5 85.73 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.031 1.3 . . . . 1.0 113.906 -173.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.64 154.39 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.81 140.78 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.827 2.051 . . . . 1.0 109.478 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.1 pt -142.49 165.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.979 1.712 . . . . 1.0 110.968 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.85 138.87 36.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.61 1.964 . . . . 1.0 111.068 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.67 157.48 42.16 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.29 1.436 . . . . 1.0 110.733 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -83.82 -3.79 58.15 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 171.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.81 3.07 20.39 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.063 1.316 . . . . 1.0 114.878 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.34 41.95 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.371 1.086 . . . . 1.0 113.961 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -66.5 83.66 0.1 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.015 1.326 . . . . 1.0 112.302 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -103.99 94.1 5.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.516 1.527 . . . . 1.0 109.474 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -44.33 -41.96 6.41 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.478 1.911 . . . . 1.0 115.422 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -59.28 -39.22 82.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.801 0.841 . . . . 1.0 112.958 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.97 -43.0 69.0 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.664 -0.648 . . . . 1.0 109.899 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.61 -42.99 79.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 1.0 112.125 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.66 -46.79 83.78 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.712 0.405 . . . . 1.0 111.827 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -62.13 -41.96 98.76 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.697 -0.627 . . . . 1.0 112.101 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -62.79 -39.99 95.96 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 1.0 110.615 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.48 -39.43 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.63 0.772 . . . . 1.0 112.71 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -80.3 -32.41 38.08 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 1.0 114.245 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.27 -4.29 4.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.15 1.537 . . . . 1.0 115.15 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.0 131.41 7.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.567 1.555 . . . . 1.0 111.959 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 -34.69 80.37 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.664 2.243 . . . . 1.0 113.42 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.72 -39.83 84.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.301 0.64 . . . . 1.0 112.061 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.43 -47.15 77.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.08 0.552 . . . . 1.0 111.094 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.0 -40.02 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.775 -0.578 . . . . 1.0 111.919 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.21 -27.6 68.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.273 -1.517 . . . . 1.0 112.43 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 t -67.58 -27.37 66.87 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.214 -0.929 . . . . 1.0 112.279 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -72.3 -15.17 61.9 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.046 -1.034 . . . . 1.0 113.141 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.14 145.79 54.92 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.396 0.888 . . . . 1.0 113.396 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.18 117.62 12.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.421 1.888 . . . . 1.0 110.545 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.94 116.33 12.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.681 1.192 . . . . 1.0 110.406 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.7 mt . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 123.9 0.88 . . . . 1.0 111.644 176.895 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.36 120.38 42.24 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.235 1.414 . . . . 1.0 108.872 169.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.36 149.49 24.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -136.62 150.15 48.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.113 1.365 . . . . 1.0 108.728 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -132.24 144.45 50.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.204 1.401 . . . . 1.0 109.698 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -120.8 91.4 47.4 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.292 1.037 . . . . 1.0 111.702 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -47.15 -25.6 4.5 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.955 3.77 . . . . 1.0 116.987 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -66.47 -26.56 67.25 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.734 1.013 . . . . 1.0 113.734 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 p -130.02 -18.26 3.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.082 1.353 . . . . 1.0 113.735 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.28 -0.85 83.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.9 1.238 . . . . 1.0 113.909 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.05 153.76 28.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.31 1.596 . . . . 1.0 115.31 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.46 140.87 42.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.839 2.056 . . . . 1.0 109.455 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.7 pt -140.28 164.35 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.02 1.728 . . . . 1.0 110.527 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -139.5 138.8 36.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.104 1.762 . . . . 1.0 111.096 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -150.87 158.69 44.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.454 1.502 . . . . 1.0 111.178 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.74 -3.13 58.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.691 1.196 . . . . 1.0 113.349 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.01 1.39 19.15 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.844 1.211 . . . . 1.0 114.993 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.83 179.11 41.87 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 118.484 1.142 . . . . 1.0 113.875 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -67.75 83.78 0.19 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.398 1.079 . . . . 1.0 112.378 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -98.71 93.97 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.698 1.599 . . . . 1.0 109.557 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -44.4 -41.35 6.11 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.117 2.167 . . . . 1.0 115.052 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -60.43 -38.14 83.16 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.309 1.044 . . . . 1.0 113.278 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -69.56 -43.78 72.2 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.399 -0.813 . . . . 1.0 109.812 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -55.78 -43.51 76.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.537 0.735 . . . . 1.0 112.386 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.25 -46.94 82.55 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.985 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -62.05 -41.14 97.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.679 -0.638 . . . . 1.0 112.364 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.94 -41.09 97.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.242 1.017 . . . . 1.0 110.733 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.03 -37.92 78.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.932 0.893 . . . . 1.0 112.761 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -81.78 -32.62 31.29 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.535 1.309 . . . . 1.0 114.535 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -130.66 -3.41 4.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.08 129.37 6.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.283 1.42 . . . . 1.0 112.319 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.24 79.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.831 2.354 . . . . 1.0 113.364 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.32 -40.09 81.77 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.934 0.788 . . . . 1.0 111.987 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.48 72.51 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.357 0.663 . . . . 1.0 110.938 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.37 -41.37 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.247 0.619 . . . . 1.0 112.217 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -66.23 -25.08 66.74 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.434 -1.416 . . . . 1.0 112.073 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 m -74.38 -21.64 59.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -73.0 -15.79 61.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.349 0.977 . . . . 1.0 113.112 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.04 145.24 56.59 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.43 118.71 12.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.378 1.871 . . . . 1.0 111.086 170.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.1 mt -64.84 131.71 47.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.195 0.998 . . . . 1.0 110.641 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 CA--C 1.547 0.857 0 C-N-CA 123.675 0.79 . . . . 1.0 111.758 177.389 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 111.45 0.167 . . . . 1.0 111.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -102.47 116.86 33.47 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.867 1.267 . . . . 1.0 108.257 168.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -84.46 146.32 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.106 1.363 . . . . 1.0 107.427 169.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -135.18 150.0 50.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.734 1.214 . . . . 1.0 109.257 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -132.79 138.02 46.99 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 1.0 109.834 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -112.45 91.31 16.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.242 1.017 . . . . 1.0 110.68 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.43 -14.47 39.29 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.843 2.362 . . . . 1.0 114.675 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -69.22 -23.76 63.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.494 1.118 . . . . 1.0 113.644 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.7 p -127.01 -22.2 3.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.993 1.317 . . . . 1.0 113.51 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.36 -4.83 74.09 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.664 1.602 . . . . 1.0 113.808 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -66.2 153.31 42.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.132 1.53 . . . . 1.0 115.132 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.8 140.39 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.851 2.06 . . . . 1.0 109.173 171.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.8 pt -139.53 165.79 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.639 1.576 . . . . 1.0 110.599 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -140.74 136.96 33.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.256 1.823 . . . . 1.0 110.737 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.49 157.2 41.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.94 1.296 . . . . 1.0 111.227 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -85.05 -4.37 59.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.21 1.004 . . . . 1.0 113.475 171.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.72 1.97 14.81 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.317 1.436 . . . . 1.0 114.995 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.46 178.84 41.18 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.392 1.096 . . . . 1.0 114.159 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.88 83.9 0.21 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.869 1.268 . . . . 1.0 112.027 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -103.82 94.04 5.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.821 1.648 . . . . 1.0 109.843 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -43.5 -40.99 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.386 1.875 . . . . 1.0 115.588 -169.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -59.13 -37.11 76.44 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.976 0.91 . . . . 1.0 113.028 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.5 tp -70.87 -45.29 64.68 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.447 0.699 . . . . 1.0 109.784 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.67 -43.51 80.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.789 0.836 . . . . 1.0 112.1 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.01 -44.1 82.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.43 -41.2 89.53 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.046 -0.409 . . . . 1.0 112.0 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.02 -40.16 92.5 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.857 0.753 . . . . 1.0 110.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.02 77.17 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.002 0.921 . . . . 1.0 113.033 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -98.48 -16.76 19.07 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.007 1.854 . . . . 1.0 116.007 -171.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -132.75 -6.48 3.19 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.029 1.492 . . . . 1.0 115.029 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.39 132.77 7.58 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.322 1.439 . . . . 1.0 112.464 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.79 -36.28 63.09 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.709 2.273 . . . . 1.0 113.542 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.5 -39.51 81.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.765 0.712 . . . . 1.0 112.021 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.33 73.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.397 0.679 . . . . 1.0 110.762 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.92 -40.9 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.339 0.656 . . . . 1.0 112.073 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -66.13 -24.45 66.68 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.492 -1.38 . . . . 1.0 112.217 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 m -75.55 -21.88 57.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.859 0.689 . . . . 1.0 112.859 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -72.94 -17.49 61.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.572 1.078 . . . . 1.0 112.892 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 145.23 54.41 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.05 119.64 14.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.286 1.834 . . . . 1.0 110.96 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.0 mt -70.84 119.5 15.07 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.361 1.064 . . . . 1.0 110.434 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 CA--C 1.547 0.832 0 C-N-CA 123.335 0.654 . . . . 1.0 111.552 175.03 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -111.91 121.92 46.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.653 1.581 . . . . 1.0 108.938 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.63 149.15 25.12 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.665 -1.235 . . . . 1.0 107.665 168.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -136.19 149.11 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.138 1.375 . . . . 1.0 108.699 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.98 143.72 50.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.225 1.41 . . . . 1.0 109.776 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.52 91.62 46.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.015 0.926 . . . . 1.0 111.821 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.27 -25.6 4.81 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.778 3.652 . . . . 1.0 116.714 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -65.95 -27.12 67.93 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.1 p -130.15 -16.49 3.58 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.01 1.324 . . . . 1.0 113.976 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.98 -0.2 87.57 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.002 1.287 . . . . 1.0 113.922 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.01 154.84 29.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -136.49 141.42 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.88 2.072 . . . . 1.0 109.494 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.9 pt -140.24 163.29 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.798 1.639 . . . . 1.0 110.457 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -140.21 137.63 34.46 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.133 1.773 . . . . 1.0 111.417 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.39 159.88 44.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.602 1.561 . . . . 1.0 111.02 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.34 -0.72 57.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.484 1.114 . . . . 1.0 113.611 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.32 5.2 23.19 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.836 1.208 . . . . 1.0 114.873 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.39 179.26 40.23 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.419 1.109 . . . . 1.0 113.864 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.26 83.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.016 1.327 . . . . 1.0 112.029 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -104.75 93.97 5.03 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.57 1.548 . . . . 1.0 109.737 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -45.38 -41.3 8.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.071 1.749 . . . . 1.0 115.365 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -58.73 -38.84 79.24 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.848 0.859 . . . . 1.0 112.893 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.94 -44.17 70.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.436 -0.79 . . . . 1.0 109.799 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -56.85 -43.36 81.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.691 0.796 . . . . 1.0 112.378 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.5 -46.06 84.19 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.72 0.408 . . . . 1.0 112.018 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -42.01 98.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.724 -0.61 . . . . 1.0 112.039 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.67 -41.28 97.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.938 0.895 . . . . 1.0 110.786 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.1 78.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.598 0.759 . . . . 1.0 112.898 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.61 -33.2 31.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.64 -2.86 4.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.347 1.61 . . . . 1.0 115.347 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.56 128.77 6.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.378 1.465 . . . . 1.0 112.256 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 -35.1 81.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.745 2.297 . . . . 1.0 113.279 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.61 -39.9 80.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.877 0.762 . . . . 1.0 112.242 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.84 73.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.403 0.681 . . . . 1.0 110.757 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -41.21 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.057 0.543 . . . . 1.0 112.25 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -66.05 -25.03 66.85 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.424 -1.423 . . . . 1.0 112.29 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.9 m -74.1 -21.99 59.67 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.461 -0.774 . . . . 1.0 112.732 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -72.85 -16.48 61.59 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.477 1.035 . . . . 1.0 112.939 170.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.74 57.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.02 117.94 12.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.218 1.807 . . . . 1.0 111.352 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.99 136.99 57.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.274 1.029 . . . . 1.0 110.723 172.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.096 0.958 . . . . 1.0 112.603 -178.247 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.621 -0.14 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -105.63 119.14 38.37 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.913 1.285 . . . . 1.0 108.365 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -86.89 148.09 25.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.463 -1.31 . . . . 1.0 107.463 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -138.25 151.19 47.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.872 1.269 . . . . 1.0 109.36 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -131.14 145.48 51.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.699 1.6 . . . . 1.0 109.072 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.57 94.11 44.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.738 0.815 . . . . 1.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.81 -26.85 10.31 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.348 3.365 . . . . 1.0 116.501 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.03 -17.81 56.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -130.62 -20.82 2.86 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.98 -6.2 82.86 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.996 1.76 . . . . 1.0 114.357 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -68.88 156.27 38.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.183 1.549 . . . . 1.0 115.183 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.72 140.11 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 127.271 2.229 . . . . 1.0 109.312 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -141.83 163.67 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.919 1.688 . . . . 1.0 110.954 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -139.45 138.7 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.218 1.807 . . . . 1.0 111.335 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.17 158.56 44.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.197 1.399 . . . . 1.0 110.927 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.417 1.087 . . . . 1.0 113.52 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.63 2.49 20.98 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.179 1.371 . . . . 1.0 114.85 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.98 179.39 38.72 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.379 1.089 . . . . 1.0 113.809 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -67.44 83.95 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.71 1.204 . . . . 1.0 112.047 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -102.72 93.92 5.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.422 1.489 . . . . 1.0 109.603 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -44.74 -40.73 6.26 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.316 1.846 . . . . 1.0 115.509 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.0 m -58.8 -38.97 79.75 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.843 0.857 . . . . 1.0 113.096 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.29 -43.69 66.64 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.536 -0.727 . . . . 1.0 109.646 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -56.16 -42.99 77.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.329 0.651 . . . . 1.0 112.294 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.74 -47.11 83.37 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.7 0.4 . . . . 1.0 111.477 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -62.62 -41.48 99.03 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.575 -0.703 . . . . 1.0 112.327 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -63.1 -39.88 95.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.954 0.902 . . . . 1.0 110.591 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.89 -39.18 79.89 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.703 0.801 . . . . 1.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -81.35 -32.73 32.81 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -174.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -128.75 -5.48 5.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.125 1.528 . . . . 1.0 115.125 -172.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.38 131.91 7.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.28 1.419 . . . . 1.0 111.909 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.63 -35.29 81.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.78 2.32 . . . . 1.0 113.073 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.77 -40.15 84.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.307 0.643 . . . . 1.0 111.761 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.26 76.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.347 0.659 . . . . 1.0 111.288 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.44 -40.01 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.744 -0.597 . . . . 1.0 112.317 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -66.9 -27.98 67.94 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.472 -1.393 . . . . 1.0 112.337 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.8 t -67.5 -26.83 66.55 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.418 -0.801 . . . . 1.0 112.429 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -72.77 -14.9 61.63 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.281 -0.887 . . . . 1.0 113.028 170.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.3 51.85 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.48 119.39 13.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.412 1.885 . . . . 1.0 110.905 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.11 122.17 18.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.625 1.17 . . . . 1.0 110.584 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 123.62 0.768 . . . . 1.0 111.672 177.728 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 111.272 0.101 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.29 119.16 38.39 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.196 1.399 . . . . 1.0 107.951 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.54 145.83 26.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.042 1.337 . . . . 1.0 107.401 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -136.09 151.33 49.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.572 1.149 . . . . 1.0 109.518 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -130.57 145.59 51.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.575 1.55 . . . . 1.0 109.31 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -117.56 93.69 43.96 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.91 0.884 . . . . 1.0 111.894 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.44 -26.79 9.19 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.294 3.33 . . . . 1.0 116.662 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -78.51 -16.92 56.96 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -131.37 -21.14 2.6 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.13 -5.66 82.94 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.654 1.597 . . . . 1.0 114.201 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.83 155.75 39.65 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.0 140.31 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.1 2.16 . . . . 1.0 109.117 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.67 164.52 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.977 1.711 . . . . 1.0 110.837 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -139.42 138.7 36.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.519 1.928 . . . . 1.0 110.891 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.28 156.63 41.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.586 1.555 . . . . 1.0 111.186 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.25 -3.03 58.68 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.502 1.121 . . . . 1.0 113.657 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 2.17 20.79 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.858 1.218 . . . . 1.0 114.98 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.9 179.02 39.11 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.503 1.152 . . . . 1.0 113.729 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.4 83.71 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.405 1.082 . . . . 1.0 112.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -98.89 94.06 6.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.639 1.576 . . . . 1.0 109.291 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 -43.09 6.56 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.254 1.822 . . . . 1.0 114.73 -169.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.5 m -57.73 -39.3 76.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.116 0.966 . . . . 1.0 112.88 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.7 tp -69.51 -43.41 73.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.385 0.674 . . . . 1.0 109.716 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -55.98 -44.51 78.62 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.44 0.696 . . . . 1.0 112.18 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.07 -45.48 87.04 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -41.82 98.47 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.507 -0.746 . . . . 1.0 112.232 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.89 -39.79 95.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.382 1.073 . . . . 1.0 110.661 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.84 76.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.623 0.769 . . . . 1.0 112.795 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -80.86 -33.01 34.75 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.296 1.221 . . . . 1.0 114.296 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -128.64 -5.72 5.21 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.69 132.14 7.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.69 1.614 . . . . 1.0 111.88 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.12 -34.61 79.02 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.706 2.271 . . . . 1.0 113.321 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.0 -39.78 83.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.477 0.711 . . . . 1.0 112.019 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.95 76.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.286 0.634 . . . . 1.0 111.032 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.363 0.505 . . . . 1.0 112.363 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.37 -28.41 68.62 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.461 -1.399 . . . . 1.0 112.07 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -22.86 64.76 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.538 -0.726 . . . . 1.0 112.752 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -76.51 -14.27 60.04 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.9 0.88 . . . . 1.0 113.068 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.35 147.55 51.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -139.42 117.27 11.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.445 1.898 . . . . 1.0 110.522 171.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.64 122.61 20.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.655 1.182 . . . . 1.0 110.322 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 124.155 0.982 . . . . 1.0 112.36 -177.778 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 110.796 -0.075 . . . . 1.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.71 120.66 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.488 1.515 . . . . 1.0 108.438 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -86.3 148.83 25.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -136.75 148.28 47.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 1.0 108.924 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -129.78 139.43 51.27 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.971 1.309 . . . . 1.0 109.723 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -115.07 90.66 24.22 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.571 1.148 . . . . 1.0 110.856 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.85 -12.74 26.97 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.185 2.59 . . . . 1.0 115.275 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -65.26 -27.52 68.7 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.3 p -128.07 -19.28 4.0 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.991 1.316 . . . . 1.0 113.734 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.32 79.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.11 1.338 . . . . 1.0 113.808 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.09 153.81 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.38 1.622 . . . . 1.0 115.38 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.19 141.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.682 1.993 . . . . 1.0 109.45 171.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.6 pt -140.05 163.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.902 1.681 . . . . 1.0 110.413 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -139.97 137.94 35.13 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.222 1.809 . . . . 1.0 111.276 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.38 159.07 44.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.219 1.408 . . . . 1.0 110.767 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -86.38 -3.07 58.93 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.277 1.031 . . . . 1.0 113.398 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.3 2.55 17.85 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.178 1.37 . . . . 1.0 115.071 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.0 179.13 42.37 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 118.379 1.09 . . . . 1.0 113.777 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.19 83.73 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.781 1.232 . . . . 1.0 112.38 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -103.54 93.98 5.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.54 1.536 . . . . 1.0 109.777 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -44.08 -41.13 5.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.305 1.842 . . . . 1.0 115.61 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -58.66 -38.04 77.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.896 0.878 . . . . 1.0 112.986 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.0 tp -70.56 -45.14 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.475 0.71 . . . . 1.0 109.614 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -56.37 -42.85 78.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.59 0.756 . . . . 1.0 112.441 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -57.45 -46.87 83.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.85 0.46 . . . . 1.0 111.58 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -62.68 -41.65 99.2 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.53 -0.731 . . . . 1.0 112.144 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -62.0 -40.57 96.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.791 0.836 . . . . 1.0 110.72 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.28 81.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.799 0.84 . . . . 1.0 112.883 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -82.01 -32.12 30.69 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -130.02 -4.19 4.51 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.297 1.591 . . . . 1.0 115.297 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 130.17 6.8 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.095 1.331 . . . . 1.0 112.326 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.14 -35.92 72.56 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.846 2.364 . . . . 1.0 113.359 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.15 -39.8 82.55 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.638 0.654 . . . . 1.0 112.052 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.527 0.731 . . . . 1.0 111.067 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.59 -40.28 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.178 0.591 . . . . 1.0 112.066 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -66.33 -25.07 66.65 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.376 -1.453 . . . . 1.0 112.413 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 t -73.12 -25.55 60.9 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.497 -0.752 . . . . 1.0 112.613 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -69.56 -17.31 63.55 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.781 -1.199 . . . . 1.0 113.084 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.53 55.96 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 118.51 12.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 1.0 111.179 170.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.74 131.34 47.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.031 0.932 . . . . 1.0 110.676 171.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 123.999 0.92 . . . . 1.0 111.404 175.303 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.858 0.318 . . . . 1.0 111.858 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -105.33 118.4 36.45 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.543 1.537 . . . . 1.0 108.005 168.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.33 148.24 26.13 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 168.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -135.84 150.03 49.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.95 1.3 . . . . 1.0 109.129 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.473 1.509 . . . . 1.0 109.387 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.38 93.02 41.94 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.121 0.969 . . . . 1.0 111.8 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.52 -26.46 8.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.41 3.407 . . . . 1.0 116.62 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -77.84 -17.97 56.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -131.57 -20.1 2.64 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.514 1.301 . . . . 1.0 114.514 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.65 -5.35 83.72 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.897 1.713 . . . . 1.0 114.15 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.23 156.51 37.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.299 1.592 . . . . 1.0 115.299 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.28 140.22 46.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 1.0 109.23 169.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.4 pt -140.53 164.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.874 1.669 . . . . 1.0 110.707 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -140.48 137.67 34.04 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.151 1.781 . . . . 1.0 111.107 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 158.23 43.6 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.421 1.489 . . . . 1.0 111.107 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -85.33 -4.63 59.22 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.117 -0.989 . . . . 1.0 113.301 171.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 3.36 15.57 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.107 1.337 . . . . 1.0 114.976 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.13 39.83 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.586 1.193 . . . . 1.0 113.947 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.48 83.78 0.17 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.714 1.206 . . . . 1.0 112.111 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -103.13 93.96 5.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.672 1.589 . . . . 1.0 109.88 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.04 -44.28 2.38 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.993 2.117 . . . . 1.0 115.429 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.4 m -59.25 -39.27 82.27 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.085 0.954 . . . . 1.0 113.247 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -69.26 -44.22 72.37 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.562 -0.711 . . . . 1.0 109.777 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -57.29 -42.4 81.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.325 0.65 . . . . 1.0 112.374 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.87 -46.07 85.4 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.683 0.393 . . . . 1.0 112.002 171.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -61.92 -41.94 98.51 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.538 -0.727 . . . . 1.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.5 -40.97 96.51 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.148 0.979 . . . . 1.0 110.91 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.38 78.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.405 0.682 . . . . 1.0 112.761 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -82.51 -33.04 28.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.491 1.293 . . . . 1.0 114.491 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.09 -3.08 4.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -171.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.72 129.62 6.66 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.376 1.465 . . . . 1.0 112.274 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.93 -35.81 75.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.647 2.231 . . . . 1.0 113.45 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.52 -39.89 81.01 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.518 0.599 . . . . 1.0 112.009 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.43 71.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.353 0.661 . . . . 1.0 110.875 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.91 -39.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.12 0.568 . . . . 1.0 112.035 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -66.68 -26.29 66.96 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.362 -1.461 . . . . 1.0 112.435 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 t -71.13 -26.14 62.88 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.646 -0.659 . . . . 1.0 112.605 169.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -69.47 -16.92 63.56 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.114 -0.991 . . . . 1.0 112.893 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.25 144.2 57.31 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.37 120.1 14.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.187 1.795 . . . . 1.0 111.374 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.3 mt -70.86 122.94 20.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.47 1.108 . . . . 1.0 110.566 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 124.507 1.123 . . . . 1.0 111.542 176.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 54.18 26.43 6.66 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 117.921 2.563 . . . . 1.0 117.921 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -67.49 154.4 41.48 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.301 -0.874 . . . . 1.0 110.778 169.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.0 t -72.57 132.16 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.822 0.849 . . . . 1.0 111.013 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -104.11 119.12 38.26 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.33 1.452 . . . . 1.0 108.022 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.42 142.92 28.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -133.67 152.16 51.82 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.397 1.079 . . . . 1.0 109.267 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -133.87 143.33 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.546 1.538 . . . . 1.0 109.614 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -117.59 94.15 45.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.58 0.752 . . . . 1.0 111.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.97 -25.77 6.72 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.553 3.502 . . . . 1.0 116.525 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -71.37 -22.59 61.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.828 1.047 . . . . 1.0 113.828 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.2 p -129.38 -21.2 3.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.04 1.336 . . . . 1.0 113.774 -174.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.99 -6.7 82.62 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.584 1.564 . . . . 1.0 114.047 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -66.21 152.93 43.79 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.57 141.83 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 127.317 2.247 . . . . 1.0 108.876 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.5 pt -140.79 163.95 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.994 1.718 . . . . 1.0 110.737 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.64 136.89 34.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.412 1.885 . . . . 1.0 111.15 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.92 158.46 43.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.636 1.574 . . . . 1.0 110.812 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.26 -4.56 58.55 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.935 -1.103 . . . . 1.0 113.507 170.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.57 3.75 16.15 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.021 1.296 . . . . 1.0 114.667 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.61 179.52 43.65 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.441 1.121 . . . . 1.0 114.107 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.69 83.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.066 1.346 . . . . 1.0 112.391 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -108.03 94.32 5.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.961 1.704 . . . . 1.0 109.862 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -39.21 -46.15 1.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 127.453 2.301 . . . . 1.0 115.445 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 m -60.59 -39.07 86.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.435 1.094 . . . . 1.0 113.155 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.0 tp -69.14 -46.42 67.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.674 -0.641 . . . . 1.0 109.459 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.15 -43.3 78.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.245 0.618 . . . . 1.0 111.846 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -60.38 -43.53 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -64.36 -43.01 95.88 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.062 -0.398 . . . . 1.0 111.917 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -62.09 -39.83 93.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.073 0.949 . . . . 1.0 110.596 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.17 -36.18 77.1 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.709 0.804 . . . . 1.0 113.008 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -97.19 -17.34 19.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -130.95 -3.78 4.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.767 1.395 . . . . 1.0 114.767 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.99 131.25 7.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.371 1.462 . . . . 1.0 112.014 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.92 -34.39 81.63 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.617 2.211 . . . . 1.0 113.442 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.3 -40.22 86.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.988 0.813 . . . . 1.0 111.957 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.66 78.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.362 0.665 . . . . 1.0 110.94 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.66 -39.24 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.362 0.665 . . . . 1.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.41 -26.2 67.12 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.232 -1.543 . . . . 1.0 111.977 171.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 t -69.38 -27.53 65.39 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.212 -0.93 . . . . 1.0 112.167 169.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -71.09 -17.45 62.58 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.011 -1.056 . . . . 1.0 112.73 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.53 52.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.44 0.904 . . . . 1.0 113.44 -174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.42 120.66 14.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 1.0 110.732 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 mt -76.0 118.02 18.32 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.54 1.136 . . . . 1.0 110.48 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.77 49.53 1.21 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.635 1.174 . . . . 1.0 112.405 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.78 47.94 0.29 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.715 1.626 . . . . 1.0 112.965 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.616 1.566 . . . . 1.0 112.813 -178.248 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 52.38 37.77 23.4 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.965 2.106 . . . . 1.0 116.296 169.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -135.79 155.47 50.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.994 1.718 . . . . 1.0 112.273 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -72.48 142.79 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.412 1.485 . . . . 1.0 111.234 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.27 119.91 38.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.501 1.521 . . . . 1.0 108.796 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -83.56 148.23 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.112 1.365 . . . . 1.0 107.642 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -135.04 150.38 50.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.571 1.148 . . . . 1.0 109.214 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -132.68 143.6 49.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.467 1.507 . . . . 1.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -118.72 91.39 42.23 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.001 0.92 . . . . 1.0 111.104 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.33 -27.47 13.44 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.987 3.125 . . . . 1.0 116.277 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -75.98 -16.54 59.96 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.368 1.067 . . . . 1.0 113.868 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.6 p -128.73 -20.9 3.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.809 1.244 . . . . 1.0 113.828 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.49 -6.82 82.14 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.624 1.583 . . . . 1.0 114.209 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.59 154.66 41.67 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.205 1.557 . . . . 1.0 115.205 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.47 141.61 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.065 2.146 . . . . 1.0 109.107 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.1 pt -141.33 165.61 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.157 1.783 . . . . 1.0 110.759 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -138.0 140.2 40.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.873 2.069 . . . . 1.0 110.866 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.21 161.39 42.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.519 1.528 . . . . 1.0 110.853 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -90.24 -1.91 57.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.903 1.281 . . . . 1.0 113.233 171.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.05 3.88 22.83 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.035 1.303 . . . . 1.0 114.717 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.51 179.27 43.73 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.398 1.099 . . . . 1.0 114.144 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -66.72 83.7 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.879 1.272 . . . . 1.0 112.337 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -104.81 94.01 5.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.74 1.616 . . . . 1.0 109.803 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -42.17 -43.85 3.49 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.831 2.052 . . . . 1.0 115.452 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -59.93 -37.43 79.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.089 0.956 . . . . 1.0 113.205 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.8 -44.85 65.75 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.652 -0.655 . . . . 1.0 109.948 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -57.16 -42.31 80.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.48 0.712 . . . . 1.0 112.096 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -56.93 -44.72 82.78 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.982 0.513 . . . . 1.0 112.329 172.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -65.93 -40.94 91.87 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.917 -0.49 . . . . 1.0 112.118 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.26 -40.32 93.65 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.937 0.79 . . . . 1.0 110.689 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.93 77.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.981 0.912 . . . . 1.0 113.083 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -98.1 -17.68 18.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -132.37 -5.71 3.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.76 132.65 7.63 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.396 1.474 . . . . 1.0 112.613 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.9 -35.51 66.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.406 2.071 . . . . 1.0 113.409 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.24 -40.54 81.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.753 0.706 . . . . 1.0 111.875 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.34 73.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.356 0.662 . . . . 1.0 110.903 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.18 -39.84 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.351 0.66 . . . . 1.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.35 -26.2 67.17 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.411 -1.431 . . . . 1.0 112.204 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.9 t -72.68 -25.36 61.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.672 -0.643 . . . . 1.0 112.645 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -70.55 -16.59 62.89 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.98 -1.075 . . . . 1.0 112.989 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.97 54.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.676 0.991 . . . . 1.0 113.676 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.19 118.69 12.94 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.211 1.805 . . . . 1.0 110.976 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.5 mt -63.72 133.1 52.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.818 0.847 . . . . 1.0 110.711 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 mt -111.62 166.03 11.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.289 1.036 . . . . 1.0 111.953 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.16 23.29 1.91 Allowed Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.483 1.04 . . . . 1.0 114.421 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.465 0 C-N-CA 124.76 1.224 . . . . 1.0 113.225 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 54.09 36.58 25.06 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.665 2.098 . . . . 1.0 116.665 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -132.0 152.22 51.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.102 1.761 . . . . 1.0 110.657 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.27 137.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.921 0.888 . . . . 1.0 111.173 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -113.86 122.96 48.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.926 1.69 . . . . 1.0 109.094 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.59 147.54 25.88 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.564 1.546 . . . . 1.0 107.819 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -135.15 149.14 49.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.811 1.244 . . . . 1.0 109.165 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.76 139.02 48.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.967 1.307 . . . . 1.0 109.868 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -115.49 90.02 24.17 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.414 1.085 . . . . 1.0 110.783 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -12.24 24.42 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.333 2.689 . . . . 1.0 115.336 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -65.41 -27.75 68.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.01 0.924 . . . . 1.0 113.245 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.1 p -127.38 -20.43 4.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.045 1.338 . . . . 1.0 113.713 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.85 -1.34 74.55 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.258 1.409 . . . . 1.0 113.628 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.25 152.91 32.17 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.256 1.576 . . . . 1.0 115.256 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.35 142.55 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.82 2.048 . . . . 1.0 109.635 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -141.02 165.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.965 1.706 . . . . 1.0 110.528 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.11 141.06 42.31 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.554 1.942 . . . . 1.0 110.91 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.19 160.99 43.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 1.0 110.805 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.33 -0.13 57.24 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.446 1.099 . . . . 1.0 113.491 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.51 4.09 26.93 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.167 1.365 . . . . 1.0 114.774 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.94 179.64 47.1 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.387 1.094 . . . . 1.0 113.598 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.62 83.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.813 1.245 . . . . 1.0 112.129 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -102.05 94.05 5.56 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.429 1.492 . . . . 1.0 109.986 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.5 -41.89 3.12 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.571 2.348 . . . . 1.0 115.307 -169.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 m -59.96 -39.05 84.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.99 0.916 . . . . 1.0 113.338 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 tp -70.43 -42.74 71.17 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.531 0.732 . . . . 1.0 109.609 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.18 -43.05 78.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.538 0.735 . . . . 1.0 112.341 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.66 -46.37 84.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -62.49 -41.6 98.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.784 -0.572 . . . . 1.0 112.186 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.6 -41.1 96.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 1.0 110.692 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.93 78.95 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 1.0 112.884 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -83.17 -32.31 26.67 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.593 1.331 . . . . 1.0 114.593 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -129.25 -4.1 4.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.253 1.575 . . . . 1.0 115.253 -173.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 130.22 6.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.286 1.422 . . . . 1.0 111.921 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.83 -35.52 78.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.649 2.232 . . . . 1.0 113.525 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.1 -40.25 82.65 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.567 0.622 . . . . 1.0 111.948 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.3 -48.98 73.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 1.0 111.207 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.2 -40.18 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.917 -0.49 . . . . 1.0 112.166 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.06 -25.14 66.9 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.294 -1.504 . . . . 1.0 112.165 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -73.18 -25.71 60.89 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.607 -0.683 . . . . 1.0 112.709 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -69.87 -16.46 63.25 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.97 -1.081 . . . . 1.0 112.877 171.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.19 144.96 56.46 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.77 1.026 . . . . 1.0 113.77 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.06 117.85 12.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.212 1.805 . . . . 1.0 110.707 170.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -63.74 131.31 47.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.032 0.933 . . . . 1.0 110.54 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.0 mt -99.42 43.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.102 0.953 . . . . 1.0 111.746 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 -177.76 48.39 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.108 1.337 . . . . 1.0 113.205 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.052 1.741 . . . . 1.0 111.737 -178.832 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 111.63 0.233 . . . . 1.0 111.63 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -79.04 -0.49 31.54 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.293 1.59 . . . . 1.0 115.293 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 154.15 2.26 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.456 1.902 . . . . 1.0 114.262 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.67 137.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.248 1.419 . . . . 1.0 110.545 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.86 120.44 41.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.404 1.482 . . . . 1.0 108.659 168.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -86.5 146.6 26.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.64 151.62 50.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.815 1.246 . . . . 1.0 108.983 175.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -132.02 144.71 50.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.273 1.429 . . . . 1.0 109.87 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -119.52 92.86 46.67 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.071 0.948 . . . . 1.0 112.246 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.63 -25.1 3.28 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.811 3.674 . . . . 1.0 117.091 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -67.09 -27.06 67.04 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.5 p -130.1 -17.5 3.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.929 1.291 . . . . 1.0 114.126 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.62 85.7 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.985 1.279 . . . . 1.0 113.896 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.14 154.6 30.6 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.228 1.566 . . . . 1.0 115.228 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 142.04 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.857 2.063 . . . . 1.0 109.565 171.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 pt -140.63 164.04 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.237 1.815 . . . . 1.0 110.656 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -140.23 137.41 34.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.055 1.742 . . . . 1.0 111.579 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.44 158.65 43.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.38 1.472 . . . . 1.0 111.166 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -83.32 -2.7 56.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.19 0.996 . . . . 1.0 113.515 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.26 25.91 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.082 1.325 . . . . 1.0 114.53 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.88 179.52 41.32 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.564 1.078 . . . . 1.0 113.805 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.6 83.79 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.132 1.373 . . . . 1.0 112.025 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -107.56 94.0 4.85 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.793 1.637 . . . . 1.0 109.865 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -41.36 -44.02 2.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.007 2.123 . . . . 1.0 115.24 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -60.82 -39.65 89.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.895 0.878 . . . . 1.0 113.23 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.93 -44.82 72.3 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.618 -0.676 . . . . 1.0 109.743 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -56.5 -43.12 79.43 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.384 0.674 . . . . 1.0 111.923 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.69 -48.38 79.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 122.662 0.385 . . . . 1.0 111.875 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.03 -43.71 98.49 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.818 -0.551 . . . . 1.0 112.211 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -62.53 -41.09 98.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 1.0 110.709 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.34 80.72 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -81.41 -32.9 32.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -129.66 -0.6 4.89 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -172.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.29 128.17 6.15 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.51 1.529 . . . . 1.0 112.113 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.88 -34.45 91.18 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.744 2.296 . . . . 1.0 113.213 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.27 -42.46 88.42 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.859 0.754 . . . . 1.0 111.646 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.49 80.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.406 0.683 . . . . 1.0 111.163 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.33 -36.4 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 1.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -66.89 -28.75 68.58 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.259 -1.525 . . . . 1.0 111.995 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.6 m -68.75 -23.77 64.36 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.138 -0.977 . . . . 1.0 112.216 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -72.9 -15.41 61.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.329 0.968 . . . . 1.0 112.442 169.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -71.47 148.13 47.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 119.17 12.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.587 1.955 . . . . 1.0 110.931 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.26 129.42 38.39 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.204 1.002 . . . . 1.0 110.625 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.6 mt -77.44 65.33 2.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.328 1.051 . . . . 1.0 112.829 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.93 34.77 1.31 Allowed Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.539 2.018 . . . . 1.0 112.453 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.842 2.057 . . . . 1.0 111.846 -172.751 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 111.252 0.093 . . . . 1.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -75.95 35.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.145 1.778 . . . . 1.0 114.453 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.6 154.56 32.38 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.937 1.695 . . . . 1.0 112.171 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.76 141.3 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.487 1.115 . . . . 1.0 110.348 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -113.3 121.26 43.86 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.685 1.594 . . . . 1.0 108.54 169.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -86.98 147.0 25.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.95 147.87 49.88 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.117 1.367 . . . . 1.0 109.018 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -129.99 137.49 50.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.075 1.35 . . . . 1.0 109.995 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -111.12 91.64 13.68 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.103 0.961 . . . . 1.0 110.543 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.22 -14.35 37.67 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.824 2.349 . . . . 1.0 114.896 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -69.78 -23.62 63.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.665 1.186 . . . . 1.0 113.562 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -127.93 -21.77 3.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.075 1.35 . . . . 1.0 113.619 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.27 -4.95 74.56 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.607 1.575 . . . . 1.0 113.873 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -66.03 153.18 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.71 141.59 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 126.914 2.086 . . . . 1.0 109.219 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -140.93 163.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.913 1.685 . . . . 1.0 110.65 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -139.18 138.54 37.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.155 1.782 . . . . 1.0 111.305 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.41 159.6 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.399 1.48 . . . . 1.0 110.876 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -87.24 -1.88 58.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.551 1.14 . . . . 1.0 113.517 171.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.75 5.49 18.15 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.151 1.358 . . . . 1.0 115.004 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.54 179.23 43.88 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.443 1.122 . . . . 1.0 114.205 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.79 83.87 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.344 1.458 . . . . 1.0 112.13 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -106.2 94.01 4.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.421 1.489 . . . . 1.0 110.215 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -37.56 -47.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.11 2.564 . . . . 1.0 115.463 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -61.49 -38.29 86.74 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.133 0.973 . . . . 1.0 113.039 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 tp -70.01 -44.41 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.675 -0.641 . . . . 1.0 109.616 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.3 -43.12 78.6 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.407 0.683 . . . . 1.0 112.203 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -58.71 -42.95 89.85 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -65.22 -41.51 94.37 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.879 0.326 . . . . 1.0 111.879 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.52 -40.01 93.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.662 0.785 . . . . 1.0 110.558 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.87 -36.0 77.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.074 0.949 . . . . 1.0 113.163 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.78 -17.62 19.25 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -131.37 -6.41 3.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.63 132.08 7.45 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.506 1.527 . . . . 1.0 112.2 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.07 -36.42 70.59 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.926 2.417 . . . . 1.0 113.447 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.78 -39.96 84.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.639 0.654 . . . . 1.0 111.9 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.91 74.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.268 0.627 . . . . 1.0 110.993 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.62 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.187 0.595 . . . . 1.0 112.17 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -66.6 -24.22 66.29 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.475 -1.39 . . . . 1.0 112.044 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -74.82 -23.63 58.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.528 -0.733 . . . . 1.0 112.718 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -71.33 -17.27 62.45 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.143 -0.973 . . . . 1.0 112.897 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.98 145.34 55.58 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.966 1.098 . . . . 1.0 113.966 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.42 117.96 12.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.116 1.766 . . . . 1.0 110.885 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.16 133.17 53.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.023 0.929 . . . . 1.0 110.777 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt -103.22 167.95 9.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.011 0.924 . . . . 1.0 111.382 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.69 178.08 48.61 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.608 1.099 . . . . 1.0 113.199 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.233 1.413 . . . . 1.0 112.199 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.317 0.103 . . . . 1.0 111.261 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -74.48 32.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.318 1.847 . . . . 1.0 114.833 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -63.28 153.06 36.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.753 1.621 . . . . 1.0 112.431 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.69 134.34 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.574 1.15 . . . . 1.0 110.82 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.58 116.0 31.72 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.086 1.355 . . . . 1.0 108.219 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -84.07 146.33 27.98 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.955 1.302 . . . . 1.0 107.533 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.6 150.47 50.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.828 1.251 . . . . 1.0 109.354 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 139.71 48.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.356 1.462 . . . . 1.0 110.022 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -116.13 89.65 26.12 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.71 1.204 . . . . 1.0 111.015 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 -12.12 23.07 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.179 2.586 . . . . 1.0 115.422 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -65.0 -28.09 69.28 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.0 p -127.71 -19.45 4.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.179 1.392 . . . . 1.0 113.963 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.45 -1.97 77.03 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.235 1.398 . . . . 1.0 113.631 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.02 152.76 31.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.236 1.569 . . . . 1.0 115.236 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 t -136.58 141.62 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.953 . . . . 1.0 109.466 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.9 pt -140.84 165.87 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.017 1.727 . . . . 1.0 110.727 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -139.31 139.18 37.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.617 1.967 . . . . 1.0 110.851 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.21 158.0 43.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.344 1.458 . . . . 1.0 110.659 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.96 -3.02 59.05 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.215 1.006 . . . . 1.0 113.514 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.54 2.62 14.92 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.813 1.197 . . . . 1.0 115.288 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.11 179.05 42.86 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.468 1.134 . . . . 1.0 113.829 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -66.57 83.79 0.1 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.086 1.355 . . . . 1.0 111.991 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -99.46 94.3 6.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.328 1.451 . . . . 1.0 110.249 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -39.84 -45.64 1.83 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 128.095 2.558 . . . . 1.0 115.118 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.8 m -60.55 -39.98 89.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.222 1.009 . . . . 1.0 113.576 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.1 tp -68.67 -42.39 77.94 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.546 -0.721 . . . . 1.0 109.918 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.07 -43.6 78.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 1.0 112.282 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.7 -45.38 85.77 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.16 -41.68 98.54 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.598 -0.689 . . . . 1.0 112.115 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -61.88 -40.91 97.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.414 1.086 . . . . 1.0 110.854 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 -38.17 79.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.481 0.713 . . . . 1.0 112.846 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.01 -33.08 30.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -129.78 -3.22 4.69 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -171.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.09 129.66 6.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.448 1.499 . . . . 1.0 112.335 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.93 -35.21 78.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.544 2.163 . . . . 1.0 113.569 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.61 -39.8 80.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.73 0.696 . . . . 1.0 112.2 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.14 -49.47 72.01 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.24 0.616 . . . . 1.0 110.805 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.4 -41.55 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.297 0.639 . . . . 1.0 112.072 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.525 -1.36 . . . . 1.0 112.269 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -75.94 -21.48 56.98 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.572 -0.705 . . . . 1.0 112.897 169.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -72.85 -16.37 61.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.548 1.067 . . . . 1.0 112.871 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.6 144.13 56.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.684 0.994 . . . . 1.0 113.684 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.09 118.45 12.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.296 1.838 . . . . 1.0 110.809 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 mt -71.23 116.47 11.58 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.514 1.126 . . . . 1.0 110.375 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.8 160.97 25.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.587 0.755 . . . . 1.0 111.487 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.5 33.65 0.27 Allowed Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.741 0.657 . . . . 1.0 114.741 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.811 1.645 . . . . 1.0 111.815 -176.488 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.723 0.297 . . . . 1.0 111.453 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -76.1 -3.56 36.69 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.271 1.582 . . . . 1.0 115.271 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -51.09 150.77 2.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.653 1.981 . . . . 1.0 113.482 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.57 141.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.8 1.24 . . . . 1.0 110.833 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -111.22 120.55 42.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.47 1.508 . . . . 1.0 108.647 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.8 148.73 25.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.654 -1.239 . . . . 1.0 107.654 169.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -136.67 149.82 48.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.098 1.359 . . . . 1.0 108.851 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -131.59 144.23 50.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.357 1.463 . . . . 1.0 109.95 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.89 91.75 47.85 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.147 0.979 . . . . 1.0 111.763 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.5 -25.99 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.835 3.69 . . . . 1.0 116.976 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.42 -27.07 67.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -129.51 -17.62 3.68 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.776 1.23 . . . . 1.0 113.935 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.24 0.14 85.24 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.033 1.301 . . . . 1.0 113.826 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.19 154.72 30.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.29 1.589 . . . . 1.0 115.29 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.55 141.23 41.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 126.852 2.061 . . . . 1.0 109.405 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -139.91 163.58 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.955 1.702 . . . . 1.0 110.674 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -139.93 137.89 35.15 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.105 1.762 . . . . 1.0 111.348 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 157.78 43.03 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.187 1.395 . . . . 1.0 111.014 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.61 -4.54 58.66 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.263 1.025 . . . . 1.0 113.442 171.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.41 1.91 19.9 Favored Glycine 0 N--CA 1.478 1.438 0 C-N-CA 125.053 1.311 . . . . 1.0 114.806 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.78 179.13 38.47 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 118.576 1.188 . . . . 1.0 113.807 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -67.42 83.87 0.16 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.737 1.215 . . . . 1.0 112.186 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.06 94.03 5.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.489 1.516 . . . . 1.0 109.903 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.33 -42.47 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.664 1.986 . . . . 1.0 115.664 -169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -59.07 -39.23 81.47 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.095 0.958 . . . . 1.0 113.013 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.96 -44.82 68.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.428 0.691 . . . . 1.0 109.777 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -56.4 -43.44 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.485 0.714 . . . . 1.0 112.156 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.63 -46.62 83.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.587 0.355 . . . . 1.0 111.877 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -62.18 -41.92 98.79 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.549 -0.719 . . . . 1.0 111.937 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.39 -41.07 96.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.966 0.906 . . . . 1.0 110.778 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.22 -38.7 78.67 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.555 0.742 . . . . 1.0 112.736 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -81.38 -32.65 32.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.94 -2.31 4.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.73 128.82 6.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.125 1.345 . . . . 1.0 112.358 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.66 -35.32 81.16 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.659 2.24 . . . . 1.0 113.513 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.7 -39.53 80.47 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.867 0.758 . . . . 1.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.05 72.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.147 0.579 . . . . 1.0 110.869 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.77 -40.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.702 -0.623 . . . . 1.0 112.176 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.43 -24.79 66.5 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.364 -1.46 . . . . 1.0 112.207 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -74.7 -21.44 59.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.561 -0.712 . . . . 1.0 112.9 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -72.95 -16.5 61.53 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.428 1.013 . . . . 1.0 112.96 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.7 145.66 55.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.39 118.06 12.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.432 1.893 . . . . 1.0 111.197 170.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 mt -63.88 131.09 46.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.174 0.99 . . . . 1.0 110.543 172.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.8 mt -98.23 162.89 12.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.659 0.783 . . . . 1.0 111.479 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.41 32.11 0.39 Allowed Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.086 0.794 . . . . 1.0 115.086 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.1 t60 . . . . . 0 C--O 1.256 1.419 0 C-N-CA 124.993 1.317 . . . . 1.0 112.929 177.885 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 111.34 0.126 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.81 42.63 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.142 1.777 . . . . 1.0 114.955 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.2 156.23 29.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.691 1.196 . . . . 1.0 111.131 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.08 130.81 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.124 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -104.02 118.45 36.69 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.293 1.437 . . . . 1.0 107.854 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -85.86 145.46 27.18 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.102 1.361 . . . . 1.0 107.37 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -136.62 152.66 50.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.586 1.154 . . . . 1.0 109.565 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -133.31 144.74 49.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.406 1.483 . . . . 1.0 109.727 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -121.37 91.49 48.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.191 0.996 . . . . 1.0 111.749 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.4 -25.52 5.04 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.752 3.635 . . . . 1.0 116.898 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -65.34 -26.82 68.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 p -129.96 -17.2 3.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.952 1.301 . . . . 1.0 113.952 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.54 86.79 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.982 1.277 . . . . 1.0 114.064 -173.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.33 154.82 34.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.03 140.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.915 2.086 . . . . 1.0 109.452 172.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -141.99 164.42 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.98 1.712 . . . . 1.0 110.89 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.13 138.02 34.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.389 1.876 . . . . 1.0 110.878 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.4 156.9 41.64 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.46 1.504 . . . . 1.0 111.025 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -84.73 -2.87 58.19 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.504 1.121 . . . . 1.0 113.663 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.65 2.28 19.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.863 1.22 . . . . 1.0 114.985 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 179.35 42.16 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.292 1.046 . . . . 1.0 113.877 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.6 83.79 0.18 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.784 1.234 . . . . 1.0 112.011 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -102.51 94.12 5.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.568 1.547 . . . . 1.0 109.858 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -39.83 -45.5 1.8 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.434 2.293 . . . . 1.0 115.429 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.1 m -60.38 -39.45 87.31 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.203 1.001 . . . . 1.0 113.015 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -69.92 -43.67 71.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.348 -0.845 . . . . 1.0 109.869 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -56.36 -43.52 79.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.377 0.671 . . . . 1.0 111.952 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -58.45 -47.46 83.92 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.015 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -60.6 -42.35 96.62 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.769 -0.582 . . . . 1.0 112.109 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.69 -40.24 96.49 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 1.0 110.782 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.39 -39.25 78.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.803 0.841 . . . . 1.0 112.971 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.58 -32.73 42.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.818 1.247 . . . . 1.0 114.133 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.2 -4.31 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.87 130.72 7.12 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.405 1.478 . . . . 1.0 111.764 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.55 -34.75 84.54 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.73 2.287 . . . . 1.0 113.424 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.456 0.703 . . . . 1.0 111.951 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.61 77.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.268 0.627 . . . . 1.0 111.005 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.74 -39.86 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.8 -0.563 . . . . 1.0 112.208 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -66.72 -27.12 67.37 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.23 -1.544 . . . . 1.0 112.178 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 t -67.96 -27.07 66.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.12 -0.988 . . . . 1.0 112.277 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.7 m0 -72.33 -15.72 61.88 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.0 -1.062 . . . . 1.0 113.115 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.68 145.92 55.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.5 0.926 . . . . 1.0 113.5 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.48 117.48 11.76 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.267 1.827 . . . . 1.0 110.443 170.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.89 118.25 13.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.471 1.109 . . . . 1.0 110.345 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -81.39 157.73 24.89 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.388 0.675 . . . . 1.0 112.086 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.23 34.46 0.26 Allowed Glycine 0 CA--C 1.538 1.489 0 C-N-CA 123.6 0.619 . . . . 1.0 114.604 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.524 1.53 . . . . 1.0 111.316 -177.907 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -77.12 64.44 2.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.82 1.648 . . . . 1.0 112.58 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -134.34 154.13 51.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.344 1.857 . . . . 1.0 111.99 -172.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.1 t -77.82 137.1 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.755 1.222 . . . . 1.0 110.704 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -102.86 117.94 35.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.575 1.15 . . . . 1.0 108.554 168.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -86.63 145.64 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.223 1.409 . . . . 1.0 107.611 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -136.4 151.85 49.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.59 1.156 . . . . 1.0 109.91 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -132.83 137.82 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.279 1.432 . . . . 1.0 109.596 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -111.65 92.47 17.08 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.83 0.852 . . . . 1.0 110.586 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.75 -14.19 38.87 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.996 2.464 . . . . 1.0 114.782 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -70.32 -22.63 62.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.592 1.157 . . . . 1.0 113.55 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.2 p -127.58 -23.16 3.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.242 1.417 . . . . 1.0 113.449 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.28 -6.4 71.84 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.829 1.68 . . . . 1.0 113.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -66.93 152.79 45.03 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.164 1.542 . . . . 1.0 115.164 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.8 t -134.09 140.39 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.96 2.104 . . . . 1.0 109.191 171.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 pt -140.94 164.56 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.756 1.622 . . . . 1.0 110.766 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -139.72 137.47 35.17 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.551 1.94 . . . . 1.0 110.884 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.59 158.49 43.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.933 1.293 . . . . 1.0 111.323 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -86.43 -2.83 58.78 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.389 1.076 . . . . 1.0 113.188 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.44 3.19 19.11 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.098 1.333 . . . . 1.0 115.015 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.2 179.21 42.86 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.569 1.184 . . . . 1.0 113.907 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -67.4 83.76 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.03 1.332 . . . . 1.0 112.055 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -104.67 94.38 5.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.704 1.602 . . . . 1.0 109.865 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -41.5 -43.2 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.832 2.053 . . . . 1.0 115.547 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -60.19 -37.82 81.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.044 0.938 . . . . 1.0 113.096 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -71.64 -44.25 64.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.273 0.629 . . . . 1.0 109.604 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -56.8 -43.14 80.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.436 0.694 . . . . 1.0 112.06 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -57.28 -44.78 84.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 172.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.18 -41.36 90.37 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.069 -0.394 . . . . 1.0 112.052 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -62.12 -38.73 90.04 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.986 0.812 . . . . 1.0 110.703 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.16 75.8 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.755 0.822 . . . . 1.0 112.916 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -98.4 -16.1 19.41 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.972 1.842 . . . . 1.0 115.972 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -130.84 -8.24 3.98 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.761 1.393 . . . . 1.0 114.761 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.36 134.25 8.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.379 1.466 . . . . 1.0 112.161 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.42 -35.88 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.605 2.203 . . . . 1.0 113.228 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -39.56 86.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.553 0.741 . . . . 1.0 111.693 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.54 78.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.398 0.679 . . . . 1.0 111.453 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.7 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.945 -0.472 . . . . 1.0 112.205 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -65.86 -27.15 68.01 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.514 -1.366 . . . . 1.0 112.239 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -68.64 -27.57 66.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.958 0.799 . . . . 1.0 112.394 170.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -72.15 -15.92 61.98 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.054 -1.029 . . . . 1.0 112.85 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.08 147.28 53.59 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.19 120.36 14.71 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.293 1.837 . . . . 1.0 110.761 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.15 116.0 15.4 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.647 1.179 . . . . 1.0 110.295 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.1 mt -78.95 160.76 27.09 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.33 0.652 . . . . 1.0 111.815 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.4 36.51 0.32 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.73 0.681 . . . . 1.0 114.449 -176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.485 1.514 . . . . 1.0 112.577 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.669 0.271 . . . . 1.0 111.428 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -76.9 -2.52 33.96 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.381 1.623 . . . . 1.0 115.381 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -51.75 153.79 2.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.599 1.959 . . . . 1.0 114.161 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.9 t -76.17 139.55 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.475 1.51 . . . . 1.0 111.05 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -106.42 119.82 40.26 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.45 1.5 . . . . 1.0 107.829 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -86.35 145.29 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.164 1.386 . . . . 1.0 107.279 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -136.2 152.09 50.4 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.737 1.215 . . . . 1.0 109.698 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -133.92 144.5 48.87 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.599 1.56 . . . . 1.0 109.435 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.67 93.94 44.74 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.763 0.825 . . . . 1.0 111.453 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.21 -26.09 7.7 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.476 3.451 . . . . 1.0 116.441 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -72.07 -21.96 61.43 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.987 1.106 . . . . 1.0 113.987 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -128.91 -21.75 3.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.095 1.358 . . . . 1.0 113.545 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.21 -6.74 82.42 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.544 1.545 . . . . 1.0 113.797 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.25 152.65 45.35 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.874 1.435 . . . . 1.0 114.874 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.05 139.97 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 127.07 2.148 . . . . 1.0 109.177 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -141.7 164.42 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.017 1.727 . . . . 1.0 110.832 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -140.51 136.06 32.53 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.326 1.851 . . . . 1.0 110.872 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.71 157.3 41.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.872 1.269 . . . . 1.0 111.173 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.96 -4.78 58.64 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.929 -1.107 . . . . 1.0 113.711 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.65 2.43 17.1 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.841 1.21 . . . . 1.0 114.925 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.87 179.12 38.8 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 118.415 1.107 . . . . 1.0 113.803 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -68.13 83.74 0.23 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.585 1.154 . . . . 1.0 112.127 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -102.87 94.92 5.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.616 1.566 . . . . 1.0 109.771 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -41.57 -43.18 2.64 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 126.784 2.034 . . . . 1.0 115.699 -170.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -37.97 79.39 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.229 1.011 . . . . 1.0 113.269 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -44.14 63.89 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.353 0.661 . . . . 1.0 109.764 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.09 -43.4 78.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.484 0.714 . . . . 1.0 111.871 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.97 -44.56 87.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.47 -40.92 89.63 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.985 -0.447 . . . . 1.0 112.015 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -62.73 -38.75 91.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.048 0.84 . . . . 1.0 110.388 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -36.3 75.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 1.0 113.169 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.1 -16.77 19.42 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.843 1.794 . . . . 1.0 115.843 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -130.72 -9.16 4.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 134.18 8.07 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.436 1.493 . . . . 1.0 111.98 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 -34.68 71.87 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.522 2.148 . . . . 1.0 113.098 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.74 -39.84 84.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.62 0.768 . . . . 1.0 111.913 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.87 80.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 1.0 111.108 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.96 -41.03 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.731 -0.605 . . . . 1.0 112.126 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.6 -30.04 71.21 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.45 -1.406 . . . . 1.0 112.123 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 t -67.99 -27.54 66.66 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.343 -0.848 . . . . 1.0 112.523 171.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -72.74 -15.44 61.66 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.15 -0.969 . . . . 1.0 113.065 170.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.04 147.53 53.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.692 0.997 . . . . 1.0 113.692 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.08 116.64 11.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.297 1.839 . . . . 1.0 110.323 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.23 132.04 46.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.962 0.905 . . . . 1.0 110.347 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.2 mt -82.29 48.59 1.29 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.959 0.885 . . . . 1.0 112.293 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.75 174.14 42.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.889 1.709 . . . . 1.0 113.076 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.367 0 C-N-CA 125.436 1.494 . . . . 1.0 112.307 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 58.06 30.63 19.56 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.521 2.328 . . . . 1.0 116.239 169.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -137.73 157.82 45.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.89 1.676 . . . . 1.0 112.431 -175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.85 138.61 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.819 1.648 . . . . 1.0 109.942 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -104.74 119.21 38.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.918 1.287 . . . . 1.0 108.657 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -86.45 145.89 26.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.221 -1.4 . . . . 1.0 107.221 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -135.9 152.5 51.07 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.615 1.166 . . . . 1.0 109.61 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -133.05 144.97 50.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.412 1.485 . . . . 1.0 109.184 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -118.03 92.12 41.48 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.179 0.992 . . . . 1.0 110.946 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.34 -27.16 12.87 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.307 3.338 . . . . 1.0 116.077 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.04 -15.71 59.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 p -128.91 -22.51 3.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.931 1.292 . . . . 1.0 113.802 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.49 80.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.928 1.727 . . . . 1.0 114.171 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.09 154.5 41.85 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.143 1.535 . . . . 1.0 115.143 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.26 140.16 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.326 2.25 . . . . 1.0 109.205 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -142.67 165.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.036 1.734 . . . . 1.0 110.994 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -138.87 138.92 37.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.74 2.016 . . . . 1.0 111.002 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.29 158.44 43.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.463 1.505 . . . . 1.0 110.977 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.52 -3.21 58.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.275 1.03 . . . . 1.0 113.545 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.94 4.32 22.76 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.091 1.329 . . . . 1.0 114.866 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 179.32 38.66 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.277 1.039 . . . . 1.0 113.789 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -65.45 83.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.222 1.409 . . . . 1.0 112.212 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -103.08 94.04 5.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.574 1.549 . . . . 1.0 110.341 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -39.77 -45.53 1.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 128.093 2.557 . . . . 1.0 115.441 -171.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.4 m -61.21 -39.87 91.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.172 0.989 . . . . 1.0 113.425 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.96 -42.66 72.88 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.643 -0.661 . . . . 1.0 109.772 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.43 -44.11 75.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.456 0.703 . . . . 1.0 112.181 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -57.66 -44.16 85.48 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -65.2 -41.46 94.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.003 -0.435 . . . . 1.0 112.028 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -62.46 -39.03 92.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.887 0.875 . . . . 1.0 110.463 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.98 76.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.037 0.935 . . . . 1.0 113.124 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -98.07 -18.11 18.73 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.853 1.797 . . . . 1.0 115.853 -171.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -129.4 -8.11 4.7 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.61 134.16 8.28 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.467 1.508 . . . . 1.0 111.937 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.85 -34.3 72.64 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.5 2.133 . . . . 1.0 113.065 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.08 -39.49 82.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.51 0.724 . . . . 1.0 112.072 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.97 76.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.458 0.703 . . . . 1.0 110.973 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.54 -41.2 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.126 0.57 . . . . 1.0 112.305 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.98 -28.26 68.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.437 -1.414 . . . . 1.0 112.241 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 m -68.91 -22.83 64.14 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 30.0 m0 -76.73 -14.19 59.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.009 0.923 . . . . 1.0 112.975 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.08 147.86 51.76 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.21 0.914 . . . . 1.0 113.362 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -139.11 117.65 12.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.57 1.948 . . . . 1.0 110.687 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -71.19 123.99 23.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.479 1.112 . . . . 1.0 110.782 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.9 mt -86.25 41.27 0.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.165 0.986 . . . . 1.0 112.556 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.58 176.13 39.2 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.546 1.546 . . . . 1.0 113.362 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.812 1.645 . . . . 1.0 112.226 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 53.14 34.3 17.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -136.23 159.39 41.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.175 1.79 . . . . 1.0 112.089 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.66 137.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.265 1.826 . . . . 1.0 110.39 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -100.65 115.52 30.42 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.375 1.07 . . . . 1.0 108.841 168.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.15 145.87 28.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 1.0 107.539 169.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -133.76 149.82 51.46 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.754 1.222 . . . . 1.0 109.074 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -130.97 144.39 51.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.517 1.527 . . . . 1.0 109.306 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -118.34 92.61 43.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.873 . . . . 1.0 111.62 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.57 -26.34 8.96 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.299 3.333 . . . . 1.0 116.78 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -18.19 57.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.02 1.118 . . . . 1.0 114.02 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -130.83 -21.22 2.75 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.08 81.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.814 1.673 . . . . 1.0 114.154 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.3 156.44 37.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.326 1.602 . . . . 1.0 115.326 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.39 140.77 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 127.141 2.176 . . . . 1.0 109.109 169.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.7 pt -140.19 166.24 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.861 1.664 . . . . 1.0 110.612 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -140.06 138.45 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.58 1.952 . . . . 1.0 111.072 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.24 159.27 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.374 1.469 . . . . 1.0 110.966 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -86.67 -2.65 58.7 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.035 -1.041 . . . . 1.0 113.314 171.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.74 4.57 22.92 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.183 1.373 . . . . 1.0 114.945 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.07 179.18 45.59 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.327 1.063 . . . . 1.0 113.871 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.18 83.99 0.09 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.987 1.315 . . . . 1.0 112.143 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -105.3 94.08 5.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.687 1.595 . . . . 1.0 109.812 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -42.01 -43.77 3.29 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.763 2.025 . . . . 1.0 115.47 -169.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -59.23 -39.16 81.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.055 0.942 . . . . 1.0 112.945 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.21 -44.69 71.57 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.682 -0.636 . . . . 1.0 109.851 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -57.07 -42.81 81.3 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.636 0.774 . . . . 1.0 112.168 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -57.73 -45.87 85.21 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.082 0.401 . . . . 1.0 112.082 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -62.4 -41.7 98.87 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.725 -0.609 . . . . 1.0 112.133 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.33 -41.42 96.98 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.009 0.924 . . . . 1.0 110.806 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.81 78.15 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.031 0.752 . . . . 1.0 113.031 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.05 -33.19 30.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.449 1.278 . . . . 1.0 114.449 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.19 -2.95 4.47 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.363 1.616 . . . . 1.0 115.363 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.38 129.23 6.56 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.433 1.492 . . . . 1.0 112.477 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.92 -35.59 76.86 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.78 2.32 . . . . 1.0 113.564 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -39.75 80.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.843 0.747 . . . . 1.0 112.18 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.21 -49.57 71.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.228 0.611 . . . . 1.0 110.816 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -40.63 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.317 0.647 . . . . 1.0 112.146 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.1 -25.38 66.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.494 -1.379 . . . . 1.0 112.178 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -74.72 -21.25 59.47 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 169.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -73.41 -16.5 61.33 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.38 0.991 . . . . 1.0 113.118 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.22 144.39 56.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.6 p -139.02 121.14 15.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.482 1.913 . . . . 1.0 110.923 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.67 115.13 12.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.542 1.137 . . . . 1.0 110.642 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.5 mt -76.23 161.08 29.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.32 0.648 . . . . 1.0 111.895 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.65 178.32 48.67 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.444 1.021 . . . . 1.0 113.479 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--O 1.256 1.422 0 C-N-CA 125.674 1.589 . . . . 1.0 111.537 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 57.97 21.55 7.85 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 118.094 2.628 . . . . 1.0 118.094 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -70.61 155.07 41.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.819 0.847 . . . . 1.0 111.396 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.9 134.19 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.544 1.138 . . . . 1.0 111.5 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -99.64 115.6 29.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.702 1.201 . . . . 1.0 108.04 168.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -84.91 145.78 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.127 1.371 . . . . 1.0 107.471 168.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -136.69 153.59 50.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.617 1.167 . . . . 1.0 109.583 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -133.61 144.68 49.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.397 1.479 . . . . 1.0 109.837 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.73 91.8 47.54 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.245 1.018 . . . . 1.0 111.817 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.06 -25.65 4.35 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.797 3.665 . . . . 1.0 117.079 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -65.49 -27.3 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -129.85 -17.85 3.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.956 1.303 . . . . 1.0 113.895 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.87 0.5 85.73 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.031 1.3 . . . . 1.0 113.906 -173.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.64 154.39 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.81 140.78 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.827 2.051 . . . . 1.0 109.478 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.1 pt -142.49 165.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.979 1.712 . . . . 1.0 110.968 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.85 138.87 36.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.61 1.964 . . . . 1.0 111.068 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.67 157.48 42.16 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.29 1.436 . . . . 1.0 110.733 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -83.82 -3.79 58.15 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 171.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.81 3.07 20.39 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.063 1.316 . . . . 1.0 114.878 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.34 41.95 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.371 1.086 . . . . 1.0 113.961 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -66.5 83.66 0.1 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.015 1.326 . . . . 1.0 112.302 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -103.99 94.1 5.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.516 1.527 . . . . 1.0 109.474 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -44.33 -41.96 6.41 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.478 1.911 . . . . 1.0 115.422 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -59.28 -39.22 82.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.801 0.841 . . . . 1.0 112.958 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.97 -43.0 69.0 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.664 -0.648 . . . . 1.0 109.899 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.61 -42.99 79.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 1.0 112.125 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.66 -46.79 83.78 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.712 0.405 . . . . 1.0 111.827 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -62.13 -41.96 98.76 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.697 -0.627 . . . . 1.0 112.101 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -62.79 -39.99 95.96 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 1.0 110.615 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.48 -39.43 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.63 0.772 . . . . 1.0 112.71 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -80.3 -32.41 38.08 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 1.0 114.245 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.27 -4.29 4.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.15 1.537 . . . . 1.0 115.15 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.0 131.41 7.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.567 1.555 . . . . 1.0 111.959 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 -34.69 80.37 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.664 2.243 . . . . 1.0 113.42 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.72 -39.83 84.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.301 0.64 . . . . 1.0 112.061 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.43 -47.15 77.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.08 0.552 . . . . 1.0 111.094 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.0 -40.02 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.775 -0.578 . . . . 1.0 111.919 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.21 -27.6 68.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.273 -1.517 . . . . 1.0 112.43 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 t -67.58 -27.37 66.87 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.214 -0.929 . . . . 1.0 112.279 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -72.3 -15.17 61.9 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.046 -1.034 . . . . 1.0 113.141 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.14 145.79 54.92 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.396 0.888 . . . . 1.0 113.396 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.18 117.62 12.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.421 1.888 . . . . 1.0 110.545 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.94 116.33 12.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.681 1.192 . . . . 1.0 110.406 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.69 173.68 12.21 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.9 0.88 . . . . 1.0 111.644 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.59 6.63 52.46 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 115.689 1.036 . . . . 1.0 115.689 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.255 1.35 0 C-N-CA 126.394 1.878 . . . . 1.0 111.616 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.428 0.633 . . . . 1.0 112.607 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -135.76 34.36 2.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.843 2.057 . . . . 1.0 110.026 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -138.27 157.79 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.17 2.188 . . . . 1.0 112.696 -169.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.0 t -81.0 141.4 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.382 1.473 . . . . 1.0 110.245 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.36 120.38 42.24 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.235 1.414 . . . . 1.0 108.872 169.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.36 149.49 24.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -136.62 150.15 48.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.113 1.365 . . . . 1.0 108.728 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -132.24 144.45 50.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.204 1.401 . . . . 1.0 109.698 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -120.8 91.4 47.4 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.292 1.037 . . . . 1.0 111.702 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -47.15 -25.6 4.5 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.955 3.77 . . . . 1.0 116.987 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -66.47 -26.56 67.25 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.734 1.013 . . . . 1.0 113.734 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 p -130.02 -18.26 3.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.082 1.353 . . . . 1.0 113.735 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.28 -0.85 83.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.9 1.238 . . . . 1.0 113.909 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.05 153.76 28.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.31 1.596 . . . . 1.0 115.31 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.46 140.87 42.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.839 2.056 . . . . 1.0 109.455 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.7 pt -140.28 164.35 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.02 1.728 . . . . 1.0 110.527 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -139.5 138.8 36.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.104 1.762 . . . . 1.0 111.096 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -150.87 158.69 44.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.454 1.502 . . . . 1.0 111.178 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.74 -3.13 58.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.691 1.196 . . . . 1.0 113.349 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.01 1.39 19.15 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.844 1.211 . . . . 1.0 114.993 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.83 179.11 41.87 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 118.484 1.142 . . . . 1.0 113.875 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -67.75 83.78 0.19 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.398 1.079 . . . . 1.0 112.378 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -98.71 93.97 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.698 1.599 . . . . 1.0 109.557 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -44.4 -41.35 6.11 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.117 2.167 . . . . 1.0 115.052 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -60.43 -38.14 83.16 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.309 1.044 . . . . 1.0 113.278 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -69.56 -43.78 72.2 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.399 -0.813 . . . . 1.0 109.812 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -55.78 -43.51 76.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.537 0.735 . . . . 1.0 112.386 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.25 -46.94 82.55 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.985 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -62.05 -41.14 97.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.679 -0.638 . . . . 1.0 112.364 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.94 -41.09 97.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.242 1.017 . . . . 1.0 110.733 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.03 -37.92 78.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.932 0.893 . . . . 1.0 112.761 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -81.78 -32.62 31.29 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.535 1.309 . . . . 1.0 114.535 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -130.66 -3.41 4.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.08 129.37 6.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.283 1.42 . . . . 1.0 112.319 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.24 79.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.831 2.354 . . . . 1.0 113.364 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.32 -40.09 81.77 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.934 0.788 . . . . 1.0 111.987 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.48 72.51 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.357 0.663 . . . . 1.0 110.938 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.37 -41.37 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.247 0.619 . . . . 1.0 112.217 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -66.23 -25.08 66.74 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.434 -1.416 . . . . 1.0 112.073 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 m -74.38 -21.64 59.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -73.0 -15.79 61.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.349 0.977 . . . . 1.0 113.112 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.04 145.24 56.59 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.43 118.71 12.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.378 1.871 . . . . 1.0 111.086 170.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.1 mt -64.84 131.71 47.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.195 0.998 . . . . 1.0 110.641 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.02 166.36 11.63 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.675 0.79 . . . . 1.0 111.758 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.56 178.62 48.37 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.507 1.051 . . . . 1.0 113.551 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.268 0 C-N-CA 125.771 1.628 . . . . 1.0 111.525 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 120.526 0.203 . . . . 1.0 111.435 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -76.93 -3.11 37.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.624 1.713 . . . . 1.0 115.624 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -51.17 151.11 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.933 1.693 . . . . 1.0 113.129 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.74 137.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.682 1.593 . . . . 1.0 111.45 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -102.47 116.86 33.47 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.867 1.267 . . . . 1.0 108.257 168.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -84.46 146.32 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.106 1.363 . . . . 1.0 107.427 169.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -135.18 150.0 50.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.734 1.214 . . . . 1.0 109.257 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -132.79 138.02 46.99 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 1.0 109.834 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -112.45 91.31 16.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.242 1.017 . . . . 1.0 110.68 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.43 -14.47 39.29 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.843 2.362 . . . . 1.0 114.675 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -69.22 -23.76 63.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.494 1.118 . . . . 1.0 113.644 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.7 p -127.01 -22.2 3.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.993 1.317 . . . . 1.0 113.51 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.36 -4.83 74.09 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.664 1.602 . . . . 1.0 113.808 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -66.2 153.31 42.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.132 1.53 . . . . 1.0 115.132 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.8 140.39 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.851 2.06 . . . . 1.0 109.173 171.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.8 pt -139.53 165.79 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.639 1.576 . . . . 1.0 110.599 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -140.74 136.96 33.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.256 1.823 . . . . 1.0 110.737 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.49 157.2 41.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.94 1.296 . . . . 1.0 111.227 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -85.05 -4.37 59.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.21 1.004 . . . . 1.0 113.475 171.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.72 1.97 14.81 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.317 1.436 . . . . 1.0 114.995 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.46 178.84 41.18 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.392 1.096 . . . . 1.0 114.159 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.88 83.9 0.21 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.869 1.268 . . . . 1.0 112.027 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -103.82 94.04 5.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.821 1.648 . . . . 1.0 109.843 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -43.5 -40.99 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.386 1.875 . . . . 1.0 115.588 -169.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -59.13 -37.11 76.44 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.976 0.91 . . . . 1.0 113.028 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.5 tp -70.87 -45.29 64.68 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.447 0.699 . . . . 1.0 109.784 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.67 -43.51 80.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.789 0.836 . . . . 1.0 112.1 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.01 -44.1 82.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.43 -41.2 89.53 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.046 -0.409 . . . . 1.0 112.0 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.02 -40.16 92.5 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.857 0.753 . . . . 1.0 110.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.02 77.17 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.002 0.921 . . . . 1.0 113.033 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -98.48 -16.76 19.07 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.007 1.854 . . . . 1.0 116.007 -171.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -132.75 -6.48 3.19 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.029 1.492 . . . . 1.0 115.029 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.39 132.77 7.58 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.322 1.439 . . . . 1.0 112.464 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.79 -36.28 63.09 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.709 2.273 . . . . 1.0 113.542 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.5 -39.51 81.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.765 0.712 . . . . 1.0 112.021 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.33 73.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.397 0.679 . . . . 1.0 110.762 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.92 -40.9 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.339 0.656 . . . . 1.0 112.073 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -66.13 -24.45 66.68 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.492 -1.38 . . . . 1.0 112.217 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 m -75.55 -21.88 57.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.859 0.689 . . . . 1.0 112.859 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -72.94 -17.49 61.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.572 1.078 . . . . 1.0 112.892 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 145.23 54.41 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.05 119.64 14.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.286 1.834 . . . . 1.0 110.96 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.0 mt -70.84 119.5 15.07 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.361 1.064 . . . . 1.0 110.434 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.36 172.86 13.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.335 0.654 . . . . 1.0 111.552 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.73 3.57 59.79 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.31 0.957 . . . . 1.0 115.454 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 126.771 2.029 . . . . 1.0 111.599 -175.651 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -75.47 33.68 0.11 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.306 1.843 . . . . 1.0 114.639 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.68 152.68 34.74 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.545 1.538 . . . . 1.0 111.952 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.29 136.22 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.129 0.972 . . . . 1.0 110.138 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -111.91 121.92 46.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.653 1.581 . . . . 1.0 108.938 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.63 149.15 25.12 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.665 -1.235 . . . . 1.0 107.665 168.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -136.19 149.11 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.138 1.375 . . . . 1.0 108.699 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.98 143.72 50.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.225 1.41 . . . . 1.0 109.776 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.52 91.62 46.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.015 0.926 . . . . 1.0 111.821 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.27 -25.6 4.81 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.778 3.652 . . . . 1.0 116.714 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -65.95 -27.12 67.93 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.1 p -130.15 -16.49 3.58 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.01 1.324 . . . . 1.0 113.976 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.98 -0.2 87.57 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.002 1.287 . . . . 1.0 113.922 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.01 154.84 29.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -136.49 141.42 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.88 2.072 . . . . 1.0 109.494 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.9 pt -140.24 163.29 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.798 1.639 . . . . 1.0 110.457 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -140.21 137.63 34.46 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.133 1.773 . . . . 1.0 111.417 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.39 159.88 44.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.602 1.561 . . . . 1.0 111.02 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.34 -0.72 57.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.484 1.114 . . . . 1.0 113.611 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.32 5.2 23.19 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.836 1.208 . . . . 1.0 114.873 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.39 179.26 40.23 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.419 1.109 . . . . 1.0 113.864 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.26 83.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.016 1.327 . . . . 1.0 112.029 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -104.75 93.97 5.03 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.57 1.548 . . . . 1.0 109.737 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -45.38 -41.3 8.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.071 1.749 . . . . 1.0 115.365 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -58.73 -38.84 79.24 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.848 0.859 . . . . 1.0 112.893 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.94 -44.17 70.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.436 -0.79 . . . . 1.0 109.799 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -56.85 -43.36 81.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.691 0.796 . . . . 1.0 112.378 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.5 -46.06 84.19 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.72 0.408 . . . . 1.0 112.018 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -42.01 98.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.724 -0.61 . . . . 1.0 112.039 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.67 -41.28 97.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.938 0.895 . . . . 1.0 110.786 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.1 78.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.598 0.759 . . . . 1.0 112.898 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.61 -33.2 31.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.64 -2.86 4.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.347 1.61 . . . . 1.0 115.347 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.56 128.77 6.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.378 1.465 . . . . 1.0 112.256 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 -35.1 81.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.745 2.297 . . . . 1.0 113.279 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.61 -39.9 80.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.877 0.762 . . . . 1.0 112.242 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.84 73.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.403 0.681 . . . . 1.0 110.757 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -41.21 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.057 0.543 . . . . 1.0 112.25 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -66.05 -25.03 66.85 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.424 -1.423 . . . . 1.0 112.29 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.9 m -74.1 -21.99 59.67 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.461 -0.774 . . . . 1.0 112.732 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -72.85 -16.48 61.59 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.477 1.035 . . . . 1.0 112.939 170.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.74 57.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.02 117.94 12.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.218 1.807 . . . . 1.0 111.352 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.99 136.99 57.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.274 1.029 . . . . 1.0 110.723 172.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.1 mt -103.83 44.98 0.98 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.096 0.958 . . . . 1.0 112.603 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.93 177.16 47.92 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.524 1.059 . . . . 1.0 114.146 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.5 t60 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.812 1.645 . . . . 1.0 111.104 -178.433 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.626 0.25 . . . . 1.0 111.625 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -76.92 62.87 2.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.816 1.646 . . . . 1.0 112.967 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -134.25 154.05 51.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.616 1.967 . . . . 1.0 112.134 -172.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.83 138.92 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.863 1.265 . . . . 1.0 110.621 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -105.63 119.14 38.37 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.913 1.285 . . . . 1.0 108.365 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -86.89 148.09 25.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.463 -1.31 . . . . 1.0 107.463 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -138.25 151.19 47.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.872 1.269 . . . . 1.0 109.36 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -131.14 145.48 51.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.699 1.6 . . . . 1.0 109.072 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.57 94.11 44.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.738 0.815 . . . . 1.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.81 -26.85 10.31 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.348 3.365 . . . . 1.0 116.501 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.03 -17.81 56.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -130.62 -20.82 2.86 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.98 -6.2 82.86 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.996 1.76 . . . . 1.0 114.357 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -68.88 156.27 38.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.183 1.549 . . . . 1.0 115.183 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.72 140.11 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 127.271 2.229 . . . . 1.0 109.312 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -141.83 163.67 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.919 1.688 . . . . 1.0 110.954 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -139.45 138.7 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.218 1.807 . . . . 1.0 111.335 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.17 158.56 44.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.197 1.399 . . . . 1.0 110.927 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.417 1.087 . . . . 1.0 113.52 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.63 2.49 20.98 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.179 1.371 . . . . 1.0 114.85 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.98 179.39 38.72 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.379 1.089 . . . . 1.0 113.809 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -67.44 83.95 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.71 1.204 . . . . 1.0 112.047 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -102.72 93.92 5.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.422 1.489 . . . . 1.0 109.603 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -44.74 -40.73 6.26 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.316 1.846 . . . . 1.0 115.509 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.0 m -58.8 -38.97 79.75 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.843 0.857 . . . . 1.0 113.096 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.29 -43.69 66.64 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.536 -0.727 . . . . 1.0 109.646 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -56.16 -42.99 77.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.329 0.651 . . . . 1.0 112.294 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.74 -47.11 83.37 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.7 0.4 . . . . 1.0 111.477 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -62.62 -41.48 99.03 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.575 -0.703 . . . . 1.0 112.327 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -63.1 -39.88 95.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.954 0.902 . . . . 1.0 110.591 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.89 -39.18 79.89 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.703 0.801 . . . . 1.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -81.35 -32.73 32.81 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -174.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -128.75 -5.48 5.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.125 1.528 . . . . 1.0 115.125 -172.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.38 131.91 7.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.28 1.419 . . . . 1.0 111.909 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.63 -35.29 81.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.78 2.32 . . . . 1.0 113.073 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.77 -40.15 84.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.307 0.643 . . . . 1.0 111.761 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.26 76.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.347 0.659 . . . . 1.0 111.288 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.44 -40.01 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.744 -0.597 . . . . 1.0 112.317 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -66.9 -27.98 67.94 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.472 -1.393 . . . . 1.0 112.337 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.8 t -67.5 -26.83 66.55 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.418 -0.801 . . . . 1.0 112.429 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -72.77 -14.9 61.63 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.281 -0.887 . . . . 1.0 113.028 170.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.3 51.85 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.48 119.39 13.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.412 1.885 . . . . 1.0 110.905 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.11 122.17 18.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.625 1.17 . . . . 1.0 110.584 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.99 163.94 17.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.62 0.768 . . . . 1.0 111.672 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.18 179.49 48.0 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.397 0.999 . . . . 1.0 113.439 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.981 1.712 . . . . 1.0 111.198 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.489 0.185 . . . . 1.0 111.361 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.6 -0.29 29.2 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 115.39 1.626 . . . . 1.0 115.39 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -52.52 150.3 5.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.97 1.708 . . . . 1.0 113.24 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.87 134.03 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.295 1.038 . . . . 1.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.29 119.16 38.39 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.196 1.399 . . . . 1.0 107.951 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.54 145.83 26.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.042 1.337 . . . . 1.0 107.401 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -136.09 151.33 49.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.572 1.149 . . . . 1.0 109.518 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -130.57 145.59 51.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.575 1.55 . . . . 1.0 109.31 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -117.56 93.69 43.96 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.91 0.884 . . . . 1.0 111.894 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.44 -26.79 9.19 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.294 3.33 . . . . 1.0 116.662 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -78.51 -16.92 56.96 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -131.37 -21.14 2.6 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.13 -5.66 82.94 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.654 1.597 . . . . 1.0 114.201 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.83 155.75 39.65 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.0 140.31 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.1 2.16 . . . . 1.0 109.117 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.67 164.52 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.977 1.711 . . . . 1.0 110.837 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -139.42 138.7 36.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.519 1.928 . . . . 1.0 110.891 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.28 156.63 41.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.586 1.555 . . . . 1.0 111.186 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.25 -3.03 58.68 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.502 1.121 . . . . 1.0 113.657 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 2.17 20.79 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.858 1.218 . . . . 1.0 114.98 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.9 179.02 39.11 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.503 1.152 . . . . 1.0 113.729 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.4 83.71 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.405 1.082 . . . . 1.0 112.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -98.89 94.06 6.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.639 1.576 . . . . 1.0 109.291 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 -43.09 6.56 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.254 1.822 . . . . 1.0 114.73 -169.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.5 m -57.73 -39.3 76.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.116 0.966 . . . . 1.0 112.88 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.7 tp -69.51 -43.41 73.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.385 0.674 . . . . 1.0 109.716 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -55.98 -44.51 78.62 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.44 0.696 . . . . 1.0 112.18 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.07 -45.48 87.04 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -41.82 98.47 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.507 -0.746 . . . . 1.0 112.232 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.89 -39.79 95.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.382 1.073 . . . . 1.0 110.661 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.84 76.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.623 0.769 . . . . 1.0 112.795 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -80.86 -33.01 34.75 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.296 1.221 . . . . 1.0 114.296 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -128.64 -5.72 5.21 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.69 132.14 7.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.69 1.614 . . . . 1.0 111.88 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.12 -34.61 79.02 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.706 2.271 . . . . 1.0 113.321 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.0 -39.78 83.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.477 0.711 . . . . 1.0 112.019 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.95 76.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.286 0.634 . . . . 1.0 111.032 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.363 0.505 . . . . 1.0 112.363 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.37 -28.41 68.62 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.461 -1.399 . . . . 1.0 112.07 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -22.86 64.76 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.538 -0.726 . . . . 1.0 112.752 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -76.51 -14.27 60.04 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.9 0.88 . . . . 1.0 113.068 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.35 147.55 51.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -139.42 117.27 11.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.445 1.898 . . . . 1.0 110.522 171.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.64 122.61 20.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.655 1.182 . . . . 1.0 110.322 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.58 47.94 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.155 0.982 . . . . 1.0 112.36 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.37 -4.35 80.73 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.257 1.408 . . . . 1.0 115.323 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.242 1.817 . . . . 1.0 111.156 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 111.552 0.205 . . . . 1.0 111.552 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.28 36.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.343 1.857 . . . . 1.0 114.48 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -63.29 153.85 33.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.713 1.605 . . . . 1.0 112.119 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.48 139.13 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.714 1.206 . . . . 1.0 110.796 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.71 120.66 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.488 1.515 . . . . 1.0 108.438 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -86.3 148.83 25.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -136.75 148.28 47.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 1.0 108.924 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -129.78 139.43 51.27 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.971 1.309 . . . . 1.0 109.723 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -115.07 90.66 24.22 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.571 1.148 . . . . 1.0 110.856 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.85 -12.74 26.97 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.185 2.59 . . . . 1.0 115.275 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -65.26 -27.52 68.7 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.3 p -128.07 -19.28 4.0 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.991 1.316 . . . . 1.0 113.734 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.32 79.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.11 1.338 . . . . 1.0 113.808 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.09 153.81 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.38 1.622 . . . . 1.0 115.38 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.19 141.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.682 1.993 . . . . 1.0 109.45 171.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.6 pt -140.05 163.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.902 1.681 . . . . 1.0 110.413 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -139.97 137.94 35.13 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.222 1.809 . . . . 1.0 111.276 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.38 159.07 44.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.219 1.408 . . . . 1.0 110.767 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -86.38 -3.07 58.93 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.277 1.031 . . . . 1.0 113.398 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.3 2.55 17.85 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.178 1.37 . . . . 1.0 115.071 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.0 179.13 42.37 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 118.379 1.09 . . . . 1.0 113.777 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.19 83.73 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.781 1.232 . . . . 1.0 112.38 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -103.54 93.98 5.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.54 1.536 . . . . 1.0 109.777 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -44.08 -41.13 5.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.305 1.842 . . . . 1.0 115.61 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -58.66 -38.04 77.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.896 0.878 . . . . 1.0 112.986 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.0 tp -70.56 -45.14 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.475 0.71 . . . . 1.0 109.614 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -56.37 -42.85 78.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.59 0.756 . . . . 1.0 112.441 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -57.45 -46.87 83.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.85 0.46 . . . . 1.0 111.58 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -62.68 -41.65 99.2 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.53 -0.731 . . . . 1.0 112.144 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -62.0 -40.57 96.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.791 0.836 . . . . 1.0 110.72 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.28 81.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.799 0.84 . . . . 1.0 112.883 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -82.01 -32.12 30.69 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -130.02 -4.19 4.51 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.297 1.591 . . . . 1.0 115.297 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 130.17 6.8 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.095 1.331 . . . . 1.0 112.326 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.14 -35.92 72.56 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.846 2.364 . . . . 1.0 113.359 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.15 -39.8 82.55 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.638 0.654 . . . . 1.0 112.052 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.527 0.731 . . . . 1.0 111.067 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.59 -40.28 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.178 0.591 . . . . 1.0 112.066 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -66.33 -25.07 66.65 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.376 -1.453 . . . . 1.0 112.413 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 t -73.12 -25.55 60.9 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.497 -0.752 . . . . 1.0 112.613 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -69.56 -17.31 63.55 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.781 -1.199 . . . . 1.0 113.084 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.53 55.96 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 118.51 12.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 1.0 111.179 170.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.74 131.34 47.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.031 0.932 . . . . 1.0 110.676 171.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt -99.79 166.83 10.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.999 0.92 . . . . 1.0 111.404 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.21 47.31 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.31 0.957 . . . . 1.0 113.581 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.566 1.547 . . . . 1.0 111.426 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 111.788 0.292 . . . . 1.0 111.788 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 54.92 29.75 12.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 126.787 2.035 . . . . 1.0 116.415 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.69 158.41 30.19 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.06 0.944 . . . . 1.0 111.715 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.7 t -66.03 137.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.832 1.253 . . . . 1.0 111.858 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -105.33 118.4 36.45 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.543 1.537 . . . . 1.0 108.005 168.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.33 148.24 26.13 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 168.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -135.84 150.03 49.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.95 1.3 . . . . 1.0 109.129 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.473 1.509 . . . . 1.0 109.387 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.38 93.02 41.94 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.121 0.969 . . . . 1.0 111.8 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.52 -26.46 8.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.41 3.407 . . . . 1.0 116.62 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -77.84 -17.97 56.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -131.57 -20.1 2.64 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.514 1.301 . . . . 1.0 114.514 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.65 -5.35 83.72 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.897 1.713 . . . . 1.0 114.15 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.23 156.51 37.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.299 1.592 . . . . 1.0 115.299 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.28 140.22 46.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 1.0 109.23 169.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.4 pt -140.53 164.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.874 1.669 . . . . 1.0 110.707 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -140.48 137.67 34.04 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.151 1.781 . . . . 1.0 111.107 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 158.23 43.6 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.421 1.489 . . . . 1.0 111.107 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -85.33 -4.63 59.22 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.117 -0.989 . . . . 1.0 113.301 171.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 3.36 15.57 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.107 1.337 . . . . 1.0 114.976 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.13 39.83 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.586 1.193 . . . . 1.0 113.947 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.48 83.78 0.17 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.714 1.206 . . . . 1.0 112.111 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -103.13 93.96 5.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.672 1.589 . . . . 1.0 109.88 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.04 -44.28 2.38 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.993 2.117 . . . . 1.0 115.429 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.4 m -59.25 -39.27 82.27 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.085 0.954 . . . . 1.0 113.247 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -69.26 -44.22 72.37 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.562 -0.711 . . . . 1.0 109.777 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -57.29 -42.4 81.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.325 0.65 . . . . 1.0 112.374 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.87 -46.07 85.4 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.683 0.393 . . . . 1.0 112.002 171.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -61.92 -41.94 98.51 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.538 -0.727 . . . . 1.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.5 -40.97 96.51 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.148 0.979 . . . . 1.0 110.91 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.38 78.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.405 0.682 . . . . 1.0 112.761 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -82.51 -33.04 28.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.491 1.293 . . . . 1.0 114.491 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.09 -3.08 4.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -171.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.72 129.62 6.66 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.376 1.465 . . . . 1.0 112.274 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.93 -35.81 75.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.647 2.231 . . . . 1.0 113.45 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.52 -39.89 81.01 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.518 0.599 . . . . 1.0 112.009 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.43 71.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.353 0.661 . . . . 1.0 110.875 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.91 -39.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.12 0.568 . . . . 1.0 112.035 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -66.68 -26.29 66.96 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.362 -1.461 . . . . 1.0 112.435 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 t -71.13 -26.14 62.88 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.646 -0.659 . . . . 1.0 112.605 169.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -69.47 -16.92 63.56 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.114 -0.991 . . . . 1.0 112.893 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.25 144.2 57.31 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.37 120.1 14.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.187 1.795 . . . . 1.0 111.374 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.3 mt -70.86 122.94 20.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.47 1.108 . . . . 1.0 110.566 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -80.17 52.16 1.51 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.507 1.123 . . . . 1.0 111.542 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.03 43.5 0.44 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.027 1.775 . . . . 1.0 112.886 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.55 1.54 . . . . 1.0 112.934 -176.227 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.534 0.206 . . . . 1.0 111.013 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -104.11 119.12 38.26 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.33 1.452 . . . . 1.0 108.022 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.42 142.92 28.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 77.0 m-85 -133.67 152.16 51.82 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.397 1.079 . . . . 1.0 109.267 174.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -133.87 143.33 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.546 1.538 . . . . 1.0 109.614 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -117.59 94.15 45.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.58 0.752 . . . . 1.0 111.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.97 -25.77 6.72 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.553 3.502 . . . . 1.0 116.525 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -71.37 -22.59 61.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.828 1.047 . . . . 1.0 113.828 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.2 p -129.38 -21.2 3.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.04 1.336 . . . . 1.0 113.774 -174.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.99 -6.7 82.62 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.584 1.564 . . . . 1.0 114.047 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -66.21 152.93 43.79 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.57 141.83 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 127.317 2.247 . . . . 1.0 108.876 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.5 pt -140.79 163.95 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.994 1.718 . . . . 1.0 110.737 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.64 136.89 34.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.412 1.885 . . . . 1.0 111.15 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.92 158.46 43.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.636 1.574 . . . . 1.0 110.812 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.26 -4.56 58.55 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.935 -1.103 . . . . 1.0 113.507 170.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.57 3.75 16.15 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.021 1.296 . . . . 1.0 114.667 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.61 179.52 43.65 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.441 1.121 . . . . 1.0 114.107 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.69 83.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.066 1.346 . . . . 1.0 112.391 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -108.03 94.32 5.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.961 1.704 . . . . 1.0 109.862 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -39.21 -46.15 1.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 127.453 2.301 . . . . 1.0 115.445 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 m -60.59 -39.07 86.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.435 1.094 . . . . 1.0 113.155 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.0 tp -69.14 -46.42 67.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.674 -0.641 . . . . 1.0 109.459 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.15 -43.3 78.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.245 0.618 . . . . 1.0 111.846 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -60.38 -43.53 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -64.36 -43.01 95.88 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.062 -0.398 . . . . 1.0 111.917 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -62.09 -39.83 93.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.073 0.949 . . . . 1.0 110.596 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.17 -36.18 77.1 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.709 0.804 . . . . 1.0 113.008 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -97.19 -17.34 19.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -130.95 -3.78 4.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.767 1.395 . . . . 1.0 114.767 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.99 131.25 7.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.371 1.462 . . . . 1.0 112.014 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.92 -34.39 81.63 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.617 2.211 . . . . 1.0 113.442 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.3 -40.22 86.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.988 0.813 . . . . 1.0 111.957 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.66 78.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.362 0.665 . . . . 1.0 110.94 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.66 -39.24 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.362 0.665 . . . . 1.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.41 -26.2 67.12 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.232 -1.543 . . . . 1.0 111.977 171.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 t -69.38 -27.53 65.39 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.212 -0.93 . . . . 1.0 112.167 169.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -71.09 -17.45 62.58 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.011 -1.056 . . . . 1.0 112.73 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -67.49 147.53 52.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.44 0.904 . . . . 1.0 113.44 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.42 120.66 14.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 1.0 110.732 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 mt -76.0 118.02 18.32 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.54 1.136 . . . . 1.0 110.48 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 124.635 1.174 . . . . 1.0 112.405 -177.687 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.322 0.106 . . . . 1.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.27 119.91 38.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.501 1.521 . . . . 1.0 108.796 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -83.56 148.23 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.112 1.365 . . . . 1.0 107.642 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -135.04 150.38 50.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.571 1.148 . . . . 1.0 109.214 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -132.68 143.6 49.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.467 1.507 . . . . 1.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -118.72 91.39 42.23 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.001 0.92 . . . . 1.0 111.104 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.33 -27.47 13.44 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.987 3.125 . . . . 1.0 116.277 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -75.98 -16.54 59.96 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.368 1.067 . . . . 1.0 113.868 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.6 p -128.73 -20.9 3.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.809 1.244 . . . . 1.0 113.828 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.49 -6.82 82.14 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.624 1.583 . . . . 1.0 114.209 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.59 154.66 41.67 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.205 1.557 . . . . 1.0 115.205 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.47 141.61 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.065 2.146 . . . . 1.0 109.107 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.1 pt -141.33 165.61 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.157 1.783 . . . . 1.0 110.759 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -138.0 140.2 40.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.873 2.069 . . . . 1.0 110.866 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.21 161.39 42.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.519 1.528 . . . . 1.0 110.853 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -90.24 -1.91 57.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.903 1.281 . . . . 1.0 113.233 171.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.05 3.88 22.83 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.035 1.303 . . . . 1.0 114.717 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.51 179.27 43.73 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.398 1.099 . . . . 1.0 114.144 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -66.72 83.7 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.879 1.272 . . . . 1.0 112.337 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -104.81 94.01 5.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.74 1.616 . . . . 1.0 109.803 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -42.17 -43.85 3.49 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.831 2.052 . . . . 1.0 115.452 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -59.93 -37.43 79.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.089 0.956 . . . . 1.0 113.205 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.8 -44.85 65.75 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.652 -0.655 . . . . 1.0 109.948 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -57.16 -42.31 80.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.48 0.712 . . . . 1.0 112.096 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -56.93 -44.72 82.78 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.982 0.513 . . . . 1.0 112.329 172.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -65.93 -40.94 91.87 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.917 -0.49 . . . . 1.0 112.118 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.26 -40.32 93.65 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.937 0.79 . . . . 1.0 110.689 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.93 77.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.981 0.912 . . . . 1.0 113.083 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -98.1 -17.68 18.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -132.37 -5.71 3.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.76 132.65 7.63 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.396 1.474 . . . . 1.0 112.613 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.9 -35.51 66.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.406 2.071 . . . . 1.0 113.409 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.24 -40.54 81.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.753 0.706 . . . . 1.0 111.875 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.34 73.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.356 0.662 . . . . 1.0 110.903 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.18 -39.84 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.351 0.66 . . . . 1.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.35 -26.2 67.17 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.411 -1.431 . . . . 1.0 112.204 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.9 t -72.68 -25.36 61.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.672 -0.643 . . . . 1.0 112.645 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -70.55 -16.59 62.89 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.98 -1.075 . . . . 1.0 112.989 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.97 54.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.676 0.991 . . . . 1.0 113.676 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.19 118.69 12.94 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.211 1.805 . . . . 1.0 110.976 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.5 mt -63.72 133.1 52.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.818 0.847 . . . . 1.0 110.711 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.289 1.036 . . . . 1.0 111.953 177.329 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.3 t . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.29 0.091 . . . . 1.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -113.86 122.96 48.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.926 1.69 . . . . 1.0 109.094 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.59 147.54 25.88 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.564 1.546 . . . . 1.0 107.819 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -135.15 149.14 49.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.811 1.244 . . . . 1.0 109.165 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.76 139.02 48.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.967 1.307 . . . . 1.0 109.868 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -115.49 90.02 24.17 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.414 1.085 . . . . 1.0 110.783 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -12.24 24.42 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.333 2.689 . . . . 1.0 115.336 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -65.41 -27.75 68.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.01 0.924 . . . . 1.0 113.245 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.1 p -127.38 -20.43 4.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.045 1.338 . . . . 1.0 113.713 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.85 -1.34 74.55 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.258 1.409 . . . . 1.0 113.628 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.25 152.91 32.17 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.256 1.576 . . . . 1.0 115.256 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.35 142.55 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.82 2.048 . . . . 1.0 109.635 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -141.02 165.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.965 1.706 . . . . 1.0 110.528 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.11 141.06 42.31 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.554 1.942 . . . . 1.0 110.91 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.19 160.99 43.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 1.0 110.805 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.33 -0.13 57.24 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.446 1.099 . . . . 1.0 113.491 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.51 4.09 26.93 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.167 1.365 . . . . 1.0 114.774 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.94 179.64 47.1 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.387 1.094 . . . . 1.0 113.598 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.62 83.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.813 1.245 . . . . 1.0 112.129 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -102.05 94.05 5.56 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.429 1.492 . . . . 1.0 109.986 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.5 -41.89 3.12 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.571 2.348 . . . . 1.0 115.307 -169.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 m -59.96 -39.05 84.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.99 0.916 . . . . 1.0 113.338 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 tp -70.43 -42.74 71.17 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.531 0.732 . . . . 1.0 109.609 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.18 -43.05 78.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.538 0.735 . . . . 1.0 112.341 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.66 -46.37 84.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -62.49 -41.6 98.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.784 -0.572 . . . . 1.0 112.186 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.6 -41.1 96.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 1.0 110.692 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.93 78.95 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 1.0 112.884 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -83.17 -32.31 26.67 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.593 1.331 . . . . 1.0 114.593 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -129.25 -4.1 4.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.253 1.575 . . . . 1.0 115.253 -173.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 130.22 6.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.286 1.422 . . . . 1.0 111.921 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.83 -35.52 78.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.649 2.232 . . . . 1.0 113.525 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.1 -40.25 82.65 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.567 0.622 . . . . 1.0 111.948 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.3 -48.98 73.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 1.0 111.207 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.2 -40.18 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.917 -0.49 . . . . 1.0 112.166 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.06 -25.14 66.9 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.294 -1.504 . . . . 1.0 112.165 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -73.18 -25.71 60.89 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.607 -0.683 . . . . 1.0 112.709 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -69.87 -16.46 63.25 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.97 -1.081 . . . . 1.0 112.877 171.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.19 144.96 56.46 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.77 1.026 . . . . 1.0 113.77 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.06 117.85 12.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.212 1.805 . . . . 1.0 110.707 170.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -63.74 131.31 47.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.032 0.933 . . . . 1.0 110.54 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 122.102 0.953 . . . . 1.0 111.746 178.119 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 110.545 -0.169 . . . . 1.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.86 120.44 41.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.404 1.482 . . . . 1.0 108.659 168.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -86.5 146.6 26.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 80.3 m-85 -135.64 151.62 50.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.815 1.246 . . . . 1.0 108.983 175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -132.02 144.71 50.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.273 1.429 . . . . 1.0 109.87 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -119.52 92.86 46.67 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.071 0.948 . . . . 1.0 112.246 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.63 -25.1 3.28 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.811 3.674 . . . . 1.0 117.091 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -67.09 -27.06 67.04 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.5 p -130.1 -17.5 3.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.929 1.291 . . . . 1.0 114.126 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.62 85.7 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.985 1.279 . . . . 1.0 113.896 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.14 154.6 30.6 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.228 1.566 . . . . 1.0 115.228 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 142.04 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.857 2.063 . . . . 1.0 109.565 171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 pt -140.63 164.04 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.237 1.815 . . . . 1.0 110.656 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -140.23 137.41 34.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.055 1.742 . . . . 1.0 111.579 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.44 158.65 43.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.38 1.472 . . . . 1.0 111.166 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -83.32 -2.7 56.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.19 0.996 . . . . 1.0 113.515 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.26 25.91 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.082 1.325 . . . . 1.0 114.53 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.88 179.52 41.32 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.564 1.078 . . . . 1.0 113.805 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.6 83.79 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.132 1.373 . . . . 1.0 112.025 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -107.56 94.0 4.85 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.793 1.637 . . . . 1.0 109.865 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -41.36 -44.02 2.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.007 2.123 . . . . 1.0 115.24 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -60.82 -39.65 89.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.895 0.878 . . . . 1.0 113.23 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.93 -44.82 72.3 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.618 -0.676 . . . . 1.0 109.743 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -56.5 -43.12 79.43 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.384 0.674 . . . . 1.0 111.923 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.69 -48.38 79.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 122.662 0.385 . . . . 1.0 111.875 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.03 -43.71 98.49 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.818 -0.551 . . . . 1.0 112.211 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -62.53 -41.09 98.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 1.0 110.709 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.34 80.72 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -81.41 -32.9 32.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -129.66 -0.6 4.89 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -172.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.29 128.17 6.15 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.51 1.529 . . . . 1.0 112.113 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.88 -34.45 91.18 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.744 2.296 . . . . 1.0 113.213 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.27 -42.46 88.42 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.859 0.754 . . . . 1.0 111.646 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.49 80.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.406 0.683 . . . . 1.0 111.163 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.33 -36.4 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 1.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -66.89 -28.75 68.58 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.259 -1.525 . . . . 1.0 111.995 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.6 m -68.75 -23.77 64.36 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.138 -0.977 . . . . 1.0 112.216 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -72.9 -15.41 61.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.329 0.968 . . . . 1.0 112.442 169.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.421 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -71.47 148.13 47.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 119.17 12.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.587 1.955 . . . . 1.0 110.931 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.26 129.42 38.39 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.204 1.002 . . . . 1.0 110.625 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 124.328 1.051 . . . . 1.0 112.829 -178.768 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -113.3 121.26 43.86 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.685 1.594 . . . . 1.0 108.54 169.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -86.98 147.0 25.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.95 147.87 49.88 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.117 1.367 . . . . 1.0 109.018 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -129.99 137.49 50.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.075 1.35 . . . . 1.0 109.995 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -111.12 91.64 13.68 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.103 0.961 . . . . 1.0 110.543 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.22 -14.35 37.67 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.824 2.349 . . . . 1.0 114.896 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -69.78 -23.62 63.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.665 1.186 . . . . 1.0 113.562 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -127.93 -21.77 3.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.075 1.35 . . . . 1.0 113.619 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.27 -4.95 74.56 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.607 1.575 . . . . 1.0 113.873 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -66.03 153.18 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.71 141.59 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 126.914 2.086 . . . . 1.0 109.219 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -140.93 163.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.913 1.685 . . . . 1.0 110.65 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -139.18 138.54 37.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.155 1.782 . . . . 1.0 111.305 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.41 159.6 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.399 1.48 . . . . 1.0 110.876 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -87.24 -1.88 58.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.551 1.14 . . . . 1.0 113.517 171.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.75 5.49 18.15 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.151 1.358 . . . . 1.0 115.004 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.54 179.23 43.88 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.443 1.122 . . . . 1.0 114.205 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.79 83.87 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.344 1.458 . . . . 1.0 112.13 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -106.2 94.01 4.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.421 1.489 . . . . 1.0 110.215 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -37.56 -47.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.11 2.564 . . . . 1.0 115.463 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -61.49 -38.29 86.74 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.133 0.973 . . . . 1.0 113.039 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 tp -70.01 -44.41 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.675 -0.641 . . . . 1.0 109.616 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.3 -43.12 78.6 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.407 0.683 . . . . 1.0 112.203 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -58.71 -42.95 89.85 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -65.22 -41.51 94.37 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.879 0.326 . . . . 1.0 111.879 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.52 -40.01 93.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.662 0.785 . . . . 1.0 110.558 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.87 -36.0 77.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.074 0.949 . . . . 1.0 113.163 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.78 -17.62 19.25 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -131.37 -6.41 3.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.63 132.08 7.45 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.506 1.527 . . . . 1.0 112.2 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.07 -36.42 70.59 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.926 2.417 . . . . 1.0 113.447 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.78 -39.96 84.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.639 0.654 . . . . 1.0 111.9 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.91 74.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.268 0.627 . . . . 1.0 110.993 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.62 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.187 0.595 . . . . 1.0 112.17 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -66.6 -24.22 66.29 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.475 -1.39 . . . . 1.0 112.044 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -74.82 -23.63 58.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.528 -0.733 . . . . 1.0 112.718 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -71.33 -17.27 62.45 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.143 -0.973 . . . . 1.0 112.897 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.98 145.34 55.58 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.966 1.098 . . . . 1.0 113.966 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.42 117.96 12.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.116 1.766 . . . . 1.0 110.885 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.16 133.17 53.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.023 0.929 . . . . 1.0 110.777 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.011 0.924 . . . . 1.0 111.382 176.643 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.82 -0.067 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.58 116.0 31.72 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.086 1.355 . . . . 1.0 108.219 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -84.07 146.33 27.98 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.955 1.302 . . . . 1.0 107.533 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.6 150.47 50.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.828 1.251 . . . . 1.0 109.354 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 139.71 48.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.356 1.462 . . . . 1.0 110.022 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -116.13 89.65 26.12 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.71 1.204 . . . . 1.0 111.015 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 -12.12 23.07 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.179 2.586 . . . . 1.0 115.422 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -65.0 -28.09 69.28 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.0 p -127.71 -19.45 4.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.179 1.392 . . . . 1.0 113.963 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.45 -1.97 77.03 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.235 1.398 . . . . 1.0 113.631 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.02 152.76 31.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.236 1.569 . . . . 1.0 115.236 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 t -136.58 141.62 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.953 . . . . 1.0 109.466 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.9 pt -140.84 165.87 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.017 1.727 . . . . 1.0 110.727 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -139.31 139.18 37.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.617 1.967 . . . . 1.0 110.851 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.21 158.0 43.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.344 1.458 . . . . 1.0 110.659 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.96 -3.02 59.05 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.215 1.006 . . . . 1.0 113.514 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.54 2.62 14.92 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.813 1.197 . . . . 1.0 115.288 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.11 179.05 42.86 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.468 1.134 . . . . 1.0 113.829 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -66.57 83.79 0.1 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.086 1.355 . . . . 1.0 111.991 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -99.46 94.3 6.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.328 1.451 . . . . 1.0 110.249 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -39.84 -45.64 1.83 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 128.095 2.558 . . . . 1.0 115.118 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.8 m -60.55 -39.98 89.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.222 1.009 . . . . 1.0 113.576 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.1 tp -68.67 -42.39 77.94 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.546 -0.721 . . . . 1.0 109.918 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.07 -43.6 78.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 1.0 112.282 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.7 -45.38 85.77 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.16 -41.68 98.54 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.598 -0.689 . . . . 1.0 112.115 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -61.88 -40.91 97.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.414 1.086 . . . . 1.0 110.854 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 -38.17 79.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.481 0.713 . . . . 1.0 112.846 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.01 -33.08 30.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -129.78 -3.22 4.69 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -171.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.09 129.66 6.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.448 1.499 . . . . 1.0 112.335 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.93 -35.21 78.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.544 2.163 . . . . 1.0 113.569 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.61 -39.8 80.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.73 0.696 . . . . 1.0 112.2 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.14 -49.47 72.01 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.24 0.616 . . . . 1.0 110.805 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.4 -41.55 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.297 0.639 . . . . 1.0 112.072 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.525 -1.36 . . . . 1.0 112.269 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -75.94 -21.48 56.98 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.572 -0.705 . . . . 1.0 112.897 169.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -72.85 -16.37 61.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.548 1.067 . . . . 1.0 112.871 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.6 144.13 56.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.684 0.994 . . . . 1.0 113.684 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.09 118.45 12.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.296 1.838 . . . . 1.0 110.809 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 mt -71.23 116.47 11.58 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.514 1.126 . . . . 1.0 110.375 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 123.587 0.755 . . . . 1.0 111.487 176.358 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.9 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.3 0.095 . . . . 1.0 110.833 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -111.22 120.55 42.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.47 1.508 . . . . 1.0 108.647 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.8 148.73 25.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.654 -1.239 . . . . 1.0 107.654 169.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -136.67 149.82 48.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.098 1.359 . . . . 1.0 108.851 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -131.59 144.23 50.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.357 1.463 . . . . 1.0 109.95 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.89 91.75 47.85 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.147 0.979 . . . . 1.0 111.763 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.5 -25.99 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.835 3.69 . . . . 1.0 116.976 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.42 -27.07 67.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -129.51 -17.62 3.68 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.776 1.23 . . . . 1.0 113.935 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.24 0.14 85.24 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.033 1.301 . . . . 1.0 113.826 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.19 154.72 30.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.29 1.589 . . . . 1.0 115.29 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.55 141.23 41.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 126.852 2.061 . . . . 1.0 109.405 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -139.91 163.58 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.955 1.702 . . . . 1.0 110.674 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -139.93 137.89 35.15 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.105 1.762 . . . . 1.0 111.348 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 157.78 43.03 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.187 1.395 . . . . 1.0 111.014 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.61 -4.54 58.66 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.263 1.025 . . . . 1.0 113.442 171.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.41 1.91 19.9 Favored Glycine 0 N--CA 1.478 1.438 0 C-N-CA 125.053 1.311 . . . . 1.0 114.806 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.78 179.13 38.47 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 118.576 1.188 . . . . 1.0 113.807 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -67.42 83.87 0.16 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.737 1.215 . . . . 1.0 112.186 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.06 94.03 5.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.489 1.516 . . . . 1.0 109.903 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.33 -42.47 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.664 1.986 . . . . 1.0 115.664 -169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -59.07 -39.23 81.47 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.095 0.958 . . . . 1.0 113.013 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.96 -44.82 68.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.428 0.691 . . . . 1.0 109.777 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -56.4 -43.44 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.485 0.714 . . . . 1.0 112.156 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.63 -46.62 83.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.587 0.355 . . . . 1.0 111.877 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -62.18 -41.92 98.79 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.549 -0.719 . . . . 1.0 111.937 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.39 -41.07 96.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.966 0.906 . . . . 1.0 110.778 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.22 -38.7 78.67 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.555 0.742 . . . . 1.0 112.736 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -81.38 -32.65 32.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.94 -2.31 4.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.73 128.82 6.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.125 1.345 . . . . 1.0 112.358 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.66 -35.32 81.16 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.659 2.24 . . . . 1.0 113.513 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.7 -39.53 80.47 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.867 0.758 . . . . 1.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.05 72.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.147 0.579 . . . . 1.0 110.869 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.77 -40.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.702 -0.623 . . . . 1.0 112.176 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.43 -24.79 66.5 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.364 -1.46 . . . . 1.0 112.207 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -74.7 -21.44 59.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.561 -0.712 . . . . 1.0 112.9 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -72.95 -16.5 61.53 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.428 1.013 . . . . 1.0 112.96 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.7 145.66 55.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.39 118.06 12.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.432 1.893 . . . . 1.0 111.197 170.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 mt -63.88 131.09 46.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.174 0.99 . . . . 1.0 110.543 172.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 123.659 0.783 . . . . 1.0 111.479 175.932 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.481 0.181 . . . . 1.0 111.124 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -104.02 118.45 36.69 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.293 1.437 . . . . 1.0 107.854 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -85.86 145.46 27.18 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.102 1.361 . . . . 1.0 107.37 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -136.62 152.66 50.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.586 1.154 . . . . 1.0 109.565 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -133.31 144.74 49.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.406 1.483 . . . . 1.0 109.727 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -121.37 91.49 48.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.191 0.996 . . . . 1.0 111.749 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.4 -25.52 5.04 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.752 3.635 . . . . 1.0 116.898 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -65.34 -26.82 68.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 p -129.96 -17.2 3.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.952 1.301 . . . . 1.0 113.952 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.54 86.79 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.982 1.277 . . . . 1.0 114.064 -173.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.33 154.82 34.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.03 140.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.915 2.086 . . . . 1.0 109.452 172.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -141.99 164.42 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.98 1.712 . . . . 1.0 110.89 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.13 138.02 34.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.389 1.876 . . . . 1.0 110.878 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.4 156.9 41.64 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.46 1.504 . . . . 1.0 111.025 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -84.73 -2.87 58.19 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.504 1.121 . . . . 1.0 113.663 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.65 2.28 19.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.863 1.22 . . . . 1.0 114.985 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 179.35 42.16 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.292 1.046 . . . . 1.0 113.877 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.6 83.79 0.18 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.784 1.234 . . . . 1.0 112.011 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -102.51 94.12 5.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.568 1.547 . . . . 1.0 109.858 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -39.83 -45.5 1.8 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.434 2.293 . . . . 1.0 115.429 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.1 m -60.38 -39.45 87.31 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.203 1.001 . . . . 1.0 113.015 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -69.92 -43.67 71.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.348 -0.845 . . . . 1.0 109.869 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -56.36 -43.52 79.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.377 0.671 . . . . 1.0 111.952 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -58.45 -47.46 83.92 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.015 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -60.6 -42.35 96.62 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.769 -0.582 . . . . 1.0 112.109 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.69 -40.24 96.49 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 1.0 110.782 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.39 -39.25 78.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.803 0.841 . . . . 1.0 112.971 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.58 -32.73 42.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.818 1.247 . . . . 1.0 114.133 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.2 -4.31 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.87 130.72 7.12 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.405 1.478 . . . . 1.0 111.764 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.55 -34.75 84.54 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.73 2.287 . . . . 1.0 113.424 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.456 0.703 . . . . 1.0 111.951 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.61 77.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.268 0.627 . . . . 1.0 111.005 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.74 -39.86 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.8 -0.563 . . . . 1.0 112.208 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -66.72 -27.12 67.37 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.23 -1.544 . . . . 1.0 112.178 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 t -67.96 -27.07 66.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.12 -0.988 . . . . 1.0 112.277 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.7 m0 -72.33 -15.72 61.88 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.0 -1.062 . . . . 1.0 113.115 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.68 145.92 55.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.5 0.926 . . . . 1.0 113.5 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.48 117.48 11.76 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.267 1.827 . . . . 1.0 110.443 170.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.89 118.25 13.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.471 1.109 . . . . 1.0 110.345 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 CA--C 1.543 0.689 0 C-N-CA 123.388 0.675 . . . . 1.0 112.086 178.132 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 110.704 -0.11 . . . . 1.0 110.704 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -102.86 117.94 35.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.575 1.15 . . . . 1.0 108.554 168.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -86.63 145.64 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.223 1.409 . . . . 1.0 107.611 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -136.4 151.85 49.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.59 1.156 . . . . 1.0 109.91 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -132.83 137.82 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.279 1.432 . . . . 1.0 109.596 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -111.65 92.47 17.08 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.83 0.852 . . . . 1.0 110.586 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.75 -14.19 38.87 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.996 2.464 . . . . 1.0 114.782 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -70.32 -22.63 62.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.592 1.157 . . . . 1.0 113.55 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.2 p -127.58 -23.16 3.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.242 1.417 . . . . 1.0 113.449 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.28 -6.4 71.84 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.829 1.68 . . . . 1.0 113.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -66.93 152.79 45.03 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.164 1.542 . . . . 1.0 115.164 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.8 t -134.09 140.39 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.96 2.104 . . . . 1.0 109.191 171.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 pt -140.94 164.56 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.756 1.622 . . . . 1.0 110.766 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -139.72 137.47 35.17 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.551 1.94 . . . . 1.0 110.884 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.59 158.49 43.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.933 1.293 . . . . 1.0 111.323 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -86.43 -2.83 58.78 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.389 1.076 . . . . 1.0 113.188 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.44 3.19 19.11 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.098 1.333 . . . . 1.0 115.015 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.2 179.21 42.86 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.569 1.184 . . . . 1.0 113.907 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -67.4 83.76 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.03 1.332 . . . . 1.0 112.055 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -104.67 94.38 5.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.704 1.602 . . . . 1.0 109.865 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -41.5 -43.2 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.832 2.053 . . . . 1.0 115.547 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -60.19 -37.82 81.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.044 0.938 . . . . 1.0 113.096 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -71.64 -44.25 64.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.273 0.629 . . . . 1.0 109.604 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -56.8 -43.14 80.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.436 0.694 . . . . 1.0 112.06 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -57.28 -44.78 84.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 172.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.18 -41.36 90.37 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.069 -0.394 . . . . 1.0 112.052 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -62.12 -38.73 90.04 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.986 0.812 . . . . 1.0 110.703 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.16 75.8 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.755 0.822 . . . . 1.0 112.916 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -98.4 -16.1 19.41 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.972 1.842 . . . . 1.0 115.972 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -130.84 -8.24 3.98 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.761 1.393 . . . . 1.0 114.761 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.36 134.25 8.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.379 1.466 . . . . 1.0 112.161 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.42 -35.88 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.605 2.203 . . . . 1.0 113.228 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -39.56 86.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.553 0.741 . . . . 1.0 111.693 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.54 78.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.398 0.679 . . . . 1.0 111.453 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.7 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.945 -0.472 . . . . 1.0 112.205 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -65.86 -27.15 68.01 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.514 -1.366 . . . . 1.0 112.239 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -68.64 -27.57 66.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.958 0.799 . . . . 1.0 112.394 170.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -72.15 -15.92 61.98 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.054 -1.029 . . . . 1.0 112.85 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.08 147.28 53.59 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.19 120.36 14.71 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.293 1.837 . . . . 1.0 110.761 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.15 116.0 15.4 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.647 1.179 . . . . 1.0 110.295 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 123.33 0.652 . . . . 1.0 111.815 178.723 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 111.05 0.018 . . . . 1.0 111.05 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -106.42 119.82 40.26 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.45 1.5 . . . . 1.0 107.829 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -86.35 145.29 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.164 1.386 . . . . 1.0 107.279 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 90.8 m-85 -136.2 152.09 50.4 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.737 1.215 . . . . 1.0 109.698 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -133.92 144.5 48.87 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.599 1.56 . . . . 1.0 109.435 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.67 93.94 44.74 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.763 0.825 . . . . 1.0 111.453 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.21 -26.09 7.7 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.476 3.451 . . . . 1.0 116.441 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -72.07 -21.96 61.43 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.987 1.106 . . . . 1.0 113.987 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -128.91 -21.75 3.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.095 1.358 . . . . 1.0 113.545 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.21 -6.74 82.42 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.544 1.545 . . . . 1.0 113.797 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.25 152.65 45.35 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.874 1.435 . . . . 1.0 114.874 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.05 139.97 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 127.07 2.148 . . . . 1.0 109.177 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -141.7 164.42 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.017 1.727 . . . . 1.0 110.832 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -140.51 136.06 32.53 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.326 1.851 . . . . 1.0 110.872 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.71 157.3 41.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.872 1.269 . . . . 1.0 111.173 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.96 -4.78 58.64 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.929 -1.107 . . . . 1.0 113.711 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.65 2.43 17.1 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.841 1.21 . . . . 1.0 114.925 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.87 179.12 38.8 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 118.415 1.107 . . . . 1.0 113.803 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -68.13 83.74 0.23 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.585 1.154 . . . . 1.0 112.127 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -102.87 94.92 5.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.616 1.566 . . . . 1.0 109.771 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -41.57 -43.18 2.64 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 126.784 2.034 . . . . 1.0 115.699 -170.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -37.97 79.39 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.229 1.011 . . . . 1.0 113.269 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -44.14 63.89 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.353 0.661 . . . . 1.0 109.764 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.09 -43.4 78.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.484 0.714 . . . . 1.0 111.871 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.97 -44.56 87.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.47 -40.92 89.63 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.985 -0.447 . . . . 1.0 112.015 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -62.73 -38.75 91.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.048 0.84 . . . . 1.0 110.388 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -36.3 75.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 1.0 113.169 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.1 -16.77 19.42 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.843 1.794 . . . . 1.0 115.843 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -130.72 -9.16 4.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 134.18 8.07 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.436 1.493 . . . . 1.0 111.98 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 -34.68 71.87 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.522 2.148 . . . . 1.0 113.098 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.74 -39.84 84.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.62 0.768 . . . . 1.0 111.913 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.87 80.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 1.0 111.108 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.96 -41.03 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.731 -0.605 . . . . 1.0 112.126 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.6 -30.04 71.21 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.45 -1.406 . . . . 1.0 112.123 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 t -67.99 -27.54 66.66 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.343 -0.848 . . . . 1.0 112.523 171.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -72.74 -15.44 61.66 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.15 -0.969 . . . . 1.0 113.065 170.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -67.04 147.53 53.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.692 0.997 . . . . 1.0 113.692 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.08 116.64 11.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.297 1.839 . . . . 1.0 110.323 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.23 132.04 46.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.962 0.905 . . . . 1.0 110.347 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 CA--C 1.547 0.852 0 CA-C-O 121.959 0.885 . . . . 1.0 112.293 178.01 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -104.74 119.21 38.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.918 1.287 . . . . 1.0 108.657 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -86.45 145.89 26.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.221 -1.4 . . . . 1.0 107.221 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -135.9 152.5 51.07 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.615 1.166 . . . . 1.0 109.61 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -133.05 144.97 50.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.412 1.485 . . . . 1.0 109.184 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -118.03 92.12 41.48 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.179 0.992 . . . . 1.0 110.946 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.34 -27.16 12.87 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.307 3.338 . . . . 1.0 116.077 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.04 -15.71 59.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 p -128.91 -22.51 3.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.931 1.292 . . . . 1.0 113.802 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.49 80.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.928 1.727 . . . . 1.0 114.171 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.09 154.5 41.85 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.143 1.535 . . . . 1.0 115.143 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.26 140.16 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.326 2.25 . . . . 1.0 109.205 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -142.67 165.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.036 1.734 . . . . 1.0 110.994 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -138.87 138.92 37.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.74 2.016 . . . . 1.0 111.002 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.29 158.44 43.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.463 1.505 . . . . 1.0 110.977 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.52 -3.21 58.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.275 1.03 . . . . 1.0 113.545 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.94 4.32 22.76 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.091 1.329 . . . . 1.0 114.866 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 179.32 38.66 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.277 1.039 . . . . 1.0 113.789 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -65.45 83.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.222 1.409 . . . . 1.0 112.212 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -103.08 94.04 5.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.574 1.549 . . . . 1.0 110.341 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -39.77 -45.53 1.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 128.093 2.557 . . . . 1.0 115.441 -171.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.4 m -61.21 -39.87 91.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.172 0.989 . . . . 1.0 113.425 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.96 -42.66 72.88 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.643 -0.661 . . . . 1.0 109.772 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.43 -44.11 75.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.456 0.703 . . . . 1.0 112.181 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -57.66 -44.16 85.48 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -65.2 -41.46 94.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.003 -0.435 . . . . 1.0 112.028 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -62.46 -39.03 92.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.887 0.875 . . . . 1.0 110.463 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.98 76.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.037 0.935 . . . . 1.0 113.124 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -98.07 -18.11 18.73 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.853 1.797 . . . . 1.0 115.853 -171.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -129.4 -8.11 4.7 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.61 134.16 8.28 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.467 1.508 . . . . 1.0 111.937 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.85 -34.3 72.64 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.5 2.133 . . . . 1.0 113.065 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.08 -39.49 82.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.51 0.724 . . . . 1.0 112.072 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.97 76.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.458 0.703 . . . . 1.0 110.973 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.54 -41.2 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.126 0.57 . . . . 1.0 112.305 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.98 -28.26 68.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.437 -1.414 . . . . 1.0 112.241 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 m -68.91 -22.83 64.14 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 30.0 m0 -76.73 -14.19 59.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.009 0.923 . . . . 1.0 112.975 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.08 147.86 51.76 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.21 0.914 . . . . 1.0 113.362 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -139.11 117.65 12.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.57 1.948 . . . . 1.0 110.687 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -71.19 123.99 23.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.479 1.112 . . . . 1.0 110.782 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 124.165 0.986 . . . . 1.0 112.556 -178.142 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 110.39 -0.226 . . . . 1.0 110.39 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -100.65 115.52 30.42 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.375 1.07 . . . . 1.0 108.841 168.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.15 145.87 28.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 1.0 107.539 169.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -133.76 149.82 51.46 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.754 1.222 . . . . 1.0 109.074 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -130.97 144.39 51.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.517 1.527 . . . . 1.0 109.306 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -118.34 92.61 43.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.873 . . . . 1.0 111.62 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.57 -26.34 8.96 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.299 3.333 . . . . 1.0 116.78 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -18.19 57.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.02 1.118 . . . . 1.0 114.02 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -130.83 -21.22 2.75 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.08 81.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.814 1.673 . . . . 1.0 114.154 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.3 156.44 37.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.326 1.602 . . . . 1.0 115.326 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.39 140.77 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 127.141 2.176 . . . . 1.0 109.109 169.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.7 pt -140.19 166.24 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.861 1.664 . . . . 1.0 110.612 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -140.06 138.45 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.58 1.952 . . . . 1.0 111.072 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.24 159.27 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.374 1.469 . . . . 1.0 110.966 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -86.67 -2.65 58.7 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.035 -1.041 . . . . 1.0 113.314 171.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.74 4.57 22.92 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.183 1.373 . . . . 1.0 114.945 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.07 179.18 45.59 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.327 1.063 . . . . 1.0 113.871 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.18 83.99 0.09 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.987 1.315 . . . . 1.0 112.143 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -105.3 94.08 5.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.687 1.595 . . . . 1.0 109.812 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -42.01 -43.77 3.29 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.763 2.025 . . . . 1.0 115.47 -169.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -59.23 -39.16 81.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.055 0.942 . . . . 1.0 112.945 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.21 -44.69 71.57 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.682 -0.636 . . . . 1.0 109.851 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -57.07 -42.81 81.3 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.636 0.774 . . . . 1.0 112.168 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -57.73 -45.87 85.21 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.082 0.401 . . . . 1.0 112.082 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -62.4 -41.7 98.87 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.725 -0.609 . . . . 1.0 112.133 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.33 -41.42 96.98 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.009 0.924 . . . . 1.0 110.806 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.81 78.15 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.031 0.752 . . . . 1.0 113.031 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.05 -33.19 30.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.449 1.278 . . . . 1.0 114.449 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.19 -2.95 4.47 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.363 1.616 . . . . 1.0 115.363 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.38 129.23 6.56 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.433 1.492 . . . . 1.0 112.477 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.92 -35.59 76.86 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.78 2.32 . . . . 1.0 113.564 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -39.75 80.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.843 0.747 . . . . 1.0 112.18 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.21 -49.57 71.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.228 0.611 . . . . 1.0 110.816 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -40.63 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.317 0.647 . . . . 1.0 112.146 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.1 -25.38 66.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.494 -1.379 . . . . 1.0 112.178 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -74.72 -21.25 59.47 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 169.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -73.41 -16.5 61.33 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.38 0.991 . . . . 1.0 113.118 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.22 144.39 56.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.6 p -139.02 121.14 15.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.482 1.913 . . . . 1.0 110.923 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.67 115.13 12.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.542 1.137 . . . . 1.0 110.642 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 123.32 0.648 . . . . 1.0 111.895 176.383 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 111.5 0.185 . . . . 1.0 111.5 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -99.64 115.6 29.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.702 1.201 . . . . 1.0 108.04 168.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -84.91 145.78 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.127 1.371 . . . . 1.0 107.471 168.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -136.69 153.59 50.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.617 1.167 . . . . 1.0 109.583 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -133.61 144.68 49.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.397 1.479 . . . . 1.0 109.837 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.73 91.8 47.54 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.245 1.018 . . . . 1.0 111.817 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.06 -25.65 4.35 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.797 3.665 . . . . 1.0 117.079 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -65.49 -27.3 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -129.85 -17.85 3.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.956 1.303 . . . . 1.0 113.895 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.87 0.5 85.73 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.031 1.3 . . . . 1.0 113.906 -173.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.64 154.39 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.81 140.78 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.827 2.051 . . . . 1.0 109.478 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.1 pt -142.49 165.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.979 1.712 . . . . 1.0 110.968 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.85 138.87 36.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.61 1.964 . . . . 1.0 111.068 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.67 157.48 42.16 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.29 1.436 . . . . 1.0 110.733 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -83.82 -3.79 58.15 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 171.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.81 3.07 20.39 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.063 1.316 . . . . 1.0 114.878 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.34 41.95 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.371 1.086 . . . . 1.0 113.961 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -66.5 83.66 0.1 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.015 1.326 . . . . 1.0 112.302 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -103.99 94.1 5.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.516 1.527 . . . . 1.0 109.474 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -44.33 -41.96 6.41 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.478 1.911 . . . . 1.0 115.422 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -59.28 -39.22 82.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.801 0.841 . . . . 1.0 112.958 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.97 -43.0 69.0 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.664 -0.648 . . . . 1.0 109.899 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.61 -42.99 79.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 1.0 112.125 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.66 -46.79 83.78 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.712 0.405 . . . . 1.0 111.827 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -62.13 -41.96 98.76 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.697 -0.627 . . . . 1.0 112.101 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -62.79 -39.99 95.96 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 1.0 110.615 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.48 -39.43 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.63 0.772 . . . . 1.0 112.71 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -80.3 -32.41 38.08 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 1.0 114.245 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.27 -4.29 4.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.15 1.537 . . . . 1.0 115.15 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.0 131.41 7.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.567 1.555 . . . . 1.0 111.959 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 -34.69 80.37 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.664 2.243 . . . . 1.0 113.42 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.72 -39.83 84.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.301 0.64 . . . . 1.0 112.061 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.43 -47.15 77.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.08 0.552 . . . . 1.0 111.094 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.0 -40.02 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.775 -0.578 . . . . 1.0 111.919 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.21 -27.6 68.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.273 -1.517 . . . . 1.0 112.43 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 t -67.58 -27.37 66.87 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.214 -0.929 . . . . 1.0 112.279 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -72.3 -15.17 61.9 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.046 -1.034 . . . . 1.0 113.141 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.14 145.79 54.92 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.396 0.888 . . . . 1.0 113.396 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.18 117.62 12.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.421 1.888 . . . . 1.0 110.545 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.94 116.33 12.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.681 1.192 . . . . 1.0 110.406 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.7 mt . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 123.9 0.88 . . . . 1.0 111.644 176.895 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.36 120.38 42.24 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.235 1.414 . . . . 1.0 108.872 169.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.36 149.49 24.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -136.62 150.15 48.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.113 1.365 . . . . 1.0 108.728 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -132.24 144.45 50.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.204 1.401 . . . . 1.0 109.698 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -120.8 91.4 47.4 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.292 1.037 . . . . 1.0 111.702 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -47.15 -25.6 4.5 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.955 3.77 . . . . 1.0 116.987 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -66.47 -26.56 67.25 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.734 1.013 . . . . 1.0 113.734 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 p -130.02 -18.26 3.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.082 1.353 . . . . 1.0 113.735 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.28 -0.85 83.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.9 1.238 . . . . 1.0 113.909 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.05 153.76 28.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.31 1.596 . . . . 1.0 115.31 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.46 140.87 42.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.839 2.056 . . . . 1.0 109.455 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.7 pt -140.28 164.35 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.02 1.728 . . . . 1.0 110.527 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -139.5 138.8 36.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.104 1.762 . . . . 1.0 111.096 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -150.87 158.69 44.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.454 1.502 . . . . 1.0 111.178 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.74 -3.13 58.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.691 1.196 . . . . 1.0 113.349 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.01 1.39 19.15 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.844 1.211 . . . . 1.0 114.993 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.83 179.11 41.87 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 118.484 1.142 . . . . 1.0 113.875 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -67.75 83.78 0.19 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.398 1.079 . . . . 1.0 112.378 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -98.71 93.97 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.698 1.599 . . . . 1.0 109.557 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -44.4 -41.35 6.11 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.117 2.167 . . . . 1.0 115.052 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -60.43 -38.14 83.16 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.309 1.044 . . . . 1.0 113.278 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -69.56 -43.78 72.2 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.399 -0.813 . . . . 1.0 109.812 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -55.78 -43.51 76.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.537 0.735 . . . . 1.0 112.386 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.25 -46.94 82.55 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.985 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -62.05 -41.14 97.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.679 -0.638 . . . . 1.0 112.364 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.94 -41.09 97.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.242 1.017 . . . . 1.0 110.733 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.03 -37.92 78.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.932 0.893 . . . . 1.0 112.761 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -81.78 -32.62 31.29 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.535 1.309 . . . . 1.0 114.535 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -130.66 -3.41 4.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.08 129.37 6.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.283 1.42 . . . . 1.0 112.319 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.24 79.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.831 2.354 . . . . 1.0 113.364 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.32 -40.09 81.77 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.934 0.788 . . . . 1.0 111.987 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.48 72.51 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.357 0.663 . . . . 1.0 110.938 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.37 -41.37 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.247 0.619 . . . . 1.0 112.217 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -66.23 -25.08 66.74 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.434 -1.416 . . . . 1.0 112.073 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 m -74.38 -21.64 59.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -73.0 -15.79 61.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.349 0.977 . . . . 1.0 113.112 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.04 145.24 56.59 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.43 118.71 12.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.378 1.871 . . . . 1.0 111.086 170.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.1 mt -64.84 131.71 47.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.195 0.998 . . . . 1.0 110.641 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 CA--C 1.547 0.857 0 C-N-CA 123.675 0.79 . . . . 1.0 111.758 177.389 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 111.45 0.167 . . . . 1.0 111.45 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -102.47 116.86 33.47 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.867 1.267 . . . . 1.0 108.257 168.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -84.46 146.32 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.106 1.363 . . . . 1.0 107.427 169.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -135.18 150.0 50.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.734 1.214 . . . . 1.0 109.257 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -132.79 138.02 46.99 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 1.0 109.834 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -112.45 91.31 16.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.242 1.017 . . . . 1.0 110.68 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.43 -14.47 39.29 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.843 2.362 . . . . 1.0 114.675 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -69.22 -23.76 63.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.494 1.118 . . . . 1.0 113.644 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.7 p -127.01 -22.2 3.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.993 1.317 . . . . 1.0 113.51 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.36 -4.83 74.09 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.664 1.602 . . . . 1.0 113.808 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -66.2 153.31 42.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.132 1.53 . . . . 1.0 115.132 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.8 140.39 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.851 2.06 . . . . 1.0 109.173 171.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.8 pt -139.53 165.79 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.639 1.576 . . . . 1.0 110.599 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -140.74 136.96 33.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.256 1.823 . . . . 1.0 110.737 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.49 157.2 41.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.94 1.296 . . . . 1.0 111.227 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -85.05 -4.37 59.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.21 1.004 . . . . 1.0 113.475 171.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.72 1.97 14.81 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.317 1.436 . . . . 1.0 114.995 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.46 178.84 41.18 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.392 1.096 . . . . 1.0 114.159 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.88 83.9 0.21 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.869 1.268 . . . . 1.0 112.027 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -103.82 94.04 5.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.821 1.648 . . . . 1.0 109.843 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -43.5 -40.99 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.386 1.875 . . . . 1.0 115.588 -169.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -59.13 -37.11 76.44 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.976 0.91 . . . . 1.0 113.028 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.5 tp -70.87 -45.29 64.68 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.447 0.699 . . . . 1.0 109.784 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.67 -43.51 80.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.789 0.836 . . . . 1.0 112.1 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.01 -44.1 82.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.43 -41.2 89.53 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.046 -0.409 . . . . 1.0 112.0 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.02 -40.16 92.5 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.857 0.753 . . . . 1.0 110.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.02 77.17 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.002 0.921 . . . . 1.0 113.033 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -98.48 -16.76 19.07 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.007 1.854 . . . . 1.0 116.007 -171.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -132.75 -6.48 3.19 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.029 1.492 . . . . 1.0 115.029 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.39 132.77 7.58 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.322 1.439 . . . . 1.0 112.464 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.79 -36.28 63.09 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.709 2.273 . . . . 1.0 113.542 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.5 -39.51 81.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.765 0.712 . . . . 1.0 112.021 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.33 73.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.397 0.679 . . . . 1.0 110.762 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.92 -40.9 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.339 0.656 . . . . 1.0 112.073 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -66.13 -24.45 66.68 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.492 -1.38 . . . . 1.0 112.217 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 m -75.55 -21.88 57.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.859 0.689 . . . . 1.0 112.859 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -72.94 -17.49 61.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.572 1.078 . . . . 1.0 112.892 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 145.23 54.41 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.05 119.64 14.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.286 1.834 . . . . 1.0 110.96 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.0 mt -70.84 119.5 15.07 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.361 1.064 . . . . 1.0 110.434 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 CA--C 1.547 0.832 0 C-N-CA 123.335 0.654 . . . . 1.0 111.552 175.03 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -111.91 121.92 46.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.653 1.581 . . . . 1.0 108.938 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.63 149.15 25.12 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.665 -1.235 . . . . 1.0 107.665 168.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -136.19 149.11 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.138 1.375 . . . . 1.0 108.699 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.98 143.72 50.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.225 1.41 . . . . 1.0 109.776 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.52 91.62 46.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.015 0.926 . . . . 1.0 111.821 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.27 -25.6 4.81 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.778 3.652 . . . . 1.0 116.714 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -65.95 -27.12 67.93 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.1 p -130.15 -16.49 3.58 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.01 1.324 . . . . 1.0 113.976 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.98 -0.2 87.57 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.002 1.287 . . . . 1.0 113.922 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.01 154.84 29.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -136.49 141.42 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.88 2.072 . . . . 1.0 109.494 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.9 pt -140.24 163.29 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.798 1.639 . . . . 1.0 110.457 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -140.21 137.63 34.46 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.133 1.773 . . . . 1.0 111.417 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.39 159.88 44.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.602 1.561 . . . . 1.0 111.02 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.34 -0.72 57.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.484 1.114 . . . . 1.0 113.611 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.32 5.2 23.19 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.836 1.208 . . . . 1.0 114.873 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.39 179.26 40.23 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.419 1.109 . . . . 1.0 113.864 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.26 83.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.016 1.327 . . . . 1.0 112.029 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -104.75 93.97 5.03 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.57 1.548 . . . . 1.0 109.737 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -45.38 -41.3 8.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.071 1.749 . . . . 1.0 115.365 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -58.73 -38.84 79.24 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.848 0.859 . . . . 1.0 112.893 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.94 -44.17 70.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.436 -0.79 . . . . 1.0 109.799 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -56.85 -43.36 81.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.691 0.796 . . . . 1.0 112.378 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.5 -46.06 84.19 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.72 0.408 . . . . 1.0 112.018 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -42.01 98.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.724 -0.61 . . . . 1.0 112.039 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.67 -41.28 97.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.938 0.895 . . . . 1.0 110.786 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.1 78.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.598 0.759 . . . . 1.0 112.898 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.61 -33.2 31.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.64 -2.86 4.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.347 1.61 . . . . 1.0 115.347 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.56 128.77 6.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.378 1.465 . . . . 1.0 112.256 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 -35.1 81.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.745 2.297 . . . . 1.0 113.279 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.61 -39.9 80.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.877 0.762 . . . . 1.0 112.242 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.84 73.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.403 0.681 . . . . 1.0 110.757 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -41.21 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.057 0.543 . . . . 1.0 112.25 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -66.05 -25.03 66.85 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.424 -1.423 . . . . 1.0 112.29 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.9 m -74.1 -21.99 59.67 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.461 -0.774 . . . . 1.0 112.732 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -72.85 -16.48 61.59 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.477 1.035 . . . . 1.0 112.939 170.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.74 57.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.02 117.94 12.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.218 1.807 . . . . 1.0 111.352 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.99 136.99 57.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.274 1.029 . . . . 1.0 110.723 172.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.096 0.958 . . . . 1.0 112.603 -178.247 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.621 -0.14 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -105.63 119.14 38.37 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.913 1.285 . . . . 1.0 108.365 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -86.89 148.09 25.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.463 -1.31 . . . . 1.0 107.463 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -138.25 151.19 47.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.872 1.269 . . . . 1.0 109.36 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -131.14 145.48 51.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.699 1.6 . . . . 1.0 109.072 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.57 94.11 44.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.738 0.815 . . . . 1.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.81 -26.85 10.31 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.348 3.365 . . . . 1.0 116.501 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.03 -17.81 56.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -130.62 -20.82 2.86 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.98 -6.2 82.86 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.996 1.76 . . . . 1.0 114.357 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -68.88 156.27 38.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.183 1.549 . . . . 1.0 115.183 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.72 140.11 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 127.271 2.229 . . . . 1.0 109.312 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -141.83 163.67 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.919 1.688 . . . . 1.0 110.954 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -139.45 138.7 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.218 1.807 . . . . 1.0 111.335 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.17 158.56 44.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.197 1.399 . . . . 1.0 110.927 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.417 1.087 . . . . 1.0 113.52 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.63 2.49 20.98 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.179 1.371 . . . . 1.0 114.85 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.98 179.39 38.72 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.379 1.089 . . . . 1.0 113.809 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -67.44 83.95 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.71 1.204 . . . . 1.0 112.047 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -102.72 93.92 5.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.422 1.489 . . . . 1.0 109.603 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -44.74 -40.73 6.26 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.316 1.846 . . . . 1.0 115.509 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.0 m -58.8 -38.97 79.75 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.843 0.857 . . . . 1.0 113.096 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.29 -43.69 66.64 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.536 -0.727 . . . . 1.0 109.646 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -56.16 -42.99 77.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.329 0.651 . . . . 1.0 112.294 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.74 -47.11 83.37 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.7 0.4 . . . . 1.0 111.477 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -62.62 -41.48 99.03 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.575 -0.703 . . . . 1.0 112.327 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -63.1 -39.88 95.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.954 0.902 . . . . 1.0 110.591 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.89 -39.18 79.89 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.703 0.801 . . . . 1.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -81.35 -32.73 32.81 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -174.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -128.75 -5.48 5.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.125 1.528 . . . . 1.0 115.125 -172.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.38 131.91 7.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.28 1.419 . . . . 1.0 111.909 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.63 -35.29 81.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.78 2.32 . . . . 1.0 113.073 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.77 -40.15 84.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.307 0.643 . . . . 1.0 111.761 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.26 76.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.347 0.659 . . . . 1.0 111.288 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.44 -40.01 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.744 -0.597 . . . . 1.0 112.317 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -66.9 -27.98 67.94 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.472 -1.393 . . . . 1.0 112.337 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.8 t -67.5 -26.83 66.55 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.418 -0.801 . . . . 1.0 112.429 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -72.77 -14.9 61.63 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.281 -0.887 . . . . 1.0 113.028 170.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.3 51.85 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.48 119.39 13.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.412 1.885 . . . . 1.0 110.905 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.11 122.17 18.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.625 1.17 . . . . 1.0 110.584 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 123.62 0.768 . . . . 1.0 111.672 177.728 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 111.272 0.101 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.29 119.16 38.39 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.196 1.399 . . . . 1.0 107.951 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.54 145.83 26.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.042 1.337 . . . . 1.0 107.401 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -136.09 151.33 49.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.572 1.149 . . . . 1.0 109.518 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -130.57 145.59 51.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.575 1.55 . . . . 1.0 109.31 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -117.56 93.69 43.96 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.91 0.884 . . . . 1.0 111.894 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.44 -26.79 9.19 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.294 3.33 . . . . 1.0 116.662 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -78.51 -16.92 56.96 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -131.37 -21.14 2.6 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.13 -5.66 82.94 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.654 1.597 . . . . 1.0 114.201 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.83 155.75 39.65 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.0 140.31 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.1 2.16 . . . . 1.0 109.117 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.67 164.52 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.977 1.711 . . . . 1.0 110.837 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -139.42 138.7 36.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.519 1.928 . . . . 1.0 110.891 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.28 156.63 41.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.586 1.555 . . . . 1.0 111.186 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.25 -3.03 58.68 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.502 1.121 . . . . 1.0 113.657 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 2.17 20.79 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.858 1.218 . . . . 1.0 114.98 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.9 179.02 39.11 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.503 1.152 . . . . 1.0 113.729 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.4 83.71 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.405 1.082 . . . . 1.0 112.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -98.89 94.06 6.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.639 1.576 . . . . 1.0 109.291 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 -43.09 6.56 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.254 1.822 . . . . 1.0 114.73 -169.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.5 m -57.73 -39.3 76.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.116 0.966 . . . . 1.0 112.88 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.7 tp -69.51 -43.41 73.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.385 0.674 . . . . 1.0 109.716 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -55.98 -44.51 78.62 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.44 0.696 . . . . 1.0 112.18 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.07 -45.48 87.04 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -41.82 98.47 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.507 -0.746 . . . . 1.0 112.232 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.89 -39.79 95.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.382 1.073 . . . . 1.0 110.661 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.84 76.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.623 0.769 . . . . 1.0 112.795 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -80.86 -33.01 34.75 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.296 1.221 . . . . 1.0 114.296 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -128.64 -5.72 5.21 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.69 132.14 7.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.69 1.614 . . . . 1.0 111.88 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.12 -34.61 79.02 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.706 2.271 . . . . 1.0 113.321 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.0 -39.78 83.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.477 0.711 . . . . 1.0 112.019 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.95 76.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.286 0.634 . . . . 1.0 111.032 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.363 0.505 . . . . 1.0 112.363 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.37 -28.41 68.62 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.461 -1.399 . . . . 1.0 112.07 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -22.86 64.76 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.538 -0.726 . . . . 1.0 112.752 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -76.51 -14.27 60.04 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.9 0.88 . . . . 1.0 113.068 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.35 147.55 51.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -139.42 117.27 11.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.445 1.898 . . . . 1.0 110.522 171.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.64 122.61 20.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.655 1.182 . . . . 1.0 110.322 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 124.155 0.982 . . . . 1.0 112.36 -177.778 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 110.796 -0.075 . . . . 1.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.71 120.66 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.488 1.515 . . . . 1.0 108.438 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -86.3 148.83 25.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -136.75 148.28 47.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 1.0 108.924 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -129.78 139.43 51.27 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.971 1.309 . . . . 1.0 109.723 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -115.07 90.66 24.22 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.571 1.148 . . . . 1.0 110.856 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.85 -12.74 26.97 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.185 2.59 . . . . 1.0 115.275 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -65.26 -27.52 68.7 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.3 p -128.07 -19.28 4.0 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.991 1.316 . . . . 1.0 113.734 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.32 79.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.11 1.338 . . . . 1.0 113.808 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.09 153.81 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.38 1.622 . . . . 1.0 115.38 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.19 141.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.682 1.993 . . . . 1.0 109.45 171.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.6 pt -140.05 163.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.902 1.681 . . . . 1.0 110.413 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -139.97 137.94 35.13 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.222 1.809 . . . . 1.0 111.276 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.38 159.07 44.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.219 1.408 . . . . 1.0 110.767 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -86.38 -3.07 58.93 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.277 1.031 . . . . 1.0 113.398 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.3 2.55 17.85 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.178 1.37 . . . . 1.0 115.071 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.0 179.13 42.37 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 118.379 1.09 . . . . 1.0 113.777 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.19 83.73 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.781 1.232 . . . . 1.0 112.38 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -103.54 93.98 5.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.54 1.536 . . . . 1.0 109.777 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -44.08 -41.13 5.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.305 1.842 . . . . 1.0 115.61 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -58.66 -38.04 77.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.896 0.878 . . . . 1.0 112.986 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.0 tp -70.56 -45.14 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.475 0.71 . . . . 1.0 109.614 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -56.37 -42.85 78.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.59 0.756 . . . . 1.0 112.441 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -57.45 -46.87 83.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.85 0.46 . . . . 1.0 111.58 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -62.68 -41.65 99.2 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.53 -0.731 . . . . 1.0 112.144 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -62.0 -40.57 96.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.791 0.836 . . . . 1.0 110.72 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.28 81.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.799 0.84 . . . . 1.0 112.883 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -82.01 -32.12 30.69 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -130.02 -4.19 4.51 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.297 1.591 . . . . 1.0 115.297 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 130.17 6.8 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.095 1.331 . . . . 1.0 112.326 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.14 -35.92 72.56 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.846 2.364 . . . . 1.0 113.359 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.15 -39.8 82.55 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.638 0.654 . . . . 1.0 112.052 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.527 0.731 . . . . 1.0 111.067 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.59 -40.28 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.178 0.591 . . . . 1.0 112.066 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -66.33 -25.07 66.65 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.376 -1.453 . . . . 1.0 112.413 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 t -73.12 -25.55 60.9 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.497 -0.752 . . . . 1.0 112.613 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -69.56 -17.31 63.55 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.781 -1.199 . . . . 1.0 113.084 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.53 55.96 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 118.51 12.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 1.0 111.179 170.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.74 131.34 47.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.031 0.932 . . . . 1.0 110.676 171.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 123.999 0.92 . . . . 1.0 111.404 175.303 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.858 0.318 . . . . 1.0 111.858 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -105.33 118.4 36.45 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.543 1.537 . . . . 1.0 108.005 168.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.33 148.24 26.13 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 168.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -135.84 150.03 49.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.95 1.3 . . . . 1.0 109.129 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.473 1.509 . . . . 1.0 109.387 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.38 93.02 41.94 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.121 0.969 . . . . 1.0 111.8 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.52 -26.46 8.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.41 3.407 . . . . 1.0 116.62 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -77.84 -17.97 56.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -131.57 -20.1 2.64 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.514 1.301 . . . . 1.0 114.514 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.65 -5.35 83.72 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.897 1.713 . . . . 1.0 114.15 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.23 156.51 37.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.299 1.592 . . . . 1.0 115.299 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.28 140.22 46.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 1.0 109.23 169.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.4 pt -140.53 164.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.874 1.669 . . . . 1.0 110.707 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -140.48 137.67 34.04 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.151 1.781 . . . . 1.0 111.107 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 158.23 43.6 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.421 1.489 . . . . 1.0 111.107 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -85.33 -4.63 59.22 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.117 -0.989 . . . . 1.0 113.301 171.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 3.36 15.57 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.107 1.337 . . . . 1.0 114.976 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.13 39.83 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.586 1.193 . . . . 1.0 113.947 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.48 83.78 0.17 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.714 1.206 . . . . 1.0 112.111 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -103.13 93.96 5.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.672 1.589 . . . . 1.0 109.88 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.04 -44.28 2.38 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.993 2.117 . . . . 1.0 115.429 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.4 m -59.25 -39.27 82.27 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.085 0.954 . . . . 1.0 113.247 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -69.26 -44.22 72.37 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.562 -0.711 . . . . 1.0 109.777 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -57.29 -42.4 81.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.325 0.65 . . . . 1.0 112.374 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.87 -46.07 85.4 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.683 0.393 . . . . 1.0 112.002 171.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -61.92 -41.94 98.51 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.538 -0.727 . . . . 1.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.5 -40.97 96.51 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.148 0.979 . . . . 1.0 110.91 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.38 78.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.405 0.682 . . . . 1.0 112.761 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -82.51 -33.04 28.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.491 1.293 . . . . 1.0 114.491 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.09 -3.08 4.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -171.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.72 129.62 6.66 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.376 1.465 . . . . 1.0 112.274 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.93 -35.81 75.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.647 2.231 . . . . 1.0 113.45 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.52 -39.89 81.01 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.518 0.599 . . . . 1.0 112.009 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.43 71.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.353 0.661 . . . . 1.0 110.875 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.91 -39.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.12 0.568 . . . . 1.0 112.035 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -66.68 -26.29 66.96 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.362 -1.461 . . . . 1.0 112.435 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 t -71.13 -26.14 62.88 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.646 -0.659 . . . . 1.0 112.605 169.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -69.47 -16.92 63.56 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.114 -0.991 . . . . 1.0 112.893 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.25 144.2 57.31 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.37 120.1 14.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.187 1.795 . . . . 1.0 111.374 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.3 mt -70.86 122.94 20.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.47 1.108 . . . . 1.0 110.566 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 124.507 1.123 . . . . 1.0 111.542 176.937 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 54.18 26.43 6.66 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 117.921 2.563 . . . . 1.0 117.921 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -67.49 154.4 41.48 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.301 -0.874 . . . . 1.0 110.778 169.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.0 t -72.57 132.16 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.822 0.849 . . . . 1.0 111.013 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -104.11 119.12 38.26 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.33 1.452 . . . . 1.0 108.022 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.42 142.92 28.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 77.0 m-85 -133.67 152.16 51.82 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.397 1.079 . . . . 1.0 109.267 174.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -133.87 143.33 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.546 1.538 . . . . 1.0 109.614 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -117.59 94.15 45.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.58 0.752 . . . . 1.0 111.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.97 -25.77 6.72 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.553 3.502 . . . . 1.0 116.525 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -71.37 -22.59 61.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.828 1.047 . . . . 1.0 113.828 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.2 p -129.38 -21.2 3.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.04 1.336 . . . . 1.0 113.774 -174.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.99 -6.7 82.62 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.584 1.564 . . . . 1.0 114.047 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -66.21 152.93 43.79 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.57 141.83 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 127.317 2.247 . . . . 1.0 108.876 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.5 pt -140.79 163.95 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.994 1.718 . . . . 1.0 110.737 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.64 136.89 34.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.412 1.885 . . . . 1.0 111.15 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.92 158.46 43.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.636 1.574 . . . . 1.0 110.812 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.26 -4.56 58.55 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.935 -1.103 . . . . 1.0 113.507 170.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.57 3.75 16.15 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.021 1.296 . . . . 1.0 114.667 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.61 179.52 43.65 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.441 1.121 . . . . 1.0 114.107 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.69 83.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.066 1.346 . . . . 1.0 112.391 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -108.03 94.32 5.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.961 1.704 . . . . 1.0 109.862 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -39.21 -46.15 1.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 127.453 2.301 . . . . 1.0 115.445 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 m -60.59 -39.07 86.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.435 1.094 . . . . 1.0 113.155 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.0 tp -69.14 -46.42 67.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.674 -0.641 . . . . 1.0 109.459 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.15 -43.3 78.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.245 0.618 . . . . 1.0 111.846 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -60.38 -43.53 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -64.36 -43.01 95.88 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.062 -0.398 . . . . 1.0 111.917 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -62.09 -39.83 93.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.073 0.949 . . . . 1.0 110.596 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.17 -36.18 77.1 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.709 0.804 . . . . 1.0 113.008 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -97.19 -17.34 19.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -130.95 -3.78 4.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.767 1.395 . . . . 1.0 114.767 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.99 131.25 7.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.371 1.462 . . . . 1.0 112.014 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.92 -34.39 81.63 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.617 2.211 . . . . 1.0 113.442 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.3 -40.22 86.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.988 0.813 . . . . 1.0 111.957 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.66 78.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.362 0.665 . . . . 1.0 110.94 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.66 -39.24 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.362 0.665 . . . . 1.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.41 -26.2 67.12 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.232 -1.543 . . . . 1.0 111.977 171.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 t -69.38 -27.53 65.39 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.212 -0.93 . . . . 1.0 112.167 169.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -71.09 -17.45 62.58 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.011 -1.056 . . . . 1.0 112.73 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -67.49 147.53 52.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.44 0.904 . . . . 1.0 113.44 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.42 120.66 14.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 1.0 110.732 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 mt -76.0 118.02 18.32 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.54 1.136 . . . . 1.0 110.48 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.77 49.53 1.21 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.635 1.174 . . . . 1.0 112.405 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.78 47.94 0.29 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.715 1.626 . . . . 1.0 112.965 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.616 1.566 . . . . 1.0 112.813 -178.248 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 52.38 37.77 23.4 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.965 2.106 . . . . 1.0 116.296 169.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -135.79 155.47 50.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.994 1.718 . . . . 1.0 112.273 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -72.48 142.79 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.412 1.485 . . . . 1.0 111.234 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.27 119.91 38.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.501 1.521 . . . . 1.0 108.796 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -83.56 148.23 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.112 1.365 . . . . 1.0 107.642 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -135.04 150.38 50.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.571 1.148 . . . . 1.0 109.214 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -132.68 143.6 49.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.467 1.507 . . . . 1.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -118.72 91.39 42.23 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.001 0.92 . . . . 1.0 111.104 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.33 -27.47 13.44 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.987 3.125 . . . . 1.0 116.277 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -75.98 -16.54 59.96 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.368 1.067 . . . . 1.0 113.868 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.6 p -128.73 -20.9 3.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.809 1.244 . . . . 1.0 113.828 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.49 -6.82 82.14 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.624 1.583 . . . . 1.0 114.209 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.59 154.66 41.67 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.205 1.557 . . . . 1.0 115.205 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.47 141.61 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.065 2.146 . . . . 1.0 109.107 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.1 pt -141.33 165.61 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.157 1.783 . . . . 1.0 110.759 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -138.0 140.2 40.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.873 2.069 . . . . 1.0 110.866 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.21 161.39 42.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.519 1.528 . . . . 1.0 110.853 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -90.24 -1.91 57.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.903 1.281 . . . . 1.0 113.233 171.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.05 3.88 22.83 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.035 1.303 . . . . 1.0 114.717 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.51 179.27 43.73 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.398 1.099 . . . . 1.0 114.144 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -66.72 83.7 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.879 1.272 . . . . 1.0 112.337 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -104.81 94.01 5.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.74 1.616 . . . . 1.0 109.803 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -42.17 -43.85 3.49 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.831 2.052 . . . . 1.0 115.452 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -59.93 -37.43 79.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.089 0.956 . . . . 1.0 113.205 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.8 -44.85 65.75 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.652 -0.655 . . . . 1.0 109.948 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -57.16 -42.31 80.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.48 0.712 . . . . 1.0 112.096 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -56.93 -44.72 82.78 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.982 0.513 . . . . 1.0 112.329 172.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -65.93 -40.94 91.87 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.917 -0.49 . . . . 1.0 112.118 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.26 -40.32 93.65 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.937 0.79 . . . . 1.0 110.689 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.93 77.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.981 0.912 . . . . 1.0 113.083 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -98.1 -17.68 18.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -132.37 -5.71 3.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.76 132.65 7.63 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.396 1.474 . . . . 1.0 112.613 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.9 -35.51 66.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.406 2.071 . . . . 1.0 113.409 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.24 -40.54 81.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.753 0.706 . . . . 1.0 111.875 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.34 73.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.356 0.662 . . . . 1.0 110.903 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.18 -39.84 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.351 0.66 . . . . 1.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.35 -26.2 67.17 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.411 -1.431 . . . . 1.0 112.204 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.9 t -72.68 -25.36 61.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.672 -0.643 . . . . 1.0 112.645 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -70.55 -16.59 62.89 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.98 -1.075 . . . . 1.0 112.989 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.97 54.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.676 0.991 . . . . 1.0 113.676 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.19 118.69 12.94 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.211 1.805 . . . . 1.0 110.976 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.5 mt -63.72 133.1 52.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.818 0.847 . . . . 1.0 110.711 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 mt -111.62 166.03 11.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.289 1.036 . . . . 1.0 111.953 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.16 23.29 1.91 Allowed Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.483 1.04 . . . . 1.0 114.421 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.465 0 C-N-CA 124.76 1.224 . . . . 1.0 113.225 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 54.09 36.58 25.06 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.665 2.098 . . . . 1.0 116.665 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -132.0 152.22 51.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.102 1.761 . . . . 1.0 110.657 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.27 137.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.921 0.888 . . . . 1.0 111.173 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -113.86 122.96 48.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.926 1.69 . . . . 1.0 109.094 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.59 147.54 25.88 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.564 1.546 . . . . 1.0 107.819 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -135.15 149.14 49.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.811 1.244 . . . . 1.0 109.165 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.76 139.02 48.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.967 1.307 . . . . 1.0 109.868 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -115.49 90.02 24.17 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.414 1.085 . . . . 1.0 110.783 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -12.24 24.42 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.333 2.689 . . . . 1.0 115.336 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -65.41 -27.75 68.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.01 0.924 . . . . 1.0 113.245 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.1 p -127.38 -20.43 4.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.045 1.338 . . . . 1.0 113.713 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.85 -1.34 74.55 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.258 1.409 . . . . 1.0 113.628 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.25 152.91 32.17 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.256 1.576 . . . . 1.0 115.256 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.35 142.55 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.82 2.048 . . . . 1.0 109.635 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -141.02 165.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.965 1.706 . . . . 1.0 110.528 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.11 141.06 42.31 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.554 1.942 . . . . 1.0 110.91 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.19 160.99 43.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 1.0 110.805 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.33 -0.13 57.24 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.446 1.099 . . . . 1.0 113.491 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.51 4.09 26.93 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.167 1.365 . . . . 1.0 114.774 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.94 179.64 47.1 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.387 1.094 . . . . 1.0 113.598 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.62 83.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.813 1.245 . . . . 1.0 112.129 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -102.05 94.05 5.56 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.429 1.492 . . . . 1.0 109.986 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.5 -41.89 3.12 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.571 2.348 . . . . 1.0 115.307 -169.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 m -59.96 -39.05 84.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.99 0.916 . . . . 1.0 113.338 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 tp -70.43 -42.74 71.17 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.531 0.732 . . . . 1.0 109.609 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.18 -43.05 78.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.538 0.735 . . . . 1.0 112.341 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.66 -46.37 84.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -62.49 -41.6 98.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.784 -0.572 . . . . 1.0 112.186 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.6 -41.1 96.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 1.0 110.692 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.93 78.95 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 1.0 112.884 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -83.17 -32.31 26.67 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.593 1.331 . . . . 1.0 114.593 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -129.25 -4.1 4.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.253 1.575 . . . . 1.0 115.253 -173.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 130.22 6.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.286 1.422 . . . . 1.0 111.921 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.83 -35.52 78.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.649 2.232 . . . . 1.0 113.525 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.1 -40.25 82.65 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.567 0.622 . . . . 1.0 111.948 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.3 -48.98 73.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 1.0 111.207 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.2 -40.18 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.917 -0.49 . . . . 1.0 112.166 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.06 -25.14 66.9 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.294 -1.504 . . . . 1.0 112.165 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -73.18 -25.71 60.89 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.607 -0.683 . . . . 1.0 112.709 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -69.87 -16.46 63.25 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.97 -1.081 . . . . 1.0 112.877 171.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.19 144.96 56.46 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.77 1.026 . . . . 1.0 113.77 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.06 117.85 12.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.212 1.805 . . . . 1.0 110.707 170.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -63.74 131.31 47.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.032 0.933 . . . . 1.0 110.54 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.0 mt -99.42 43.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.102 0.953 . . . . 1.0 111.746 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 -177.76 48.39 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.108 1.337 . . . . 1.0 113.205 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.052 1.741 . . . . 1.0 111.737 -178.832 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 111.63 0.233 . . . . 1.0 111.63 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -79.04 -0.49 31.54 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.293 1.59 . . . . 1.0 115.293 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 154.15 2.26 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.456 1.902 . . . . 1.0 114.262 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.67 137.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.248 1.419 . . . . 1.0 110.545 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.86 120.44 41.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.404 1.482 . . . . 1.0 108.659 168.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -86.5 146.6 26.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 80.3 m-85 -135.64 151.62 50.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.815 1.246 . . . . 1.0 108.983 175.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -132.02 144.71 50.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.273 1.429 . . . . 1.0 109.87 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -119.52 92.86 46.67 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.071 0.948 . . . . 1.0 112.246 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.63 -25.1 3.28 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.811 3.674 . . . . 1.0 117.091 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -67.09 -27.06 67.04 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.5 p -130.1 -17.5 3.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.929 1.291 . . . . 1.0 114.126 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.62 85.7 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.985 1.279 . . . . 1.0 113.896 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.14 154.6 30.6 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.228 1.566 . . . . 1.0 115.228 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 142.04 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.857 2.063 . . . . 1.0 109.565 171.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 pt -140.63 164.04 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.237 1.815 . . . . 1.0 110.656 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -140.23 137.41 34.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.055 1.742 . . . . 1.0 111.579 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.44 158.65 43.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.38 1.472 . . . . 1.0 111.166 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -83.32 -2.7 56.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.19 0.996 . . . . 1.0 113.515 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.26 25.91 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.082 1.325 . . . . 1.0 114.53 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.88 179.52 41.32 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.564 1.078 . . . . 1.0 113.805 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.6 83.79 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.132 1.373 . . . . 1.0 112.025 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -107.56 94.0 4.85 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.793 1.637 . . . . 1.0 109.865 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -41.36 -44.02 2.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.007 2.123 . . . . 1.0 115.24 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -60.82 -39.65 89.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.895 0.878 . . . . 1.0 113.23 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.93 -44.82 72.3 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.618 -0.676 . . . . 1.0 109.743 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -56.5 -43.12 79.43 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.384 0.674 . . . . 1.0 111.923 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.69 -48.38 79.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 122.662 0.385 . . . . 1.0 111.875 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.03 -43.71 98.49 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.818 -0.551 . . . . 1.0 112.211 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -62.53 -41.09 98.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 1.0 110.709 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.34 80.72 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -81.41 -32.9 32.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -129.66 -0.6 4.89 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -172.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.29 128.17 6.15 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.51 1.529 . . . . 1.0 112.113 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.88 -34.45 91.18 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.744 2.296 . . . . 1.0 113.213 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.27 -42.46 88.42 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.859 0.754 . . . . 1.0 111.646 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.49 80.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.406 0.683 . . . . 1.0 111.163 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.33 -36.4 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 1.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -66.89 -28.75 68.58 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.259 -1.525 . . . . 1.0 111.995 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.6 m -68.75 -23.77 64.36 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.138 -0.977 . . . . 1.0 112.216 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -72.9 -15.41 61.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.329 0.968 . . . . 1.0 112.442 169.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.421 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -71.47 148.13 47.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 119.17 12.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.587 1.955 . . . . 1.0 110.931 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.26 129.42 38.39 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.204 1.002 . . . . 1.0 110.625 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.6 mt -77.44 65.33 2.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.328 1.051 . . . . 1.0 112.829 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.93 34.77 1.31 Allowed Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.539 2.018 . . . . 1.0 112.453 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.842 2.057 . . . . 1.0 111.846 -172.751 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 111.252 0.093 . . . . 1.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -75.95 35.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.145 1.778 . . . . 1.0 114.453 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.6 154.56 32.38 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.937 1.695 . . . . 1.0 112.171 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.76 141.3 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.487 1.115 . . . . 1.0 110.348 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -113.3 121.26 43.86 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.685 1.594 . . . . 1.0 108.54 169.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -86.98 147.0 25.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.95 147.87 49.88 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.117 1.367 . . . . 1.0 109.018 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -129.99 137.49 50.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.075 1.35 . . . . 1.0 109.995 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -111.12 91.64 13.68 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.103 0.961 . . . . 1.0 110.543 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.22 -14.35 37.67 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.824 2.349 . . . . 1.0 114.896 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -69.78 -23.62 63.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.665 1.186 . . . . 1.0 113.562 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -127.93 -21.77 3.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.075 1.35 . . . . 1.0 113.619 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.27 -4.95 74.56 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.607 1.575 . . . . 1.0 113.873 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -66.03 153.18 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.71 141.59 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 126.914 2.086 . . . . 1.0 109.219 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -140.93 163.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.913 1.685 . . . . 1.0 110.65 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -139.18 138.54 37.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.155 1.782 . . . . 1.0 111.305 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.41 159.6 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.399 1.48 . . . . 1.0 110.876 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -87.24 -1.88 58.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.551 1.14 . . . . 1.0 113.517 171.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.75 5.49 18.15 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.151 1.358 . . . . 1.0 115.004 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.54 179.23 43.88 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.443 1.122 . . . . 1.0 114.205 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.79 83.87 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.344 1.458 . . . . 1.0 112.13 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -106.2 94.01 4.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.421 1.489 . . . . 1.0 110.215 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -37.56 -47.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.11 2.564 . . . . 1.0 115.463 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -61.49 -38.29 86.74 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.133 0.973 . . . . 1.0 113.039 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 tp -70.01 -44.41 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.675 -0.641 . . . . 1.0 109.616 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.3 -43.12 78.6 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.407 0.683 . . . . 1.0 112.203 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -58.71 -42.95 89.85 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -65.22 -41.51 94.37 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.879 0.326 . . . . 1.0 111.879 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.52 -40.01 93.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.662 0.785 . . . . 1.0 110.558 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.87 -36.0 77.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.074 0.949 . . . . 1.0 113.163 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.78 -17.62 19.25 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -131.37 -6.41 3.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.63 132.08 7.45 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.506 1.527 . . . . 1.0 112.2 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.07 -36.42 70.59 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.926 2.417 . . . . 1.0 113.447 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.78 -39.96 84.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.639 0.654 . . . . 1.0 111.9 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.91 74.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.268 0.627 . . . . 1.0 110.993 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.62 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.187 0.595 . . . . 1.0 112.17 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -66.6 -24.22 66.29 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.475 -1.39 . . . . 1.0 112.044 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -74.82 -23.63 58.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.528 -0.733 . . . . 1.0 112.718 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -71.33 -17.27 62.45 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.143 -0.973 . . . . 1.0 112.897 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.98 145.34 55.58 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.966 1.098 . . . . 1.0 113.966 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.42 117.96 12.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.116 1.766 . . . . 1.0 110.885 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.16 133.17 53.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.023 0.929 . . . . 1.0 110.777 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt -103.22 167.95 9.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.011 0.924 . . . . 1.0 111.382 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.69 178.08 48.61 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.608 1.099 . . . . 1.0 113.199 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.233 1.413 . . . . 1.0 112.199 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.317 0.103 . . . . 1.0 111.261 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -74.48 32.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.318 1.847 . . . . 1.0 114.833 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -63.28 153.06 36.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.753 1.621 . . . . 1.0 112.431 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.69 134.34 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.574 1.15 . . . . 1.0 110.82 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.58 116.0 31.72 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.086 1.355 . . . . 1.0 108.219 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -84.07 146.33 27.98 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.955 1.302 . . . . 1.0 107.533 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.6 150.47 50.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.828 1.251 . . . . 1.0 109.354 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 139.71 48.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.356 1.462 . . . . 1.0 110.022 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -116.13 89.65 26.12 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.71 1.204 . . . . 1.0 111.015 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 -12.12 23.07 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.179 2.586 . . . . 1.0 115.422 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -65.0 -28.09 69.28 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.0 p -127.71 -19.45 4.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.179 1.392 . . . . 1.0 113.963 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.45 -1.97 77.03 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.235 1.398 . . . . 1.0 113.631 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.02 152.76 31.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.236 1.569 . . . . 1.0 115.236 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 t -136.58 141.62 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.953 . . . . 1.0 109.466 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.9 pt -140.84 165.87 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.017 1.727 . . . . 1.0 110.727 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -139.31 139.18 37.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.617 1.967 . . . . 1.0 110.851 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.21 158.0 43.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.344 1.458 . . . . 1.0 110.659 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.96 -3.02 59.05 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.215 1.006 . . . . 1.0 113.514 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.54 2.62 14.92 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.813 1.197 . . . . 1.0 115.288 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.11 179.05 42.86 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.468 1.134 . . . . 1.0 113.829 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -66.57 83.79 0.1 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.086 1.355 . . . . 1.0 111.991 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -99.46 94.3 6.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.328 1.451 . . . . 1.0 110.249 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -39.84 -45.64 1.83 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 128.095 2.558 . . . . 1.0 115.118 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.8 m -60.55 -39.98 89.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.222 1.009 . . . . 1.0 113.576 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.1 tp -68.67 -42.39 77.94 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.546 -0.721 . . . . 1.0 109.918 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.07 -43.6 78.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 1.0 112.282 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.7 -45.38 85.77 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.16 -41.68 98.54 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.598 -0.689 . . . . 1.0 112.115 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -61.88 -40.91 97.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.414 1.086 . . . . 1.0 110.854 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 -38.17 79.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.481 0.713 . . . . 1.0 112.846 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.01 -33.08 30.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -129.78 -3.22 4.69 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -171.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.09 129.66 6.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.448 1.499 . . . . 1.0 112.335 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.93 -35.21 78.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.544 2.163 . . . . 1.0 113.569 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.61 -39.8 80.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.73 0.696 . . . . 1.0 112.2 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.14 -49.47 72.01 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.24 0.616 . . . . 1.0 110.805 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.4 -41.55 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.297 0.639 . . . . 1.0 112.072 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.525 -1.36 . . . . 1.0 112.269 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -75.94 -21.48 56.98 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.572 -0.705 . . . . 1.0 112.897 169.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -72.85 -16.37 61.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.548 1.067 . . . . 1.0 112.871 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.6 144.13 56.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.684 0.994 . . . . 1.0 113.684 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.09 118.45 12.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.296 1.838 . . . . 1.0 110.809 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 mt -71.23 116.47 11.58 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.514 1.126 . . . . 1.0 110.375 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.8 160.97 25.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.587 0.755 . . . . 1.0 111.487 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.5 33.65 0.27 Allowed Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.741 0.657 . . . . 1.0 114.741 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.811 1.645 . . . . 1.0 111.815 -176.488 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.723 0.297 . . . . 1.0 111.453 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -76.1 -3.56 36.69 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.271 1.582 . . . . 1.0 115.271 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -51.09 150.77 2.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.653 1.981 . . . . 1.0 113.482 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.57 141.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.8 1.24 . . . . 1.0 110.833 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -111.22 120.55 42.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.47 1.508 . . . . 1.0 108.647 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.8 148.73 25.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.654 -1.239 . . . . 1.0 107.654 169.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -136.67 149.82 48.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.098 1.359 . . . . 1.0 108.851 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -131.59 144.23 50.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.357 1.463 . . . . 1.0 109.95 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.89 91.75 47.85 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.147 0.979 . . . . 1.0 111.763 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.5 -25.99 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.835 3.69 . . . . 1.0 116.976 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.42 -27.07 67.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -129.51 -17.62 3.68 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.776 1.23 . . . . 1.0 113.935 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.24 0.14 85.24 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.033 1.301 . . . . 1.0 113.826 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.19 154.72 30.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.29 1.589 . . . . 1.0 115.29 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.55 141.23 41.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 126.852 2.061 . . . . 1.0 109.405 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -139.91 163.58 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.955 1.702 . . . . 1.0 110.674 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -139.93 137.89 35.15 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.105 1.762 . . . . 1.0 111.348 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 157.78 43.03 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.187 1.395 . . . . 1.0 111.014 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.61 -4.54 58.66 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.263 1.025 . . . . 1.0 113.442 171.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.41 1.91 19.9 Favored Glycine 0 N--CA 1.478 1.438 0 C-N-CA 125.053 1.311 . . . . 1.0 114.806 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.78 179.13 38.47 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 118.576 1.188 . . . . 1.0 113.807 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -67.42 83.87 0.16 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.737 1.215 . . . . 1.0 112.186 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.06 94.03 5.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.489 1.516 . . . . 1.0 109.903 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.33 -42.47 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.664 1.986 . . . . 1.0 115.664 -169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -59.07 -39.23 81.47 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.095 0.958 . . . . 1.0 113.013 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.96 -44.82 68.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.428 0.691 . . . . 1.0 109.777 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -56.4 -43.44 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.485 0.714 . . . . 1.0 112.156 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.63 -46.62 83.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.587 0.355 . . . . 1.0 111.877 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -62.18 -41.92 98.79 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.549 -0.719 . . . . 1.0 111.937 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.39 -41.07 96.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.966 0.906 . . . . 1.0 110.778 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.22 -38.7 78.67 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.555 0.742 . . . . 1.0 112.736 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -81.38 -32.65 32.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.94 -2.31 4.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.73 128.82 6.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.125 1.345 . . . . 1.0 112.358 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.66 -35.32 81.16 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.659 2.24 . . . . 1.0 113.513 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.7 -39.53 80.47 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.867 0.758 . . . . 1.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.05 72.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.147 0.579 . . . . 1.0 110.869 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.77 -40.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.702 -0.623 . . . . 1.0 112.176 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.43 -24.79 66.5 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.364 -1.46 . . . . 1.0 112.207 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -74.7 -21.44 59.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.561 -0.712 . . . . 1.0 112.9 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -72.95 -16.5 61.53 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.428 1.013 . . . . 1.0 112.96 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.7 145.66 55.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.39 118.06 12.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.432 1.893 . . . . 1.0 111.197 170.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 mt -63.88 131.09 46.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.174 0.99 . . . . 1.0 110.543 172.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.8 mt -98.23 162.89 12.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.659 0.783 . . . . 1.0 111.479 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.41 32.11 0.39 Allowed Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.086 0.794 . . . . 1.0 115.086 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.1 t60 . . . . . 0 C--O 1.256 1.419 0 C-N-CA 124.993 1.317 . . . . 1.0 112.929 177.885 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 111.34 0.126 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.81 42.63 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.142 1.777 . . . . 1.0 114.955 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.2 156.23 29.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.691 1.196 . . . . 1.0 111.131 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.08 130.81 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.124 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -104.02 118.45 36.69 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.293 1.437 . . . . 1.0 107.854 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -85.86 145.46 27.18 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.102 1.361 . . . . 1.0 107.37 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -136.62 152.66 50.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.586 1.154 . . . . 1.0 109.565 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -133.31 144.74 49.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.406 1.483 . . . . 1.0 109.727 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -121.37 91.49 48.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.191 0.996 . . . . 1.0 111.749 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.4 -25.52 5.04 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.752 3.635 . . . . 1.0 116.898 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -65.34 -26.82 68.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 p -129.96 -17.2 3.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.952 1.301 . . . . 1.0 113.952 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.54 86.79 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.982 1.277 . . . . 1.0 114.064 -173.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.33 154.82 34.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.03 140.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.915 2.086 . . . . 1.0 109.452 172.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -141.99 164.42 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.98 1.712 . . . . 1.0 110.89 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.13 138.02 34.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.389 1.876 . . . . 1.0 110.878 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.4 156.9 41.64 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.46 1.504 . . . . 1.0 111.025 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -84.73 -2.87 58.19 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.504 1.121 . . . . 1.0 113.663 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.65 2.28 19.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.863 1.22 . . . . 1.0 114.985 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 179.35 42.16 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.292 1.046 . . . . 1.0 113.877 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.6 83.79 0.18 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.784 1.234 . . . . 1.0 112.011 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -102.51 94.12 5.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.568 1.547 . . . . 1.0 109.858 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -39.83 -45.5 1.8 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.434 2.293 . . . . 1.0 115.429 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.1 m -60.38 -39.45 87.31 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.203 1.001 . . . . 1.0 113.015 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -69.92 -43.67 71.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.348 -0.845 . . . . 1.0 109.869 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -56.36 -43.52 79.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.377 0.671 . . . . 1.0 111.952 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -58.45 -47.46 83.92 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.015 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -60.6 -42.35 96.62 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.769 -0.582 . . . . 1.0 112.109 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.69 -40.24 96.49 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 1.0 110.782 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.39 -39.25 78.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.803 0.841 . . . . 1.0 112.971 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.58 -32.73 42.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.818 1.247 . . . . 1.0 114.133 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.2 -4.31 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.87 130.72 7.12 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.405 1.478 . . . . 1.0 111.764 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.55 -34.75 84.54 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.73 2.287 . . . . 1.0 113.424 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.456 0.703 . . . . 1.0 111.951 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.61 77.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.268 0.627 . . . . 1.0 111.005 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.74 -39.86 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.8 -0.563 . . . . 1.0 112.208 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -66.72 -27.12 67.37 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.23 -1.544 . . . . 1.0 112.178 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 t -67.96 -27.07 66.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.12 -0.988 . . . . 1.0 112.277 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.7 m0 -72.33 -15.72 61.88 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.0 -1.062 . . . . 1.0 113.115 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.68 145.92 55.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.5 0.926 . . . . 1.0 113.5 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.48 117.48 11.76 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.267 1.827 . . . . 1.0 110.443 170.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.89 118.25 13.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.471 1.109 . . . . 1.0 110.345 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -81.39 157.73 24.89 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.388 0.675 . . . . 1.0 112.086 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.23 34.46 0.26 Allowed Glycine 0 CA--C 1.538 1.489 0 C-N-CA 123.6 0.619 . . . . 1.0 114.604 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.524 1.53 . . . . 1.0 111.316 -177.907 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -77.12 64.44 2.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.82 1.648 . . . . 1.0 112.58 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -134.34 154.13 51.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.344 1.857 . . . . 1.0 111.99 -172.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.1 t -77.82 137.1 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.755 1.222 . . . . 1.0 110.704 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -102.86 117.94 35.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.575 1.15 . . . . 1.0 108.554 168.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -86.63 145.64 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.223 1.409 . . . . 1.0 107.611 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -136.4 151.85 49.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.59 1.156 . . . . 1.0 109.91 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -132.83 137.82 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.279 1.432 . . . . 1.0 109.596 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -111.65 92.47 17.08 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.83 0.852 . . . . 1.0 110.586 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.75 -14.19 38.87 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.996 2.464 . . . . 1.0 114.782 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -70.32 -22.63 62.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.592 1.157 . . . . 1.0 113.55 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.2 p -127.58 -23.16 3.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.242 1.417 . . . . 1.0 113.449 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.28 -6.4 71.84 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.829 1.68 . . . . 1.0 113.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -66.93 152.79 45.03 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.164 1.542 . . . . 1.0 115.164 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.8 t -134.09 140.39 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.96 2.104 . . . . 1.0 109.191 171.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 pt -140.94 164.56 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.756 1.622 . . . . 1.0 110.766 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -139.72 137.47 35.17 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.551 1.94 . . . . 1.0 110.884 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.59 158.49 43.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.933 1.293 . . . . 1.0 111.323 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -86.43 -2.83 58.78 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.389 1.076 . . . . 1.0 113.188 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.44 3.19 19.11 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.098 1.333 . . . . 1.0 115.015 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.2 179.21 42.86 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.569 1.184 . . . . 1.0 113.907 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -67.4 83.76 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.03 1.332 . . . . 1.0 112.055 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -104.67 94.38 5.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.704 1.602 . . . . 1.0 109.865 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -41.5 -43.2 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.832 2.053 . . . . 1.0 115.547 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -60.19 -37.82 81.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.044 0.938 . . . . 1.0 113.096 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -71.64 -44.25 64.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.273 0.629 . . . . 1.0 109.604 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -56.8 -43.14 80.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.436 0.694 . . . . 1.0 112.06 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -57.28 -44.78 84.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 172.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.18 -41.36 90.37 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.069 -0.394 . . . . 1.0 112.052 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -62.12 -38.73 90.04 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.986 0.812 . . . . 1.0 110.703 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.16 75.8 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.755 0.822 . . . . 1.0 112.916 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -98.4 -16.1 19.41 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.972 1.842 . . . . 1.0 115.972 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -130.84 -8.24 3.98 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.761 1.393 . . . . 1.0 114.761 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.36 134.25 8.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.379 1.466 . . . . 1.0 112.161 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.42 -35.88 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.605 2.203 . . . . 1.0 113.228 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -39.56 86.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.553 0.741 . . . . 1.0 111.693 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.54 78.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.398 0.679 . . . . 1.0 111.453 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.7 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.945 -0.472 . . . . 1.0 112.205 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -65.86 -27.15 68.01 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.514 -1.366 . . . . 1.0 112.239 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -68.64 -27.57 66.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.958 0.799 . . . . 1.0 112.394 170.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -72.15 -15.92 61.98 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.054 -1.029 . . . . 1.0 112.85 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.08 147.28 53.59 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.19 120.36 14.71 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.293 1.837 . . . . 1.0 110.761 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.15 116.0 15.4 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.647 1.179 . . . . 1.0 110.295 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.1 mt -78.95 160.76 27.09 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.33 0.652 . . . . 1.0 111.815 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.4 36.51 0.32 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.73 0.681 . . . . 1.0 114.449 -176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.485 1.514 . . . . 1.0 112.577 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.669 0.271 . . . . 1.0 111.428 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -76.9 -2.52 33.96 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.381 1.623 . . . . 1.0 115.381 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -51.75 153.79 2.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.599 1.959 . . . . 1.0 114.161 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.9 t -76.17 139.55 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.475 1.51 . . . . 1.0 111.05 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -106.42 119.82 40.26 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.45 1.5 . . . . 1.0 107.829 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -86.35 145.29 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.164 1.386 . . . . 1.0 107.279 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 90.8 m-85 -136.2 152.09 50.4 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.737 1.215 . . . . 1.0 109.698 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -133.92 144.5 48.87 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.599 1.56 . . . . 1.0 109.435 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.67 93.94 44.74 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.763 0.825 . . . . 1.0 111.453 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.21 -26.09 7.7 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.476 3.451 . . . . 1.0 116.441 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -72.07 -21.96 61.43 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.987 1.106 . . . . 1.0 113.987 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -128.91 -21.75 3.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.095 1.358 . . . . 1.0 113.545 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.21 -6.74 82.42 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.544 1.545 . . . . 1.0 113.797 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.25 152.65 45.35 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.874 1.435 . . . . 1.0 114.874 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.05 139.97 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 127.07 2.148 . . . . 1.0 109.177 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -141.7 164.42 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.017 1.727 . . . . 1.0 110.832 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -140.51 136.06 32.53 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.326 1.851 . . . . 1.0 110.872 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.71 157.3 41.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.872 1.269 . . . . 1.0 111.173 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.96 -4.78 58.64 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.929 -1.107 . . . . 1.0 113.711 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.65 2.43 17.1 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.841 1.21 . . . . 1.0 114.925 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.87 179.12 38.8 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 118.415 1.107 . . . . 1.0 113.803 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -68.13 83.74 0.23 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.585 1.154 . . . . 1.0 112.127 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -102.87 94.92 5.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.616 1.566 . . . . 1.0 109.771 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -41.57 -43.18 2.64 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 126.784 2.034 . . . . 1.0 115.699 -170.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -37.97 79.39 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.229 1.011 . . . . 1.0 113.269 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -44.14 63.89 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.353 0.661 . . . . 1.0 109.764 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.09 -43.4 78.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.484 0.714 . . . . 1.0 111.871 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.97 -44.56 87.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.47 -40.92 89.63 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.985 -0.447 . . . . 1.0 112.015 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -62.73 -38.75 91.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.048 0.84 . . . . 1.0 110.388 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -36.3 75.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 1.0 113.169 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.1 -16.77 19.42 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.843 1.794 . . . . 1.0 115.843 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -130.72 -9.16 4.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 134.18 8.07 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.436 1.493 . . . . 1.0 111.98 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 -34.68 71.87 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.522 2.148 . . . . 1.0 113.098 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.74 -39.84 84.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.62 0.768 . . . . 1.0 111.913 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.87 80.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 1.0 111.108 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.96 -41.03 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.731 -0.605 . . . . 1.0 112.126 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.6 -30.04 71.21 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.45 -1.406 . . . . 1.0 112.123 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 t -67.99 -27.54 66.66 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.343 -0.848 . . . . 1.0 112.523 171.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -72.74 -15.44 61.66 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.15 -0.969 . . . . 1.0 113.065 170.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -67.04 147.53 53.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.692 0.997 . . . . 1.0 113.692 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.08 116.64 11.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.297 1.839 . . . . 1.0 110.323 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.23 132.04 46.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.962 0.905 . . . . 1.0 110.347 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.2 mt -82.29 48.59 1.29 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.959 0.885 . . . . 1.0 112.293 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.75 174.14 42.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.889 1.709 . . . . 1.0 113.076 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.367 0 C-N-CA 125.436 1.494 . . . . 1.0 112.307 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 58.06 30.63 19.56 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.521 2.328 . . . . 1.0 116.239 169.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -137.73 157.82 45.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.89 1.676 . . . . 1.0 112.431 -175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.85 138.61 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.819 1.648 . . . . 1.0 109.942 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -104.74 119.21 38.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.918 1.287 . . . . 1.0 108.657 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -86.45 145.89 26.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.221 -1.4 . . . . 1.0 107.221 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -135.9 152.5 51.07 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.615 1.166 . . . . 1.0 109.61 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -133.05 144.97 50.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.412 1.485 . . . . 1.0 109.184 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -118.03 92.12 41.48 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.179 0.992 . . . . 1.0 110.946 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.34 -27.16 12.87 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.307 3.338 . . . . 1.0 116.077 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.04 -15.71 59.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 p -128.91 -22.51 3.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.931 1.292 . . . . 1.0 113.802 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.49 80.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.928 1.727 . . . . 1.0 114.171 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.09 154.5 41.85 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.143 1.535 . . . . 1.0 115.143 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.26 140.16 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.326 2.25 . . . . 1.0 109.205 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -142.67 165.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.036 1.734 . . . . 1.0 110.994 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -138.87 138.92 37.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.74 2.016 . . . . 1.0 111.002 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.29 158.44 43.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.463 1.505 . . . . 1.0 110.977 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.52 -3.21 58.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.275 1.03 . . . . 1.0 113.545 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.94 4.32 22.76 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.091 1.329 . . . . 1.0 114.866 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 179.32 38.66 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.277 1.039 . . . . 1.0 113.789 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -65.45 83.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.222 1.409 . . . . 1.0 112.212 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -103.08 94.04 5.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.574 1.549 . . . . 1.0 110.341 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -39.77 -45.53 1.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 128.093 2.557 . . . . 1.0 115.441 -171.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.4 m -61.21 -39.87 91.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.172 0.989 . . . . 1.0 113.425 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.96 -42.66 72.88 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.643 -0.661 . . . . 1.0 109.772 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.43 -44.11 75.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.456 0.703 . . . . 1.0 112.181 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -57.66 -44.16 85.48 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -65.2 -41.46 94.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.003 -0.435 . . . . 1.0 112.028 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -62.46 -39.03 92.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.887 0.875 . . . . 1.0 110.463 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.98 76.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.037 0.935 . . . . 1.0 113.124 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -98.07 -18.11 18.73 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.853 1.797 . . . . 1.0 115.853 -171.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -129.4 -8.11 4.7 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.61 134.16 8.28 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.467 1.508 . . . . 1.0 111.937 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.85 -34.3 72.64 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.5 2.133 . . . . 1.0 113.065 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.08 -39.49 82.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.51 0.724 . . . . 1.0 112.072 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.97 76.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.458 0.703 . . . . 1.0 110.973 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.54 -41.2 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.126 0.57 . . . . 1.0 112.305 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.98 -28.26 68.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.437 -1.414 . . . . 1.0 112.241 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 m -68.91 -22.83 64.14 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 30.0 m0 -76.73 -14.19 59.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.009 0.923 . . . . 1.0 112.975 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.08 147.86 51.76 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.21 0.914 . . . . 1.0 113.362 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -139.11 117.65 12.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.57 1.948 . . . . 1.0 110.687 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -71.19 123.99 23.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.479 1.112 . . . . 1.0 110.782 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.9 mt -86.25 41.27 0.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.165 0.986 . . . . 1.0 112.556 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.58 176.13 39.2 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.546 1.546 . . . . 1.0 113.362 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.812 1.645 . . . . 1.0 112.226 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 53.14 34.3 17.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -136.23 159.39 41.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.175 1.79 . . . . 1.0 112.089 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.66 137.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.265 1.826 . . . . 1.0 110.39 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -100.65 115.52 30.42 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.375 1.07 . . . . 1.0 108.841 168.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.15 145.87 28.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 1.0 107.539 169.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -133.76 149.82 51.46 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.754 1.222 . . . . 1.0 109.074 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -130.97 144.39 51.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.517 1.527 . . . . 1.0 109.306 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -118.34 92.61 43.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.873 . . . . 1.0 111.62 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.57 -26.34 8.96 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.299 3.333 . . . . 1.0 116.78 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -18.19 57.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.02 1.118 . . . . 1.0 114.02 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -130.83 -21.22 2.75 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.08 81.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.814 1.673 . . . . 1.0 114.154 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.3 156.44 37.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.326 1.602 . . . . 1.0 115.326 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.39 140.77 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 127.141 2.176 . . . . 1.0 109.109 169.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.7 pt -140.19 166.24 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.861 1.664 . . . . 1.0 110.612 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -140.06 138.45 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.58 1.952 . . . . 1.0 111.072 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.24 159.27 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.374 1.469 . . . . 1.0 110.966 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -86.67 -2.65 58.7 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.035 -1.041 . . . . 1.0 113.314 171.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.74 4.57 22.92 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.183 1.373 . . . . 1.0 114.945 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.07 179.18 45.59 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.327 1.063 . . . . 1.0 113.871 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.18 83.99 0.09 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.987 1.315 . . . . 1.0 112.143 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -105.3 94.08 5.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.687 1.595 . . . . 1.0 109.812 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -42.01 -43.77 3.29 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.763 2.025 . . . . 1.0 115.47 -169.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -59.23 -39.16 81.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.055 0.942 . . . . 1.0 112.945 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.21 -44.69 71.57 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.682 -0.636 . . . . 1.0 109.851 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -57.07 -42.81 81.3 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.636 0.774 . . . . 1.0 112.168 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -57.73 -45.87 85.21 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.082 0.401 . . . . 1.0 112.082 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -62.4 -41.7 98.87 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.725 -0.609 . . . . 1.0 112.133 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.33 -41.42 96.98 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.009 0.924 . . . . 1.0 110.806 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.81 78.15 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.031 0.752 . . . . 1.0 113.031 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.05 -33.19 30.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.449 1.278 . . . . 1.0 114.449 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.19 -2.95 4.47 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.363 1.616 . . . . 1.0 115.363 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.38 129.23 6.56 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.433 1.492 . . . . 1.0 112.477 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.92 -35.59 76.86 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.78 2.32 . . . . 1.0 113.564 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -39.75 80.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.843 0.747 . . . . 1.0 112.18 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.21 -49.57 71.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.228 0.611 . . . . 1.0 110.816 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -40.63 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.317 0.647 . . . . 1.0 112.146 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.1 -25.38 66.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.494 -1.379 . . . . 1.0 112.178 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -74.72 -21.25 59.47 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 169.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -73.41 -16.5 61.33 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.38 0.991 . . . . 1.0 113.118 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.22 144.39 56.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.6 p -139.02 121.14 15.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.482 1.913 . . . . 1.0 110.923 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.67 115.13 12.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.542 1.137 . . . . 1.0 110.642 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.5 mt -76.23 161.08 29.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.32 0.648 . . . . 1.0 111.895 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.65 178.32 48.67 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.444 1.021 . . . . 1.0 113.479 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--O 1.256 1.422 0 C-N-CA 125.674 1.589 . . . . 1.0 111.537 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 57.97 21.55 7.85 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 118.094 2.628 . . . . 1.0 118.094 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -70.61 155.07 41.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.819 0.847 . . . . 1.0 111.396 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.9 134.19 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.544 1.138 . . . . 1.0 111.5 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -99.64 115.6 29.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.702 1.201 . . . . 1.0 108.04 168.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -84.91 145.78 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.127 1.371 . . . . 1.0 107.471 168.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -136.69 153.59 50.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.617 1.167 . . . . 1.0 109.583 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -133.61 144.68 49.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.397 1.479 . . . . 1.0 109.837 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.73 91.8 47.54 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.245 1.018 . . . . 1.0 111.817 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.06 -25.65 4.35 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.797 3.665 . . . . 1.0 117.079 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -65.49 -27.3 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -129.85 -17.85 3.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.956 1.303 . . . . 1.0 113.895 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.87 0.5 85.73 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.031 1.3 . . . . 1.0 113.906 -173.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.64 154.39 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.81 140.78 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.827 2.051 . . . . 1.0 109.478 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.1 pt -142.49 165.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.979 1.712 . . . . 1.0 110.968 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.85 138.87 36.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.61 1.964 . . . . 1.0 111.068 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.67 157.48 42.16 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.29 1.436 . . . . 1.0 110.733 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -83.82 -3.79 58.15 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 171.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.81 3.07 20.39 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.063 1.316 . . . . 1.0 114.878 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.34 41.95 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.371 1.086 . . . . 1.0 113.961 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -66.5 83.66 0.1 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.015 1.326 . . . . 1.0 112.302 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -103.99 94.1 5.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.516 1.527 . . . . 1.0 109.474 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -44.33 -41.96 6.41 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.478 1.911 . . . . 1.0 115.422 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -59.28 -39.22 82.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.801 0.841 . . . . 1.0 112.958 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.97 -43.0 69.0 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.664 -0.648 . . . . 1.0 109.899 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.61 -42.99 79.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 1.0 112.125 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.66 -46.79 83.78 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.712 0.405 . . . . 1.0 111.827 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -62.13 -41.96 98.76 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.697 -0.627 . . . . 1.0 112.101 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -62.79 -39.99 95.96 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 1.0 110.615 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.48 -39.43 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.63 0.772 . . . . 1.0 112.71 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -80.3 -32.41 38.08 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 1.0 114.245 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.27 -4.29 4.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.15 1.537 . . . . 1.0 115.15 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.0 131.41 7.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.567 1.555 . . . . 1.0 111.959 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 -34.69 80.37 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.664 2.243 . . . . 1.0 113.42 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.72 -39.83 84.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.301 0.64 . . . . 1.0 112.061 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.43 -47.15 77.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.08 0.552 . . . . 1.0 111.094 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.0 -40.02 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.775 -0.578 . . . . 1.0 111.919 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.21 -27.6 68.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.273 -1.517 . . . . 1.0 112.43 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 t -67.58 -27.37 66.87 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.214 -0.929 . . . . 1.0 112.279 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -72.3 -15.17 61.9 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.046 -1.034 . . . . 1.0 113.141 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.14 145.79 54.92 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.396 0.888 . . . . 1.0 113.396 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.18 117.62 12.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.421 1.888 . . . . 1.0 110.545 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.94 116.33 12.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.681 1.192 . . . . 1.0 110.406 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.69 173.68 12.21 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.9 0.88 . . . . 1.0 111.644 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.59 6.63 52.46 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 115.689 1.036 . . . . 1.0 115.689 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.255 1.35 0 C-N-CA 126.394 1.878 . . . . 1.0 111.616 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.428 0.633 . . . . 1.0 112.607 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -135.76 34.36 2.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.843 2.057 . . . . 1.0 110.026 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -138.27 157.79 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.17 2.188 . . . . 1.0 112.696 -169.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.0 t -81.0 141.4 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.382 1.473 . . . . 1.0 110.245 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.36 120.38 42.24 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.235 1.414 . . . . 1.0 108.872 169.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.36 149.49 24.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -136.62 150.15 48.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.113 1.365 . . . . 1.0 108.728 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -132.24 144.45 50.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.204 1.401 . . . . 1.0 109.698 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -120.8 91.4 47.4 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.292 1.037 . . . . 1.0 111.702 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -47.15 -25.6 4.5 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.955 3.77 . . . . 1.0 116.987 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -66.47 -26.56 67.25 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.734 1.013 . . . . 1.0 113.734 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 p -130.02 -18.26 3.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.082 1.353 . . . . 1.0 113.735 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.28 -0.85 83.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.9 1.238 . . . . 1.0 113.909 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.05 153.76 28.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.31 1.596 . . . . 1.0 115.31 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.46 140.87 42.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.839 2.056 . . . . 1.0 109.455 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.7 pt -140.28 164.35 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.02 1.728 . . . . 1.0 110.527 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -139.5 138.8 36.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.104 1.762 . . . . 1.0 111.096 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -150.87 158.69 44.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.454 1.502 . . . . 1.0 111.178 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.74 -3.13 58.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.691 1.196 . . . . 1.0 113.349 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.01 1.39 19.15 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.844 1.211 . . . . 1.0 114.993 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.83 179.11 41.87 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 118.484 1.142 . . . . 1.0 113.875 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -67.75 83.78 0.19 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.398 1.079 . . . . 1.0 112.378 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -98.71 93.97 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.698 1.599 . . . . 1.0 109.557 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -44.4 -41.35 6.11 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.117 2.167 . . . . 1.0 115.052 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -60.43 -38.14 83.16 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.309 1.044 . . . . 1.0 113.278 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -69.56 -43.78 72.2 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.399 -0.813 . . . . 1.0 109.812 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -55.78 -43.51 76.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.537 0.735 . . . . 1.0 112.386 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.25 -46.94 82.55 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.985 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -62.05 -41.14 97.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.679 -0.638 . . . . 1.0 112.364 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.94 -41.09 97.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.242 1.017 . . . . 1.0 110.733 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.03 -37.92 78.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.932 0.893 . . . . 1.0 112.761 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -81.78 -32.62 31.29 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.535 1.309 . . . . 1.0 114.535 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -130.66 -3.41 4.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.08 129.37 6.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.283 1.42 . . . . 1.0 112.319 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.24 79.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.831 2.354 . . . . 1.0 113.364 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.32 -40.09 81.77 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.934 0.788 . . . . 1.0 111.987 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.48 72.51 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.357 0.663 . . . . 1.0 110.938 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.37 -41.37 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.247 0.619 . . . . 1.0 112.217 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -66.23 -25.08 66.74 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.434 -1.416 . . . . 1.0 112.073 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 m -74.38 -21.64 59.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -73.0 -15.79 61.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.349 0.977 . . . . 1.0 113.112 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.04 145.24 56.59 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.43 118.71 12.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.378 1.871 . . . . 1.0 111.086 170.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.1 mt -64.84 131.71 47.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.195 0.998 . . . . 1.0 110.641 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.02 166.36 11.63 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.675 0.79 . . . . 1.0 111.758 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.56 178.62 48.37 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.507 1.051 . . . . 1.0 113.551 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.268 0 C-N-CA 125.771 1.628 . . . . 1.0 111.525 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 120.526 0.203 . . . . 1.0 111.435 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -76.93 -3.11 37.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.624 1.713 . . . . 1.0 115.624 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -51.17 151.11 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.933 1.693 . . . . 1.0 113.129 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.74 137.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.682 1.593 . . . . 1.0 111.45 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -102.47 116.86 33.47 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.867 1.267 . . . . 1.0 108.257 168.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -84.46 146.32 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.106 1.363 . . . . 1.0 107.427 169.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -135.18 150.0 50.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.734 1.214 . . . . 1.0 109.257 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -132.79 138.02 46.99 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 1.0 109.834 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -112.45 91.31 16.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.242 1.017 . . . . 1.0 110.68 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.43 -14.47 39.29 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.843 2.362 . . . . 1.0 114.675 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -69.22 -23.76 63.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.494 1.118 . . . . 1.0 113.644 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.7 p -127.01 -22.2 3.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.993 1.317 . . . . 1.0 113.51 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.36 -4.83 74.09 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.664 1.602 . . . . 1.0 113.808 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -66.2 153.31 42.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.132 1.53 . . . . 1.0 115.132 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.8 140.39 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.851 2.06 . . . . 1.0 109.173 171.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.8 pt -139.53 165.79 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.639 1.576 . . . . 1.0 110.599 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -140.74 136.96 33.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.256 1.823 . . . . 1.0 110.737 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.49 157.2 41.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.94 1.296 . . . . 1.0 111.227 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -85.05 -4.37 59.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.21 1.004 . . . . 1.0 113.475 171.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.72 1.97 14.81 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.317 1.436 . . . . 1.0 114.995 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.46 178.84 41.18 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.392 1.096 . . . . 1.0 114.159 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.88 83.9 0.21 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.869 1.268 . . . . 1.0 112.027 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -103.82 94.04 5.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.821 1.648 . . . . 1.0 109.843 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -43.5 -40.99 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.386 1.875 . . . . 1.0 115.588 -169.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -59.13 -37.11 76.44 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.976 0.91 . . . . 1.0 113.028 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.5 tp -70.87 -45.29 64.68 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.447 0.699 . . . . 1.0 109.784 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.67 -43.51 80.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.789 0.836 . . . . 1.0 112.1 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.01 -44.1 82.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.43 -41.2 89.53 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.046 -0.409 . . . . 1.0 112.0 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.02 -40.16 92.5 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.857 0.753 . . . . 1.0 110.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.02 77.17 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.002 0.921 . . . . 1.0 113.033 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -98.48 -16.76 19.07 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.007 1.854 . . . . 1.0 116.007 -171.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -132.75 -6.48 3.19 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.029 1.492 . . . . 1.0 115.029 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.39 132.77 7.58 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.322 1.439 . . . . 1.0 112.464 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.79 -36.28 63.09 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.709 2.273 . . . . 1.0 113.542 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.5 -39.51 81.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.765 0.712 . . . . 1.0 112.021 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.33 73.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.397 0.679 . . . . 1.0 110.762 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.92 -40.9 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.339 0.656 . . . . 1.0 112.073 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -66.13 -24.45 66.68 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.492 -1.38 . . . . 1.0 112.217 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 m -75.55 -21.88 57.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.859 0.689 . . . . 1.0 112.859 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -72.94 -17.49 61.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.572 1.078 . . . . 1.0 112.892 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 145.23 54.41 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.05 119.64 14.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.286 1.834 . . . . 1.0 110.96 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.0 mt -70.84 119.5 15.07 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.361 1.064 . . . . 1.0 110.434 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.36 172.86 13.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.335 0.654 . . . . 1.0 111.552 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.73 3.57 59.79 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.31 0.957 . . . . 1.0 115.454 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 126.771 2.029 . . . . 1.0 111.599 -175.651 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -75.47 33.68 0.11 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.306 1.843 . . . . 1.0 114.639 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.68 152.68 34.74 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.545 1.538 . . . . 1.0 111.952 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.29 136.22 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.129 0.972 . . . . 1.0 110.138 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -111.91 121.92 46.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.653 1.581 . . . . 1.0 108.938 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.63 149.15 25.12 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.665 -1.235 . . . . 1.0 107.665 168.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -136.19 149.11 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.138 1.375 . . . . 1.0 108.699 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.98 143.72 50.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.225 1.41 . . . . 1.0 109.776 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.52 91.62 46.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.015 0.926 . . . . 1.0 111.821 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.27 -25.6 4.81 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.778 3.652 . . . . 1.0 116.714 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -65.95 -27.12 67.93 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.1 p -130.15 -16.49 3.58 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.01 1.324 . . . . 1.0 113.976 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.98 -0.2 87.57 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.002 1.287 . . . . 1.0 113.922 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.01 154.84 29.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -136.49 141.42 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.88 2.072 . . . . 1.0 109.494 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.9 pt -140.24 163.29 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.798 1.639 . . . . 1.0 110.457 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -140.21 137.63 34.46 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.133 1.773 . . . . 1.0 111.417 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.39 159.88 44.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.602 1.561 . . . . 1.0 111.02 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.34 -0.72 57.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.484 1.114 . . . . 1.0 113.611 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.32 5.2 23.19 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.836 1.208 . . . . 1.0 114.873 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.39 179.26 40.23 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.419 1.109 . . . . 1.0 113.864 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.26 83.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.016 1.327 . . . . 1.0 112.029 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -104.75 93.97 5.03 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.57 1.548 . . . . 1.0 109.737 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -45.38 -41.3 8.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.071 1.749 . . . . 1.0 115.365 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -58.73 -38.84 79.24 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.848 0.859 . . . . 1.0 112.893 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.94 -44.17 70.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.436 -0.79 . . . . 1.0 109.799 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -56.85 -43.36 81.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.691 0.796 . . . . 1.0 112.378 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.5 -46.06 84.19 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.72 0.408 . . . . 1.0 112.018 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -42.01 98.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.724 -0.61 . . . . 1.0 112.039 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.67 -41.28 97.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.938 0.895 . . . . 1.0 110.786 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.1 78.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.598 0.759 . . . . 1.0 112.898 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.61 -33.2 31.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.64 -2.86 4.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.347 1.61 . . . . 1.0 115.347 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.56 128.77 6.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.378 1.465 . . . . 1.0 112.256 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 -35.1 81.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.745 2.297 . . . . 1.0 113.279 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.61 -39.9 80.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.877 0.762 . . . . 1.0 112.242 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.84 73.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.403 0.681 . . . . 1.0 110.757 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -41.21 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.057 0.543 . . . . 1.0 112.25 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -66.05 -25.03 66.85 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.424 -1.423 . . . . 1.0 112.29 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.9 m -74.1 -21.99 59.67 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.461 -0.774 . . . . 1.0 112.732 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -72.85 -16.48 61.59 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.477 1.035 . . . . 1.0 112.939 170.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.74 57.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.02 117.94 12.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.218 1.807 . . . . 1.0 111.352 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.99 136.99 57.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.274 1.029 . . . . 1.0 110.723 172.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.1 mt -103.83 44.98 0.98 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.096 0.958 . . . . 1.0 112.603 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.93 177.16 47.92 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.524 1.059 . . . . 1.0 114.146 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.5 t60 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.812 1.645 . . . . 1.0 111.104 -178.433 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.626 0.25 . . . . 1.0 111.625 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -76.92 62.87 2.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.816 1.646 . . . . 1.0 112.967 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -134.25 154.05 51.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.616 1.967 . . . . 1.0 112.134 -172.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.83 138.92 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.863 1.265 . . . . 1.0 110.621 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -105.63 119.14 38.37 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.913 1.285 . . . . 1.0 108.365 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -86.89 148.09 25.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.463 -1.31 . . . . 1.0 107.463 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -138.25 151.19 47.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.872 1.269 . . . . 1.0 109.36 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -131.14 145.48 51.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.699 1.6 . . . . 1.0 109.072 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.57 94.11 44.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.738 0.815 . . . . 1.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.81 -26.85 10.31 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.348 3.365 . . . . 1.0 116.501 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.03 -17.81 56.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -130.62 -20.82 2.86 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.98 -6.2 82.86 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.996 1.76 . . . . 1.0 114.357 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -68.88 156.27 38.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.183 1.549 . . . . 1.0 115.183 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.72 140.11 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 127.271 2.229 . . . . 1.0 109.312 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -141.83 163.67 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.919 1.688 . . . . 1.0 110.954 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -139.45 138.7 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.218 1.807 . . . . 1.0 111.335 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.17 158.56 44.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.197 1.399 . . . . 1.0 110.927 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.417 1.087 . . . . 1.0 113.52 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.63 2.49 20.98 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.179 1.371 . . . . 1.0 114.85 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.98 179.39 38.72 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.379 1.089 . . . . 1.0 113.809 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -67.44 83.95 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.71 1.204 . . . . 1.0 112.047 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -102.72 93.92 5.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.422 1.489 . . . . 1.0 109.603 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -44.74 -40.73 6.26 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.316 1.846 . . . . 1.0 115.509 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.0 m -58.8 -38.97 79.75 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.843 0.857 . . . . 1.0 113.096 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.29 -43.69 66.64 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.536 -0.727 . . . . 1.0 109.646 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -56.16 -42.99 77.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.329 0.651 . . . . 1.0 112.294 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.74 -47.11 83.37 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.7 0.4 . . . . 1.0 111.477 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -62.62 -41.48 99.03 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.575 -0.703 . . . . 1.0 112.327 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -63.1 -39.88 95.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.954 0.902 . . . . 1.0 110.591 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.89 -39.18 79.89 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.703 0.801 . . . . 1.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -81.35 -32.73 32.81 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -174.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -128.75 -5.48 5.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.125 1.528 . . . . 1.0 115.125 -172.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.38 131.91 7.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.28 1.419 . . . . 1.0 111.909 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.63 -35.29 81.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.78 2.32 . . . . 1.0 113.073 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.77 -40.15 84.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.307 0.643 . . . . 1.0 111.761 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.26 76.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.347 0.659 . . . . 1.0 111.288 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.44 -40.01 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.744 -0.597 . . . . 1.0 112.317 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -66.9 -27.98 67.94 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.472 -1.393 . . . . 1.0 112.337 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.8 t -67.5 -26.83 66.55 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.418 -0.801 . . . . 1.0 112.429 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -72.77 -14.9 61.63 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.281 -0.887 . . . . 1.0 113.028 170.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.3 51.85 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.48 119.39 13.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.412 1.885 . . . . 1.0 110.905 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.11 122.17 18.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.625 1.17 . . . . 1.0 110.584 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.99 163.94 17.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.62 0.768 . . . . 1.0 111.672 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.18 179.49 48.0 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.397 0.999 . . . . 1.0 113.439 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.981 1.712 . . . . 1.0 111.198 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.489 0.185 . . . . 1.0 111.361 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.6 -0.29 29.2 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 115.39 1.626 . . . . 1.0 115.39 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -52.52 150.3 5.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.97 1.708 . . . . 1.0 113.24 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.87 134.03 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.295 1.038 . . . . 1.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.29 119.16 38.39 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.196 1.399 . . . . 1.0 107.951 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.54 145.83 26.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.042 1.337 . . . . 1.0 107.401 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -136.09 151.33 49.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.572 1.149 . . . . 1.0 109.518 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -130.57 145.59 51.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.575 1.55 . . . . 1.0 109.31 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -117.56 93.69 43.96 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.91 0.884 . . . . 1.0 111.894 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.44 -26.79 9.19 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.294 3.33 . . . . 1.0 116.662 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -78.51 -16.92 56.96 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -131.37 -21.14 2.6 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.13 -5.66 82.94 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.654 1.597 . . . . 1.0 114.201 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.83 155.75 39.65 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.0 140.31 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.1 2.16 . . . . 1.0 109.117 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.67 164.52 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.977 1.711 . . . . 1.0 110.837 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -139.42 138.7 36.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.519 1.928 . . . . 1.0 110.891 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.28 156.63 41.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.586 1.555 . . . . 1.0 111.186 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.25 -3.03 58.68 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.502 1.121 . . . . 1.0 113.657 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 2.17 20.79 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.858 1.218 . . . . 1.0 114.98 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.9 179.02 39.11 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.503 1.152 . . . . 1.0 113.729 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.4 83.71 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.405 1.082 . . . . 1.0 112.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -98.89 94.06 6.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.639 1.576 . . . . 1.0 109.291 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 -43.09 6.56 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.254 1.822 . . . . 1.0 114.73 -169.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.5 m -57.73 -39.3 76.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.116 0.966 . . . . 1.0 112.88 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.7 tp -69.51 -43.41 73.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.385 0.674 . . . . 1.0 109.716 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -55.98 -44.51 78.62 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.44 0.696 . . . . 1.0 112.18 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.07 -45.48 87.04 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -41.82 98.47 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.507 -0.746 . . . . 1.0 112.232 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.89 -39.79 95.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.382 1.073 . . . . 1.0 110.661 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.84 76.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.623 0.769 . . . . 1.0 112.795 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -80.86 -33.01 34.75 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.296 1.221 . . . . 1.0 114.296 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -128.64 -5.72 5.21 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.69 132.14 7.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.69 1.614 . . . . 1.0 111.88 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.12 -34.61 79.02 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.706 2.271 . . . . 1.0 113.321 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.0 -39.78 83.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.477 0.711 . . . . 1.0 112.019 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.95 76.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.286 0.634 . . . . 1.0 111.032 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.363 0.505 . . . . 1.0 112.363 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.37 -28.41 68.62 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.461 -1.399 . . . . 1.0 112.07 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -22.86 64.76 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.538 -0.726 . . . . 1.0 112.752 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -76.51 -14.27 60.04 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.9 0.88 . . . . 1.0 113.068 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.35 147.55 51.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -139.42 117.27 11.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.445 1.898 . . . . 1.0 110.522 171.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.64 122.61 20.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.655 1.182 . . . . 1.0 110.322 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.58 47.94 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.155 0.982 . . . . 1.0 112.36 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.37 -4.35 80.73 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.257 1.408 . . . . 1.0 115.323 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.242 1.817 . . . . 1.0 111.156 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 111.552 0.205 . . . . 1.0 111.552 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.28 36.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.343 1.857 . . . . 1.0 114.48 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -63.29 153.85 33.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.713 1.605 . . . . 1.0 112.119 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.48 139.13 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.714 1.206 . . . . 1.0 110.796 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.71 120.66 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.488 1.515 . . . . 1.0 108.438 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -86.3 148.83 25.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -136.75 148.28 47.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 1.0 108.924 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -129.78 139.43 51.27 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.971 1.309 . . . . 1.0 109.723 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -115.07 90.66 24.22 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.571 1.148 . . . . 1.0 110.856 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.85 -12.74 26.97 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.185 2.59 . . . . 1.0 115.275 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -65.26 -27.52 68.7 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.3 p -128.07 -19.28 4.0 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.991 1.316 . . . . 1.0 113.734 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.32 79.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.11 1.338 . . . . 1.0 113.808 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.09 153.81 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.38 1.622 . . . . 1.0 115.38 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.19 141.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.682 1.993 . . . . 1.0 109.45 171.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.6 pt -140.05 163.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.902 1.681 . . . . 1.0 110.413 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -139.97 137.94 35.13 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.222 1.809 . . . . 1.0 111.276 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.38 159.07 44.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.219 1.408 . . . . 1.0 110.767 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -86.38 -3.07 58.93 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.277 1.031 . . . . 1.0 113.398 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.3 2.55 17.85 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.178 1.37 . . . . 1.0 115.071 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.0 179.13 42.37 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 118.379 1.09 . . . . 1.0 113.777 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.19 83.73 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.781 1.232 . . . . 1.0 112.38 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -103.54 93.98 5.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.54 1.536 . . . . 1.0 109.777 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -44.08 -41.13 5.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.305 1.842 . . . . 1.0 115.61 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -58.66 -38.04 77.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.896 0.878 . . . . 1.0 112.986 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.0 tp -70.56 -45.14 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.475 0.71 . . . . 1.0 109.614 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -56.37 -42.85 78.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.59 0.756 . . . . 1.0 112.441 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -57.45 -46.87 83.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.85 0.46 . . . . 1.0 111.58 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -62.68 -41.65 99.2 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.53 -0.731 . . . . 1.0 112.144 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -62.0 -40.57 96.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.791 0.836 . . . . 1.0 110.72 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.28 81.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.799 0.84 . . . . 1.0 112.883 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -82.01 -32.12 30.69 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -130.02 -4.19 4.51 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.297 1.591 . . . . 1.0 115.297 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 130.17 6.8 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.095 1.331 . . . . 1.0 112.326 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.14 -35.92 72.56 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.846 2.364 . . . . 1.0 113.359 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.15 -39.8 82.55 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.638 0.654 . . . . 1.0 112.052 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.527 0.731 . . . . 1.0 111.067 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.59 -40.28 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.178 0.591 . . . . 1.0 112.066 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -66.33 -25.07 66.65 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.376 -1.453 . . . . 1.0 112.413 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 t -73.12 -25.55 60.9 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.497 -0.752 . . . . 1.0 112.613 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -69.56 -17.31 63.55 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.781 -1.199 . . . . 1.0 113.084 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.53 55.96 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 118.51 12.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 1.0 111.179 170.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.74 131.34 47.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.031 0.932 . . . . 1.0 110.676 171.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt -99.79 166.83 10.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.999 0.92 . . . . 1.0 111.404 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.21 47.31 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.31 0.957 . . . . 1.0 113.581 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.566 1.547 . . . . 1.0 111.426 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 111.788 0.292 . . . . 1.0 111.788 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 54.92 29.75 12.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 126.787 2.035 . . . . 1.0 116.415 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.69 158.41 30.19 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.06 0.944 . . . . 1.0 111.715 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.7 t -66.03 137.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.832 1.253 . . . . 1.0 111.858 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -105.33 118.4 36.45 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.543 1.537 . . . . 1.0 108.005 168.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.33 148.24 26.13 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 168.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -135.84 150.03 49.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.95 1.3 . . . . 1.0 109.129 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.473 1.509 . . . . 1.0 109.387 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.38 93.02 41.94 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.121 0.969 . . . . 1.0 111.8 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.52 -26.46 8.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.41 3.407 . . . . 1.0 116.62 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -77.84 -17.97 56.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -131.57 -20.1 2.64 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.514 1.301 . . . . 1.0 114.514 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.65 -5.35 83.72 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.897 1.713 . . . . 1.0 114.15 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.23 156.51 37.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.299 1.592 . . . . 1.0 115.299 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.28 140.22 46.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 1.0 109.23 169.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.4 pt -140.53 164.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.874 1.669 . . . . 1.0 110.707 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -140.48 137.67 34.04 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.151 1.781 . . . . 1.0 111.107 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 158.23 43.6 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.421 1.489 . . . . 1.0 111.107 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -85.33 -4.63 59.22 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.117 -0.989 . . . . 1.0 113.301 171.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 3.36 15.57 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.107 1.337 . . . . 1.0 114.976 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.13 39.83 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.586 1.193 . . . . 1.0 113.947 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.48 83.78 0.17 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.714 1.206 . . . . 1.0 112.111 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -103.13 93.96 5.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.672 1.589 . . . . 1.0 109.88 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.04 -44.28 2.38 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.993 2.117 . . . . 1.0 115.429 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.4 m -59.25 -39.27 82.27 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.085 0.954 . . . . 1.0 113.247 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -69.26 -44.22 72.37 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.562 -0.711 . . . . 1.0 109.777 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -57.29 -42.4 81.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.325 0.65 . . . . 1.0 112.374 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.87 -46.07 85.4 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.683 0.393 . . . . 1.0 112.002 171.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -61.92 -41.94 98.51 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.538 -0.727 . . . . 1.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.5 -40.97 96.51 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.148 0.979 . . . . 1.0 110.91 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.38 78.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.405 0.682 . . . . 1.0 112.761 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -82.51 -33.04 28.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.491 1.293 . . . . 1.0 114.491 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.09 -3.08 4.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -171.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.72 129.62 6.66 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.376 1.465 . . . . 1.0 112.274 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.93 -35.81 75.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.647 2.231 . . . . 1.0 113.45 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.52 -39.89 81.01 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.518 0.599 . . . . 1.0 112.009 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.43 71.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.353 0.661 . . . . 1.0 110.875 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.91 -39.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.12 0.568 . . . . 1.0 112.035 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -66.68 -26.29 66.96 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.362 -1.461 . . . . 1.0 112.435 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 t -71.13 -26.14 62.88 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.646 -0.659 . . . . 1.0 112.605 169.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -69.47 -16.92 63.56 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.114 -0.991 . . . . 1.0 112.893 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.25 144.2 57.31 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.37 120.1 14.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.187 1.795 . . . . 1.0 111.374 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.3 mt -70.86 122.94 20.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.47 1.108 . . . . 1.0 110.566 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -80.17 52.16 1.51 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.507 1.123 . . . . 1.0 111.542 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.03 43.5 0.44 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.027 1.775 . . . . 1.0 112.886 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.55 1.54 . . . . 1.0 112.934 -176.227 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.0 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.534 0.206 . . . . 1.0 111.013 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -104.11 119.12 38.26 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.33 1.452 . . . . 1.0 108.022 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.42 142.92 28.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 77.0 m-85 -133.67 152.16 51.82 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.397 1.079 . . . . 1.0 109.267 174.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -133.87 143.33 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.546 1.538 . . . . 1.0 109.614 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -117.59 94.15 45.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.58 0.752 . . . . 1.0 111.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.97 -25.77 6.72 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.553 3.502 . . . . 1.0 116.525 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -71.37 -22.59 61.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.828 1.047 . . . . 1.0 113.828 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.2 p -129.38 -21.2 3.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.04 1.336 . . . . 1.0 113.774 -174.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.99 -6.7 82.62 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.584 1.564 . . . . 1.0 114.047 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -66.21 152.93 43.79 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.57 141.83 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 127.317 2.247 . . . . 1.0 108.876 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.5 pt -140.79 163.95 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.994 1.718 . . . . 1.0 110.737 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.64 136.89 34.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.412 1.885 . . . . 1.0 111.15 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.92 158.46 43.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.636 1.574 . . . . 1.0 110.812 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.26 -4.56 58.55 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.935 -1.103 . . . . 1.0 113.507 170.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.57 3.75 16.15 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.021 1.296 . . . . 1.0 114.667 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.61 179.52 43.65 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.441 1.121 . . . . 1.0 114.107 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.69 83.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.066 1.346 . . . . 1.0 112.391 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -108.03 94.32 5.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.961 1.704 . . . . 1.0 109.862 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -39.21 -46.15 1.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 127.453 2.301 . . . . 1.0 115.445 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 m -60.59 -39.07 86.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.435 1.094 . . . . 1.0 113.155 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.0 tp -69.14 -46.42 67.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.674 -0.641 . . . . 1.0 109.459 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.15 -43.3 78.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.245 0.618 . . . . 1.0 111.846 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -60.38 -43.53 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -64.36 -43.01 95.88 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.062 -0.398 . . . . 1.0 111.917 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -62.09 -39.83 93.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.073 0.949 . . . . 1.0 110.596 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.17 -36.18 77.1 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.709 0.804 . . . . 1.0 113.008 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -97.19 -17.34 19.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -130.95 -3.78 4.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.767 1.395 . . . . 1.0 114.767 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.99 131.25 7.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.371 1.462 . . . . 1.0 112.014 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.92 -34.39 81.63 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.617 2.211 . . . . 1.0 113.442 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.3 -40.22 86.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.988 0.813 . . . . 1.0 111.957 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.66 78.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.362 0.665 . . . . 1.0 110.94 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.66 -39.24 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.362 0.665 . . . . 1.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.41 -26.2 67.12 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.232 -1.543 . . . . 1.0 111.977 171.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 t -69.38 -27.53 65.39 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.212 -0.93 . . . . 1.0 112.167 169.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -71.09 -17.45 62.58 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.011 -1.056 . . . . 1.0 112.73 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -67.49 147.53 52.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.44 0.904 . . . . 1.0 113.44 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.42 120.66 14.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 1.0 110.732 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 mt -76.0 118.02 18.32 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.54 1.136 . . . . 1.0 110.48 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 124.635 1.174 . . . . 1.0 112.405 -177.687 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.322 0.106 . . . . 1.0 111.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.27 119.91 38.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.501 1.521 . . . . 1.0 108.796 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -83.56 148.23 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.112 1.365 . . . . 1.0 107.642 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -135.04 150.38 50.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.571 1.148 . . . . 1.0 109.214 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -132.68 143.6 49.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.467 1.507 . . . . 1.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -118.72 91.39 42.23 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.001 0.92 . . . . 1.0 111.104 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.33 -27.47 13.44 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.987 3.125 . . . . 1.0 116.277 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -75.98 -16.54 59.96 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.368 1.067 . . . . 1.0 113.868 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.6 p -128.73 -20.9 3.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.809 1.244 . . . . 1.0 113.828 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.49 -6.82 82.14 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.624 1.583 . . . . 1.0 114.209 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.59 154.66 41.67 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.205 1.557 . . . . 1.0 115.205 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.47 141.61 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.065 2.146 . . . . 1.0 109.107 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.1 pt -141.33 165.61 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.157 1.783 . . . . 1.0 110.759 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -138.0 140.2 40.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.873 2.069 . . . . 1.0 110.866 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.21 161.39 42.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.519 1.528 . . . . 1.0 110.853 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -90.24 -1.91 57.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.903 1.281 . . . . 1.0 113.233 171.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.05 3.88 22.83 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.035 1.303 . . . . 1.0 114.717 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.51 179.27 43.73 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.398 1.099 . . . . 1.0 114.144 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -66.72 83.7 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.879 1.272 . . . . 1.0 112.337 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -104.81 94.01 5.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.74 1.616 . . . . 1.0 109.803 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -42.17 -43.85 3.49 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.831 2.052 . . . . 1.0 115.452 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -59.93 -37.43 79.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.089 0.956 . . . . 1.0 113.205 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.8 -44.85 65.75 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.652 -0.655 . . . . 1.0 109.948 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -57.16 -42.31 80.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.48 0.712 . . . . 1.0 112.096 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -56.93 -44.72 82.78 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.982 0.513 . . . . 1.0 112.329 172.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -65.93 -40.94 91.87 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.917 -0.49 . . . . 1.0 112.118 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.26 -40.32 93.65 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.937 0.79 . . . . 1.0 110.689 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.93 77.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.981 0.912 . . . . 1.0 113.083 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -98.1 -17.68 18.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -132.37 -5.71 3.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.76 132.65 7.63 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.396 1.474 . . . . 1.0 112.613 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.9 -35.51 66.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.406 2.071 . . . . 1.0 113.409 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.24 -40.54 81.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.753 0.706 . . . . 1.0 111.875 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.34 73.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.356 0.662 . . . . 1.0 110.903 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.18 -39.84 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.351 0.66 . . . . 1.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.35 -26.2 67.17 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.411 -1.431 . . . . 1.0 112.204 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.9 t -72.68 -25.36 61.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.672 -0.643 . . . . 1.0 112.645 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -70.55 -16.59 62.89 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.98 -1.075 . . . . 1.0 112.989 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.97 54.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.676 0.991 . . . . 1.0 113.676 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.19 118.69 12.94 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.211 1.805 . . . . 1.0 110.976 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.5 mt -63.72 133.1 52.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.818 0.847 . . . . 1.0 110.711 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 CA--C 1.544 0.714 0 C-N-CA 124.289 1.036 . . . . 1.0 111.953 177.329 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.3 t . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.29 0.091 . . . . 1.0 111.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -113.86 122.96 48.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.926 1.69 . . . . 1.0 109.094 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.59 147.54 25.88 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.564 1.546 . . . . 1.0 107.819 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -135.15 149.14 49.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.811 1.244 . . . . 1.0 109.165 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.76 139.02 48.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.967 1.307 . . . . 1.0 109.868 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -115.49 90.02 24.17 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.414 1.085 . . . . 1.0 110.783 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -12.24 24.42 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.333 2.689 . . . . 1.0 115.336 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -65.41 -27.75 68.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.01 0.924 . . . . 1.0 113.245 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.1 p -127.38 -20.43 4.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.045 1.338 . . . . 1.0 113.713 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.85 -1.34 74.55 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.258 1.409 . . . . 1.0 113.628 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.25 152.91 32.17 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.256 1.576 . . . . 1.0 115.256 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.35 142.55 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.82 2.048 . . . . 1.0 109.635 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -141.02 165.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.965 1.706 . . . . 1.0 110.528 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.11 141.06 42.31 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.554 1.942 . . . . 1.0 110.91 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.19 160.99 43.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 1.0 110.805 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.33 -0.13 57.24 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.446 1.099 . . . . 1.0 113.491 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.51 4.09 26.93 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.167 1.365 . . . . 1.0 114.774 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.94 179.64 47.1 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.387 1.094 . . . . 1.0 113.598 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.62 83.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.813 1.245 . . . . 1.0 112.129 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -102.05 94.05 5.56 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.429 1.492 . . . . 1.0 109.986 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.5 -41.89 3.12 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.571 2.348 . . . . 1.0 115.307 -169.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 m -59.96 -39.05 84.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.99 0.916 . . . . 1.0 113.338 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 tp -70.43 -42.74 71.17 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.531 0.732 . . . . 1.0 109.609 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.18 -43.05 78.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.538 0.735 . . . . 1.0 112.341 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.66 -46.37 84.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -62.49 -41.6 98.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.784 -0.572 . . . . 1.0 112.186 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.6 -41.1 96.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 1.0 110.692 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.93 78.95 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 1.0 112.884 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -83.17 -32.31 26.67 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.593 1.331 . . . . 1.0 114.593 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -129.25 -4.1 4.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.253 1.575 . . . . 1.0 115.253 -173.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 130.22 6.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.286 1.422 . . . . 1.0 111.921 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.83 -35.52 78.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.649 2.232 . . . . 1.0 113.525 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.1 -40.25 82.65 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.567 0.622 . . . . 1.0 111.948 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.3 -48.98 73.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 1.0 111.207 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.2 -40.18 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.917 -0.49 . . . . 1.0 112.166 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.06 -25.14 66.9 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.294 -1.504 . . . . 1.0 112.165 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -73.18 -25.71 60.89 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.607 -0.683 . . . . 1.0 112.709 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -69.87 -16.46 63.25 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.97 -1.081 . . . . 1.0 112.877 171.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.19 144.96 56.46 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.77 1.026 . . . . 1.0 113.77 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.06 117.85 12.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.212 1.805 . . . . 1.0 110.707 170.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -63.74 131.31 47.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.032 0.933 . . . . 1.0 110.54 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.0 mt . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 122.102 0.953 . . . . 1.0 111.746 178.119 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 110.545 -0.169 . . . . 1.0 110.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.86 120.44 41.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.404 1.482 . . . . 1.0 108.659 168.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -86.5 146.6 26.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 80.3 m-85 -135.64 151.62 50.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.815 1.246 . . . . 1.0 108.983 175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -132.02 144.71 50.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.273 1.429 . . . . 1.0 109.87 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -119.52 92.86 46.67 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.071 0.948 . . . . 1.0 112.246 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.63 -25.1 3.28 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.811 3.674 . . . . 1.0 117.091 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -67.09 -27.06 67.04 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.5 p -130.1 -17.5 3.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.929 1.291 . . . . 1.0 114.126 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.62 85.7 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.985 1.279 . . . . 1.0 113.896 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.14 154.6 30.6 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.228 1.566 . . . . 1.0 115.228 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 142.04 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.857 2.063 . . . . 1.0 109.565 171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 pt -140.63 164.04 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.237 1.815 . . . . 1.0 110.656 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -140.23 137.41 34.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.055 1.742 . . . . 1.0 111.579 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.44 158.65 43.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.38 1.472 . . . . 1.0 111.166 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -83.32 -2.7 56.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.19 0.996 . . . . 1.0 113.515 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.26 25.91 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.082 1.325 . . . . 1.0 114.53 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.88 179.52 41.32 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.564 1.078 . . . . 1.0 113.805 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.6 83.79 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.132 1.373 . . . . 1.0 112.025 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -107.56 94.0 4.85 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.793 1.637 . . . . 1.0 109.865 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -41.36 -44.02 2.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.007 2.123 . . . . 1.0 115.24 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -60.82 -39.65 89.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.895 0.878 . . . . 1.0 113.23 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.93 -44.82 72.3 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.618 -0.676 . . . . 1.0 109.743 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -56.5 -43.12 79.43 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.384 0.674 . . . . 1.0 111.923 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.69 -48.38 79.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 122.662 0.385 . . . . 1.0 111.875 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.03 -43.71 98.49 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.818 -0.551 . . . . 1.0 112.211 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -62.53 -41.09 98.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 1.0 110.709 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.34 80.72 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -81.41 -32.9 32.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -129.66 -0.6 4.89 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -172.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.29 128.17 6.15 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.51 1.529 . . . . 1.0 112.113 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.88 -34.45 91.18 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.744 2.296 . . . . 1.0 113.213 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.27 -42.46 88.42 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.859 0.754 . . . . 1.0 111.646 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.49 80.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.406 0.683 . . . . 1.0 111.163 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.33 -36.4 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 1.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -66.89 -28.75 68.58 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.259 -1.525 . . . . 1.0 111.995 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.6 m -68.75 -23.77 64.36 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.138 -0.977 . . . . 1.0 112.216 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -72.9 -15.41 61.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.329 0.968 . . . . 1.0 112.442 169.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.421 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -71.47 148.13 47.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 119.17 12.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.587 1.955 . . . . 1.0 110.931 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.26 129.42 38.39 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.204 1.002 . . . . 1.0 110.625 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 124.328 1.051 . . . . 1.0 112.829 -178.768 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.2 t . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 110.348 -0.242 . . . . 1.0 110.348 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -113.3 121.26 43.86 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.685 1.594 . . . . 1.0 108.54 169.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -86.98 147.0 25.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.95 147.87 49.88 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.117 1.367 . . . . 1.0 109.018 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -129.99 137.49 50.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.075 1.35 . . . . 1.0 109.995 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -111.12 91.64 13.68 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.103 0.961 . . . . 1.0 110.543 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.22 -14.35 37.67 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.824 2.349 . . . . 1.0 114.896 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -69.78 -23.62 63.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.665 1.186 . . . . 1.0 113.562 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -127.93 -21.77 3.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.075 1.35 . . . . 1.0 113.619 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.27 -4.95 74.56 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.607 1.575 . . . . 1.0 113.873 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -66.03 153.18 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.71 141.59 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 126.914 2.086 . . . . 1.0 109.219 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -140.93 163.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.913 1.685 . . . . 1.0 110.65 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -139.18 138.54 37.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.155 1.782 . . . . 1.0 111.305 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.41 159.6 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.399 1.48 . . . . 1.0 110.876 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -87.24 -1.88 58.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.551 1.14 . . . . 1.0 113.517 171.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.75 5.49 18.15 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.151 1.358 . . . . 1.0 115.004 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.54 179.23 43.88 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.443 1.122 . . . . 1.0 114.205 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.79 83.87 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.344 1.458 . . . . 1.0 112.13 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -106.2 94.01 4.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.421 1.489 . . . . 1.0 110.215 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -37.56 -47.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.11 2.564 . . . . 1.0 115.463 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -61.49 -38.29 86.74 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.133 0.973 . . . . 1.0 113.039 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 tp -70.01 -44.41 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.675 -0.641 . . . . 1.0 109.616 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.3 -43.12 78.6 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.407 0.683 . . . . 1.0 112.203 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -58.71 -42.95 89.85 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -65.22 -41.51 94.37 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.879 0.326 . . . . 1.0 111.879 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.52 -40.01 93.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.662 0.785 . . . . 1.0 110.558 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.87 -36.0 77.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.074 0.949 . . . . 1.0 113.163 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.78 -17.62 19.25 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -131.37 -6.41 3.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.63 132.08 7.45 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.506 1.527 . . . . 1.0 112.2 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.07 -36.42 70.59 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.926 2.417 . . . . 1.0 113.447 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.78 -39.96 84.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.639 0.654 . . . . 1.0 111.9 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.91 74.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.268 0.627 . . . . 1.0 110.993 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.62 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.187 0.595 . . . . 1.0 112.17 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -66.6 -24.22 66.29 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.475 -1.39 . . . . 1.0 112.044 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -74.82 -23.63 58.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.528 -0.733 . . . . 1.0 112.718 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -71.33 -17.27 62.45 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.143 -0.973 . . . . 1.0 112.897 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.98 145.34 55.58 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.966 1.098 . . . . 1.0 113.966 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.42 117.96 12.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.116 1.766 . . . . 1.0 110.885 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.16 133.17 53.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.023 0.929 . . . . 1.0 110.777 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.011 0.924 . . . . 1.0 111.382 176.643 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 110.82 -0.067 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.58 116.0 31.72 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.086 1.355 . . . . 1.0 108.219 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -84.07 146.33 27.98 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.955 1.302 . . . . 1.0 107.533 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.6 150.47 50.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.828 1.251 . . . . 1.0 109.354 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 139.71 48.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.356 1.462 . . . . 1.0 110.022 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -116.13 89.65 26.12 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.71 1.204 . . . . 1.0 111.015 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 -12.12 23.07 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.179 2.586 . . . . 1.0 115.422 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -65.0 -28.09 69.28 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.0 p -127.71 -19.45 4.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.179 1.392 . . . . 1.0 113.963 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.45 -1.97 77.03 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.235 1.398 . . . . 1.0 113.631 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.02 152.76 31.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.236 1.569 . . . . 1.0 115.236 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 t -136.58 141.62 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.953 . . . . 1.0 109.466 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.9 pt -140.84 165.87 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.017 1.727 . . . . 1.0 110.727 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -139.31 139.18 37.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.617 1.967 . . . . 1.0 110.851 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.21 158.0 43.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.344 1.458 . . . . 1.0 110.659 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.96 -3.02 59.05 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.215 1.006 . . . . 1.0 113.514 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.54 2.62 14.92 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.813 1.197 . . . . 1.0 115.288 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.11 179.05 42.86 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.468 1.134 . . . . 1.0 113.829 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -66.57 83.79 0.1 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.086 1.355 . . . . 1.0 111.991 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -99.46 94.3 6.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.328 1.451 . . . . 1.0 110.249 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -39.84 -45.64 1.83 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 128.095 2.558 . . . . 1.0 115.118 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.8 m -60.55 -39.98 89.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.222 1.009 . . . . 1.0 113.576 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.1 tp -68.67 -42.39 77.94 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.546 -0.721 . . . . 1.0 109.918 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.07 -43.6 78.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 1.0 112.282 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.7 -45.38 85.77 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.16 -41.68 98.54 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.598 -0.689 . . . . 1.0 112.115 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -61.88 -40.91 97.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.414 1.086 . . . . 1.0 110.854 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 -38.17 79.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.481 0.713 . . . . 1.0 112.846 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.01 -33.08 30.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -129.78 -3.22 4.69 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -171.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.09 129.66 6.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.448 1.499 . . . . 1.0 112.335 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.93 -35.21 78.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.544 2.163 . . . . 1.0 113.569 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.61 -39.8 80.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.73 0.696 . . . . 1.0 112.2 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.14 -49.47 72.01 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.24 0.616 . . . . 1.0 110.805 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.4 -41.55 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.297 0.639 . . . . 1.0 112.072 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.525 -1.36 . . . . 1.0 112.269 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -75.94 -21.48 56.98 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.572 -0.705 . . . . 1.0 112.897 169.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -72.85 -16.37 61.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.548 1.067 . . . . 1.0 112.871 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.6 144.13 56.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.684 0.994 . . . . 1.0 113.684 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.09 118.45 12.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.296 1.838 . . . . 1.0 110.809 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 mt -71.23 116.47 11.58 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.514 1.126 . . . . 1.0 110.375 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.4 mt . . . . . 0 CA--C 1.546 0.814 0 C-N-CA 123.587 0.755 . . . . 1.0 111.487 176.358 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.9 t . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 120.3 0.095 . . . . 1.0 110.833 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -111.22 120.55 42.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.47 1.508 . . . . 1.0 108.647 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.8 148.73 25.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.654 -1.239 . . . . 1.0 107.654 169.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -136.67 149.82 48.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.098 1.359 . . . . 1.0 108.851 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -131.59 144.23 50.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.357 1.463 . . . . 1.0 109.95 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.89 91.75 47.85 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.147 0.979 . . . . 1.0 111.763 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.5 -25.99 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.835 3.69 . . . . 1.0 116.976 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.42 -27.07 67.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -129.51 -17.62 3.68 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.776 1.23 . . . . 1.0 113.935 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.24 0.14 85.24 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.033 1.301 . . . . 1.0 113.826 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.19 154.72 30.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.29 1.589 . . . . 1.0 115.29 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.55 141.23 41.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 126.852 2.061 . . . . 1.0 109.405 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -139.91 163.58 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.955 1.702 . . . . 1.0 110.674 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -139.93 137.89 35.15 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.105 1.762 . . . . 1.0 111.348 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 157.78 43.03 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.187 1.395 . . . . 1.0 111.014 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.61 -4.54 58.66 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.263 1.025 . . . . 1.0 113.442 171.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.41 1.91 19.9 Favored Glycine 0 N--CA 1.478 1.438 0 C-N-CA 125.053 1.311 . . . . 1.0 114.806 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.78 179.13 38.47 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 118.576 1.188 . . . . 1.0 113.807 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -67.42 83.87 0.16 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.737 1.215 . . . . 1.0 112.186 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.06 94.03 5.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.489 1.516 . . . . 1.0 109.903 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.33 -42.47 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.664 1.986 . . . . 1.0 115.664 -169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -59.07 -39.23 81.47 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.095 0.958 . . . . 1.0 113.013 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.96 -44.82 68.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.428 0.691 . . . . 1.0 109.777 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -56.4 -43.44 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.485 0.714 . . . . 1.0 112.156 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.63 -46.62 83.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.587 0.355 . . . . 1.0 111.877 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -62.18 -41.92 98.79 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.549 -0.719 . . . . 1.0 111.937 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.39 -41.07 96.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.966 0.906 . . . . 1.0 110.778 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.22 -38.7 78.67 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.555 0.742 . . . . 1.0 112.736 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -81.38 -32.65 32.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.94 -2.31 4.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.73 128.82 6.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.125 1.345 . . . . 1.0 112.358 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.66 -35.32 81.16 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.659 2.24 . . . . 1.0 113.513 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.7 -39.53 80.47 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.867 0.758 . . . . 1.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.05 72.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.147 0.579 . . . . 1.0 110.869 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.77 -40.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.702 -0.623 . . . . 1.0 112.176 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.43 -24.79 66.5 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.364 -1.46 . . . . 1.0 112.207 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -74.7 -21.44 59.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.561 -0.712 . . . . 1.0 112.9 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -72.95 -16.5 61.53 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.428 1.013 . . . . 1.0 112.96 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.7 145.66 55.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.39 118.06 12.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.432 1.893 . . . . 1.0 111.197 170.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 mt -63.88 131.09 46.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.174 0.99 . . . . 1.0 110.543 172.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.8 mt . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 123.659 0.783 . . . . 1.0 111.479 175.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.481 0.181 . . . . 1.0 111.124 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -104.02 118.45 36.69 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.293 1.437 . . . . 1.0 107.854 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -85.86 145.46 27.18 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.102 1.361 . . . . 1.0 107.37 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -136.62 152.66 50.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.586 1.154 . . . . 1.0 109.565 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -133.31 144.74 49.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.406 1.483 . . . . 1.0 109.727 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -121.37 91.49 48.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.191 0.996 . . . . 1.0 111.749 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.4 -25.52 5.04 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.752 3.635 . . . . 1.0 116.898 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -65.34 -26.82 68.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 p -129.96 -17.2 3.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.952 1.301 . . . . 1.0 113.952 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.54 86.79 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.982 1.277 . . . . 1.0 114.064 -173.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.33 154.82 34.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.03 140.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.915 2.086 . . . . 1.0 109.452 172.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -141.99 164.42 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.98 1.712 . . . . 1.0 110.89 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.13 138.02 34.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.389 1.876 . . . . 1.0 110.878 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.4 156.9 41.64 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.46 1.504 . . . . 1.0 111.025 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -84.73 -2.87 58.19 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.504 1.121 . . . . 1.0 113.663 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.65 2.28 19.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.863 1.22 . . . . 1.0 114.985 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 179.35 42.16 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.292 1.046 . . . . 1.0 113.877 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.6 83.79 0.18 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.784 1.234 . . . . 1.0 112.011 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -102.51 94.12 5.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.568 1.547 . . . . 1.0 109.858 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -39.83 -45.5 1.8 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.434 2.293 . . . . 1.0 115.429 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.1 m -60.38 -39.45 87.31 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.203 1.001 . . . . 1.0 113.015 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -69.92 -43.67 71.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.348 -0.845 . . . . 1.0 109.869 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -56.36 -43.52 79.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.377 0.671 . . . . 1.0 111.952 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -58.45 -47.46 83.92 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.015 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -60.6 -42.35 96.62 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.769 -0.582 . . . . 1.0 112.109 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.69 -40.24 96.49 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 1.0 110.782 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.39 -39.25 78.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.803 0.841 . . . . 1.0 112.971 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.58 -32.73 42.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.818 1.247 . . . . 1.0 114.133 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.2 -4.31 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.87 130.72 7.12 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.405 1.478 . . . . 1.0 111.764 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.55 -34.75 84.54 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.73 2.287 . . . . 1.0 113.424 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.456 0.703 . . . . 1.0 111.951 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.61 77.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.268 0.627 . . . . 1.0 111.005 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.74 -39.86 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.8 -0.563 . . . . 1.0 112.208 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -66.72 -27.12 67.37 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.23 -1.544 . . . . 1.0 112.178 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 t -67.96 -27.07 66.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.12 -0.988 . . . . 1.0 112.277 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.7 m0 -72.33 -15.72 61.88 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.0 -1.062 . . . . 1.0 113.115 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.68 145.92 55.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.5 0.926 . . . . 1.0 113.5 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.48 117.48 11.76 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.267 1.827 . . . . 1.0 110.443 170.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.89 118.25 13.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.471 1.109 . . . . 1.0 110.345 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt . . . . . 0 CA--C 1.543 0.689 0 C-N-CA 123.388 0.675 . . . . 1.0 112.086 178.132 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 110.704 -0.11 . . . . 1.0 110.704 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -102.86 117.94 35.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.575 1.15 . . . . 1.0 108.554 168.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -86.63 145.64 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.223 1.409 . . . . 1.0 107.611 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -136.4 151.85 49.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.59 1.156 . . . . 1.0 109.91 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -132.83 137.82 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.279 1.432 . . . . 1.0 109.596 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -111.65 92.47 17.08 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.83 0.852 . . . . 1.0 110.586 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.75 -14.19 38.87 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.996 2.464 . . . . 1.0 114.782 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -70.32 -22.63 62.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.592 1.157 . . . . 1.0 113.55 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.2 p -127.58 -23.16 3.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.242 1.417 . . . . 1.0 113.449 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.28 -6.4 71.84 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.829 1.68 . . . . 1.0 113.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -66.93 152.79 45.03 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.164 1.542 . . . . 1.0 115.164 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.8 t -134.09 140.39 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.96 2.104 . . . . 1.0 109.191 171.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 pt -140.94 164.56 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.756 1.622 . . . . 1.0 110.766 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -139.72 137.47 35.17 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.551 1.94 . . . . 1.0 110.884 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.59 158.49 43.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.933 1.293 . . . . 1.0 111.323 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -86.43 -2.83 58.78 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.389 1.076 . . . . 1.0 113.188 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.44 3.19 19.11 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.098 1.333 . . . . 1.0 115.015 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.2 179.21 42.86 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.569 1.184 . . . . 1.0 113.907 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -67.4 83.76 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.03 1.332 . . . . 1.0 112.055 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -104.67 94.38 5.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.704 1.602 . . . . 1.0 109.865 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -41.5 -43.2 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.832 2.053 . . . . 1.0 115.547 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -60.19 -37.82 81.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.044 0.938 . . . . 1.0 113.096 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -71.64 -44.25 64.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.273 0.629 . . . . 1.0 109.604 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -56.8 -43.14 80.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.436 0.694 . . . . 1.0 112.06 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -57.28 -44.78 84.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 172.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.18 -41.36 90.37 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.069 -0.394 . . . . 1.0 112.052 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -62.12 -38.73 90.04 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.986 0.812 . . . . 1.0 110.703 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.16 75.8 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.755 0.822 . . . . 1.0 112.916 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -98.4 -16.1 19.41 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.972 1.842 . . . . 1.0 115.972 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -130.84 -8.24 3.98 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.761 1.393 . . . . 1.0 114.761 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.36 134.25 8.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.379 1.466 . . . . 1.0 112.161 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.42 -35.88 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.605 2.203 . . . . 1.0 113.228 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -39.56 86.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.553 0.741 . . . . 1.0 111.693 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.54 78.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.398 0.679 . . . . 1.0 111.453 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.7 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.945 -0.472 . . . . 1.0 112.205 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -65.86 -27.15 68.01 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.514 -1.366 . . . . 1.0 112.239 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -68.64 -27.57 66.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.958 0.799 . . . . 1.0 112.394 170.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -72.15 -15.92 61.98 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.054 -1.029 . . . . 1.0 112.85 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.08 147.28 53.59 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.19 120.36 14.71 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.293 1.837 . . . . 1.0 110.761 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.15 116.0 15.4 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.647 1.179 . . . . 1.0 110.295 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.1 mt . . . . . 0 CA--C 1.545 0.751 0 C-N-CA 123.33 0.652 . . . . 1.0 111.815 178.723 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.9 t . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 111.05 0.018 . . . . 1.0 111.05 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -106.42 119.82 40.26 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.45 1.5 . . . . 1.0 107.829 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -86.35 145.29 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.164 1.386 . . . . 1.0 107.279 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 90.8 m-85 -136.2 152.09 50.4 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.737 1.215 . . . . 1.0 109.698 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -133.92 144.5 48.87 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.599 1.56 . . . . 1.0 109.435 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.67 93.94 44.74 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.763 0.825 . . . . 1.0 111.453 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.21 -26.09 7.7 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.476 3.451 . . . . 1.0 116.441 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -72.07 -21.96 61.43 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.987 1.106 . . . . 1.0 113.987 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -128.91 -21.75 3.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.095 1.358 . . . . 1.0 113.545 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.21 -6.74 82.42 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.544 1.545 . . . . 1.0 113.797 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.25 152.65 45.35 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.874 1.435 . . . . 1.0 114.874 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.05 139.97 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 127.07 2.148 . . . . 1.0 109.177 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -141.7 164.42 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.017 1.727 . . . . 1.0 110.832 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -140.51 136.06 32.53 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.326 1.851 . . . . 1.0 110.872 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.71 157.3 41.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.872 1.269 . . . . 1.0 111.173 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.96 -4.78 58.64 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.929 -1.107 . . . . 1.0 113.711 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.65 2.43 17.1 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.841 1.21 . . . . 1.0 114.925 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.87 179.12 38.8 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 118.415 1.107 . . . . 1.0 113.803 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -68.13 83.74 0.23 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.585 1.154 . . . . 1.0 112.127 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -102.87 94.92 5.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.616 1.566 . . . . 1.0 109.771 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -41.57 -43.18 2.64 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 126.784 2.034 . . . . 1.0 115.699 -170.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -37.97 79.39 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.229 1.011 . . . . 1.0 113.269 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -44.14 63.89 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.353 0.661 . . . . 1.0 109.764 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.09 -43.4 78.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.484 0.714 . . . . 1.0 111.871 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.97 -44.56 87.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.47 -40.92 89.63 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.985 -0.447 . . . . 1.0 112.015 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -62.73 -38.75 91.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.048 0.84 . . . . 1.0 110.388 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -36.3 75.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 1.0 113.169 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.1 -16.77 19.42 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.843 1.794 . . . . 1.0 115.843 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -130.72 -9.16 4.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 134.18 8.07 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.436 1.493 . . . . 1.0 111.98 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 -34.68 71.87 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.522 2.148 . . . . 1.0 113.098 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.74 -39.84 84.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.62 0.768 . . . . 1.0 111.913 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.87 80.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 1.0 111.108 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.96 -41.03 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.731 -0.605 . . . . 1.0 112.126 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.6 -30.04 71.21 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.45 -1.406 . . . . 1.0 112.123 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 t -67.99 -27.54 66.66 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.343 -0.848 . . . . 1.0 112.523 171.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -72.74 -15.44 61.66 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.15 -0.969 . . . . 1.0 113.065 170.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -67.04 147.53 53.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.692 0.997 . . . . 1.0 113.692 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.08 116.64 11.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.297 1.839 . . . . 1.0 110.323 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.23 132.04 46.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.962 0.905 . . . . 1.0 110.347 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 CA--C 1.547 0.852 0 CA-C-O 121.959 0.885 . . . . 1.0 112.293 178.01 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 109.942 -0.392 . . . . 1.0 109.942 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -104.74 119.21 38.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.918 1.287 . . . . 1.0 108.657 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -86.45 145.89 26.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.221 -1.4 . . . . 1.0 107.221 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -135.9 152.5 51.07 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.615 1.166 . . . . 1.0 109.61 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -133.05 144.97 50.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.412 1.485 . . . . 1.0 109.184 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -118.03 92.12 41.48 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.179 0.992 . . . . 1.0 110.946 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.34 -27.16 12.87 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.307 3.338 . . . . 1.0 116.077 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.04 -15.71 59.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 p -128.91 -22.51 3.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.931 1.292 . . . . 1.0 113.802 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.49 80.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.928 1.727 . . . . 1.0 114.171 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.09 154.5 41.85 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.143 1.535 . . . . 1.0 115.143 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.26 140.16 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.326 2.25 . . . . 1.0 109.205 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -142.67 165.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.036 1.734 . . . . 1.0 110.994 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -138.87 138.92 37.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.74 2.016 . . . . 1.0 111.002 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.29 158.44 43.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.463 1.505 . . . . 1.0 110.977 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.52 -3.21 58.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.275 1.03 . . . . 1.0 113.545 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.94 4.32 22.76 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.091 1.329 . . . . 1.0 114.866 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 179.32 38.66 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.277 1.039 . . . . 1.0 113.789 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -65.45 83.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.222 1.409 . . . . 1.0 112.212 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -103.08 94.04 5.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.574 1.549 . . . . 1.0 110.341 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -39.77 -45.53 1.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 128.093 2.557 . . . . 1.0 115.441 -171.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.4 m -61.21 -39.87 91.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.172 0.989 . . . . 1.0 113.425 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.96 -42.66 72.88 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.643 -0.661 . . . . 1.0 109.772 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.43 -44.11 75.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.456 0.703 . . . . 1.0 112.181 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -57.66 -44.16 85.48 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -65.2 -41.46 94.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.003 -0.435 . . . . 1.0 112.028 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -62.46 -39.03 92.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.887 0.875 . . . . 1.0 110.463 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.98 76.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.037 0.935 . . . . 1.0 113.124 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -98.07 -18.11 18.73 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.853 1.797 . . . . 1.0 115.853 -171.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -129.4 -8.11 4.7 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.61 134.16 8.28 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.467 1.508 . . . . 1.0 111.937 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.85 -34.3 72.64 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.5 2.133 . . . . 1.0 113.065 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.08 -39.49 82.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.51 0.724 . . . . 1.0 112.072 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.97 76.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.458 0.703 . . . . 1.0 110.973 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.54 -41.2 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.126 0.57 . . . . 1.0 112.305 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.98 -28.26 68.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.437 -1.414 . . . . 1.0 112.241 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 m -68.91 -22.83 64.14 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 30.0 m0 -76.73 -14.19 59.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.009 0.923 . . . . 1.0 112.975 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.08 147.86 51.76 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.21 0.914 . . . . 1.0 113.362 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -139.11 117.65 12.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.57 1.948 . . . . 1.0 110.687 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -71.19 123.99 23.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.479 1.112 . . . . 1.0 110.782 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 CA--C 1.545 0.782 0 C-N-CA 124.165 0.986 . . . . 1.0 112.556 -178.142 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 110.39 -0.226 . . . . 1.0 110.39 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -100.65 115.52 30.42 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.375 1.07 . . . . 1.0 108.841 168.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.15 145.87 28.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 1.0 107.539 169.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -133.76 149.82 51.46 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.754 1.222 . . . . 1.0 109.074 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -130.97 144.39 51.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.517 1.527 . . . . 1.0 109.306 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -118.34 92.61 43.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.873 . . . . 1.0 111.62 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.57 -26.34 8.96 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.299 3.333 . . . . 1.0 116.78 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -18.19 57.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.02 1.118 . . . . 1.0 114.02 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -130.83 -21.22 2.75 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.08 81.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.814 1.673 . . . . 1.0 114.154 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.3 156.44 37.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.326 1.602 . . . . 1.0 115.326 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.39 140.77 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 127.141 2.176 . . . . 1.0 109.109 169.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.7 pt -140.19 166.24 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.861 1.664 . . . . 1.0 110.612 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -140.06 138.45 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.58 1.952 . . . . 1.0 111.072 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.24 159.27 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.374 1.469 . . . . 1.0 110.966 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -86.67 -2.65 58.7 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.035 -1.041 . . . . 1.0 113.314 171.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.74 4.57 22.92 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.183 1.373 . . . . 1.0 114.945 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.07 179.18 45.59 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.327 1.063 . . . . 1.0 113.871 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.18 83.99 0.09 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.987 1.315 . . . . 1.0 112.143 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -105.3 94.08 5.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.687 1.595 . . . . 1.0 109.812 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -42.01 -43.77 3.29 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.763 2.025 . . . . 1.0 115.47 -169.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -59.23 -39.16 81.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.055 0.942 . . . . 1.0 112.945 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.21 -44.69 71.57 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.682 -0.636 . . . . 1.0 109.851 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -57.07 -42.81 81.3 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.636 0.774 . . . . 1.0 112.168 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -57.73 -45.87 85.21 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.082 0.401 . . . . 1.0 112.082 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -62.4 -41.7 98.87 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.725 -0.609 . . . . 1.0 112.133 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.33 -41.42 96.98 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.009 0.924 . . . . 1.0 110.806 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.81 78.15 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.031 0.752 . . . . 1.0 113.031 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.05 -33.19 30.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.449 1.278 . . . . 1.0 114.449 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.19 -2.95 4.47 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.363 1.616 . . . . 1.0 115.363 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.38 129.23 6.56 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.433 1.492 . . . . 1.0 112.477 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.92 -35.59 76.86 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.78 2.32 . . . . 1.0 113.564 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -39.75 80.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.843 0.747 . . . . 1.0 112.18 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.21 -49.57 71.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.228 0.611 . . . . 1.0 110.816 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -40.63 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.317 0.647 . . . . 1.0 112.146 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.1 -25.38 66.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.494 -1.379 . . . . 1.0 112.178 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -74.72 -21.25 59.47 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 169.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -73.41 -16.5 61.33 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.38 0.991 . . . . 1.0 113.118 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.22 144.39 56.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.6 p -139.02 121.14 15.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.482 1.913 . . . . 1.0 110.923 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.67 115.13 12.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.542 1.137 . . . . 1.0 110.642 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.5 mt . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 123.32 0.648 . . . . 1.0 111.895 176.383 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 111.5 0.185 . . . . 1.0 111.5 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -99.64 115.6 29.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.702 1.201 . . . . 1.0 108.04 168.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -84.91 145.78 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.127 1.371 . . . . 1.0 107.471 168.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -136.69 153.59 50.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.617 1.167 . . . . 1.0 109.583 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -133.61 144.68 49.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.397 1.479 . . . . 1.0 109.837 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.73 91.8 47.54 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.245 1.018 . . . . 1.0 111.817 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.06 -25.65 4.35 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.797 3.665 . . . . 1.0 117.079 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -65.49 -27.3 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -129.85 -17.85 3.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.956 1.303 . . . . 1.0 113.895 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.87 0.5 85.73 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.031 1.3 . . . . 1.0 113.906 -173.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.64 154.39 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.81 140.78 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.827 2.051 . . . . 1.0 109.478 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.1 pt -142.49 165.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.979 1.712 . . . . 1.0 110.968 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.85 138.87 36.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.61 1.964 . . . . 1.0 111.068 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.67 157.48 42.16 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.29 1.436 . . . . 1.0 110.733 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -83.82 -3.79 58.15 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 171.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.81 3.07 20.39 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.063 1.316 . . . . 1.0 114.878 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.34 41.95 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.371 1.086 . . . . 1.0 113.961 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -66.5 83.66 0.1 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.015 1.326 . . . . 1.0 112.302 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -103.99 94.1 5.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.516 1.527 . . . . 1.0 109.474 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -44.33 -41.96 6.41 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.478 1.911 . . . . 1.0 115.422 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -59.28 -39.22 82.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.801 0.841 . . . . 1.0 112.958 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.97 -43.0 69.0 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.664 -0.648 . . . . 1.0 109.899 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.61 -42.99 79.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 1.0 112.125 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.66 -46.79 83.78 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.712 0.405 . . . . 1.0 111.827 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -62.13 -41.96 98.76 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.697 -0.627 . . . . 1.0 112.101 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -62.79 -39.99 95.96 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 1.0 110.615 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.48 -39.43 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.63 0.772 . . . . 1.0 112.71 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -80.3 -32.41 38.08 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 1.0 114.245 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.27 -4.29 4.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.15 1.537 . . . . 1.0 115.15 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.0 131.41 7.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.567 1.555 . . . . 1.0 111.959 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 -34.69 80.37 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.664 2.243 . . . . 1.0 113.42 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.72 -39.83 84.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.301 0.64 . . . . 1.0 112.061 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.43 -47.15 77.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.08 0.552 . . . . 1.0 111.094 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.0 -40.02 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.775 -0.578 . . . . 1.0 111.919 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.21 -27.6 68.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.273 -1.517 . . . . 1.0 112.43 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 t -67.58 -27.37 66.87 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.214 -0.929 . . . . 1.0 112.279 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -72.3 -15.17 61.9 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.046 -1.034 . . . . 1.0 113.141 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.14 145.79 54.92 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.396 0.888 . . . . 1.0 113.396 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.18 117.62 12.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.421 1.888 . . . . 1.0 110.545 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.94 116.33 12.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.681 1.192 . . . . 1.0 110.406 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.7 mt . . . . . 0 CA--C 1.546 0.801 0 C-N-CA 123.9 0.88 . . . . 1.0 111.644 176.895 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.0 t . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 110.245 -0.28 . . . . 1.0 110.245 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.36 120.38 42.24 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.235 1.414 . . . . 1.0 108.872 169.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.36 149.49 24.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -136.62 150.15 48.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.113 1.365 . . . . 1.0 108.728 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -132.24 144.45 50.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.204 1.401 . . . . 1.0 109.698 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -120.8 91.4 47.4 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.292 1.037 . . . . 1.0 111.702 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -47.15 -25.6 4.5 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.955 3.77 . . . . 1.0 116.987 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -66.47 -26.56 67.25 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.734 1.013 . . . . 1.0 113.734 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 p -130.02 -18.26 3.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.082 1.353 . . . . 1.0 113.735 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.28 -0.85 83.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.9 1.238 . . . . 1.0 113.909 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.05 153.76 28.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.31 1.596 . . . . 1.0 115.31 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.46 140.87 42.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.839 2.056 . . . . 1.0 109.455 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.7 pt -140.28 164.35 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.02 1.728 . . . . 1.0 110.527 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -139.5 138.8 36.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.104 1.762 . . . . 1.0 111.096 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -150.87 158.69 44.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.454 1.502 . . . . 1.0 111.178 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.74 -3.13 58.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.691 1.196 . . . . 1.0 113.349 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.01 1.39 19.15 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.844 1.211 . . . . 1.0 114.993 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.83 179.11 41.87 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 118.484 1.142 . . . . 1.0 113.875 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -67.75 83.78 0.19 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.398 1.079 . . . . 1.0 112.378 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -98.71 93.97 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.698 1.599 . . . . 1.0 109.557 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -44.4 -41.35 6.11 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.117 2.167 . . . . 1.0 115.052 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -60.43 -38.14 83.16 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.309 1.044 . . . . 1.0 113.278 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -69.56 -43.78 72.2 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.399 -0.813 . . . . 1.0 109.812 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -55.78 -43.51 76.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.537 0.735 . . . . 1.0 112.386 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.25 -46.94 82.55 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.985 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -62.05 -41.14 97.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.679 -0.638 . . . . 1.0 112.364 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.94 -41.09 97.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.242 1.017 . . . . 1.0 110.733 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.03 -37.92 78.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.932 0.893 . . . . 1.0 112.761 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -81.78 -32.62 31.29 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.535 1.309 . . . . 1.0 114.535 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -130.66 -3.41 4.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.08 129.37 6.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.283 1.42 . . . . 1.0 112.319 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.24 79.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.831 2.354 . . . . 1.0 113.364 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.32 -40.09 81.77 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.934 0.788 . . . . 1.0 111.987 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.48 72.51 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.357 0.663 . . . . 1.0 110.938 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.37 -41.37 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.247 0.619 . . . . 1.0 112.217 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -66.23 -25.08 66.74 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.434 -1.416 . . . . 1.0 112.073 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 m -74.38 -21.64 59.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -73.0 -15.79 61.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.349 0.977 . . . . 1.0 113.112 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.04 145.24 56.59 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.43 118.71 12.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.378 1.871 . . . . 1.0 111.086 170.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.1 mt -64.84 131.71 47.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.195 0.998 . . . . 1.0 110.641 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 CA--C 1.547 0.857 0 C-N-CA 123.675 0.79 . . . . 1.0 111.758 177.389 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 111.45 0.167 . . . . 1.0 111.45 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -102.47 116.86 33.47 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.867 1.267 . . . . 1.0 108.257 168.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -84.46 146.32 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.106 1.363 . . . . 1.0 107.427 169.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -135.18 150.0 50.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.734 1.214 . . . . 1.0 109.257 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -132.79 138.02 46.99 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 1.0 109.834 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -112.45 91.31 16.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.242 1.017 . . . . 1.0 110.68 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.43 -14.47 39.29 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.843 2.362 . . . . 1.0 114.675 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -69.22 -23.76 63.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.494 1.118 . . . . 1.0 113.644 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.7 p -127.01 -22.2 3.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.993 1.317 . . . . 1.0 113.51 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.36 -4.83 74.09 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.664 1.602 . . . . 1.0 113.808 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -66.2 153.31 42.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.132 1.53 . . . . 1.0 115.132 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.8 140.39 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.851 2.06 . . . . 1.0 109.173 171.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.8 pt -139.53 165.79 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.639 1.576 . . . . 1.0 110.599 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -140.74 136.96 33.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.256 1.823 . . . . 1.0 110.737 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.49 157.2 41.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.94 1.296 . . . . 1.0 111.227 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -85.05 -4.37 59.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.21 1.004 . . . . 1.0 113.475 171.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.72 1.97 14.81 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.317 1.436 . . . . 1.0 114.995 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.46 178.84 41.18 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.392 1.096 . . . . 1.0 114.159 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.88 83.9 0.21 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.869 1.268 . . . . 1.0 112.027 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -103.82 94.04 5.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.821 1.648 . . . . 1.0 109.843 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -43.5 -40.99 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.386 1.875 . . . . 1.0 115.588 -169.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -59.13 -37.11 76.44 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.976 0.91 . . . . 1.0 113.028 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.5 tp -70.87 -45.29 64.68 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.447 0.699 . . . . 1.0 109.784 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.67 -43.51 80.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.789 0.836 . . . . 1.0 112.1 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.01 -44.1 82.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.43 -41.2 89.53 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.046 -0.409 . . . . 1.0 112.0 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.02 -40.16 92.5 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.857 0.753 . . . . 1.0 110.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.02 77.17 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.002 0.921 . . . . 1.0 113.033 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -98.48 -16.76 19.07 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.007 1.854 . . . . 1.0 116.007 -171.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -132.75 -6.48 3.19 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.029 1.492 . . . . 1.0 115.029 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.39 132.77 7.58 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.322 1.439 . . . . 1.0 112.464 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.79 -36.28 63.09 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.709 2.273 . . . . 1.0 113.542 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.5 -39.51 81.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.765 0.712 . . . . 1.0 112.021 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.33 73.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.397 0.679 . . . . 1.0 110.762 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.92 -40.9 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.339 0.656 . . . . 1.0 112.073 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -66.13 -24.45 66.68 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.492 -1.38 . . . . 1.0 112.217 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 m -75.55 -21.88 57.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.859 0.689 . . . . 1.0 112.859 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -72.94 -17.49 61.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.572 1.078 . . . . 1.0 112.892 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 145.23 54.41 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.05 119.64 14.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.286 1.834 . . . . 1.0 110.96 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.0 mt -70.84 119.5 15.07 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.361 1.064 . . . . 1.0 110.434 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 CA--C 1.547 0.832 0 C-N-CA 123.335 0.654 . . . . 1.0 111.552 175.03 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 110.138 -0.319 . . . . 1.0 110.138 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -111.91 121.92 46.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.653 1.581 . . . . 1.0 108.938 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.63 149.15 25.12 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.665 -1.235 . . . . 1.0 107.665 168.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -136.19 149.11 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.138 1.375 . . . . 1.0 108.699 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.98 143.72 50.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.225 1.41 . . . . 1.0 109.776 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.52 91.62 46.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.015 0.926 . . . . 1.0 111.821 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.27 -25.6 4.81 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.778 3.652 . . . . 1.0 116.714 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -65.95 -27.12 67.93 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.1 p -130.15 -16.49 3.58 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.01 1.324 . . . . 1.0 113.976 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.98 -0.2 87.57 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.002 1.287 . . . . 1.0 113.922 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.01 154.84 29.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -136.49 141.42 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.88 2.072 . . . . 1.0 109.494 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.9 pt -140.24 163.29 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.798 1.639 . . . . 1.0 110.457 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -140.21 137.63 34.46 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.133 1.773 . . . . 1.0 111.417 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.39 159.88 44.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.602 1.561 . . . . 1.0 111.02 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.34 -0.72 57.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.484 1.114 . . . . 1.0 113.611 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.32 5.2 23.19 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.836 1.208 . . . . 1.0 114.873 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.39 179.26 40.23 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.419 1.109 . . . . 1.0 113.864 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.26 83.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.016 1.327 . . . . 1.0 112.029 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -104.75 93.97 5.03 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.57 1.548 . . . . 1.0 109.737 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -45.38 -41.3 8.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.071 1.749 . . . . 1.0 115.365 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -58.73 -38.84 79.24 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.848 0.859 . . . . 1.0 112.893 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.94 -44.17 70.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.436 -0.79 . . . . 1.0 109.799 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -56.85 -43.36 81.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.691 0.796 . . . . 1.0 112.378 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.5 -46.06 84.19 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.72 0.408 . . . . 1.0 112.018 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -42.01 98.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.724 -0.61 . . . . 1.0 112.039 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.67 -41.28 97.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.938 0.895 . . . . 1.0 110.786 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.1 78.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.598 0.759 . . . . 1.0 112.898 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.61 -33.2 31.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.64 -2.86 4.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.347 1.61 . . . . 1.0 115.347 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.56 128.77 6.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.378 1.465 . . . . 1.0 112.256 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 -35.1 81.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.745 2.297 . . . . 1.0 113.279 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.61 -39.9 80.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.877 0.762 . . . . 1.0 112.242 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.84 73.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.403 0.681 . . . . 1.0 110.757 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -41.21 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.057 0.543 . . . . 1.0 112.25 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -66.05 -25.03 66.85 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.424 -1.423 . . . . 1.0 112.29 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.9 m -74.1 -21.99 59.67 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.461 -0.774 . . . . 1.0 112.732 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -72.85 -16.48 61.59 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.477 1.035 . . . . 1.0 112.939 170.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.74 57.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.02 117.94 12.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.218 1.807 . . . . 1.0 111.352 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.99 136.99 57.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.274 1.029 . . . . 1.0 110.723 172.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.096 0.958 . . . . 1.0 112.603 -178.247 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.621 -0.14 . . . . 1.0 110.621 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -105.63 119.14 38.37 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.913 1.285 . . . . 1.0 108.365 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -86.89 148.09 25.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.463 -1.31 . . . . 1.0 107.463 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -138.25 151.19 47.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.872 1.269 . . . . 1.0 109.36 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -131.14 145.48 51.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.699 1.6 . . . . 1.0 109.072 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.57 94.11 44.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.738 0.815 . . . . 1.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.81 -26.85 10.31 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.348 3.365 . . . . 1.0 116.501 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.03 -17.81 56.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -130.62 -20.82 2.86 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.98 -6.2 82.86 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.996 1.76 . . . . 1.0 114.357 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -68.88 156.27 38.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.183 1.549 . . . . 1.0 115.183 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.72 140.11 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 127.271 2.229 . . . . 1.0 109.312 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -141.83 163.67 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.919 1.688 . . . . 1.0 110.954 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -139.45 138.7 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.218 1.807 . . . . 1.0 111.335 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.17 158.56 44.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.197 1.399 . . . . 1.0 110.927 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.417 1.087 . . . . 1.0 113.52 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.63 2.49 20.98 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.179 1.371 . . . . 1.0 114.85 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.98 179.39 38.72 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.379 1.089 . . . . 1.0 113.809 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -67.44 83.95 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.71 1.204 . . . . 1.0 112.047 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -102.72 93.92 5.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.422 1.489 . . . . 1.0 109.603 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -44.74 -40.73 6.26 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.316 1.846 . . . . 1.0 115.509 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.0 m -58.8 -38.97 79.75 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.843 0.857 . . . . 1.0 113.096 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.29 -43.69 66.64 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.536 -0.727 . . . . 1.0 109.646 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -56.16 -42.99 77.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.329 0.651 . . . . 1.0 112.294 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.74 -47.11 83.37 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.7 0.4 . . . . 1.0 111.477 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -62.62 -41.48 99.03 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.575 -0.703 . . . . 1.0 112.327 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -63.1 -39.88 95.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.954 0.902 . . . . 1.0 110.591 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.89 -39.18 79.89 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.703 0.801 . . . . 1.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -81.35 -32.73 32.81 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -174.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -128.75 -5.48 5.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.125 1.528 . . . . 1.0 115.125 -172.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.38 131.91 7.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.28 1.419 . . . . 1.0 111.909 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.63 -35.29 81.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.78 2.32 . . . . 1.0 113.073 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.77 -40.15 84.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.307 0.643 . . . . 1.0 111.761 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.26 76.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.347 0.659 . . . . 1.0 111.288 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.44 -40.01 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.744 -0.597 . . . . 1.0 112.317 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -66.9 -27.98 67.94 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.472 -1.393 . . . . 1.0 112.337 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.8 t -67.5 -26.83 66.55 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.418 -0.801 . . . . 1.0 112.429 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -72.77 -14.9 61.63 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.281 -0.887 . . . . 1.0 113.028 170.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.3 51.85 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.48 119.39 13.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.412 1.885 . . . . 1.0 110.905 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.11 122.17 18.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.625 1.17 . . . . 1.0 110.584 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 123.62 0.768 . . . . 1.0 111.672 177.728 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.5 t . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 111.272 0.101 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.29 119.16 38.39 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.196 1.399 . . . . 1.0 107.951 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.54 145.83 26.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.042 1.337 . . . . 1.0 107.401 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -136.09 151.33 49.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.572 1.149 . . . . 1.0 109.518 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -130.57 145.59 51.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.575 1.55 . . . . 1.0 109.31 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -117.56 93.69 43.96 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.91 0.884 . . . . 1.0 111.894 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.44 -26.79 9.19 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.294 3.33 . . . . 1.0 116.662 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -78.51 -16.92 56.96 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -131.37 -21.14 2.6 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.13 -5.66 82.94 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.654 1.597 . . . . 1.0 114.201 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.83 155.75 39.65 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.0 140.31 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.1 2.16 . . . . 1.0 109.117 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.67 164.52 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.977 1.711 . . . . 1.0 110.837 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -139.42 138.7 36.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.519 1.928 . . . . 1.0 110.891 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.28 156.63 41.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.586 1.555 . . . . 1.0 111.186 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.25 -3.03 58.68 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.502 1.121 . . . . 1.0 113.657 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 2.17 20.79 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.858 1.218 . . . . 1.0 114.98 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.9 179.02 39.11 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.503 1.152 . . . . 1.0 113.729 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.4 83.71 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.405 1.082 . . . . 1.0 112.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -98.89 94.06 6.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.639 1.576 . . . . 1.0 109.291 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 -43.09 6.56 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.254 1.822 . . . . 1.0 114.73 -169.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.5 m -57.73 -39.3 76.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.116 0.966 . . . . 1.0 112.88 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.7 tp -69.51 -43.41 73.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.385 0.674 . . . . 1.0 109.716 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -55.98 -44.51 78.62 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.44 0.696 . . . . 1.0 112.18 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.07 -45.48 87.04 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -41.82 98.47 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.507 -0.746 . . . . 1.0 112.232 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.89 -39.79 95.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.382 1.073 . . . . 1.0 110.661 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.84 76.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.623 0.769 . . . . 1.0 112.795 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -80.86 -33.01 34.75 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.296 1.221 . . . . 1.0 114.296 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -128.64 -5.72 5.21 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.69 132.14 7.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.69 1.614 . . . . 1.0 111.88 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.12 -34.61 79.02 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.706 2.271 . . . . 1.0 113.321 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.0 -39.78 83.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.477 0.711 . . . . 1.0 112.019 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.95 76.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.286 0.634 . . . . 1.0 111.032 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.363 0.505 . . . . 1.0 112.363 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.37 -28.41 68.62 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.461 -1.399 . . . . 1.0 112.07 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -22.86 64.76 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.538 -0.726 . . . . 1.0 112.752 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -76.51 -14.27 60.04 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.9 0.88 . . . . 1.0 113.068 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.35 147.55 51.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -139.42 117.27 11.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.445 1.898 . . . . 1.0 110.522 171.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.64 122.61 20.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.655 1.182 . . . . 1.0 110.322 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.546 0.804 0 C-N-CA 124.155 0.982 . . . . 1.0 112.36 -177.778 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 110.796 -0.075 . . . . 1.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.71 120.66 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.488 1.515 . . . . 1.0 108.438 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -86.3 148.83 25.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -136.75 148.28 47.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 1.0 108.924 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -129.78 139.43 51.27 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.971 1.309 . . . . 1.0 109.723 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -115.07 90.66 24.22 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.571 1.148 . . . . 1.0 110.856 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.85 -12.74 26.97 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.185 2.59 . . . . 1.0 115.275 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -65.26 -27.52 68.7 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.3 p -128.07 -19.28 4.0 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.991 1.316 . . . . 1.0 113.734 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.32 79.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.11 1.338 . . . . 1.0 113.808 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.09 153.81 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.38 1.622 . . . . 1.0 115.38 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.19 141.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.682 1.993 . . . . 1.0 109.45 171.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.6 pt -140.05 163.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.902 1.681 . . . . 1.0 110.413 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -139.97 137.94 35.13 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.222 1.809 . . . . 1.0 111.276 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.38 159.07 44.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.219 1.408 . . . . 1.0 110.767 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -86.38 -3.07 58.93 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.277 1.031 . . . . 1.0 113.398 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.3 2.55 17.85 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.178 1.37 . . . . 1.0 115.071 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.0 179.13 42.37 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 118.379 1.09 . . . . 1.0 113.777 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.19 83.73 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.781 1.232 . . . . 1.0 112.38 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -103.54 93.98 5.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.54 1.536 . . . . 1.0 109.777 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -44.08 -41.13 5.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.305 1.842 . . . . 1.0 115.61 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -58.66 -38.04 77.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.896 0.878 . . . . 1.0 112.986 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.0 tp -70.56 -45.14 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.475 0.71 . . . . 1.0 109.614 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -56.37 -42.85 78.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.59 0.756 . . . . 1.0 112.441 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -57.45 -46.87 83.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.85 0.46 . . . . 1.0 111.58 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -62.68 -41.65 99.2 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.53 -0.731 . . . . 1.0 112.144 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -62.0 -40.57 96.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.791 0.836 . . . . 1.0 110.72 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.28 81.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.799 0.84 . . . . 1.0 112.883 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -82.01 -32.12 30.69 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -130.02 -4.19 4.51 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.297 1.591 . . . . 1.0 115.297 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 130.17 6.8 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.095 1.331 . . . . 1.0 112.326 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.14 -35.92 72.56 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.846 2.364 . . . . 1.0 113.359 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.15 -39.8 82.55 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.638 0.654 . . . . 1.0 112.052 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.527 0.731 . . . . 1.0 111.067 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.59 -40.28 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.178 0.591 . . . . 1.0 112.066 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -66.33 -25.07 66.65 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.376 -1.453 . . . . 1.0 112.413 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 t -73.12 -25.55 60.9 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.497 -0.752 . . . . 1.0 112.613 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -69.56 -17.31 63.55 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.781 -1.199 . . . . 1.0 113.084 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.53 55.96 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 118.51 12.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 1.0 111.179 170.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.74 131.34 47.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.031 0.932 . . . . 1.0 110.676 171.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt . . . . . 0 CA--C 1.544 0.749 0 C-N-CA 123.999 0.92 . . . . 1.0 111.404 175.303 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.7 t . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.858 0.318 . . . . 1.0 111.858 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -105.33 118.4 36.45 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.543 1.537 . . . . 1.0 108.005 168.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.33 148.24 26.13 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 168.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -135.84 150.03 49.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.95 1.3 . . . . 1.0 109.129 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.473 1.509 . . . . 1.0 109.387 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.38 93.02 41.94 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.121 0.969 . . . . 1.0 111.8 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.52 -26.46 8.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.41 3.407 . . . . 1.0 116.62 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -77.84 -17.97 56.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -131.57 -20.1 2.64 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.514 1.301 . . . . 1.0 114.514 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.65 -5.35 83.72 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.897 1.713 . . . . 1.0 114.15 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.23 156.51 37.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.299 1.592 . . . . 1.0 115.299 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.28 140.22 46.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 1.0 109.23 169.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.4 pt -140.53 164.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.874 1.669 . . . . 1.0 110.707 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -140.48 137.67 34.04 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.151 1.781 . . . . 1.0 111.107 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 158.23 43.6 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.421 1.489 . . . . 1.0 111.107 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -85.33 -4.63 59.22 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.117 -0.989 . . . . 1.0 113.301 171.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 3.36 15.57 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.107 1.337 . . . . 1.0 114.976 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.13 39.83 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.586 1.193 . . . . 1.0 113.947 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.48 83.78 0.17 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.714 1.206 . . . . 1.0 112.111 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -103.13 93.96 5.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.672 1.589 . . . . 1.0 109.88 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.04 -44.28 2.38 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.993 2.117 . . . . 1.0 115.429 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.4 m -59.25 -39.27 82.27 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.085 0.954 . . . . 1.0 113.247 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -69.26 -44.22 72.37 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.562 -0.711 . . . . 1.0 109.777 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -57.29 -42.4 81.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.325 0.65 . . . . 1.0 112.374 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.87 -46.07 85.4 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.683 0.393 . . . . 1.0 112.002 171.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -61.92 -41.94 98.51 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.538 -0.727 . . . . 1.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.5 -40.97 96.51 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.148 0.979 . . . . 1.0 110.91 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.38 78.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.405 0.682 . . . . 1.0 112.761 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -82.51 -33.04 28.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.491 1.293 . . . . 1.0 114.491 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.09 -3.08 4.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -171.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.72 129.62 6.66 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.376 1.465 . . . . 1.0 112.274 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.93 -35.81 75.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.647 2.231 . . . . 1.0 113.45 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.52 -39.89 81.01 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.518 0.599 . . . . 1.0 112.009 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.43 71.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.353 0.661 . . . . 1.0 110.875 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.91 -39.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.12 0.568 . . . . 1.0 112.035 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -66.68 -26.29 66.96 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.362 -1.461 . . . . 1.0 112.435 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 t -71.13 -26.14 62.88 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.646 -0.659 . . . . 1.0 112.605 169.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -69.47 -16.92 63.56 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.114 -0.991 . . . . 1.0 112.893 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.25 144.2 57.31 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.37 120.1 14.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.187 1.795 . . . . 1.0 111.374 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.3 mt -70.86 122.94 20.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.47 1.108 . . . . 1.0 110.566 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 124.507 1.123 . . . . 1.0 111.542 176.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 54.18 26.43 6.66 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 117.921 2.563 . . . . 1.0 117.921 169.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -67.49 154.4 41.48 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.301 -0.874 . . . . 1.0 110.778 169.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.0 t -72.57 132.16 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.822 0.849 . . . . 1.0 111.013 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -104.11 119.12 38.26 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.33 1.452 . . . . 1.0 108.022 168.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.42 142.92 28.07 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.045 -1.465 . . . . 1.0 107.045 168.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 77.0 m-85 -133.67 152.16 51.82 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.397 1.079 . . . . 1.0 109.267 174.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -133.87 143.33 48.23 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.546 1.538 . . . . 1.0 109.614 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -117.59 94.15 45.04 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 123.58 0.752 . . . . 1.0 111.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -47.97 -25.77 6.72 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 124.553 3.502 . . . . 1.0 116.525 175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -71.37 -22.59 61.87 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.828 1.047 . . . . 1.0 113.828 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.2 p -129.38 -21.2 3.22 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.04 1.336 . . . . 1.0 113.774 -174.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.99 -6.7 82.62 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.584 1.564 . . . . 1.0 114.047 -176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -66.21 152.93 43.79 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 114.998 1.481 . . . . 1.0 114.998 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.8 t -133.57 141.83 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 127.317 2.247 . . . . 1.0 108.876 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.5 pt -140.79 163.95 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 125.994 1.718 . . . . 1.0 110.737 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.64 136.89 34.78 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.412 1.885 . . . . 1.0 111.15 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.92 158.46 43.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.636 1.574 . . . . 1.0 110.812 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -83.26 -4.56 58.55 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 120.935 -1.103 . . . . 1.0 113.507 170.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.57 3.75 16.15 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.021 1.296 . . . . 1.0 114.667 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.61 179.52 43.65 Favored Glycine 0 CA--C 1.537 1.409 0 CA-C-N 118.441 1.121 . . . . 1.0 114.107 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.69 83.81 0.07 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.066 1.346 . . . . 1.0 112.391 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -108.03 94.32 5.01 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.961 1.704 . . . . 1.0 109.862 -176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -39.21 -46.15 1.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 127.453 2.301 . . . . 1.0 115.445 -169.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 m -60.59 -39.07 86.75 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.435 1.094 . . . . 1.0 113.155 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.0 tp -69.14 -46.42 67.66 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.674 -0.641 . . . . 1.0 109.459 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -56.15 -43.3 78.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.245 0.618 . . . . 1.0 111.846 178.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -60.38 -43.53 96.52 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.776 0.658 . . . . 1.0 112.776 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -64.36 -43.01 95.88 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 122.062 -0.398 . . . . 1.0 111.917 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -62.09 -39.83 93.78 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.073 0.949 . . . . 1.0 110.596 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.17 -36.18 77.1 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.709 0.804 . . . . 1.0 113.008 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -97.19 -17.34 19.94 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 115.773 1.768 . . . . 1.0 115.773 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -130.95 -3.78 4.01 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.767 1.395 . . . . 1.0 114.767 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.99 131.25 7.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.371 1.462 . . . . 1.0 112.014 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -61.92 -34.39 81.63 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.617 2.211 . . . . 1.0 113.442 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.3 -40.22 86.01 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.988 0.813 . . . . 1.0 111.957 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.66 78.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.362 0.665 . . . . 1.0 110.94 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.3 t -65.66 -39.24 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.362 0.665 . . . . 1.0 112.512 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -66.41 -26.2 67.12 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 120.232 -1.543 . . . . 1.0 111.977 171.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.7 t -69.38 -27.53 65.39 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.212 -0.93 . . . . 1.0 112.167 169.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.2 m0 -71.09 -17.45 62.58 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.011 -1.056 . . . . 1.0 112.73 169.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.418 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -67.49 147.53 52.71 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.44 0.904 . . . . 1.0 113.44 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.42 120.66 14.82 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.258 1.823 . . . . 1.0 110.732 172.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.8 mt -76.0 118.02 18.32 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.54 1.136 . . . . 1.0 110.48 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt -80.77 49.53 1.21 Allowed 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.635 1.174 . . . . 1.0 112.405 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.78 47.94 0.29 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 125.715 1.626 . . . . 1.0 112.965 -173.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 125.616 1.566 . . . . 1.0 112.813 -178.248 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 112.045 0.387 . . . . 1.0 112.045 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 52.38 37.77 23.4 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 126.965 2.106 . . . . 1.0 116.296 169.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -135.79 155.47 50.31 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.994 1.718 . . . . 1.0 112.273 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 50.6 t -72.48 142.79 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.412 1.485 . . . . 1.0 111.234 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -114.27 119.91 38.63 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.501 1.521 . . . . 1.0 108.796 168.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -83.56 148.23 27.3 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.112 1.365 . . . . 1.0 107.642 169.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -135.04 150.38 50.28 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.571 1.148 . . . . 1.0 109.214 171.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -132.68 143.6 49.75 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.467 1.507 . . . . 1.0 109.297 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -118.72 91.39 42.23 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.001 0.92 . . . . 1.0 111.104 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -49.33 -27.47 13.44 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.987 3.125 . . . . 1.0 116.277 177.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -75.98 -16.54 59.96 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.368 1.067 . . . . 1.0 113.868 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 46.6 p -128.73 -20.9 3.48 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.809 1.244 . . . . 1.0 113.828 -178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.49 -6.82 82.14 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.624 1.583 . . . . 1.0 114.209 -175.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -69.59 154.66 41.67 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.205 1.557 . . . . 1.0 115.205 -176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -134.47 141.61 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 127.065 2.146 . . . . 1.0 109.107 170.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.1 pt -141.33 165.61 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.157 1.783 . . . . 1.0 110.759 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -138.0 140.2 40.04 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.873 2.069 . . . . 1.0 110.866 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.21 161.39 42.81 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.519 1.528 . . . . 1.0 110.853 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.7 mtmt -90.24 -1.91 57.98 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.903 1.281 . . . . 1.0 113.233 171.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.05 3.88 22.83 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.035 1.303 . . . . 1.0 114.717 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.51 179.27 43.73 Favored Glycine 0 CA--C 1.535 1.335 0 CA-C-N 118.398 1.099 . . . . 1.0 114.144 176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -66.72 83.7 0.11 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.879 1.272 . . . . 1.0 112.337 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -104.81 94.01 5.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.74 1.616 . . . . 1.0 109.803 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -42.17 -43.85 3.49 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 126.831 2.052 . . . . 1.0 115.452 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.3 m -59.93 -37.43 79.47 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.089 0.956 . . . . 1.0 113.205 177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.8 -44.85 65.75 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.652 -0.655 . . . . 1.0 109.948 174.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -57.16 -42.31 80.85 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.48 0.712 . . . . 1.0 112.096 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -56.93 -44.72 82.78 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 122.982 0.513 . . . . 1.0 112.329 172.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -65.93 -40.94 91.87 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.917 -0.49 . . . . 1.0 112.118 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.26 -40.32 93.65 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 118.937 0.79 . . . . 1.0 110.689 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -35.93 77.23 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.981 0.912 . . . . 1.0 113.083 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -98.1 -17.68 18.94 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -171.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 12.5 m-90 -132.37 -5.71 3.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.077 1.51 . . . . 1.0 115.077 176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.76 132.65 7.63 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.396 1.474 . . . . 1.0 112.613 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.9 -35.51 66.59 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.406 2.071 . . . . 1.0 113.409 -176.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.24 -40.54 81.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.753 0.706 . . . . 1.0 111.875 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.51 -49.34 73.95 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.356 0.662 . . . . 1.0 110.903 174.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.18 -39.84 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 123.351 0.66 . . . . 1.0 112.171 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.35 -26.2 67.17 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 120.411 -1.431 . . . . 1.0 112.204 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.9 t -72.68 -25.36 61.22 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.672 -0.643 . . . . 1.0 112.645 169.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.9 m0 -70.55 -16.59 62.89 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 120.98 -1.075 . . . . 1.0 112.989 171.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.21 145.97 54.37 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.676 0.991 . . . . 1.0 113.676 -175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -139.19 118.69 12.94 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.211 1.805 . . . . 1.0 110.976 170.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.5 mt -63.72 133.1 52.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.818 0.847 . . . . 1.0 110.711 172.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 22.3 mt -111.62 166.03 11.51 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.289 1.036 . . . . 1.0 111.953 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -145.16 23.29 1.91 Allowed Glycine 0 CA--C 1.539 1.563 0 C-N-CA 124.483 1.04 . . . . 1.0 114.421 176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.465 0 C-N-CA 124.76 1.224 . . . . 1.0 113.225 178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.704 0 N-CA-C 112.129 0.418 . . . . 1.0 112.129 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 54.09 36.58 25.06 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.665 2.098 . . . . 1.0 116.665 169.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 mttm -132.0 152.22 51.27 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 126.102 1.761 . . . . 1.0 110.657 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.27 137.58 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.921 0.888 . . . . 1.0 111.173 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -113.86 122.96 48.61 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.926 1.69 . . . . 1.0 109.094 169.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.59 147.54 25.88 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 125.564 1.546 . . . . 1.0 107.819 169.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -135.15 149.14 49.92 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.811 1.244 . . . . 1.0 109.165 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -131.76 139.02 48.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.967 1.307 . . . . 1.0 109.868 177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -115.49 90.02 24.17 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.414 1.085 . . . . 1.0 110.783 -177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.77 -12.24 24.42 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.333 2.689 . . . . 1.0 115.336 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -65.41 -27.75 68.76 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.01 0.924 . . . . 1.0 113.245 171.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 64.1 p -127.38 -20.43 4.05 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.045 1.338 . . . . 1.0 113.713 -178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.85 -1.34 74.55 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 125.258 1.409 . . . . 1.0 113.628 -173.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -62.25 152.91 32.17 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 115.256 1.576 . . . . 1.0 115.256 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.35 142.55 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 126.82 2.048 . . . . 1.0 109.635 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.3 pt -141.02 165.23 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.965 1.706 . . . . 1.0 110.528 174.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.11 141.06 42.31 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.554 1.942 . . . . 1.0 110.91 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.19 160.99 43.53 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.685 1.594 . . . . 1.0 110.805 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.33 -0.13 57.24 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.446 1.099 . . . . 1.0 113.491 171.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.51 4.09 26.93 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.167 1.365 . . . . 1.0 114.774 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.94 179.64 47.1 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 118.387 1.094 . . . . 1.0 113.598 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.62 83.67 0.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.813 1.245 . . . . 1.0 112.129 177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -102.05 94.05 5.56 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.429 1.492 . . . . 1.0 109.986 -177.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.5 -41.89 3.12 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 127.571 2.348 . . . . 1.0 115.307 -169.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 m -59.96 -39.05 84.26 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.99 0.916 . . . . 1.0 113.338 175.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.5 tp -70.43 -42.74 71.17 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.531 0.732 . . . . 1.0 109.609 176.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.18 -43.05 78.03 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.538 0.735 . . . . 1.0 112.341 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -57.66 -46.37 84.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 172.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.6 m0 -62.49 -41.6 98.92 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.784 -0.572 . . . . 1.0 112.186 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.6 -41.1 96.96 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.13 0.972 . . . . 1.0 110.692 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.93 78.95 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.643 0.777 . . . . 1.0 112.884 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -83.17 -32.31 26.67 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.593 1.331 . . . . 1.0 114.593 -174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -129.25 -4.1 4.95 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 115.253 1.575 . . . . 1.0 115.253 -173.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.92 130.22 6.82 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.286 1.422 . . . . 1.0 111.921 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -61.83 -35.52 78.16 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.649 2.232 . . . . 1.0 113.525 -177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -68.1 -40.25 82.65 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.567 0.622 . . . . 1.0 111.948 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.3 -48.98 73.59 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.392 0.677 . . . . 1.0 111.207 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.3 t -63.2 -40.18 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.917 -0.49 . . . . 1.0 112.166 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -66.06 -25.14 66.9 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 120.294 -1.504 . . . . 1.0 112.165 174.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.4 t -73.18 -25.71 60.89 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.607 -0.683 . . . . 1.0 112.709 169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -69.87 -16.46 63.25 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.97 -1.081 . . . . 1.0 112.877 171.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.19 144.96 56.46 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.77 1.026 . . . . 1.0 113.77 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.06 117.85 12.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.212 1.805 . . . . 1.0 110.707 170.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -63.74 131.31 47.49 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.032 0.933 . . . . 1.0 110.54 172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.0 mt -99.42 43.92 1.04 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.102 0.953 . . . . 1.0 111.746 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 177.88 -177.76 48.39 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.108 1.337 . . . . 1.0 113.205 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 C--O 1.251 1.168 0 C-N-CA 126.052 1.741 . . . . 1.0 111.737 -178.832 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 111.63 0.233 . . . . 1.0 111.63 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.4 mtm180 -79.04 -0.49 31.54 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.293 1.59 . . . . 1.0 115.293 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.8 mmtt -51.91 154.15 2.26 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.456 1.902 . . . . 1.0 114.262 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.6 t -77.67 137.53 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.248 1.419 . . . . 1.0 110.545 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -105.86 120.44 41.73 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 125.404 1.482 . . . . 1.0 108.659 168.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -86.5 146.6 26.33 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.794 -1.558 . . . . 1.0 106.794 168.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 80.3 m-85 -135.64 151.62 50.41 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.815 1.246 . . . . 1.0 108.983 175.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -132.02 144.71 50.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.273 1.429 . . . . 1.0 109.87 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -119.52 92.86 46.67 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.071 0.948 . . . . 1.0 112.246 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_exo -46.63 -25.1 3.28 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.811 3.674 . . . . 1.0 117.091 175.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -67.09 -27.06 67.04 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.628 0.973 . . . . 1.0 113.628 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 63.5 p -130.1 -17.5 3.46 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.929 1.291 . . . . 1.0 114.126 -176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.84 0.62 85.7 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 124.985 1.279 . . . . 1.0 113.896 -173.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.14 154.6 30.6 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 115.228 1.566 . . . . 1.0 115.228 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.53 142.04 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.857 2.063 . . . . 1.0 109.565 171.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.6 pt -140.63 164.04 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 126.237 1.815 . . . . 1.0 110.656 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -140.23 137.41 34.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.055 1.742 . . . . 1.0 111.579 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.44 158.65 43.96 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.38 1.472 . . . . 1.0 111.166 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -83.32 -2.7 56.35 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.19 0.996 . . . . 1.0 113.515 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.06 4.26 25.91 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.082 1.325 . . . . 1.0 114.53 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.88 179.52 41.32 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.564 1.078 . . . . 1.0 113.805 176.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -65.6 83.79 0.06 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.132 1.373 . . . . 1.0 112.025 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -107.56 94.0 4.85 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.793 1.637 . . . . 1.0 109.865 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -41.36 -44.02 2.66 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 127.007 2.123 . . . . 1.0 115.24 -169.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 19.5 m -60.82 -39.65 89.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.895 0.878 . . . . 1.0 113.23 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.93 -44.82 72.3 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.618 -0.676 . . . . 1.0 109.743 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -56.5 -43.12 79.43 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.384 0.674 . . . . 1.0 111.923 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.69 -48.38 79.71 Favored 'General case' 0 C--O 1.223 -0.33 0 C-N-CA 122.662 0.385 . . . . 1.0 111.875 172.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -61.03 -43.71 98.49 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.818 -0.551 . . . . 1.0 112.211 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -62.53 -41.09 98.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 1.0 110.709 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.34 80.72 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -81.41 -32.9 32.51 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -129.66 -0.6 4.89 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -172.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 99.29 128.17 6.15 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.51 1.529 . . . . 1.0 112.113 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.88 -34.45 91.18 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.744 2.296 . . . . 1.0 113.213 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -66.27 -42.46 88.42 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.859 0.754 . . . . 1.0 111.646 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.81 -47.49 80.63 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.406 0.683 . . . . 1.0 111.163 174.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -65.33 -36.4 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.198 0.599 . . . . 1.0 112.397 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -66.89 -28.75 68.58 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.259 -1.525 . . . . 1.0 111.995 171.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 64.6 m -68.75 -23.77 64.36 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.138 -0.977 . . . . 1.0 112.216 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -72.9 -15.41 61.58 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 119.329 0.968 . . . . 1.0 112.442 169.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.421 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -71.47 148.13 47.12 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.817 1.043 . . . . 1.0 113.817 -175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.73 119.17 12.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.587 1.955 . . . . 1.0 110.931 171.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 44.6 mt -72.26 129.42 38.39 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.204 1.002 . . . . 1.0 110.625 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.6 mt -77.44 65.33 2.96 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.328 1.051 . . . . 1.0 112.829 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.93 34.77 1.31 Allowed Glycine 0 CA--C 1.539 1.544 0 C-N-CA 126.539 2.018 . . . . 1.0 112.453 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.842 2.057 . . . . 1.0 111.846 -172.751 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 111.252 0.093 . . . . 1.0 111.252 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -75.95 35.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.145 1.778 . . . . 1.0 114.453 -177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -63.6 154.56 32.38 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.937 1.695 . . . . 1.0 112.171 176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.2 t -71.76 141.3 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.487 1.115 . . . . 1.0 110.348 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -113.3 121.26 43.86 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.685 1.594 . . . . 1.0 108.54 169.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -86.98 147.0 25.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.833 -1.173 . . . . 1.0 107.833 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -134.95 147.87 49.88 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.117 1.367 . . . . 1.0 109.018 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -129.99 137.49 50.32 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.075 1.35 . . . . 1.0 109.995 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -111.12 91.64 13.68 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 124.103 0.961 . . . . 1.0 110.543 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -62.22 -14.35 37.67 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.824 2.349 . . . . 1.0 114.896 -176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -69.78 -23.62 63.38 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.665 1.186 . . . . 1.0 113.562 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -127.93 -21.77 3.62 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.075 1.35 . . . . 1.0 113.619 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.27 -4.95 74.56 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.607 1.575 . . . . 1.0 113.873 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -66.03 153.18 42.91 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.146 1.536 . . . . 1.0 115.146 -178.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.9 t -134.71 141.59 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 126.914 2.086 . . . . 1.0 109.219 170.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.1 pt -140.93 163.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.913 1.685 . . . . 1.0 110.65 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -139.18 138.54 37.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.155 1.782 . . . . 1.0 111.305 177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.41 159.6 44.16 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.399 1.48 . . . . 1.0 110.876 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -87.24 -1.88 58.22 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.551 1.14 . . . . 1.0 113.517 171.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.75 5.49 18.15 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.151 1.358 . . . . 1.0 115.004 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.54 179.23 43.88 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-N 118.443 1.122 . . . . 1.0 114.205 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -65.79 83.87 0.07 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.344 1.458 . . . . 1.0 112.13 176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -106.2 94.01 4.93 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.421 1.489 . . . . 1.0 110.215 -174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -37.56 -47.46 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.11 2.564 . . . . 1.0 115.463 -172.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -61.49 -38.29 86.74 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.133 0.973 . . . . 1.0 113.039 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.3 tp -70.01 -44.41 69.39 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.675 -0.641 . . . . 1.0 109.616 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -56.3 -43.12 78.6 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.407 0.683 . . . . 1.0 112.203 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -58.71 -42.95 89.85 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 44.1 m0 -65.22 -41.51 94.37 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.879 0.326 . . . . 1.0 111.879 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.52 -40.01 93.08 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.662 0.785 . . . . 1.0 110.558 175.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.87 -36.0 77.57 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.074 0.949 . . . . 1.0 113.163 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -97.78 -17.62 19.25 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 116.182 1.919 . . . . 1.0 116.182 -171.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -131.37 -6.41 3.77 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.919 1.452 . . . . 1.0 114.919 176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.63 132.08 7.45 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 125.506 1.527 . . . . 1.0 112.2 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.07 -36.42 70.59 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.926 2.417 . . . . 1.0 113.447 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.78 -39.96 84.02 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 118.639 0.654 . . . . 1.0 111.9 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.0 -48.91 74.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.268 0.627 . . . . 1.0 110.993 174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.8 t -63.62 -40.33 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 123.187 0.595 . . . . 1.0 112.17 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -66.6 -24.22 66.29 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.475 -1.39 . . . . 1.0 112.044 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.7 t -74.82 -23.63 58.49 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.528 -0.733 . . . . 1.0 112.718 169.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -71.33 -17.27 62.45 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 121.143 -0.973 . . . . 1.0 112.897 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.98 145.34 55.58 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.966 1.098 . . . . 1.0 113.966 -176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.42 117.96 12.19 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.116 1.766 . . . . 1.0 110.885 169.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 67.7 mt -63.16 133.17 53.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.023 0.929 . . . . 1.0 110.777 172.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.4 mt -103.22 167.95 9.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.011 0.924 . . . . 1.0 111.382 176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.69 178.08 48.61 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 124.608 1.099 . . . . 1.0 113.199 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.212 0 C-N-CA 125.233 1.413 . . . . 1.0 112.199 178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 120.317 0.103 . . . . 1.0 111.261 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.3 mtp180 -74.48 32.69 0.09 Allowed 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 126.318 1.847 . . . . 1.0 114.833 -177.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -63.28 153.06 36.0 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.753 1.621 . . . . 1.0 112.431 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t -74.69 134.34 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.574 1.15 . . . . 1.0 110.82 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -102.58 116.0 31.72 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.086 1.355 . . . . 1.0 108.219 168.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -84.07 146.33 27.98 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 124.955 1.302 . . . . 1.0 107.533 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.6 150.47 50.7 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.828 1.251 . . . . 1.0 109.354 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -132.24 139.71 48.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.356 1.462 . . . . 1.0 110.022 175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -116.13 89.65 26.12 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.71 1.204 . . . . 1.0 111.015 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -61.53 -12.12 23.07 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 123.179 2.586 . . . . 1.0 115.422 -176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -65.0 -28.09 69.28 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.489 0.922 . . . . 1.0 113.489 171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.0 p -127.71 -19.45 4.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.179 1.392 . . . . 1.0 113.963 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.45 -1.97 77.03 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 125.235 1.398 . . . . 1.0 113.631 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -62.02 152.76 31.54 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.236 1.569 . . . . 1.0 115.236 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.0 t -136.58 141.62 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.581 1.953 . . . . 1.0 109.466 172.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.9 pt -140.84 165.87 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.017 1.727 . . . . 1.0 110.727 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -139.31 139.18 37.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.617 1.967 . . . . 1.0 110.851 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.21 158.0 43.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.344 1.458 . . . . 1.0 110.659 176.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.96 -3.02 59.05 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.215 1.006 . . . . 1.0 113.514 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.54 2.62 14.92 Favored Glycine 0 CA--C 1.538 1.486 0 C-N-CA 124.813 1.197 . . . . 1.0 115.288 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.11 179.05 42.86 Favored Glycine 0 CA--C 1.536 1.391 0 CA-C-N 118.468 1.134 . . . . 1.0 113.829 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -66.57 83.79 0.1 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.086 1.355 . . . . 1.0 111.991 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -99.46 94.3 6.35 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.328 1.451 . . . . 1.0 110.249 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 tmtt? -39.84 -45.64 1.83 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 128.095 2.558 . . . . 1.0 115.118 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.8 m -60.55 -39.98 89.9 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.222 1.009 . . . . 1.0 113.576 176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.1 tp -68.67 -42.39 77.94 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.546 -0.721 . . . . 1.0 109.918 175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -56.07 -43.6 78.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.527 0.731 . . . . 1.0 112.282 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -57.7 -45.38 85.77 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 112.36 0.504 . . . . 1.0 112.36 171.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -62.16 -41.68 98.54 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.598 -0.689 . . . . 1.0 112.115 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -61.88 -40.91 97.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.414 1.086 . . . . 1.0 110.854 176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.93 -38.17 79.34 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.481 0.713 . . . . 1.0 112.846 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -82.01 -33.08 30.23 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 114.504 1.298 . . . . 1.0 114.504 -174.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.4 m-90 -129.78 -3.22 4.69 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -171.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.09 129.66 6.73 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.448 1.499 . . . . 1.0 112.335 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.93 -35.21 78.82 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.544 2.163 . . . . 1.0 113.569 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -68.61 -39.8 80.69 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 118.73 0.696 . . . . 1.0 112.2 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.14 -49.47 72.01 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.24 0.616 . . . . 1.0 110.805 174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 88.4 t -63.4 -41.55 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 123.297 0.639 . . . . 1.0 112.072 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -66.01 -23.56 66.59 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 120.525 -1.36 . . . . 1.0 112.269 173.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -75.94 -21.48 56.98 Favored 'General case' 0 CA--C 1.544 0.714 0 O-C-N 121.572 -0.705 . . . . 1.0 112.897 169.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -72.85 -16.37 61.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.548 1.067 . . . . 1.0 112.871 169.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.6 144.13 56.51 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 113.684 0.994 . . . . 1.0 113.684 -176.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.09 118.45 12.8 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.296 1.838 . . . . 1.0 110.809 172.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 60.7 mt -71.23 116.47 11.58 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.514 1.126 . . . . 1.0 110.375 176.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.4 mt -79.8 160.97 25.94 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.587 0.755 . . . . 1.0 111.487 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.5 33.65 0.27 Allowed Glycine 0 CA--C 1.536 1.376 0 N-CA-C 114.741 0.657 . . . . 1.0 114.741 -177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.811 1.645 . . . . 1.0 111.815 -176.488 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.723 0.297 . . . . 1.0 111.453 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -76.1 -3.56 36.69 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 115.271 1.582 . . . . 1.0 115.271 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -51.09 150.77 2.99 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.653 1.981 . . . . 1.0 113.482 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.9 t -75.57 141.84 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.8 1.24 . . . . 1.0 110.833 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -111.22 120.55 42.65 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.47 1.508 . . . . 1.0 108.647 168.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -86.8 148.73 25.27 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 107.654 -1.239 . . . . 1.0 107.654 169.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -136.67 149.82 48.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.098 1.359 . . . . 1.0 108.851 175.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -131.59 144.23 50.92 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.357 1.463 . . . . 1.0 109.95 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.89 91.75 47.85 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 124.147 0.979 . . . . 1.0 111.763 -175.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -46.5 -25.99 3.85 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.835 3.69 . . . . 1.0 116.976 176.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -66.42 -27.07 67.55 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.751 1.019 . . . . 1.0 113.751 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -129.51 -17.62 3.68 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.776 1.23 . . . . 1.0 113.935 -177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.24 0.14 85.24 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.033 1.301 . . . . 1.0 113.826 -173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -63.19 154.72 30.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 115.29 1.589 . . . . 1.0 115.29 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.55 141.23 41.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 126.852 2.061 . . . . 1.0 109.405 171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.3 pt -139.91 163.58 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.955 1.702 . . . . 1.0 110.674 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -139.93 137.89 35.15 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.105 1.762 . . . . 1.0 111.348 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 157.78 43.03 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.187 1.395 . . . . 1.0 111.014 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.61 -4.54 58.66 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.263 1.025 . . . . 1.0 113.442 171.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.41 1.91 19.9 Favored Glycine 0 N--CA 1.478 1.438 0 C-N-CA 125.053 1.311 . . . . 1.0 114.806 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.78 179.13 38.47 Favored Glycine 0 CA--C 1.536 1.383 0 CA-C-N 118.576 1.188 . . . . 1.0 113.807 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -67.42 83.87 0.16 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.737 1.215 . . . . 1.0 112.186 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.06 94.03 5.33 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.489 1.516 . . . . 1.0 109.903 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.33 -42.47 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 126.664 1.986 . . . . 1.0 115.664 -169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.6 m -59.07 -39.23 81.47 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.095 0.958 . . . . 1.0 113.013 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.2 tp -69.96 -44.82 68.72 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.428 0.691 . . . . 1.0 109.777 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -56.4 -43.44 79.32 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.485 0.714 . . . . 1.0 112.156 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.63 -46.62 83.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 122.587 0.355 . . . . 1.0 111.877 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -62.18 -41.92 98.79 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.549 -0.719 . . . . 1.0 111.937 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt -61.39 -41.07 96.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.966 0.906 . . . . 1.0 110.778 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.22 -38.7 78.67 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.555 0.742 . . . . 1.0 112.736 177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -81.38 -32.65 32.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -175.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.94 -2.31 4.08 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.481 1.66 . . . . 1.0 115.481 -171.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.73 128.82 6.48 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 125.125 1.345 . . . . 1.0 112.358 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.66 -35.32 81.16 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.659 2.24 . . . . 1.0 113.513 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -68.7 -39.53 80.47 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.867 0.758 . . . . 1.0 112.189 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -49.05 72.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.147 0.579 . . . . 1.0 110.869 174.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.77 -40.86 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 121.702 -0.623 . . . . 1.0 112.176 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -66.43 -24.79 66.5 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.364 -1.46 . . . . 1.0 112.207 173.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -74.7 -21.44 59.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.561 -0.712 . . . . 1.0 112.9 169.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -72.95 -16.5 61.53 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.428 1.013 . . . . 1.0 112.96 170.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.7 145.66 55.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.024 1.12 . . . . 1.0 114.024 -174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.39 118.06 12.28 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.432 1.893 . . . . 1.0 111.197 170.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 64.6 mt -63.88 131.09 46.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.174 0.99 . . . . 1.0 110.543 172.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.8 mt -98.23 162.89 12.96 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.659 0.783 . . . . 1.0 111.479 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.41 32.11 0.39 Allowed Glycine 0 CA--C 1.537 1.453 0 N-CA-C 115.086 0.794 . . . . 1.0 115.086 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 78.1 t60 . . . . . 0 C--O 1.256 1.419 0 C-N-CA 124.993 1.317 . . . . 1.0 112.929 177.885 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 111.34 0.126 . . . . 1.0 111.34 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -75.81 42.63 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.142 1.777 . . . . 1.0 114.955 -174.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -64.2 156.23 29.32 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.691 1.196 . . . . 1.0 111.131 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.8 t -70.08 130.81 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 115.346 -0.843 . . . . 1.0 111.124 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -104.02 118.45 36.69 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.293 1.437 . . . . 1.0 107.854 168.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -85.86 145.46 27.18 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.102 1.361 . . . . 1.0 107.37 168.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -136.62 152.66 50.68 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.586 1.154 . . . . 1.0 109.565 176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -133.31 144.74 49.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.406 1.483 . . . . 1.0 109.727 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -121.37 91.49 48.27 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 124.191 0.996 . . . . 1.0 111.749 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -47.4 -25.52 5.04 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.752 3.635 . . . . 1.0 116.898 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -65.34 -26.82 68.2 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.859 1.059 . . . . 1.0 113.859 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.9 p -129.96 -17.2 3.56 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.952 1.301 . . . . 1.0 113.952 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.25 0.54 86.79 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.982 1.277 . . . . 1.0 114.064 -173.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -64.33 154.82 34.19 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 115.071 1.508 . . . . 1.0 115.071 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.0 t -137.03 140.95 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 126.915 2.086 . . . . 1.0 109.452 172.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.2 pt -141.99 164.42 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.98 1.712 . . . . 1.0 110.89 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -140.13 138.02 34.91 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.389 1.876 . . . . 1.0 110.878 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.4 156.9 41.64 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.46 1.504 . . . . 1.0 111.025 176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -84.73 -2.87 58.19 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.504 1.121 . . . . 1.0 113.663 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.65 2.28 19.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.863 1.22 . . . . 1.0 114.985 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.05 179.35 42.16 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-N 118.292 1.046 . . . . 1.0 113.877 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.6 83.79 0.18 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.784 1.234 . . . . 1.0 112.011 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -102.51 94.12 5.5 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.568 1.547 . . . . 1.0 109.858 -177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -39.83 -45.5 1.8 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 127.434 2.293 . . . . 1.0 115.429 -170.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.1 m -60.38 -39.45 87.31 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.203 1.001 . . . . 1.0 113.015 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.6 tp -69.92 -43.67 71.19 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.348 -0.845 . . . . 1.0 109.869 175.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -56.36 -43.52 79.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.377 0.671 . . . . 1.0 111.952 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -58.45 -47.46 83.92 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.231 -0.44 . . . . 1.0 112.015 172.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -60.6 -42.35 96.62 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.769 -0.582 . . . . 1.0 112.109 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.69 -40.24 96.49 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.213 1.005 . . . . 1.0 110.782 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.39 -39.25 78.1 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.803 0.841 . . . . 1.0 112.971 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -79.58 -32.73 42.04 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.818 1.247 . . . . 1.0 114.133 -174.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.2 -4.31 4.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.309 1.596 . . . . 1.0 115.309 -172.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.87 130.72 7.12 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.405 1.478 . . . . 1.0 111.764 175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.55 -34.75 84.54 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.73 2.287 . . . . 1.0 113.424 -176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.55 -40.22 84.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.456 0.703 . . . . 1.0 111.951 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.78 -47.61 77.49 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.268 0.627 . . . . 1.0 111.005 174.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.74 -39.86 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.8 -0.563 . . . . 1.0 112.208 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -66.72 -27.12 67.37 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 120.23 -1.544 . . . . 1.0 112.178 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.7 t -67.96 -27.07 66.28 Favored 'General case' 0 CA--C 1.545 0.754 0 O-C-N 121.12 -0.988 . . . . 1.0 112.277 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.7 m0 -72.33 -15.72 61.88 Favored 'General case' 0 CA--C 1.544 0.75 0 O-C-N 121.0 -1.062 . . . . 1.0 113.115 170.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.68 145.92 55.04 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.5 0.926 . . . . 1.0 113.5 -175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.48 117.48 11.76 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.267 1.827 . . . . 1.0 110.443 170.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.7 mt -70.89 118.25 13.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.471 1.109 . . . . 1.0 110.345 175.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.9 mt -81.39 157.73 24.89 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.388 0.675 . . . . 1.0 112.086 178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -165.23 34.46 0.26 Allowed Glycine 0 CA--C 1.538 1.489 0 C-N-CA 123.6 0.619 . . . . 1.0 114.604 -176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.524 1.53 . . . . 1.0 111.316 -177.907 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 111.679 0.252 . . . . 1.0 111.679 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -77.12 64.44 2.56 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.82 1.648 . . . . 1.0 112.58 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -134.34 154.13 51.5 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.344 1.857 . . . . 1.0 111.99 -172.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.1 t -77.82 137.1 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.755 1.222 . . . . 1.0 110.704 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -102.86 117.94 35.73 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.575 1.15 . . . . 1.0 108.554 168.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -86.63 145.64 26.64 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.223 1.409 . . . . 1.0 107.611 168.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -136.4 151.85 49.98 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.59 1.156 . . . . 1.0 109.91 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -132.83 137.82 46.87 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.279 1.432 . . . . 1.0 109.596 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 59.2 t-20 -111.65 92.47 17.08 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.83 0.852 . . . . 1.0 110.586 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.75 -14.19 38.87 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.996 2.464 . . . . 1.0 114.782 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -70.32 -22.63 62.79 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.592 1.157 . . . . 1.0 113.55 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 69.2 p -127.58 -23.16 3.5 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.242 1.417 . . . . 1.0 113.449 -176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.28 -6.4 71.84 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 125.829 1.68 . . . . 1.0 113.728 -176.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -66.93 152.79 45.03 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 115.164 1.542 . . . . 1.0 115.164 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.8 t -134.09 140.39 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 126.96 2.104 . . . . 1.0 109.191 171.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.1 pt -140.94 164.56 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.756 1.622 . . . . 1.0 110.766 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -139.72 137.47 35.17 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.551 1.94 . . . . 1.0 110.884 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.59 158.49 43.59 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.933 1.293 . . . . 1.0 111.323 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.1 mtpt -86.43 -2.83 58.78 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.389 1.076 . . . . 1.0 113.188 171.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.44 3.19 19.11 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.098 1.333 . . . . 1.0 115.015 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.2 179.21 42.86 Favored Glycine 0 CA--C 1.535 1.336 0 CA-C-N 118.569 1.184 . . . . 1.0 113.907 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -67.4 83.76 0.16 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.03 1.332 . . . . 1.0 112.055 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -104.67 94.38 5.26 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.704 1.602 . . . . 1.0 109.865 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -41.5 -43.2 2.58 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 126.832 2.053 . . . . 1.0 115.547 -170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -60.19 -37.82 81.37 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.044 0.938 . . . . 1.0 113.096 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.9 tp -71.64 -44.25 64.67 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.273 0.629 . . . . 1.0 109.604 175.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -56.8 -43.14 80.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.436 0.694 . . . . 1.0 112.06 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -57.28 -44.78 84.31 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.425 0.528 . . . . 1.0 112.425 172.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.18 -41.36 90.37 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 122.069 -0.394 . . . . 1.0 112.052 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.8 mtpt -62.12 -38.73 90.04 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 118.986 0.812 . . . . 1.0 110.703 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.16 75.8 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.755 0.822 . . . . 1.0 112.916 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -98.4 -16.1 19.41 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 115.972 1.842 . . . . 1.0 115.972 -170.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 19.8 m-90 -130.84 -8.24 3.98 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.761 1.393 . . . . 1.0 114.761 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.36 134.25 8.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.379 1.466 . . . . 1.0 112.161 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.42 -35.88 69.67 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.605 2.203 . . . . 1.0 113.228 -176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -67.26 -39.56 86.13 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.553 0.741 . . . . 1.0 111.693 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.67 -47.54 78.07 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.398 0.679 . . . . 1.0 111.453 174.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.7 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.945 -0.472 . . . . 1.0 112.205 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -65.86 -27.15 68.01 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.514 -1.366 . . . . 1.0 112.239 172.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.8 t -68.64 -27.57 66.12 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.958 0.799 . . . . 1.0 112.394 170.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -72.15 -15.92 61.98 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.054 -1.029 . . . . 1.0 112.85 170.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -66.08 147.28 53.59 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 -174.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.4 p -139.19 120.36 14.71 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.293 1.837 . . . . 1.0 110.761 171.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.2 mt -75.15 116.0 15.4 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.647 1.179 . . . . 1.0 110.295 177.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.1 mt -78.95 160.76 27.09 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.33 0.652 . . . . 1.0 111.815 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -163.4 36.51 0.32 Allowed Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.73 0.681 . . . . 1.0 114.449 -176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.485 1.514 . . . . 1.0 112.577 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 120.669 0.271 . . . . 1.0 111.428 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -76.9 -2.52 33.96 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.381 1.623 . . . . 1.0 115.381 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -51.75 153.79 2.29 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 126.599 1.959 . . . . 1.0 114.161 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 81.9 t -76.17 139.55 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.475 1.51 . . . . 1.0 111.05 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -106.42 119.82 40.26 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.45 1.5 . . . . 1.0 107.829 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -86.35 145.29 26.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 125.164 1.386 . . . . 1.0 107.279 168.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 120' ' ' ALA . 90.8 m-85 -136.2 152.09 50.4 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.737 1.215 . . . . 1.0 109.698 175.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -133.92 144.5 48.87 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.599 1.56 . . . . 1.0 109.435 174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.67 93.94 44.74 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.763 0.825 . . . . 1.0 111.453 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.21 -26.09 7.7 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 124.476 3.451 . . . . 1.0 116.441 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -72.07 -21.96 61.43 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.987 1.106 . . . . 1.0 113.987 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 65.6 p -128.91 -21.75 3.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.095 1.358 . . . . 1.0 113.545 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.21 -6.74 82.42 Favored Glycine 0 CA--C 1.539 1.542 0 C-N-CA 125.544 1.545 . . . . 1.0 113.797 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.25 152.65 45.35 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.874 1.435 . . . . 1.0 114.874 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 42.3 t -134.05 139.97 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 127.07 2.148 . . . . 1.0 109.177 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.8 pt -141.7 164.42 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.017 1.727 . . . . 1.0 110.832 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -140.51 136.06 32.53 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.326 1.851 . . . . 1.0 110.872 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.71 157.3 41.86 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.872 1.269 . . . . 1.0 111.173 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -82.96 -4.78 58.64 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 120.929 -1.107 . . . . 1.0 113.711 171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.65 2.43 17.1 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.841 1.21 . . . . 1.0 114.925 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.87 179.12 38.8 Favored Glycine 0 CA--C 1.535 1.308 0 CA-C-N 118.415 1.107 . . . . 1.0 113.803 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -68.13 83.74 0.23 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.585 1.154 . . . . 1.0 112.127 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -102.87 94.92 5.84 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.616 1.566 . . . . 1.0 109.771 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -41.57 -43.18 2.64 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 126.784 2.034 . . . . 1.0 115.699 -170.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -37.97 79.39 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.229 1.011 . . . . 1.0 113.269 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.2 tp -72.02 -44.14 63.89 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.353 0.661 . . . . 1.0 109.764 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 46.1 tttp -56.09 -43.4 78.0 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.484 0.714 . . . . 1.0 111.871 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -57.97 -44.56 87.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.339 0.496 . . . . 1.0 112.339 173.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -66.47 -40.92 89.63 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.985 -0.447 . . . . 1.0 112.015 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -62.73 -38.75 91.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 119.048 0.84 . . . . 1.0 110.388 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.7 -36.3 75.83 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 1.0 113.169 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -98.1 -16.77 19.42 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.843 1.794 . . . . 1.0 115.843 -171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -130.72 -9.16 4.01 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.14 134.18 8.07 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.436 1.493 . . . . 1.0 111.98 176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.8 -34.68 71.87 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.522 2.148 . . . . 1.0 113.098 -176.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -67.74 -39.84 84.21 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.62 0.768 . . . . 1.0 111.913 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.85 -46.87 80.06 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.343 0.657 . . . . 1.0 111.108 174.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.4 t -63.96 -41.03 91.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 O-C-N 121.731 -0.605 . . . . 1.0 112.126 178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -63.6 -30.04 71.21 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.45 -1.406 . . . . 1.0 112.123 172.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.6 t -67.99 -27.54 66.66 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.343 -0.848 . . . . 1.0 112.523 171.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 27.9 m0 -72.74 -15.44 61.66 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.15 -0.969 . . . . 1.0 113.065 170.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.41 ' HB2' ' CE2' ' A' ' 85' ' ' TYR . . . -67.04 147.53 53.07 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.692 0.997 . . . . 1.0 113.692 -174.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.08 116.64 11.35 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.297 1.839 . . . . 1.0 110.323 170.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 57.0 mt -68.23 132.04 46.44 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.962 0.905 . . . . 1.0 110.347 173.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.2 mt -82.29 48.59 1.29 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.959 0.885 . . . . 1.0 112.293 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.75 174.14 42.06 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.889 1.709 . . . . 1.0 113.076 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.367 0 C-N-CA 125.436 1.494 . . . . 1.0 112.307 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 112.18 0.437 . . . . 1.0 112.18 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 58.06 30.63 19.56 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 127.521 2.328 . . . . 1.0 116.239 169.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -137.73 157.82 45.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.89 1.676 . . . . 1.0 112.431 -175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.85 138.61 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.819 1.648 . . . . 1.0 109.942 174.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -104.74 119.21 38.47 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.918 1.287 . . . . 1.0 108.657 168.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -86.45 145.89 26.64 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.221 -1.4 . . . . 1.0 107.221 168.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -135.9 152.5 51.07 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.615 1.166 . . . . 1.0 109.61 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -133.05 144.97 50.39 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.412 1.485 . . . . 1.0 109.184 174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -118.03 92.12 41.48 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.179 0.992 . . . . 1.0 110.946 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.34 -27.16 12.87 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 124.307 3.338 . . . . 1.0 116.077 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -77.04 -15.71 59.52 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 49.8 p -128.91 -22.51 3.2 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.931 1.292 . . . . 1.0 113.802 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.37 -6.49 80.77 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 125.928 1.727 . . . . 1.0 114.171 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -70.09 154.5 41.85 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 115.143 1.535 . . . . 1.0 115.143 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.26 140.16 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 127.326 2.25 . . . . 1.0 109.205 171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 39.4 pt -142.67 165.13 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.036 1.734 . . . . 1.0 110.994 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -138.87 138.92 37.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.74 2.016 . . . . 1.0 111.002 176.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.29 158.44 43.85 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.463 1.505 . . . . 1.0 110.977 176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.52 -3.21 58.28 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.275 1.03 . . . . 1.0 113.545 171.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.94 4.32 22.76 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 125.091 1.329 . . . . 1.0 114.866 177.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.93 179.32 38.66 Favored Glycine 0 CA--C 1.536 1.38 0 CA-C-N 118.277 1.039 . . . . 1.0 113.789 176.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -65.45 83.71 0.06 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.222 1.409 . . . . 1.0 112.212 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -103.08 94.04 5.33 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.574 1.549 . . . . 1.0 110.341 -176.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -39.77 -45.53 1.76 Allowed 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 128.093 2.557 . . . . 1.0 115.441 -171.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.4 m -61.21 -39.87 91.86 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.172 0.989 . . . . 1.0 113.425 176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.5 tp -69.96 -42.66 72.88 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.643 -0.661 . . . . 1.0 109.772 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -55.43 -44.11 75.97 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.456 0.703 . . . . 1.0 112.181 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -57.66 -44.16 85.48 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 112.925 0.713 . . . . 1.0 112.925 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -65.2 -41.46 94.48 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 122.003 -0.435 . . . . 1.0 112.028 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -62.46 -39.03 92.1 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.887 0.875 . . . . 1.0 110.463 176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.98 76.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.037 0.935 . . . . 1.0 113.124 176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -98.07 -18.11 18.73 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.853 1.797 . . . . 1.0 115.853 -171.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 14.0 m-90 -129.4 -8.11 4.7 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.722 1.379 . . . . 1.0 114.722 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.61 134.16 8.28 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.467 1.508 . . . . 1.0 111.937 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.85 -34.3 72.64 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.5 2.133 . . . . 1.0 113.065 -176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -68.08 -39.49 82.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.51 0.724 . . . . 1.0 112.072 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.56 -47.97 76.75 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.458 0.703 . . . . 1.0 110.973 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 97.7 t -63.54 -41.2 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.126 0.57 . . . . 1.0 112.305 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -65.98 -28.26 68.76 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 120.437 -1.414 . . . . 1.0 112.241 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.1 m -68.91 -22.83 64.14 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 30.0 m0 -76.73 -14.19 59.96 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.009 0.923 . . . . 1.0 112.975 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.08 147.86 51.76 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.21 0.914 . . . . 1.0 113.362 -174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 p -139.11 117.65 12.13 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.57 1.948 . . . . 1.0 110.687 170.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.8 mt -71.19 123.99 23.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.479 1.112 . . . . 1.0 110.782 175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 25.9 mt -86.25 41.27 0.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.165 0.986 . . . . 1.0 112.556 -178.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.58 176.13 39.2 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.546 1.546 . . . . 1.0 113.362 -177.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.202 0 C-N-CA 125.812 1.645 . . . . 1.0 112.226 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 111.993 0.368 . . . . 1.0 111.993 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 53.14 34.3 17.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 116.508 2.04 . . . . 1.0 116.508 169.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -136.23 159.39 41.89 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.175 1.79 . . . . 1.0 112.089 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 66.4 t -108.66 137.37 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.265 1.826 . . . . 1.0 110.39 -179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -100.65 115.52 30.42 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.375 1.07 . . . . 1.0 108.841 168.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -84.15 145.87 28.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 1.0 107.539 169.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -133.76 149.82 51.46 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.754 1.222 . . . . 1.0 109.074 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -130.97 144.39 51.44 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.517 1.527 . . . . 1.0 109.306 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -118.34 92.61 43.57 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.881 0.873 . . . . 1.0 111.62 -174.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -48.57 -26.34 8.96 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.299 3.333 . . . . 1.0 116.78 175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -18.19 57.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 114.02 1.118 . . . . 1.0 114.02 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 43.6 p -130.83 -21.22 2.75 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.177 1.177 . . . . 1.0 114.177 -176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.08 81.33 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.814 1.673 . . . . 1.0 114.154 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.3 156.44 37.72 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.326 1.602 . . . . 1.0 115.326 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.39 140.77 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 127.141 2.176 . . . . 1.0 109.109 169.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.7 pt -140.19 166.24 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.861 1.664 . . . . 1.0 110.612 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -140.06 138.45 35.39 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.58 1.952 . . . . 1.0 111.072 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.24 159.27 44.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.374 1.469 . . . . 1.0 110.966 177.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -86.67 -2.65 58.7 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.035 -1.041 . . . . 1.0 113.314 171.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.74 4.57 22.92 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 125.183 1.373 . . . . 1.0 114.945 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.07 179.18 45.59 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-N 118.327 1.063 . . . . 1.0 113.871 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -66.18 83.99 0.09 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.987 1.315 . . . . 1.0 112.143 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -105.3 94.08 5.03 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.687 1.595 . . . . 1.0 109.812 -175.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -42.01 -43.77 3.29 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 126.763 2.025 . . . . 1.0 115.47 -169.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -59.23 -39.16 81.89 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.055 0.942 . . . . 1.0 112.945 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.21 -44.69 71.57 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.682 -0.636 . . . . 1.0 109.851 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -57.07 -42.81 81.3 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.636 0.774 . . . . 1.0 112.168 177.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -57.73 -45.87 85.21 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 112.082 0.401 . . . . 1.0 112.082 171.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -62.4 -41.7 98.87 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.725 -0.609 . . . . 1.0 112.133 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.33 -41.42 96.98 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.009 0.924 . . . . 1.0 110.806 176.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.24 -37.81 78.15 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 113.031 0.752 . . . . 1.0 113.031 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.05 -33.19 30.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.449 1.278 . . . . 1.0 114.449 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.19 -2.95 4.47 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.363 1.616 . . . . 1.0 115.363 -171.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.38 129.23 6.56 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.433 1.492 . . . . 1.0 112.477 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.92 -35.59 76.86 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.78 2.32 . . . . 1.0 113.564 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.7 -39.75 80.34 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.843 0.747 . . . . 1.0 112.18 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.21 -49.57 71.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.228 0.611 . . . . 1.0 110.816 174.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 85.5 t -63.96 -40.63 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.317 0.647 . . . . 1.0 112.146 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -66.1 -25.38 66.98 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.494 -1.379 . . . . 1.0 112.178 173.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.0 m -74.72 -21.25 59.47 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 1.0 112.948 169.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.9 m0 -73.41 -16.5 61.33 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.38 0.991 . . . . 1.0 113.118 169.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -63.22 144.39 56.97 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.6 p -139.02 121.14 15.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.482 1.913 . . . . 1.0 110.923 171.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.67 115.13 12.72 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.542 1.137 . . . . 1.0 110.642 176.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.5 mt -76.23 161.08 29.08 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.32 0.648 . . . . 1.0 111.895 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -178.65 178.32 48.67 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 124.444 1.021 . . . . 1.0 113.479 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 C--O 1.256 1.422 0 C-N-CA 125.674 1.589 . . . . 1.0 111.537 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 112.646 0.61 . . . . 1.0 112.646 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 57.97 21.55 7.85 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 118.094 2.628 . . . . 1.0 118.094 169.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -70.61 155.07 41.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.819 0.847 . . . . 1.0 111.396 169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.4 t -67.9 134.19 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.544 1.138 . . . . 1.0 111.5 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -99.64 115.6 29.81 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 124.702 1.201 . . . . 1.0 108.04 168.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -84.91 145.78 27.61 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.127 1.371 . . . . 1.0 107.471 168.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -136.69 153.59 50.85 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.617 1.167 . . . . 1.0 109.583 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -133.61 144.68 49.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.397 1.479 . . . . 1.0 109.837 174.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.73 91.8 47.54 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 124.245 1.018 . . . . 1.0 111.817 -177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.06 -25.65 4.35 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.797 3.665 . . . . 1.0 117.079 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -65.49 -27.3 68.39 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 113.786 1.032 . . . . 1.0 113.786 178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -129.85 -17.85 3.51 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.956 1.303 . . . . 1.0 113.895 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.87 0.5 85.73 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 125.031 1.3 . . . . 1.0 113.906 -173.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -63.64 154.39 33.03 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 114.99 1.478 . . . . 1.0 114.99 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 39.5 t -137.81 140.78 40.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 126.827 2.051 . . . . 1.0 109.478 172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.1 pt -142.49 165.14 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.979 1.712 . . . . 1.0 110.968 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -139.85 138.87 36.1 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.61 1.964 . . . . 1.0 111.068 176.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.7 t -151.67 157.48 42.16 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.29 1.436 . . . . 1.0 110.733 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.8 mtmt -83.82 -3.79 58.15 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.737 1.014 . . . . 1.0 113.737 171.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.81 3.07 20.39 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.063 1.316 . . . . 1.0 114.878 177.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 179.34 41.95 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.371 1.086 . . . . 1.0 113.961 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -66.5 83.66 0.1 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.015 1.326 . . . . 1.0 112.302 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -103.99 94.1 5.22 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.516 1.527 . . . . 1.0 109.474 -177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -44.33 -41.96 6.41 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.478 1.911 . . . . 1.0 115.422 -169.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.1 m -59.28 -39.22 82.24 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.801 0.841 . . . . 1.0 112.958 176.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.7 tp -70.97 -43.0 69.0 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.664 -0.648 . . . . 1.0 109.899 175.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.61 -42.99 79.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 1.0 112.125 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -57.66 -46.79 83.78 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 122.712 0.405 . . . . 1.0 111.827 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.5 m0 -62.13 -41.96 98.76 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.697 -0.627 . . . . 1.0 112.101 177.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -62.79 -39.99 95.96 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.303 1.041 . . . . 1.0 110.615 177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.48 -39.43 77.69 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.63 0.772 . . . . 1.0 112.71 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -80.3 -32.41 38.08 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.874 1.27 . . . . 1.0 114.245 -175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.27 -4.29 4.37 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 115.15 1.537 . . . . 1.0 115.15 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.0 131.41 7.35 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.567 1.555 . . . . 1.0 111.959 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.97 -34.69 80.37 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.664 2.243 . . . . 1.0 113.42 -177.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.72 -39.83 84.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.301 0.64 . . . . 1.0 112.061 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.43 -47.15 77.22 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.08 0.552 . . . . 1.0 111.094 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.5 t -64.0 -40.02 87.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.775 -0.578 . . . . 1.0 111.919 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -66.21 -27.6 68.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.273 -1.517 . . . . 1.0 112.43 172.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 13.2 t -67.58 -27.37 66.87 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.214 -0.929 . . . . 1.0 112.279 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -72.3 -15.17 61.9 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 121.046 -1.034 . . . . 1.0 113.141 170.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -67.14 145.79 54.92 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.396 0.888 . . . . 1.0 113.396 -175.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.18 117.62 12.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.421 1.888 . . . . 1.0 110.545 171.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.94 116.33 12.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.681 1.192 . . . . 1.0 110.406 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.69 173.68 12.21 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.9 0.88 . . . . 1.0 111.644 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.59 6.63 52.46 Favored Glycine 0 CA--C 1.54 1.649 0 N-CA-C 115.689 1.036 . . . . 1.0 115.689 -179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.255 1.35 0 C-N-CA 126.394 1.878 . . . . 1.0 111.616 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.428 0.633 . . . . 1.0 112.607 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 94.9 mtt-85 -135.76 34.36 2.91 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 126.843 2.057 . . . . 1.0 110.026 170.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -138.27 157.79 45.57 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.17 2.188 . . . . 1.0 112.696 -169.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 73.0 t -81.0 141.4 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.382 1.473 . . . . 1.0 110.245 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.36 120.38 42.24 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.235 1.414 . . . . 1.0 108.872 169.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.36 149.49 24.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.68 -1.23 . . . . 1.0 107.68 168.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -136.62 150.15 48.38 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.113 1.365 . . . . 1.0 108.728 175.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -132.24 144.45 50.63 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.204 1.401 . . . . 1.0 109.698 176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -120.8 91.4 47.4 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 124.292 1.037 . . . . 1.0 111.702 -176.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -47.15 -25.6 4.5 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.955 3.77 . . . . 1.0 116.987 177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -66.47 -26.56 67.25 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.734 1.013 . . . . 1.0 113.734 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.1 p -130.02 -18.26 3.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.082 1.353 . . . . 1.0 113.735 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.28 -0.85 83.97 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.9 1.238 . . . . 1.0 113.909 -173.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -62.05 153.76 28.77 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 115.31 1.596 . . . . 1.0 115.31 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.6 t -136.46 140.87 42.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 C-N-CA 126.839 2.056 . . . . 1.0 109.455 171.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.7 pt -140.28 164.35 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 126.02 1.728 . . . . 1.0 110.527 174.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -139.5 138.8 36.67 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.104 1.762 . . . . 1.0 111.096 177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -150.87 158.69 44.45 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.454 1.502 . . . . 1.0 111.178 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -88.74 -3.13 58.85 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.691 1.196 . . . . 1.0 113.349 173.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.01 1.39 19.15 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 124.844 1.211 . . . . 1.0 114.993 177.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.83 179.11 41.87 Favored Glycine 0 CA--C 1.536 1.4 0 CA-C-N 118.484 1.142 . . . . 1.0 113.875 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -67.75 83.78 0.19 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.398 1.079 . . . . 1.0 112.378 177.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -98.71 93.97 6.38 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.698 1.599 . . . . 1.0 109.557 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? -44.4 -41.35 6.11 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 127.117 2.167 . . . . 1.0 115.052 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -60.43 -38.14 83.16 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.309 1.044 . . . . 1.0 113.278 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.3 tp -69.56 -43.78 72.2 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.399 -0.813 . . . . 1.0 109.812 174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -55.78 -43.51 76.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.537 0.735 . . . . 1.0 112.386 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.25 -46.94 82.55 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.354 -0.385 . . . . 1.0 111.985 171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -62.05 -41.14 97.82 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.679 -0.638 . . . . 1.0 112.364 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 mtpt -61.94 -41.09 97.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.242 1.017 . . . . 1.0 110.733 176.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.03 -37.92 78.88 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.932 0.893 . . . . 1.0 112.761 176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -81.78 -32.62 31.29 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.535 1.309 . . . . 1.0 114.535 -175.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.6 m-90 -130.66 -3.41 4.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.282 1.586 . . . . 1.0 115.282 -171.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.08 129.37 6.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 125.283 1.42 . . . . 1.0 112.319 174.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.82 -35.24 79.86 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.831 2.354 . . . . 1.0 113.364 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.32 -40.09 81.77 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.934 0.788 . . . . 1.0 111.987 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.48 72.51 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.357 0.663 . . . . 1.0 110.938 174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.3 t -63.37 -41.37 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.247 0.619 . . . . 1.0 112.217 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -66.23 -25.08 66.74 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.434 -1.416 . . . . 1.0 112.073 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.8 m -74.38 -21.64 59.57 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 113.094 0.776 . . . . 1.0 113.094 169.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -73.0 -15.79 61.52 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.349 0.977 . . . . 1.0 113.112 170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.04 145.24 56.59 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 113.862 1.06 . . . . 1.0 113.862 -175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.43 118.71 12.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.378 1.871 . . . . 1.0 111.086 170.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.1 mt -64.84 131.71 47.48 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.195 0.998 . . . . 1.0 110.641 172.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 31.5 mt -97.02 166.36 11.63 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.675 0.79 . . . . 1.0 111.758 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.56 178.62 48.37 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.507 1.051 . . . . 1.0 113.551 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.268 0 C-N-CA 125.771 1.628 . . . . 1.0 111.525 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 120.526 0.203 . . . . 1.0 111.435 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.3 mtm180 -76.93 -3.11 37.09 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 115.624 1.713 . . . . 1.0 115.624 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -51.17 151.11 2.9 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.933 1.693 . . . . 1.0 113.129 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.8 t -69.74 137.09 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.682 1.593 . . . . 1.0 111.45 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -102.47 116.86 33.47 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.867 1.267 . . . . 1.0 108.257 168.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -84.46 146.32 27.68 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.106 1.363 . . . . 1.0 107.427 169.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -135.18 150.0 50.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.734 1.214 . . . . 1.0 109.257 175.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -132.79 138.02 46.99 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.205 1.402 . . . . 1.0 109.834 176.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 -112.45 91.31 16.4 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.242 1.017 . . . . 1.0 110.68 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.43 -14.47 39.29 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.843 2.362 . . . . 1.0 114.675 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -69.22 -23.76 63.93 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.494 1.118 . . . . 1.0 113.644 173.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.7 p -127.01 -22.2 3.84 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.993 1.317 . . . . 1.0 113.51 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.36 -4.83 74.09 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 125.664 1.602 . . . . 1.0 113.808 -175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -66.2 153.31 42.8 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 115.132 1.53 . . . . 1.0 115.132 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 37.0 t -135.8 140.39 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.851 2.06 . . . . 1.0 109.173 171.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 36.8 pt -139.53 165.79 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.639 1.576 . . . . 1.0 110.599 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -140.74 136.96 33.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 126.256 1.823 . . . . 1.0 110.737 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.49 157.2 41.99 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.94 1.296 . . . . 1.0 111.227 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -85.05 -4.37 59.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.21 1.004 . . . . 1.0 113.475 171.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.72 1.97 14.81 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.317 1.436 . . . . 1.0 114.995 178.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.46 178.84 41.18 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 118.392 1.096 . . . . 1.0 114.159 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -67.88 83.9 0.21 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.869 1.268 . . . . 1.0 112.027 178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -103.82 94.04 5.21 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.821 1.648 . . . . 1.0 109.843 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -43.5 -40.99 4.17 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 126.386 1.875 . . . . 1.0 115.588 -169.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.2 m -59.13 -37.11 76.44 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.976 0.91 . . . . 1.0 113.028 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 47.5 tp -70.87 -45.29 64.68 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.447 0.699 . . . . 1.0 109.784 175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -56.67 -43.51 80.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.789 0.836 . . . . 1.0 112.1 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -57.01 -44.1 82.45 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 173.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 45.6 m0 -66.43 -41.2 89.53 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 122.046 -0.409 . . . . 1.0 112.0 177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -61.02 -40.16 92.5 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 118.857 0.753 . . . . 1.0 110.536 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.02 77.17 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.002 0.921 . . . . 1.0 113.033 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -98.48 -16.76 19.07 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 116.007 1.854 . . . . 1.0 116.007 -171.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 18.0 m-90 -132.75 -6.48 3.19 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 115.029 1.492 . . . . 1.0 115.029 176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 104.39 132.77 7.58 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.322 1.439 . . . . 1.0 112.464 174.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.79 -36.28 63.09 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.709 2.273 . . . . 1.0 113.542 -175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.5 -39.51 81.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.765 0.712 . . . . 1.0 112.021 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.33 73.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.397 0.679 . . . . 1.0 110.762 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.92 -40.9 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 123.339 0.656 . . . . 1.0 112.073 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -66.13 -24.45 66.68 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.492 -1.38 . . . . 1.0 112.217 173.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 20.9 m -75.55 -21.88 57.53 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.859 0.689 . . . . 1.0 112.859 169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -72.94 -17.49 61.48 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.572 1.078 . . . . 1.0 112.892 169.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -62.34 145.23 54.41 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 p -139.05 119.64 14.03 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.286 1.834 . . . . 1.0 110.96 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 59.0 mt -70.84 119.5 15.07 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.361 1.064 . . . . 1.0 110.434 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.2 mt -79.36 172.86 13.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.335 0.654 . . . . 1.0 111.552 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.73 3.57 59.79 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.31 0.957 . . . . 1.0 115.454 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 . . . . . 0 C--O 1.251 1.163 0 C-N-CA 126.771 2.029 . . . . 1.0 111.599 -175.651 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 111.458 0.17 . . . . 1.0 111.458 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -75.47 33.68 0.11 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 126.306 1.843 . . . . 1.0 114.639 -176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.68 152.68 34.74 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.545 1.538 . . . . 1.0 111.952 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.7 t -81.29 136.22 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.129 0.972 . . . . 1.0 110.138 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -111.91 121.92 46.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.653 1.581 . . . . 1.0 108.938 169.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -86.63 149.15 25.12 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.665 -1.235 . . . . 1.0 107.665 168.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -136.19 149.11 48.44 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 125.138 1.375 . . . . 1.0 108.699 174.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.98 143.72 50.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.225 1.41 . . . . 1.0 109.776 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -120.52 91.62 46.97 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.015 0.926 . . . . 1.0 111.821 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -47.27 -25.6 4.81 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.778 3.652 . . . . 1.0 116.714 176.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -65.95 -27.12 67.93 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.865 1.061 . . . . 1.0 113.865 178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 60.1 p -130.15 -16.49 3.58 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.01 1.324 . . . . 1.0 113.976 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.98 -0.2 87.57 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.002 1.287 . . . . 1.0 113.922 -173.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -63.01 154.84 29.34 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 115.266 1.58 . . . . 1.0 115.266 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.9 t -136.49 141.42 41.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.88 2.072 . . . . 1.0 109.494 170.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 33.9 pt -140.24 163.29 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 125.798 1.639 . . . . 1.0 110.457 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -140.21 137.63 34.46 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.133 1.773 . . . . 1.0 111.417 177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.39 159.88 44.03 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.602 1.561 . . . . 1.0 111.02 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.34 -0.72 57.19 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.484 1.114 . . . . 1.0 113.611 170.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.32 5.2 23.19 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.836 1.208 . . . . 1.0 114.873 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.39 179.26 40.23 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 118.419 1.109 . . . . 1.0 113.864 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.26 83.86 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.016 1.327 . . . . 1.0 112.029 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -104.75 93.97 5.03 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.57 1.548 . . . . 1.0 109.737 -177.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -45.38 -41.3 8.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 126.071 1.749 . . . . 1.0 115.365 -169.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 23.9 m -58.73 -38.84 79.24 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.848 0.859 . . . . 1.0 112.893 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.3 tp -69.94 -44.17 70.12 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.436 -0.79 . . . . 1.0 109.799 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -56.85 -43.36 81.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.691 0.796 . . . . 1.0 112.378 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -57.5 -46.06 84.19 Favored 'General case' 0 C--O 1.225 -0.215 0 C-N-CA 122.72 0.408 . . . . 1.0 112.018 172.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -42.01 98.67 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.724 -0.61 . . . . 1.0 112.039 177.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.67 -41.28 97.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.938 0.895 . . . . 1.0 110.786 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.09 -38.1 78.8 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.598 0.759 . . . . 1.0 112.898 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -81.61 -33.2 31.63 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.378 1.251 . . . . 1.0 114.378 -175.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -130.64 -2.86 4.22 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.347 1.61 . . . . 1.0 115.347 -171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.56 128.77 6.42 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.378 1.465 . . . . 1.0 112.256 173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.75 -35.1 81.37 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.745 2.297 . . . . 1.0 113.279 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -68.61 -39.9 80.64 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.877 0.762 . . . . 1.0 112.242 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.62 -48.84 73.37 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.403 0.681 . . . . 1.0 110.757 174.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -41.21 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.057 0.543 . . . . 1.0 112.25 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -66.05 -25.03 66.85 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.424 -1.423 . . . . 1.0 112.29 173.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.9 m -74.1 -21.99 59.67 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.461 -0.774 . . . . 1.0 112.732 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -72.85 -16.48 61.59 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 119.477 1.035 . . . . 1.0 112.939 170.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.81 144.74 57.05 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.032 1.123 . . . . 1.0 114.032 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.02 117.94 12.43 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.218 1.807 . . . . 1.0 111.352 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.99 136.99 57.79 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.274 1.029 . . . . 1.0 110.723 172.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 29.1 mt -103.83 44.98 0.98 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.096 0.958 . . . . 1.0 112.603 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.93 177.16 47.92 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.524 1.059 . . . . 1.0 114.146 178.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 70.5 t60 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.812 1.645 . . . . 1.0 111.104 -178.433 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.626 0.25 . . . . 1.0 111.625 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -76.92 62.87 2.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.816 1.646 . . . . 1.0 112.967 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -134.25 154.05 51.51 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 126.616 1.967 . . . . 1.0 112.134 -172.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.83 138.92 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.863 1.265 . . . . 1.0 110.621 176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -105.63 119.14 38.37 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.913 1.285 . . . . 1.0 108.365 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -86.89 148.09 25.51 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 107.463 -1.31 . . . . 1.0 107.463 168.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -138.25 151.19 47.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.872 1.269 . . . . 1.0 109.36 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -131.14 145.48 51.99 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.699 1.6 . . . . 1.0 109.072 173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -117.57 94.11 44.94 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.738 0.815 . . . . 1.0 111.538 -177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.81 -26.85 10.31 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.348 3.365 . . . . 1.0 116.501 175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -78.03 -17.81 56.61 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.818 1.044 . . . . 1.0 113.818 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 44.5 p -130.62 -20.82 2.86 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.133 1.16 . . . . 1.0 114.133 -176.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.98 -6.2 82.86 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.996 1.76 . . . . 1.0 114.357 -176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -68.88 156.27 38.77 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 115.183 1.549 . . . . 1.0 115.183 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t -133.72 140.11 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 127.271 2.229 . . . . 1.0 109.312 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.8 pt -141.83 163.67 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.919 1.688 . . . . 1.0 110.954 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -139.45 138.7 36.66 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 126.218 1.807 . . . . 1.0 111.335 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.17 158.56 44.12 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.197 1.399 . . . . 1.0 110.927 177.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.417 1.087 . . . . 1.0 113.52 172.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.63 2.49 20.98 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 125.179 1.371 . . . . 1.0 114.85 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.98 179.39 38.72 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 118.379 1.089 . . . . 1.0 113.809 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -67.44 83.95 0.16 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.71 1.204 . . . . 1.0 112.047 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -102.72 93.92 5.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.422 1.489 . . . . 1.0 109.603 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -44.74 -40.73 6.26 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 126.316 1.846 . . . . 1.0 115.509 -169.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.0 m -58.8 -38.97 79.75 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.843 0.857 . . . . 1.0 113.096 176.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.1 tp -71.29 -43.69 66.64 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.536 -0.727 . . . . 1.0 109.646 175.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -56.16 -42.99 77.91 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.329 0.651 . . . . 1.0 112.294 176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -57.74 -47.11 83.37 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.7 0.4 . . . . 1.0 111.477 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -62.62 -41.48 99.03 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.575 -0.703 . . . . 1.0 112.327 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -63.1 -39.88 95.99 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.954 0.902 . . . . 1.0 110.591 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.89 -39.18 79.89 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.703 0.801 . . . . 1.0 112.793 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -81.35 -32.73 32.81 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -174.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -128.75 -5.48 5.16 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 115.125 1.528 . . . . 1.0 115.125 -172.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.38 131.91 7.51 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 125.28 1.419 . . . . 1.0 111.909 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.63 -35.29 81.58 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.78 2.32 . . . . 1.0 113.073 -177.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -67.77 -40.15 84.04 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.307 0.643 . . . . 1.0 111.761 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.04 -48.26 76.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.347 0.659 . . . . 1.0 111.288 173.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.44 -40.01 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 121.744 -0.597 . . . . 1.0 112.317 178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -66.9 -27.98 67.94 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.472 -1.393 . . . . 1.0 112.337 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.8 t -67.5 -26.83 66.55 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 121.418 -0.801 . . . . 1.0 112.429 169.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -72.77 -14.9 61.63 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.281 -0.887 . . . . 1.0 113.028 170.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.3 51.85 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.748 1.018 . . . . 1.0 113.748 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.1 p -139.48 119.39 13.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.412 1.885 . . . . 1.0 110.905 170.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.8 mt -70.11 122.17 18.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.625 1.17 . . . . 1.0 110.584 175.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.2 mt -85.99 163.94 17.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.62 0.768 . . . . 1.0 111.672 177.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.18 179.49 48.0 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 124.397 0.999 . . . . 1.0 113.439 177.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.253 1.267 0 C-N-CA 125.981 1.712 . . . . 1.0 111.198 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 120.489 0.185 . . . . 1.0 111.361 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.6 mtm180 -78.6 -0.29 29.2 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 115.39 1.626 . . . . 1.0 115.39 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -52.52 150.3 5.08 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.97 1.708 . . . . 1.0 113.24 174.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.5 t -74.87 134.03 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.295 1.038 . . . . 1.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -105.29 119.16 38.39 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.196 1.399 . . . . 1.0 107.951 168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -86.54 145.83 26.61 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.042 1.337 . . . . 1.0 107.401 168.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -136.09 151.33 49.71 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.572 1.149 . . . . 1.0 109.518 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -130.57 145.59 51.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.575 1.55 . . . . 1.0 109.31 173.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -117.56 93.69 43.96 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 123.91 0.884 . . . . 1.0 111.894 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.44 -26.79 9.19 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 124.294 3.33 . . . . 1.0 116.662 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -78.51 -16.92 56.96 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.985 1.106 . . . . 1.0 113.985 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -131.37 -21.14 2.6 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.542 1.312 . . . . 1.0 114.542 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.13 -5.66 82.94 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 125.654 1.597 . . . . 1.0 114.201 -176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.83 155.75 39.65 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 115.126 1.528 . . . . 1.0 115.126 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.0 140.31 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 127.1 2.16 . . . . 1.0 109.117 170.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 38.0 pt -141.67 164.52 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.977 1.711 . . . . 1.0 110.837 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -139.42 138.7 36.73 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.519 1.928 . . . . 1.0 110.891 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.28 156.63 41.22 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.586 1.555 . . . . 1.0 111.186 176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -85.25 -3.03 58.68 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.502 1.121 . . . . 1.0 113.657 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 115.82 2.17 20.79 Favored Glycine 0 CA--C 1.538 1.483 0 C-N-CA 124.858 1.218 . . . . 1.0 114.98 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.9 179.02 39.11 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 118.503 1.152 . . . . 1.0 113.729 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -68.4 83.71 0.26 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.405 1.082 . . . . 1.0 112.125 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -98.89 94.06 6.37 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.639 1.576 . . . . 1.0 109.291 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.04 -43.09 6.56 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 126.254 1.822 . . . . 1.0 114.73 -169.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.5 m -57.73 -39.3 76.99 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.116 0.966 . . . . 1.0 112.88 177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.7 tp -69.51 -43.41 73.12 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.385 0.674 . . . . 1.0 109.716 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -55.98 -44.51 78.62 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.44 0.696 . . . . 1.0 112.18 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -58.07 -45.48 87.04 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 172.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -61.99 -41.82 98.47 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.507 -0.746 . . . . 1.0 112.232 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -62.89 -39.79 95.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.382 1.073 . . . . 1.0 110.661 177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.82 -38.84 76.71 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.623 0.769 . . . . 1.0 112.795 176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -80.86 -33.01 34.75 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.296 1.221 . . . . 1.0 114.296 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -128.64 -5.72 5.21 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -172.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 102.69 132.14 7.57 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.69 1.614 . . . . 1.0 111.88 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -62.12 -34.61 79.02 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 122.706 2.271 . . . . 1.0 113.321 -177.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.0 -39.78 83.14 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 123.477 0.711 . . . . 1.0 112.019 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.59 -47.95 76.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.286 0.634 . . . . 1.0 111.032 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 112.363 0.505 . . . . 1.0 112.363 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -66.37 -28.41 68.62 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.461 -1.399 . . . . 1.0 112.07 172.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.9 m -68.23 -22.86 64.76 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.538 -0.726 . . . . 1.0 112.752 169.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 29.2 m0 -76.51 -14.27 60.04 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.9 0.88 . . . . 1.0 113.068 169.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -68.35 147.55 51.97 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.5 p -139.42 117.27 11.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.445 1.898 . . . . 1.0 110.522 171.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 47.2 mt -71.64 122.61 20.86 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.655 1.182 . . . . 1.0 110.322 175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.58 47.94 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.155 0.982 . . . . 1.0 112.36 -177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.37 -4.35 80.73 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.257 1.408 . . . . 1.0 115.323 -174.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.242 1.817 . . . . 1.0 111.156 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 111.552 0.205 . . . . 1.0 111.552 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -76.28 36.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.343 1.857 . . . . 1.0 114.48 -177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -63.29 153.85 33.51 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.713 1.605 . . . . 1.0 112.119 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.48 139.13 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.714 1.206 . . . . 1.0 110.796 177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -110.71 120.66 43.15 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.488 1.515 . . . . 1.0 108.438 168.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -86.3 148.83 25.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 168.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -136.75 148.28 47.18 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.938 1.295 . . . . 1.0 108.924 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -129.78 139.43 51.27 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.971 1.309 . . . . 1.0 109.723 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -115.07 90.66 24.22 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 124.571 1.148 . . . . 1.0 110.856 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.85 -12.74 26.97 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.185 2.59 . . . . 1.0 115.275 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -65.26 -27.52 68.7 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.637 0.977 . . . . 1.0 113.637 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 61.3 p -128.07 -19.28 4.0 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.991 1.316 . . . . 1.0 113.734 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.42 -1.32 79.14 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.11 1.338 . . . . 1.0 113.808 -173.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -63.09 153.81 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.38 1.622 . . . . 1.0 115.38 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 38.7 t -136.19 141.4 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 126.682 1.993 . . . . 1.0 109.45 171.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 34.6 pt -140.05 163.46 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.902 1.681 . . . . 1.0 110.413 174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -139.97 137.94 35.13 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.222 1.809 . . . . 1.0 111.276 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -151.38 159.07 44.44 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.219 1.408 . . . . 1.0 110.767 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -86.38 -3.07 58.93 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.277 1.031 . . . . 1.0 113.398 171.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.3 2.55 17.85 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.178 1.37 . . . . 1.0 115.071 177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.0 179.13 42.37 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 118.379 1.09 . . . . 1.0 113.777 177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -67.19 83.73 0.14 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.781 1.232 . . . . 1.0 112.38 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -103.54 93.98 5.23 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.54 1.536 . . . . 1.0 109.777 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -44.08 -41.13 5.34 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.305 1.842 . . . . 1.0 115.61 -169.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 3.4 m -58.66 -38.04 77.32 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.896 0.878 . . . . 1.0 112.986 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.0 tp -70.56 -45.14 65.99 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.475 0.71 . . . . 1.0 109.614 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -56.37 -42.85 78.54 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.59 0.756 . . . . 1.0 112.441 176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -57.45 -46.87 83.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.85 0.46 . . . . 1.0 111.58 172.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -62.68 -41.65 99.2 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 121.53 -0.731 . . . . 1.0 112.144 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -62.0 -40.57 96.11 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.791 0.836 . . . . 1.0 110.72 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.28 81.75 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.799 0.84 . . . . 1.0 112.883 176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -82.01 -32.12 30.69 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -174.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -130.02 -4.19 4.51 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.297 1.591 . . . . 1.0 115.297 -173.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.99 130.17 6.8 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.095 1.331 . . . . 1.0 112.326 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.14 -35.92 72.56 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.846 2.364 . . . . 1.0 113.359 -176.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -68.15 -39.8 82.55 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 118.638 0.654 . . . . 1.0 112.052 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.01 -49.58 71.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.527 0.731 . . . . 1.0 111.067 174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.59 -40.28 88.46 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 123.178 0.591 . . . . 1.0 112.066 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -66.33 -25.07 66.65 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 120.376 -1.453 . . . . 1.0 112.413 173.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 t -73.12 -25.55 60.9 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.497 -0.752 . . . . 1.0 112.613 169.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -69.56 -17.31 63.55 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.781 -1.199 . . . . 1.0 113.084 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -64.48 145.53 55.96 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -139.46 118.51 12.6 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.358 1.863 . . . . 1.0 111.179 170.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 70.4 mt -63.74 131.34 47.59 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.031 0.932 . . . . 1.0 110.676 171.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 28.4 mt -99.79 166.83 10.9 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.999 0.92 . . . . 1.0 111.404 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.09 179.21 47.31 Favored Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.31 0.957 . . . . 1.0 113.581 177.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.254 1.333 0 C-N-CA 125.566 1.547 . . . . 1.0 111.426 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 111.788 0.292 . . . . 1.0 111.788 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 54.92 29.75 12.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 126.787 2.035 . . . . 1.0 116.415 169.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -66.69 158.41 30.19 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.06 0.944 . . . . 1.0 111.715 170.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.7 t -66.03 137.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.832 1.253 . . . . 1.0 111.858 -176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -105.33 118.4 36.45 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 125.543 1.537 . . . . 1.0 108.005 168.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -85.33 148.24 26.13 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.626 -1.25 . . . . 1.0 107.626 168.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -135.84 150.03 49.27 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.95 1.3 . . . . 1.0 109.129 175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -131.43 144.41 51.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.473 1.509 . . . . 1.0 109.387 174.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.38 93.02 41.94 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 124.121 0.969 . . . . 1.0 111.8 -175.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -48.52 -26.46 8.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.41 3.407 . . . . 1.0 116.62 175.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -77.84 -17.97 56.8 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.909 1.078 . . . . 1.0 113.909 -179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 42.2 p -131.57 -20.1 2.64 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.514 1.301 . . . . 1.0 114.514 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.65 -5.35 83.72 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.897 1.713 . . . . 1.0 114.15 -175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -68.23 156.51 37.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.299 1.592 . . . . 1.0 115.299 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.28 140.22 46.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.175 2.19 . . . . 1.0 109.23 169.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 37.4 pt -140.53 164.95 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.874 1.669 . . . . 1.0 110.707 176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -140.48 137.67 34.04 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.151 1.781 . . . . 1.0 111.107 177.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -151.25 158.23 43.6 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.421 1.489 . . . . 1.0 111.107 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -85.33 -4.63 59.22 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.117 -0.989 . . . . 1.0 113.301 171.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.02 3.36 15.57 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.107 1.337 . . . . 1.0 114.976 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.18 179.13 39.83 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-N 118.586 1.193 . . . . 1.0 113.947 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.48 83.78 0.17 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.714 1.206 . . . . 1.0 112.111 177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -103.13 93.96 5.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.672 1.589 . . . . 1.0 109.88 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -41.04 -44.28 2.38 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 126.993 2.117 . . . . 1.0 115.429 -169.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 22.4 m -59.25 -39.27 82.27 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.085 0.954 . . . . 1.0 113.247 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 tp -69.26 -44.22 72.37 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 121.562 -0.711 . . . . 1.0 109.777 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 tttm -57.29 -42.4 81.63 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.325 0.65 . . . . 1.0 112.374 177.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -57.87 -46.07 85.4 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 122.683 0.393 . . . . 1.0 112.002 171.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -61.92 -41.94 98.51 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.538 -0.727 . . . . 1.0 112.072 177.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -61.5 -40.97 96.51 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.148 0.979 . . . . 1.0 110.91 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -69.08 -38.38 78.99 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.405 0.682 . . . . 1.0 112.761 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -82.51 -33.04 28.44 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 114.491 1.293 . . . . 1.0 114.491 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -130.09 -3.08 4.52 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.181 1.548 . . . . 1.0 115.181 -171.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.72 129.62 6.66 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.376 1.465 . . . . 1.0 112.274 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.93 -35.81 75.56 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.647 2.231 . . . . 1.0 113.45 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -68.52 -39.89 81.01 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.518 0.599 . . . . 1.0 112.009 178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.31 -49.43 71.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.353 0.661 . . . . 1.0 110.875 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.91 -39.98 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.12 0.568 . . . . 1.0 112.035 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 -66.68 -26.29 66.96 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 120.362 -1.461 . . . . 1.0 112.435 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 15.6 t -71.13 -26.14 62.88 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.646 -0.659 . . . . 1.0 112.605 169.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -69.47 -16.92 63.56 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.114 -0.991 . . . . 1.0 112.893 171.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -65.25 144.2 57.31 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.37 120.1 14.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.187 1.795 . . . . 1.0 111.374 171.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 55.3 mt -70.86 122.94 20.85 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.47 1.108 . . . . 1.0 110.566 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 34.7 mt -80.17 52.16 1.51 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.507 1.123 . . . . 1.0 111.542 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.03 43.5 0.44 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 126.027 1.775 . . . . 1.0 112.886 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 125.55 1.54 . . . . 1.0 112.934 -176.227 . . . . . . . . 0 0 . 1 stop_ save_